QUARTERLY REPORT

Q1 2020 — Form 10-Q

Q1 2020PDF · 356 pages2.0 MB
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
È 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
or
‘ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number: 001-14965
The Goldman Sachs Group, Inc.(Exact name of registrant as specified in its charter)
Delaware 	13-4019460
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
200 West Street, New York, N.Y. 	10282
(Address of principal executive offices) 	(Zip Code)
(212) 902-1000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
symbol
Exchange
on which
registered
Common stock, par value $.01 per share 	GS 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series A 	GS PrA 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series C 	GS PrC 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of Floating Rate Non-Cumulative Preferred Stock, Series D 	GS PrD 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of 5.50% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J 	GS PrJ 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of 6.375% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K GS PrK 	NYSE
Depositary Shares, Each Representing 1/1,000th Interest in a Share of 6.30% Non-Cumulative Preferred Stock, Series N 	GS PrN 	NYSE
5.793% Fixed-to-Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital II 	GS/43PE 	NYSE
Floating Rate Normal Automatic Preferred Enhanced Capital Securities of Goldman Sachs Capital III 	GS/43PF 	NYSE
Medium-Term Notes, Series A, Index-Linked Notes due 2037 of GS Finance Corp. 	GCE NYSE Arca
Medium-Term Notes, Series B, Index-Linked Notes due 2037 	GSC NYSE Arca
Medium-Term Notes, Series E, Index-Linked Notes due 2028 of GS Finance Corp. 	FRLG NYSE Arca
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. È Yes ‘ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). È Yes ‘ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth
company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer È 	Accelerated filer ‘ 	Non-accelerated filer ‘ 	Smaller reporting company ‘ 	Emerging growth company ‘
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‘
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ‘ Yes È No
As of April 17, 2020, there were 343,886,589 shares of the registrant’s common stock outstanding.

-- 1 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Q U A R T E R L Y R E P O R T O N F O R M 1 0 - Q F O R T H E Q U A R T E R E N D E D M A R C H 3 1 , 2 0 2 0
INDEX
Form 10-Q Item Number 	Page No.
PART I
FINANCIAL INFORMATION 	1
Item 1
Financial Statements (Unaudited) 	1
Consolidated Statements of Earnings 	1
Consolidated Statements of Comprehensive Income 	1
Consolidated Balance Sheets 	2
Consolidated Statements of Changes in Shareholders’ Equity 	3
Consolidated Statements of Cash Flows 	4
Notes to Consolidated Financial Statements 	5
Note 1. Description of Business 	5
Note 2. Basis of Presentation 	5
Note 3. Significant Accounting Policies 	6
Note 4. Fair Value Measurements 	11
Note 5. Trading Assets and Liabilities 	16
Note 6. Trading Cash Instruments 	17
Note 7. Derivatives and Hedging Activities 	20
Note 8. Investments 	29
Note 9. Loans 	34
Note 10. Fair Value Option 	43
Note 11. Collateralized Agreements and Financings 	47
Note 12. Other Assets 	51
Note 13. Deposits 	54
Note 14. Unsecured Borrowings 	55
Note 15. Other Liabilities 	58
Note 16. Securitization Activities 	59
Note 17. Variable Interest Entities 	61
Note 18. Commitments, Contingencies and Guarantees 	64
Note 19. Shareholders’ Equity 	68
Note 20. Regulation and Capital Adequacy 	70
Note 21. Earnings Per Common Share 	78
Note 22. Transactions with Affiliated Funds 	78
Note 23. Interest Income and Interest Expense 	79
Note 24. Income Taxes 	79
Note 25. Business Segments 	80
Note 26. Credit Concentrations 	82
Note 27. Legal Proceedings 	83
Page No.
Report of Independent Registered Public Accounting Firm 	93
Statistical Disclosures 	94
Item 2
Management’s Discussion and Analysis of Financial Condition
and Results of Operations 	96
Introduction 	96
Executive Overview 	96
Business Environment 	98
Critical Accounting Policies 	98
Use of Estimates 	100
Recent Accounting Developments 	101
Results of Operations 	101
Balance Sheet and Funding Sources 	114
Equity Capital Management and Regulatory Capital 	117
Regulatory and Other Matters 	122
Off-Balance Sheet Arrangements and Contractual Obligations 124
Risk Management 	126
Overview and Structure of Risk Management 	126
Liquidity Risk Management 	131
Market Risk Management 	137
Credit Risk Management 	142
Operational Risk Management 	149
Model Risk Management 	150
Available Information 	151
Cautionary Statement Pursuant to the U.S. Private Securities
Litigation Reform Act of 1995 	152
Item 3
Quantitative and Qualitative Disclosures About Market Risk 154
Item 4
Controls and Procedures 	154
PART II
OTHER INFORMATION 	154
Item 1
Legal Proceedings 	154
Item 1A
Risk Factors 	154
Item 2
Unregistered Sales of Equity Securities and Use of Proceeds 	155
Item 6
Exhibits 	155
SIGNATURES 	155
Goldman Sachs March 2020 Form 10-Q

-- 2 of 356 --

PART I. FINANCIAL INFORMATION
Item 1. 	Financial Statements (Unaudited)
T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Consolidated Statements of Earnings
(Unaudited)
Three Months
Ended March
in millions, except per share amounts 	2020 	2019
Revenues
Investment banking 	$1,742 	$ 1,618
Investment management 	1,768 	1,436
Commissions and fees 	1,020 	745
Market making 	3,682 	2,723
Other principal transactions 	(782) 	1,067
Total non-interest revenues 	7,430 	7,589
Interest income 	4,750 	5,597
Interest expense 	3,437 	4,379
Net interest income 	1,313 	1,218
Total net revenues 	8,743 	8,807
Provision for credit losses 	937 	224
Operating expenses
Compensation and benefits 	3,235 	3,259
Brokerage, clearing, exchange and distribution fees 	975 	762
Market development 	153 	184
Communications and technology 	321 	286
Depreciation and amortization 	437 	368
Occupancy 	238 	225
Professional fees 	347 	298
Other expenses 	752 	482
Total operating expenses 	6,458 	5,864
Pre-tax earnings 	1,348 	2,719
Provision for taxes 	135 	468
Net earnings 	1,213 	2,251
Preferred stock dividends 	90 	69
Net earnings applicable to common shareholders 	$1,123 	$ 2,182
Earnings per common share
Basic 	$ 3.12 	$ 5.73
Diluted 	$ 3.11 	$ 5.71
Average common shares
Basic 	358.0 	379.8
Diluted 	361.1 	382.4
Consolidated Statements of Comprehensive Income
(Unaudited)
Three Months
Ended March
$ in millions 	2020 	2019
Net earnings 	$1,213 	$ 2,251
Other comprehensive income/(loss) adjustments, net of tax:
Currency translation 	(17) 	4
Debt valuation adjustment 	2,914 	(1,417)
Pension and postretirement liabilities 	7 	(7)
Available-for-sale securities 	517 	114
Other comprehensive income/(loss) 	3,421 	(1,306)
Comprehensive income 	$4,634 	$ 	945
The accompanying notes are an integral part of these consolidated financial statements.
1 	Goldman Sachs March 2020 Form 10-Q

-- 3 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Consolidated Balance Sheets
(Unaudited)
As of
$ in millions
March
2020
December
2019
Assets
Cash and cash equivalents 	$ 105,489 $133,546
Collateralized agreements:
Securities purchased under agreements to resell (at fair value) 	132,333 	85,691
Securities borrowed (includes $29,771 and $26,279 at fair value) 	121,670 	136,071
Customer and other receivables (includes $53 and $53 at fair value) 	120,927 	74,605
Trading assets (at fair value and includes $59,128 and $66,605 pledged as collateral) 	375,471 	355,332
Investments (includes $62,655 and $57,827 at fair value, and $10,765 and $10,968 pledged as collateral) 	68,694 	63,937
Loans (net of allowance of $2,868 and $1,441, and includes $13,829 and $14,386 at fair value) 	128,453 	108,904
Other assets 	36,719 	34,882
Total assets 	$1,089,756 $992,968
Liabilities and shareholders’ equity
Deposits (includes $24,722 and $17,765 at fair value) 	$ 219,994 $190,019
Collateralized financings:
Securities sold under agreements to repurchase (at fair value) 	95,864 	117,756
Securities loaned (includes $1,148 and $714 at fair value) 	13,869 	14,985
Other secured financings (includes $29,991 and $18,071 at fair value) 	37,196 	19,277
Customer and other payables 	213,178 	174,817
Trading liabilities (at fair value) 	136,358 	108,835
Unsecured short-term borrowings (includes $18,983 and $26,007 at fair value) 	37,148 	48,287
Unsecured long-term borrowings (includes $43,313 and $43,661 at fair value) 	225,476 	207,076
Other liabilities (includes $327 and $150 at fair value) 	18,294 	21,651
Total liabilities 	997,377 	902,703
Commitments, contingencies and guarantees
Shareholders’ equity
Preferred stock; aggregate liquidation preference of $11,203 and $11,203 	11,203 	11,203
Common stock; 901,409,000 and 896,782,650 shares issued, and 343,856,654 and 347,343,184 shares outstanding 	9 	9
Share-based awards 	3,037 	3,195
Nonvoting common stock; no shares issued and outstanding 	– 	–
Additional paid-in capital 	55,621 	54,883
Retained earnings 	106,501 	106,465
Accumulated other comprehensive income/(loss) 	1,937 	(1,484)
Stock held in treasury, at cost; 557,552,348 and 549,439,468 shares 	(85,929) 	(84,006)
Total shareholders’ equity 	92,379 	90,265
Total liabilities and shareholders’ equity 	$1,089,756 $992,968
The accompanying notes are an integral part of these consolidated financial statements.
Goldman Sachs March 2020 Form 10-Q 	2

-- 4 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Consolidated Statements of Changes in Shareholders’ Equity
(Unaudited)
Three Months
Ended March
$ in millions 	2020 	2019
Preferred stock
Beginning balance 	$ 11,203 	$ 11,203
Issued 	350 	–
Redeemed 	(350) 	–
Ending balance 	11,203 	11,203
Common stock
Beginning balance 	9 	9
Issued 	– 	–
Ending balance 	9 	9
Share-based awards
Beginning balance 	3,195 	2,845
Issuance and amortization of share-based awards 	1,397 	1,506
Delivery of common stock underlying share-based awards 	(1,547) 	(1,596)
Forfeiture of share-based awards 	(8) 	(16)
Ending balance 	3,037 	2,739
Additional paid-in capital
Beginning balance 	54,883 	54,005
Delivery of common stock underlying share-based awards 	1,541 	1,587
Cancellation of share-based awards in satisfaction of withholding tax requirements 	(803) 	(730)
Ending balance 	55,621 	54,862
Retained earnings
Beginning balance, as previously reported 	106,465 	100,100
Cumulative effect of change in accounting principle for:
Current expected credit losses, net of tax 	(638) 	–
Leases, net of tax 	– 	12
Beginning balance, adjusted 	105,827 	100,112
Net earnings 	1,213 	2,251
Dividends and dividend equivalents declared on common stock and share-based awards 	(449) 	(306)
Dividends declared on preferred stock 	(89) 	(69)
Preferred stock redemption premium 	(1) 	–
Ending balance 	106,501 	101,988
Accumulated other comprehensive income/(loss)
Beginning balance 	(1,484) 	693
Other comprehensive income/(loss) 	3,421 	(1,306)
Ending balance 	1,937 	(613)
Stock held in treasury, at cost
Beginning balance 	(84,006) 	(78,670)
Repurchased 	(1,928) 	(1,250)
Reissued 	10 	11
Other 	(5) 	(6)
Ending balance 	(85,929) 	(79,915)
Total shareholders’ equity 	$ 92,379 	$ 90,273
The accompanying notes are an integral part of these consolidated financial statements.
3 	Goldman Sachs March 2020 Form 10-Q

-- 5 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Consolidated Statements of Cash Flows
(Unaudited)
Three Months
Ended March
$ in millions 	2020 	2019
Cash flows from operating activities
Net earnings 	$ 	1,213 	$ 	2,251
Adjustments to reconcile net earnings to net cash used for operating activities:
Depreciation and amortization 	437 	368
Share-based compensation 	1,395 	1,503
Gain related to extinguishment of unsecured borrowings 	(1) 	–
Provision for credit losses 	937 	224
Changes in operating assets and liabilities:
Customer and other receivables and payables, net 	(7,961) 	3,991
Collateralized transactions (excluding other secured financings), net 	(55,249) 	(13,215)
Trading assets 	(20,580) 	(26,494)
Trading liabilities 	27,523 	(7,888)
Loans held for sale, net 	2,624 	652
Other, net 	(3,369) 	(5,760)
Net cash used for operating activities 	(53,031) 	(44,368)
Cash flows from investing activities
Purchase of property, leasehold improvements and equipment 	(2,843) 	(2,128)
Proceeds from sales of property, leasehold improvements and equipment 	397 	2,266
Purchase of investments 	(10,214) 	(6,848)
Proceeds from sales and paydowns of investments 	3,889 	6,207
Loans, net (excluding loans held for sale) 	(23,565) 	(1,636)
Net cash used for investing activities 	(32,336) 	(2,139)
Cash flows from financing activities
Unsecured short-term borrowings, net 	2,915 	381
Other secured financings (short-term), net 	16,307 	(2,690)
Proceeds from issuance of other secured financings (long-term) 	2,969 	1,442
Repayment of other secured financings (long-term), including the current portion 	(445) 	(525)
Purchase of Trust Preferred securities 	(11) 	–
Proceeds from issuance of unsecured long-term borrowings 	26,506 	6,253
Repayment of unsecured long-term borrowings, including the current portion 	(16,175) 	(7,251)
Derivative contracts with a financing element, net 	134 	2,586
Deposits, net 	28,381 	5,594
Preferred stock redemption 	(350) 	–
Common stock repurchased 	(1,928) 	(1,250)
Settlement of share-based awards in satisfaction of withholding tax requirements 	(804) 	(730)
Dividends and dividend equivalents paid on common stock, preferred stock and share-based awards 	(538) 	(375)
Proceeds from issuance of preferred stock, net of issuance costs 	349 	–
Other financing, net 	– 	409
Net cash provided by financing activities 	57,310 	3,844
Net decrease in cash and cash equivalents 	(28,057) 	(42,663)
Cash and cash equivalents, beginning balance 	133,546 	130,547
Cash and cash equivalents, ending balance 	$105,489 	$ 87,884
Supplemental disclosures:
Cash payments for interest, net of capitalized interest 	$ 	4,041 	$ 	4,372
Cash payments/(refunds) for income taxes, net 	$ 	474 	$ 	(109)
See Notes 12, 14 and 16 for information about non-cash activities.
The accompanying notes are an integral part of these consolidated financial statements.
Goldman Sachs March 2020 Form 10-Q 	4

-- 6 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 1.
Description of Business
The Goldman Sachs Group, Inc. (Group Inc. or parent
company), a Delaware corporation, together with its
consolidated subsidiaries (collectively, the firm), is a leading
global 	investment 	banking, 	securities 	and 	investment
management firm that provides a wide range of financial
services to a substantial and diversified client base that
includes corporations, financial institutions, governments
and 	individuals. 	Founded 	in 	1869, 	the 	firm 	is
headquartered in New York and maintains offices in all
major financial centers around the world.
The firm reports its activities in the following four business
segments:
Investment Banking
The firm provides a broad range of investment banking
services to a diverse group of corporations, financial
institutions, investment funds and governments. Services
include strategic advisory assignments with respect to
mergers and acquisitions, divestitures, corporate defense
activities, restructurings and spin-offs, and equity and debt
underwriting of public offerings and private placements.
The firm also provides lending to corporate clients,
including middle-market lending, relationship lending and
acquisition financing.
Global Markets
The firm facilitates client transactions and makes markets
in fixed income, equity, currency and commodity products
with institutional clients, such as corporations, financial
institutions, investment funds and governments. The firm
also makes markets in and clears institutional client
transactions on major stock, options and futures exchanges
worldwide and provides prime brokerage and other equities
financing activities, including securities lending, margin
lending and swaps. The firm also provides financing to
clients through repurchase agreements, as well as through
structured credit, warehouse and asset-backed lending.
Asset Management
The firm manages assets and offers investment products
(primarily 	through 	separately 	managed accounts and
commingled vehicles, such as mutual funds and private
investment funds) across all major asset classes to a diverse
set of institutional clients and a network of third-party
distributors around the world. The firm makes equity
investments, which include alternative investing activities
related 	to 	public 	and 	private 	equity 	investments 	in
corporate, real estate and infrastructure assets, as well as
investments 	through 	consolidated 	investment 	entities,
substantially all of which are engaged in real estate
investment activities. The firm also invests in corporate
debt and provides financing for real estate and other assets.
Consumer & Wealth Management
The firm provides investing and wealth advisory solutions,
including financial planning and counseling, executing
brokerage transactions and managing assets for individuals
in its wealth management business. The firm also provides
loans and accepts deposits through its consumer banking
digital platform, Marcus by Goldman Sachs, and through
its private bank, as well as issues credit cards to consumers.
Note 2.
Basis of Presentation
These consolidated financial statements are prepared in
accordance with accounting principles generally accepted in
the United States (U.S. GAAP) and include the accounts of
Group Inc. and all other entities in which the firm has a
controlling financial interest. Intercompany transactions
and balances have been eliminated.
These consolidated financial statements are unaudited and
should be read in conjunction with the audited consolidated
financial statements included in the firm’s Annual Report
on Form 10-K for the year ended December 31, 2019.
References to “the 2019 Form 10-K” are to the firm’s
Annual 	Report 	on 	Form 	10-K 	for 	the 	year 	ended
December 31, 2019. Certain disclosures included in the
annual financial statements have been condensed or
omitted from these financial statements as they are not
required for interim financial statements under U.S. GAAP
and the rules of the Securities and Exchange Commission.
These unaudited consolidated financial statements reflect
all adjustments that are, in the opinion of management,
necessary for a fair statement of the results for the interim
periods presented. These adjustments are of a normal,
recurring nature. Interim period operating results may not
be indicative of the operating results for a full year.
All references to March 2020 and March 2019 refer to the
firm’s periods ended, or the dates, as the context requires,
March 31, 2020 and March 31, 2019, respectively. All
references 	to 	December 	2019 	refer 	to 	the 	date
December 31, 2019. Any reference to a future year refers to
a year ending on December 31 of that year.
Beginning in the fourth quarter of 2019, the firm changed
its business segments and balance sheet presentation to
better reflect the nature of the firm’s activities. See Note 2 in
Part II, Item 8 of the 2019 Form 10-K for further
information. 	Reclassifications 	have 	been 	made 	to
previously reported amounts to conform to the current
presentation.
5 	Goldman Sachs March 2020 Form 10-Q

-- 7 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 3.
Significant Accounting Policies
The firm’s significant accounting policies include when and
how to measure the fair value of assets and liabilities,
measuring the allowance for credit losses on loans and
lending commitments accounted for at amortized cost, and
when to consolidate an entity. See Note 4 for policies on
fair value measurements, Note 9 for policies on the
allowance for credit losses, and below and Note 17 for
policies on consolidation accounting. All other significant
accounting policies are either described below or included
in the following footnotes:
Fair Value Measurements 	Note 4
Trading Assets and Liabilities 	Note 5
Trading Cash Instruments 	Note 6
Derivatives and Hedging Activities 	Note 7
Investments 	Note 8
Loans 	Note 9
Fair Value Option 	Note 10
Collateralized Agreements and Financings 	Note 11
Other Assets 	Note 12
Deposits 	Note 13
Unsecured Borrowings 	Note 14
Other Liabilities 	Note 15
Securitization Activities 	Note 16
Variable Interest Entities 	Note 17
Commitments, Contingencies and Guarantees 	Note 18
Shareholders’ Equity 	Note 19
Regulation and Capital Adequacy 	Note 20
Earnings Per Common Share 	Note 21
Transactions with Affiliated Funds 	Note 22
Interest Income and Interest Expense 	Note 23
Income Taxes 	Note 24
Business Segments 	Note 25
Credit Concentrations 	Note 26
Legal Proceedings 	Note 27
Consolidation
The firm consolidates entities in which the firm has a
controlling financial interest. The firm determines whether
it has a controlling financial interest in an entity by first
evaluating whether the entity is a voting interest entity or a
variable interest entity (VIE).
Voting Interest Entities. Voting interest entities are
entities in which (i) the total equity investment at risk is
sufficient to enable the entity to finance its activities
independently and (ii) the equity holders have the power to
direct the activities of the entity that most significantly
impact its economic performance, the obligation to absorb
the losses of the entity and the right to receive the residual
returns of the entity. The usual condition for a controlling
financial interest in a voting interest entity is ownership of a
majority voting interest. If the firm has a controlling
majority voting interest in a voting interest entity, the entity
is consolidated.
Variable Interest Entities. A VIE is an entity that lacks
one or more of the characteristics of a voting interest entity.
The firm has a controlling financial interest in a VIE when
the firm has a variable interest or interests that provide it
with (i) the power to direct the activities of the VIE that
most significantly impact the VIE’s economic performance
and (ii) the obligation to absorb losses of the VIE or the
right to receive benefits from the VIE that could potentially
be significant to the VIE. See Note 17 for further
information about VIEs.
Equity-Method Investments. When the firm does not
have a controlling financial interest in an entity but can
exert significant influence over the entity’s operating and
financial policies, the investment is generally accounted for
at fair value by electing the fair value option available under
U.S. GAAP. Significant influence generally exists when the
firm owns 20% to 50% of the entity’s common stock or
in-substance common stock.
In certain cases, the firm applies the equity method of
accounting to new investments that are strategic in nature
or closely related to the firm’s principal business activities,
when the firm has a significant degree of involvement in the
cash flows or operations of the investee or when cost-
benefit considerations are less significant. See Note 8 for
further information about equity-method investments.
Goldman Sachs March 2020 Form 10-Q 	6

-- 8 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Investment Funds. The firm has formed investment funds
with third-party investors. These funds are typically
organized as limited partnerships or limited liability
companies for which the firm acts as general partner or
manager. Generally, the firm does not hold a majority of
the economic interests in these funds. These funds are
usually voting interest entities and generally are not
consolidated because third-party investors typically have
rights to terminate the funds or to remove the firm as
general partner or manager. Investments in these funds are
generally measured at net asset value (NAV) and are
included in investments. See Notes 8, 18 and 22 for further
information about investments in funds.
Use of Estimates
Preparation of these consolidated financial statements
requires management to make certain estimates and
assumptions, the most important of which relate to fair
value measurements, the allowance for credit losses on
loans and lending commitments accounted for at amortized
cost, discretionary compensation accruals, accounting for
goodwill and identifiable intangible assets, provisions for
losses that may arise from litigation and regulatory
proceedings (including governmental investigations), and
provisions for losses that may arise from tax audits. These
estimates and assumptions are based on the best available
information but actual results could be materially different.
Revenue Recognition
Financial Assets and Liabilities at Fair Value. Trading
assets and liabilities and certain investments are recorded at
fair value either under the fair value option or in accordance
with other U.S. GAAP. In addition, the firm has elected to
account for certain of its loans and other financial assets
and liabilities at fair value by electing the fair value option.
The fair value of a financial instrument is the amount that
would be received to sell an asset or paid to transfer a
liability 	in 	an 	orderly 	transaction 	between 	market
participants at the measurement date. Financial assets are
marked to bid prices and financial liabilities are marked to
offer prices. Fair value measurements do not include
transaction costs. Fair value gains or losses are generally
included in market making or other principal transactions.
See Note 4 for further information about fair value
measurements.
Revenue 	from 	Contracts 	with 	Clients. 	The 	firm
recognizes revenue earned from contracts with clients for
services, 	such 	as 	investment 	banking, 	investment
management, and execution and clearing (contracts with
clients), when the performance obligations related to the
underlying transaction are completed.
Revenues from these contracts with clients represent
approximately 	55% 	of 	total 	non-interest 	revenues
(including approximately 85% of investment banking
revenues, approximately 95% of investment management
revenues and all commissions and fees) for the three months
ended March 2020, and approximately 50% of total
non-interest revenues (including approximately 90% of
investment banking revenues, approximately 95% of
investment management revenues and all commissions and
fees) for the three months ended March 2019. See Note 25
for information about net revenues by business segment.
Investment Banking
Advisory. Fees from financial advisory assignments are
recognized in revenues when the services related to the
underlying transaction are completed under the terms of the
assignment. 	Non-refundable 	deposits 	and 	milestone
payments 	in 	connection 	with 	financial 	advisory
assignments are recognized in revenues upon completion of
the underlying transaction or when the assignment is
otherwise concluded.
Expenses associated with financial advisory assignments
are recognized when incurred and are included in other
expenses. Client reimbursements for such expenses are
included in investment banking revenues.
Underwriting. Fees from underwriting assignments are
recognized in revenues upon completion of the underlying
transaction based on the terms of the assignment.
Expenses associated with underwriting assignments are
generally deferred until the related revenue is recognized or
the assignment is otherwise concluded. Such expenses are
included in other expenses.
7 	Goldman Sachs March 2020 Form 10-Q

-- 9 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Investment Management
The firm earns management fees and incentive fees for
investment management services, which are included in
investment 	management 	revenues. 	The 	firm 	makes
payments to brokers and advisors related to the placement
of the firm’s investment funds (distribution fees), which are
included in brokerage, clearing, exchange and distribution
fees.
Management Fees. Management fees for mutual funds
are calculated as a percentage of daily net asset value and
are received monthly. Management fees for hedge funds
and separately managed accounts are calculated as a
percentage of month-end net asset value and are generally
received quarterly. Management fees for private equity
funds are calculated as a percentage of monthly invested
capital or committed capital and are received quarterly,
semi-annually 	or 	annually, 	depending 	on 	the 	fund.
Management fees are recognized over time in the period the
services are provided.
Distribution fees paid by the firm are calculated based on
either a percentage of the management fee, the investment
fund’s net asset value or the committed capital. Such fees
are 	included 	in 	brokerage, 	clearing, 	exchange 	and
distribution fees.
Incentive 	Fees. 	Incentive 	fees 	are 	calculated 	as 	a
percentage of a fund’s or separately managed account’s
return, or excess return above a specified benchmark or
other performance target. Incentive fees are generally based
on investment performance over a twelve-month period or
over the life of a fund. Fees that are based on performance
over a twelve-month period are subject to adjustment prior
to the end of the measurement period. For fees that are
based on investment performance over the life of the fund,
future investment underperformance may require fees
previously distributed to the firm to be returned to the fund.
Incentive fees earned from a fund or separately managed
account are recognized when it is probable that a significant
reversal of such fees will not occur, which is generally when
such fees are no longer subject to fluctuations in the market
value of investments held by the fund or separately
managed account. Therefore, incentive fees recognized
during the period may relate to performance obligations
satisfied in previous periods.
Commissions and Fees
The firm earns commissions and fees from executing and
clearing client transactions on stock, options and futures
markets, as well as over-the-counter (OTC) transactions.
Commissions and fees are recognized on the day the trade is
executed. The firm also provides third-party research
services to clients in connection with certain soft-dollar
arrangements. Third-party research costs incurred by the
firm in connection with such arrangements are presented
net within commissions and fees.
Remaining Performance Obligations
Remaining performance obligations are services that the
firm has committed to perform in the future in connection
with its contracts with clients. The firm’s remaining
performance 	obligations 	are 	generally 	related 	to 	its
financial advisory assignments and certain investment
management activities. Revenues associated with remaining
performance obligations relating to financial advisory
assignments cannot be determined until the outcome of the
transaction. 	For 	the 	firm’s 	investment 	management
activities, where fees are calculated based on the net asset
value of the fund or separately managed account, future
revenues associated with such remaining performance
obligations cannot be determined as such fees are subject to
fluctuations in the market value of investments held by the
fund or separately managed account.
The firm is able to determine the future revenues associated
with management fees calculated based on committed
capital. As of March 2020, substantially all future net
revenues associated with such remaining performance
obligations will be recognized through 2027. Annual
revenues associated with such performance obligations
average less than $250 million through 2027.
Transfers of Financial Assets
Transfers of financial assets are accounted for as sales when
the firm has relinquished control over the assets transferred.
For transfers of financial assets accounted for as sales, any
gains or losses are recognized in net revenues. Assets or
liabilities that arise from the firm’s continuing involvement
with transferred financial assets are initially recognized at
fair value. For transfers of financial assets that are not
accounted for as sales, the assets are generally included in
trading assets and the transfer is accounted for as a
collateralized financing, with the related interest expense
recognized over the life of the transaction. See Note 11 for
further information about transfers of financial assets
accounted for as collateralized financings and Note 16 for
further information about transfers of financial assets
accounted for as sales.
Goldman Sachs March 2020 Form 10-Q 	8

-- 10 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Cash and Cash Equivalents
The firm defines cash equivalents as highly liquid overnight
deposits held in the ordinary course of business. Cash and
cash equivalents included cash and due from banks of
$11.70 billion as of March 2020 and $12.57 billion as of
December 2019. Cash and cash equivalents also included
interest-bearing deposits with banks of $93.79 billion as of
March 2020 and $120.98 billion as of December 2019.
The firm segregates cash for regulatory and other purposes
related to client activity. Cash and cash equivalents
segregated 	for 	regulatory 	and 	other 	purposes 	were
$28.93 billion as of March 2020 and $22.78 billion as of
December 2019. In addition, the firm segregates securities
for regulatory and other purposes related to client activity.
See Note 11 for further information about segregated
securities.
Customer and Other Receivables
Customer and other receivables included receivables from
customers and counterparties of $72.63 billion as of
March 2020 and $50.90 billion as of December 2019, and
receivables 	from 	brokers, 	dealers 	and 	clearing
organizations of $48.30 billion as of March 2020 and
$23.71 billion as of December 2019. Such receivables
primarily consist of customer margin loans, receivables
resulting from unsettled transactions and collateral posted
in connection with certain derivative transactions.
Substantially all of these receivables are accounted for at
amortized cost net of any allowance for credit losses, which
generally approximates fair value. As these receivables are
not accounted for at fair value, they are not included in the
firm’s fair value hierarchy in Notes 4 through 10. Had these
receivables been included in the firm’s fair value hierarchy,
substantially all would have been classified in level 2 as of
both March 2020 and December 2019. See Note 10 for
further information about customer and other receivables
accounted for at fair value under the fair value option.
Interest on customer and other receivables is recognized
over the life of the transaction and included in interest
income.
Customer and other receivables includes receivables from
contracts with clients and contract assets. Contract assets
represent the firm’s right to receive consideration for
services provided in connection with its contracts with
clients for which collection is conditional and not merely
subject to the passage of time. The firm’s receivables from
contracts with clients were $2.31 billion as of March 2020
and $2.27 billion as of December 2019. As of both
March 2020 and December 2019 contract assets were not
material.
Customer and Other Payables
Customer 	and 	other 	payables 	included 	payables 	to
customers and counterparties of $201.68 billion as of
March 2020 and $170.21 billion as of December 2019, and
payables to brokers, dealers and clearing organizations of
$11.50 billion as of March 2020 and $4.61 billion as of
December 	2019. 	Such 	payables 	primarily 	consist 	of
customer credit balances related to the firm’s prime
brokerage activities. Customer and other payables are
accounted for at cost plus accrued interest, which generally
approximates 	fair 	value. 	As 	these 	payables 	are 	not
accounted for at fair value, they are not included in the
firm’s fair value hierarchy in Notes 4 through 10. Had these
payables been included in the firm’s fair value hierarchy,
substantially all would have been classified in level 2 as of
both March 2020 and December 2019. Interest on
customer and other payables is recognized over the life of
the transaction and included in interest expense.
Offsetting Assets and Liabilities
To reduce credit exposures on derivatives and securities
financing transactions, the firm may enter into master
netting agreements or similar arrangements (collectively,
netting agreements) with counterparties that permit it to
offset receivables and payables with such counterparties. A
netting agreement is a contract with a counterparty that
permits net settlement of multiple transactions with that
counterparty, including upon the exercise of termination
rights by a non-defaulting party. Upon exercise of such
termination rights, all transactions governed by the netting
agreement are terminated and a net settlement amount is
calculated. In addition, the firm receives and posts cash and
securities collateral with respect to its derivatives and
securities financing transactions, subject to the terms of the
related credit support agreements or similar arrangements
(collectively, credit support agreements). An enforceable
credit support agreement grants the non-defaulting party
exercising termination rights the right to liquidate the
collateral and apply the proceeds to any amounts owed. In
order to assess enforceability of the firm’s right of setoff
under netting and credit support agreements, the firm
evaluates various factors, including applicable bankruptcy
laws, local statutes and regulatory provisions in the
jurisdiction of the parties to the agreement.
9 	Goldman Sachs March 2020 Form 10-Q

-- 11 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Derivatives are reported on a net-by-counterparty basis
(i.e., the net payable or receivable for derivative assets and
liabilities for a given counterparty) in the consolidated
balance sheets when a legal right of setoff exists under an
enforceable netting agreement. Securities purchased under
agreements to resell (resale agreements) and securities sold
under agreements to repurchase (repurchase agreements)
and securities borrowed and loaned transactions with the
same 	term 	and 	currency 	are 	presented 	on 	a
net-by-counterparty basis in the consolidated balance
sheets when such transactions meet certain settlement
criteria and are subject to netting agreements.
In the consolidated balance sheets, derivatives are reported
net of cash collateral received and posted under enforceable
credit support agreements, when transacted under an
enforceable netting agreement. In the consolidated balance
sheets, resale and repurchase agreements, and securities
borrowed and loaned, are not reported net of the related
cash and securities received or posted as collateral. See
Note 11 for further information about collateral received
and pledged, including rights to deliver or repledge
collateral. See Notes 7 and 11 for further information about
offsetting assets and liabilities.
Share-based Compensation
The cost of employee services received in exchange for a
share-based award is generally measured based on the
grant-date fair value of the award. Share-based awards that
do not require future service (i.e., vested awards, including
awards 	granted 	to 	retirement-eligible 	employees) 	are
expensed immediately. Share-based awards that require
future service are amortized over the relevant service
period. Forfeitures are recorded when they occur.
Cash dividend equivalents paid on outstanding restricted
stock units (RSUs) are charged to retained earnings. If RSUs
that require future service are forfeited, the related dividend
equivalents originally charged to retained earnings are
reclassified to compensation expense in the period in which
forfeiture occurs.
The firm generally issues new shares of common stock upon
delivery of share-based awards. In certain cases, primarily
related to conflicted employment (as outlined in the
applicable award agreements), the firm may cash settle
share-based compensation awards accounted for as equity
instruments. For these awards, whose terms allow for cash
settlement, additional paid-in capital is adjusted to the
extent of the difference between the value of the award at
the time of cash settlement and the grant-date value of the
award. The tax effect related to the settlement of share-
based awards is recorded in income tax benefit or expense.
Foreign Currency Translation
Assets and liabilities denominated in non-U.S. currencies
are translated at rates of exchange prevailing on the date of
the consolidated balance sheets and revenues and expenses
are translated at average rates of exchange for the period.
Foreign 	currency 	remeasurement 	gains 	or 	losses 	on
transactions in nonfunctional currencies are recognized in
earnings. Gains or losses on translation of the financial
statements of a non-U.S. operation, when the functional
currency is other than the U.S. dollar, are included, net of
hedges and taxes, in the consolidated statements of
comprehensive income.
Recent Accounting Developments
Leases (ASC 842). In February 2016, the FASB issued ASU
No. 2016-02, “Leases (Topic 842).” This ASU requires
that, for leases longer than one year, a lessee recognize in
the balance sheet a right-of-use asset, representing the right
to use the underlying asset for the lease term, and a lease
liability, representing the liability to make lease payments.
It also requires that for finance leases, a lessee recognize
interest expense on the lease liability, separately from the
amortization of the right-of-use asset in the statements of
earnings, while for operating leases, such amounts should
be recognized as a combined expense. It also requires that
for 	qualifying 	sale-leaseback 	transactions 	the 	seller
recognize any gain or loss (based on the estimated fair value
of the asset at the time of sale) when control of the asset is
transferred instead of amortizing it over the lease period. In
addition, this ASU requires expanded disclosures about the
nature and terms of lease agreements.
The firm adopted this ASU in January 2019 under a
modified 	retrospective 	approach. 	Upon 	adoption, 	in
accordance with the ASU, the firm elected to not reassess
the lease classification or initial direct costs of existing
leases, and to not reassess whether existing contracts
contain a lease. In addition, the firm has elected to account
for each contract’s lease and non-lease components as a
single lease component. The impact of adoption was a gross
up of $1.77 billion on the firm’s consolidated balance sheet
and an increase to retained earnings of $12 million (net of
tax) as of January 1, 2019.
Goldman Sachs March 2020 Form 10-Q 	10

-- 12 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Measurement 	of 	Credit 	Losses 	on 	Financial
Instruments (ASC 326). In June 2016, the FASB issued
ASU No. 2016-13, “Financial Instruments — Credit Losses
(Topic 326) — Measurement of Credit Losses on Financial
Instruments.” This ASU amends several aspects of the
measurement 	of 	credit 	losses 	on 	certain 	financial
instruments, including replacing the existing incurred credit
loss model and other models with the Current Expected
Credit Losses (CECL) model and amending certain aspects
of 	accounting 	for 	purchased 	financial 	assets 	with
deterioration in credit quality since origination.
The firm adopted this ASU in January 2020 under a
modified retrospective approach. As a result of adopting
this ASU, the firm’s allowance for credit losses on financial
assets and commitments that are measured at amortized
cost reflects management’s estimate of credit losses over the
remaining expected life of such assets. Expected credit
losses 	for 	newly 	recognized 	financial 	assets 	and
commitments, as well as changes to expected credit losses
during the period, are recognized in earnings. These
expected credit losses are measured based on historical
experience, current conditions and forecasts that affect the
collectability of the reported amount.
The cumulative effect of measuring the allowance under
CECL 	as 	a 	result 	of 	adopting 	this 	ASU 	as 	of
January 1, 2020 was an increase in the allowance for credit
losses of $848 million. The increase in the allowance is
driven by the fact that the allowance under CECL covers
expected credit losses over the full expected life of the loan
portfolios and also takes into account forecasts of expected
future economic conditions. In addition, in accordance with
the ASU, the firm elected the fair value option for loans that
were 	previously 	accounted 	for 	as 	Purchased 	Credit
Impaired (PCI), which resulted in a decrease to the
allowance for PCI loans of $169 million. The cumulative
effect of adopting this ASU was a decrease to retained
earnings of $638 million (net of tax).
Facilitation of the Effects of Reference Rate Reform on
Financial Reporting (ASC 848). In March 2020, the FASB
issued ASU No. 2020-04, “Reference Rate Reform —
Facilitation of the Effects of Reference Rate Reform on
Financial 	Reporting.” 	This 	ASU 	provides 	optional
exceptions for applying generally accepted accounting
principles to contracts, hedging relationships and other
transactions affected by reference rate reform. The firm
adopted this ASU in March 2020 and adoption did not
have a material impact on the firm’s consolidated financial
statements.
Note 4.
Fair Value Measurements
The fair value of a financial instrument is the amount that
would be received to sell an asset or paid to transfer a
liability 	in 	an 	orderly 	transaction 	between 	market
participants at the measurement date. Financial assets are
marked to bid prices and financial liabilities are marked to
offer prices. Fair value measurements do not include
transaction costs. The firm measures certain financial assets
and liabilities as a portfolio (i.e., based on its net exposure
to market and/or credit risks).
The best evidence of fair value is a quoted price in an active
market. If quoted prices in active markets are not available,
fair value is determined by reference to prices for similar
instruments, quoted prices or recent transactions in less
active 	markets, 	or 	internally 	developed 	models 	that
primarily use market-based or independently sourced
inputs, 	including, 	but 	not 	limited 	to, 	interest 	rates,
volatilities, equity or debt prices, foreign exchange rates,
commodity prices, credit spreads and funding spreads (i.e.,
the spread or difference between the interest rate at which a
borrower could finance a given financial instrument relative
to a benchmark interest rate).
U.S. GAAP has a three-level hierarchy for disclosure of fair
value measurements. This hierarchy prioritizes inputs to the
valuation techniques used to measure fair value, giving the
highest priority to level 1 inputs and the lowest priority to
level 3 inputs. A financial instrument’s level in this
hierarchy is based on the lowest level of input that is
significant to its fair value measurement. In evaluating the
significance of a valuation input, the firm considers, among
other factors, a portfolio’s net risk exposure to that input.
The fair value hierarchy is as follows:
Level 1. Inputs are unadjusted quoted prices in active
markets to which the firm had access at the measurement
date for identical, unrestricted assets or liabilities.
Level 2. Inputs to valuation techniques are observable,
either directly or indirectly.
Level 3. One or more inputs to valuation techniques are
significant and unobservable.
The fair values for substantially all of the firm’s financial
assets and liabilities are based on observable prices and
inputs and are classified in levels 1 and 2 of the fair value
hierarchy. Certain level 2 and level 3 financial assets and
liabilities may require valuation adjustments that a market
participant would require to arrive at fair value for factors,
such as counterparty and the firm’s credit quality, funding
risk, transfer restrictions, liquidity and bid/offer spreads.
Valuation adjustments are generally based on market
evidence.
11 	Goldman Sachs March 2020 Form 10-Q

-- 13 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The valuation techniques and nature of significant inputs
used to determine the fair value of the firm’s financial
instruments are described below. See Notes 5 through 10
for further information about significant unobservable
inputs used to value level 3 financial instruments.
Valuation Techniques and Significant Inputs for
Trading Cash Instruments, Investments and Loans
Level 1. Level 1 instruments include U.S. government
obligations, most non-U.S. government obligations, certain
agency obligations, certain corporate debt instruments,
certain money market instruments and actively traded listed
equities. These instruments are valued using quoted prices
for identical unrestricted instruments in active markets. The
firm defines active markets for equity instruments based on
the average daily trading volume both in absolute terms and
relative to the market capitalization for the instrument. The
firm defines active markets for debt instruments based on
both the average daily trading volume and the number of
days with trading activity.
Level 2. Level 2 instruments include certain non-U.S.
government obligations, most agency obligations, most
mortgage-backed loans and securities, most corporate debt
instruments, most state and municipal obligations, most
money market instruments, most other debt obligations,
restricted or less liquid listed equities, certain private
equities, commodities and certain lending commitments.
Valuations of level 2 instruments can be verified to quoted
prices, recent trading activity for identical or similar
instruments, broker or dealer quotations or alternative
pricing sources with reasonable levels of price transparency.
Consideration is given to the nature of the quotations (e.g.,
indicative or firm) and the relationship of recent market
activity to the prices provided from alternative pricing
sources.
Valuation adjustments are typically made to level 2
instruments (i) if the instrument is subject to transfer
restrictions and/or (ii) for other premiums and liquidity
discounts that a market participant would require to arrive
at fair value. Valuation adjustments are generally based on
market evidence.
Level 3. Level 3 instruments have one or more significant
valuation inputs that are not observable. Absent evidence to
the contrary, level 3 instruments are initially valued at
transaction price, which is considered to be the best initial
estimate of fair value. Subsequently, the firm uses other
methodologies to determine fair value, which vary based on
the type of instrument. Valuation inputs and assumptions
are changed when corroborated by substantive observable
evidence, including values realized on sales.
Valuation techniques of level 3 instruments vary by
instrument, but are generally based on discounted cash flow
techniques. The valuation techniques and the nature of
significant inputs used to determine the fair values of each
type of level 3 instrument are described below:
Loans and Securities Backed by Commercial Real
Estate
Loans and securities backed by commercial real estate are
directly or indirectly collateralized by a single property or a
portfolio of properties, and may include tranches of varying
levels of subordination. Significant inputs are generally
determined based on relative value analyses and include:
‰ Market yields implied by transactions of similar or related
assets and/or current levels and changes in market indices,
such as the CMBX (an index that tracks the performance
of commercial mortgage bonds);
‰ Transaction prices in both the underlying collateral and
instruments 	with 	the 	same 	or 	similar 	underlying
collateral;
‰ A measure of expected future cash flows in a default
scenario (recovery rates) implied by the value of the
underlying collateral, which is mainly driven by current
performance 	of 	the 	underlying 	collateral 	and
capitalization rates. Recovery rates are expressed as a
percentage of notional or face value of the instrument and
reflect the benefit of credit enhancements on certain
instruments; and
‰ Timing of expected future cash flows (duration) which, in
certain cases, may incorporate the impact of other
unobservable inputs (e.g., prepayment speeds).
Loans and Securities Backed by Residential Real
Estate
Loans and securities backed by residential real estate are
directly 	or 	indirectly 	collateralized 	by 	portfolios 	of
residential real estate and may include tranches of varying
levels of subordination. Significant inputs are generally
determined 	based 	on 	relative 	value 	analyses, 	which
incorporate 	comparisons 	to 	instruments 	with 	similar
collateral and risk profiles. Significant inputs include:
‰ Market yields implied by transactions of similar or related
assets;
‰ Transaction prices in both the underlying collateral and
instruments 	with 	the 	same 	or 	similar 	underlying
collateral;
‰ Cumulative loss expectations, driven by default rates,
home price projections, residential property liquidation
timelines, related costs and subsequent recoveries; and
‰ Duration, driven by underlying loan prepayment speeds
and residential property liquidation timelines.
Goldman Sachs March 2020 Form 10-Q 	12

-- 14 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Corporate Debt Instruments
Corporate debt instruments includes corporate loans, debt
securities and convertible debentures. Significant inputs for
corporate debt instruments are generally determined based
on relative value analyses, which incorporate comparisons
both to prices of credit default swaps that reference the
same or similar underlying instrument or entity and to
other debt instruments for the same or similar issuer for
which observable prices or broker quotations are available.
Significant inputs include:
‰ Market yields implied by transactions of similar or related
assets and/or current levels and trends of market indices,
such as the CDX (an index that tracks the performance of
corporate credit);
‰ Current performance and recovery assumptions and,
where the firm uses credit default swaps to value the
related instrument, the cost of borrowing the underlying
reference obligation;
‰ Duration; and
‰ Market and transaction multiples for corporate debt
instruments with convertibility or participation options.
Equity Securities
Equity securities consists of private equities. Recent third-
party completed or pending transactions (e.g., merger
proposals, debt restructurings, tender offers) are considered
the best evidence for any change in fair value. When these
are not available, the following valuation methodologies
are used, as appropriate:
‰ Industry 	multiples 	(primarily 	EBITDA 	and 	revenue
multiples) and public comparables;
‰ Transactions in similar instruments;
‰ Discounted cash flow techniques; and
‰ Third-party appraisals.
The firm also considers changes in the outlook for the
relevant industry and financial performance of the issuer as
compared to projected performance. Significant inputs
include:
‰ Market and transaction multiples;
‰ Discount rates and capitalization rates; and
‰ For equity securities with debt-like features, market yields
implied by transactions of similar or related assets,
current performance and recovery assumptions, and
duration.
Other Trading Cash Instruments, Investments and
Loans
The significant inputs to the valuation of other instruments,
such 	as 	U.S. 	and 	non-U.S. 	government 	and 	agency
obligations, state and municipal obligations, and other loans
and debt obligations are generally determined based on
relative value analyses, which incorporate comparisons both
to prices of credit default swaps that reference the same or
similar underlying instrument or entity and to other debt
instruments for the same issuer for which observable prices
or broker quotations are available. Significant inputs include:
‰ Market yields implied by transactions of similar or related
assets and/or current levels and trends of market indices;
‰ Current performance and recovery assumptions and,
where the firm uses credit default swaps to value the
related instrument, the cost of borrowing the underlying
reference obligation; and
‰ Duration.
Valuation Techniques and Significant Inputs for
Derivatives
The firm’s level 2 and level 3 derivatives are valued using
derivative pricing models (e.g., discounted cash flow
models, correlation models and models that incorporate
option 	pricing 	methodologies, 	such 	as 	Monte 	Carlo
simulations). Price transparency of derivatives can generally
be characterized by product type, as described below.
‰ Interest Rate. In general, the key inputs used to value
interest rate derivatives are transparent, even for most
long-dated contracts. Interest rate swaps and options
denominated in the currencies of leading industrialized
nations are characterized by high trading volumes and tight
bid/offer spreads. Interest rate derivatives that reference
indices, such as an inflation index, or the shape of the yield
curve (e.g., 10-year swap rate vs. 2-year swap rate) are
more complex, but the key inputs are generally observable.
‰ Credit. Price transparency for credit default swaps,
including both single names and baskets of credits, varies
by market and underlying reference entity or obligation.
Credit 	default 	swaps 	that 	reference 	indices, 	large
corporates and major sovereigns generally exhibit the
most price transparency. For credit default swaps with
other underliers, price transparency varies based on credit
rating, the cost of borrowing the underlying reference
obligations, 	and 	the 	availability 	of 	the 	underlying
reference obligations for delivery upon the default of the
issuer. Credit default swaps that reference loans, asset-
backed securities and emerging market debt instruments
tend to have less price transparency than those that
reference corporate bonds. In addition, more complex
credit 	derivatives, 	such 	as 	those 	sensitive 	to 	the
correlation between two or more underlying reference
obligations, generally have less price transparency.
13 	Goldman Sachs March 2020 Form 10-Q

-- 15 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
‰ Currency. Prices for currency derivatives based on the
exchange 	rates 	of 	leading 	industrialized 	nations,
including 	those 	with 	longer 	tenors, 	are 	generally
transparent. The primary difference between the price
transparency of developed and emerging market currency
derivatives is that emerging markets tend to be only
observable for contracts with shorter tenors.
‰ Commodity. 	Commodity 	derivatives 	include
transactions referenced to energy (e.g., oil and natural
gas), 	metals 	(e.g., 	precious 	and 	base) 	and 	soft
commodities (e.g., agricultural). Price transparency varies
based on the underlying commodity, delivery location,
tenor and product quality (e.g., diesel fuel compared to
unleaded gasoline). In general, price transparency for
commodity derivatives is greater for contracts with
shorter tenors and contracts that are more closely aligned
with major and/or benchmark commodity indices.
‰ Equity. Price transparency for equity derivatives varies by
market and underlier. Options on indices and the
common stock of corporates included in major equity
indices exhibit the most price transparency. Equity
derivatives generally have observable market prices,
except for contracts with long tenors or reference prices
that differ significantly from current market prices. More
complex equity derivatives, such as those sensitive to the
correlation between two or more individual stocks,
generally have less price transparency.
Liquidity is essential to observability of all product types. If
transaction volumes decline, previously transparent prices
and other inputs may become unobservable. Conversely,
even highly structured products may at times have trading
volumes large enough to provide observability of prices and
other inputs.
Level 1. Level 1 derivatives include short-term contracts for
future delivery of securities when the underlying security is
a level 1 instrument, and exchange-traded derivatives if
they are actively traded and are valued at their quoted
market price.
Level 2. Level 2 derivatives include OTC derivatives for
which all significant valuation inputs are corroborated by
market evidence and exchange-traded derivatives that are
not actively traded and/or that are valued using models that
calibrate to market-clearing levels of OTC derivatives.
The selection of a particular model to value a derivative
depends on the contractual terms of and specific risks
inherent in the instrument, as well as the availability of
pricing information in the market. For derivatives that
trade in liquid markets, model selection does not involve
significant management judgment because outputs of
models can be calibrated to market-clearing levels.
Valuation models require a variety of inputs, such as
contractual terms, market prices, yield curves, discount
rates (including those derived from interest rates on
collateral received and posted as specified in credit support
agreements for collateralized derivatives), credit curves,
measures of volatility, prepayment rates, loss severity rates
and correlations of such inputs. Significant inputs to the
valuations of level 2 derivatives can be verified to market
transactions, 	broker 	or 	dealer 	quotations 	or 	other
alternative pricing sources with reasonable levels of price
transparency. Consideration is given to the nature of the
quotations (e.g., indicative or firm) and the relationship of
recent 	market 	activity 	to 	the 	prices 	provided 	from
alternative pricing sources.
Level 3. Level 3 derivatives are valued using models which
utilize observable level 1 and/or level 2 inputs, as well as
unobservable level 3 inputs. The significant unobservable
inputs used to value the firm’s level 3 derivatives are
described below.
‰ For level 3 interest rate and currency derivatives,
significant unobservable inputs include correlations of
certain currencies and interest rates (e.g., the correlation
between Euro inflation and Euro interest rates). In
addition, for level 3 interest rate derivatives, significant
unobservable 	inputs 	include 	specific 	interest 	rate
volatilities.
‰ For level 3 credit derivatives, significant unobservable
inputs include illiquid credit spreads and upfront credit
points, which are unique to specific reference obligations
and 	reference 	entities, 	recovery 	rates 	and 	certain
correlations required to value credit derivatives (e.g., the
likelihood 	of 	default 	of 	the 	underlying 	reference
obligation relative to one another).
‰ For 	level 	3 	commodity 	derivatives, 	significant
unobservable inputs include volatilities for options with
strike prices that differ significantly from current market
prices and prices or spreads for certain products for which
the product quality or physical location of the commodity
is not aligned with benchmark indices.
‰ For level 3 equity derivatives, significant unobservable
inputs generally include equity volatility inputs for
options that are long-dated and/or have strike prices that
differ 	significantly 	from 	current 	market 	prices. 	In
addition, the valuation of certain structured trades
requires the use of level 3 correlation inputs, such as the
correlation of the price performance of two or more
individual 	stocks 	or 	the 	correlation 	of 	the 	price
performance for a basket of stocks to another asset class,
such as commodities.
Goldman Sachs March 2020 Form 10-Q 	14

-- 16 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Subsequent to the initial valuation of a level 3 derivative, the
firm updates the level 1 and level 2 inputs to reflect observable
market changes and any resulting gains and losses are
classified in level 3. Level 3 inputs are changed when
corroborated by evidence, such as similar market transactions,
third-party pricing services and/or broker or dealer quotations
or other empirical market data. In circumstances where the
firm cannot verify the model value by reference to market
transactions, it is possible that a different valuation model
could produce a materially different estimate of fair value. See
Note 7 for further information about significant unobservable
inputs used in the valuation of level 3 derivatives.
Valuation Adjustments. Valuation adjustments are integral
to determining the fair value of derivative portfolios and are
used to adjust the mid-market valuations produced by
derivative pricing models to the exit price valuation. These
adjustments incorporate bid/offer spreads, the cost of liquidity,
credit 	valuation 	adjustments 	and 	funding 	valuation
adjustments, which account for the credit and funding risk
inherent 	in 	the 	uncollateralized 	portion 	of 	derivative
portfolios. The firm also makes funding valuation adjustments
to collateralized derivatives where the terms of the agreement
do not permit the firm to deliver or repledge collateral
received. Market-based inputs are generally used when
calibrating valuation adjustments to market-clearing levels.
In 	addition, 	for 	derivatives 	that 	include 	significant
unobservable inputs, the firm makes model or exit price
adjustments to account for the valuation uncertainty
present in the transaction.
Valuation Techniques and Significant Inputs for
Other Financial Instruments at Fair Value
In addition to trading cash instruments, derivatives, and
certain investments and loans, the firm accounts for certain
of its other financial assets and liabilities at fair value under
the fair value option. Such instruments include repurchase
agreements 	and 	substantially 	all 	resale 	agreements;
securities borrowed and loaned in Fixed Income, Currency
and Commodities (FICC) financing; certain customer and
other receivables, including certain margin loans; certain
time deposits, including structured certificates of deposit,
which are hybrid financial instruments; substantially all
other secured financings, including transfers of assets
accounted for as financings and collateralized central bank
financings; 	certain 	unsecured 	short- 	and 	long-term
borrowings, substantially all of which are hybrid financial
instruments; and other liabilities. These instruments are
generally valued based on discounted cash flow techniques,
which incorporate inputs with reasonable levels of price
transparency, and are generally classified in level 2 because
the inputs are observable. Valuation adjustments may be
made for liquidity and for counterparty and the firm’s
credit quality. The significant inputs used to value the firm’s
other financial instruments are described below.
Resale and Repurchase Agreements and Securities
Borrowed and Loaned. The significant inputs to the
valuation 	of 	resale 	and 	repurchase 	agreements 	and
securities borrowed and loaned are funding spreads, the
amount and timing of expected future cash flows and
interest rates.
Customer and Other Receivables. The significant inputs
to the valuation of receivables are interest rates, the amount
and timing of expected future cash flows and funding
spreads.
Deposits. The significant inputs to the valuation of time
deposits are interest rates and the amount and timing of
future cash flows. The inputs used to value the embedded
derivative component of hybrid financial instruments are
consistent with the inputs used to value the firm’s other
derivative instruments described above. See Note 7 for
further information about derivatives and Note 13 for
further information about deposits.
Other Secured Financings. The significant inputs to the
valuation of other secured financings are the amount and
timing of expected future cash flows, interest rates, funding
spreads, the fair value of the collateral delivered by the firm
(determined using the amount and timing of expected
future cash flows, market prices, market yields and
recovery assumptions) and the frequency of additional
collateral calls. See Note 11 for further information about
other secured financings.
Unsecured Short- and Long-Term Borrowings. The
significant inputs to the valuation of unsecured short- and
long-term borrowings are the amount and timing of
expected future cash flows, interest rates, the credit spreads
of the firm and commodity prices for prepaid commodity
transactions. The inputs used to value the embedded
derivative component of hybrid financial instruments are
consistent with the inputs used to value the firm’s other
derivative instruments described above. See Note 7 for
further information about derivatives and Note 14 for
further information about borrowings.
Other Liabilities. The significant inputs to the valuation of
other liabilities are the amount and timing of expected
future cash flows and equity volatility and correlation
inputs. The inputs used to value the embedded derivative
component of hybrid financial instruments are consistent
with the inputs used to value the firm’s other derivative
instruments described above. See Note 7 for further
information about derivatives.
15 	Goldman Sachs March 2020 Form 10-Q

-- 17 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Financial Assets and Liabilities at Fair Value
The table below presents financial assets and liabilities
accounted for at fair value.
As of
$ in millions
March
2020
December
2019
Total level 1 financial assets 	$ 217,934 	$242,562
Total level 2 financial assets 	440,469 	325,259
Total level 3 financial assets 	30,776 	23,068
Investments in funds at NAV 	3,545 	4,206
Counterparty and cash collateral netting 	(78,612) 	(55,527)
Total financial assets at fair value 	$ 614,112 	$539,568
Total assets 	$1,089,756 	$992,968
Total level 3 financial assets divided by:
Total assets 	2.8% 	2.3%
Total financial assets at fair value 	5.0% 	4.3%
Total level 1 financial liabilities 	$ 	63,117 	$ 54,790
Total level 2 financial liabilities 	320,820 	293,902
Total level 3 financial liabilities 	27,565 	25,938
Counterparty and cash collateral netting 	(60,796) 	(41,671)
Total financial liabilities at fair value 	$ 350,706 	$332,959
Total level 3 financial liabilities divided by
total financial liabilities at fair value 	7.9% 	7.8%
In the table above:
‰ Counterparty netting among positions classified in the
same level is included in that level.
‰ Counterparty and cash collateral netting represents the
impact on derivatives of netting across levels of the fair
value hierarchy.
The table below presents a summary of level 3 financial assets.
As of
$ in millions
March
2020
December
2019
Trading assets:
Trading cash instruments 	$ 	1,234 	$ 	1,242
Derivatives 	7,381 	4,654
Investments 	19,408 	15,282
Loans 	2,753 	1,890
Total 	$ 	30,776 	$ 23,068
Level 3 financial assets as of March 2020 increased
compared with December 2019, primarily reflecting an
increase in level 3 investments. See Notes 5 through 10 for
further information about level 3 financial assets (including
information about unrealized gains and losses related to
level 3 financial assets and transfers in and out of level 3).
Note 5.
Trading Assets and Liabilities
Trading assets and liabilities include trading cash instruments
and derivatives held in connection with the firm’s market-
making or risk management activities. These assets and
liabilities are accounted for at fair value either under the fair
value option or in accordance with other U.S. GAAP, and the
related fair value gains and losses are generally recognized in
the consolidated statements of earnings.
The table below presents a summary of trading assets and
liabilities.
$ in millions
Trading
Assets
Trading
Liabilities
As of March 2020
Trading cash instruments 	$300,900 	$ 74,319
Derivatives 	74,571 	62,039
Total 	$375,471 	$136,358
As of December 2019
Trading cash instruments 	$310,080 	$ 65,033
Derivatives 	45,252 	43,802
Total 	$355,332 	$108,835
See Note 6 for further information about trading cash
instruments and Note 7 for further information about
derivatives.
Gains and Losses from Market Making
The table below presents market making revenues by major
product type.
Three Months
Ended March
$ in millions 	2020 	2019
Interest rates 	$ 	737 	$ 	1,260
Credit 	1,842 	242
Currencies 	(735) 	718
Equities 	1,700 	390
Commodities 	138 	113
Total 	$ 	3,682 	$ 	2,723
In the table above:
‰ Gains/(losses) include both realized and unrealized gains
and losses. Gains/(losses) exclude related interest income
and interest expense. See Note 23 for further information
about interest income and interest expense.
‰ Gains and losses included in market making are primarily
related 	to 	the 	firm’s trading assets and liabilities,
including both derivative and non-derivative financial
instruments.
‰ Gains/(losses) are not representative of the manner in
which the firm manages its business activities because
many of the firm’s market-making and client facilitation
strategies utilize financial instruments across various
product types. Accordingly, gains or losses in one product
type frequently offset gains or losses in other product
types. For example, most of the firm’s longer-term
derivatives across product types are sensitive to changes
in interest rates and may be economically hedged with
interest rate swaps. Similarly, a significant portion of the
firm’s trading cash instruments and derivatives across
product types has exposure to foreign currencies and may
be economically hedged with foreign currency contracts.
Goldman Sachs March 2020 Form 10-Q 	16

-- 18 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 6.
Trading Cash Instruments
Trading cash instruments consists of instruments held in
connection 	with 	the 	firm’s 	market-making 	or 	risk
management activities. These instruments are accounted for
at fair value and the related fair value gains and losses are
recognized in the consolidated statements of earnings.
Fair Value of Trading Cash Instruments by Level
The table below presents trading cash instruments by level
within the fair value hierarchy.
$ in millions 	Level 1 	Level 2 Level 3 	Total
As of March 2020
Assets
Government and agency obligations:
U.S. 	$ 89,564 $ 49,771 $ 	11 $139,346
Non-U.S. 	37,925 	9,493 	16 	47,434
Loans and securities backed by:
Commercial real estate 	– 	2,411 	130 	2,541
Residential real estate 	– 	6,906 	251 	7,157
Corporate debt instruments 	683 	24,804 	719 	26,206
State and municipal obligations 	– 	347 	– 	347
Other debt obligations 	328 	3,206 	34 	3,568
Equity securities 	70,795 	1,191 	73 	72,059
Commodities 	– 	2,242 	– 	2,242
Total 	$199,295 $100,371 $1,234 $300,900
Liabilities
Government and agency obligations:
U.S. 	$ (10,959) $ 	(11) $ 	– $ (10,970)
Non-U.S. 	(23,065) 	(2,445) 	(1) (25,511)
Loans and securities backed by:
Commercial real estate 	– 	(26) 	(1) 	(27)
Residential real estate 	– 	(2) 	– 	(2)
Corporate debt instruments 	(7) 	(8,160) 	(177) 	(8,344)
Other debt obligations 	– 	(5) 	– 	(5)
Equity securities 	(29,037) 	(379) 	(15) (29,431)
Commodities 	– 	(29) 	– 	(29)
Total 	$ (63,068) $ (11,057) $ (194) $ (74,319)
As of December 2019
Assets
Government and agency obligations:
U.S. 	$108,200 $ 34,714 $ 	21 $142,935
Non-U.S. 	33,709 	11,108 	22 	44,839
Loans and securities backed by:
Commercial real estate 	– 	2,031 	191 	2,222
Residential real estate 	– 	5,794 	231 	6,025
Corporate debt instruments 	1,313 	26,768 	692 	28,773
State and municipal obligations 	– 	680 	– 	680
Other debt obligations 	409 	1,074 	10 	1,493
Equity securities 	78,782 	489 	75 	79,346
Commodities 	– 	3,767 	– 	3,767
Total 	$222,413 $ 86,425 $1,242 $310,080
Liabilities
Government and agency obligations:
U.S. 	$ (9,914) $ 	(47) $ 	– $ (9,961)
Non-U.S. 	(21,213) 	(2,205) 	(6) 	(23,424)
Loans and securities backed by:
Commercial real estate 	– 	(31) 	(1) 	(32)
Residential real estate 	– 	(2) 	– 	(2)
Corporate debt instruments 	(115) 	(7,494) 	(253) 	(7,862)
State and Municipal obligations 	– 	(2) 	– 	(2)
Equity securities 	(23,519) 	(212) 	(13) 	(23,744)
Commodities 	– 	(6) 	– 	(6)
Total 	$ (54,761) $ (9,999) $ (273) $ (65,033)
In the table above:
‰ Trading cash instrument assets are shown as positive
amounts and trading cash instrument liabilities are shown
as negative amounts.
‰ Corporate debt instruments includes corporate loans,
debt 	securities, 	convertible 	debentures, 	prepaid
commodity transactions and transfers of assets accounted
for as secured loans rather than purchases.
‰ Equity securities includes public equities and exchange-
traded funds.
‰ Other 	debt 	obligations 	includes 	other 	asset-backed
securities and money market instruments.
See Note 4 for an overview of the firm’s fair value
measurement policies and the valuation techniques and
significant inputs used to determine the fair value of trading
cash instruments.
Significant Unobservable Inputs
The table below presents the amount of level 3 assets, and
ranges and weighted averages of significant unobservable
inputs used to value level 3 trading cash instruments.
Level 3 Assets and Range of Significant
Unobservable Inputs (Weighted Average) as of
$ in millions
March
2020
December
2019
Loans and securities backed by commercial real estate
Level 3 assets 	$130 	$191
Yield 	4.3% to 22.0% (15.5%) 2.7% to 21.7% (13.5%)
Recovery rate 	7.0% to 88.0% (59.9%) 11.4% to 81.1% (55.6%)
Duration (years) 	1.0 to 6.0 (3.3) 	0.3 to 6.6 (2.8)
Loans and securities backed by residential real estate
Level 3 assets 	$251 	$231
Yield 	1.4% to 9.2% (4.4%) 	1.2% to 12.0% (5.8%)
Cumulative loss rate 4.0% to 33.0% (16.0%) 5.4% to 30.4% (16.3%)
Duration (years) 	2.1 to 14.3 (8.3) 	2.3 to 12.4 (5.7)
Corporate debt instruments
Level 3 assets 	$719 	$692
Yield 	2.3% to 46.8% (15.6%) 	0.1% to 20.4% (7.2%)
Recovery rate 	0.0% to 70.0% (55.8%) 0.0% to 69.7% (54.9%)
Duration (years) 	1.3 to 5.6 (3.4) 	1.7 to 16.6 (5.1)
Level 3 government and agency obligations, other debt
obligations and equity securities were not material as of
both March 2020 and December 2019, and therefore are
not included in the table above.
17 	Goldman Sachs March 2020 Form 10-Q

-- 19 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In the table above:
‰ Ranges represent the significant unobservable inputs that
were used in the valuation of each type of trading cash
instrument.
‰ Weighted averages are calculated by weighting each input
by the relative fair value of the trading cash instruments.
‰ The ranges and weighted averages of these inputs are not
representative of the appropriate inputs to use when
calculating the fair value of any one trading cash
instrument. For example, the highest recovery rate for
corporate debt instruments is appropriate for valuing a
specific corporate debt instrument, but may not be
appropriate 	for 	valuing 	any 	other 	corporate 	debt
instrument. Accordingly, the ranges of inputs do not
represent uncertainty in, or possible ranges of, fair value
measurements of level 3 trading cash instruments.
‰ Increases in yield, duration or cumulative loss rate used in
the valuation of level 3 trading cash instruments would
have resulted in a lower fair value measurement, while
increases in recovery rate would have resulted in a higher
fair value measurement as of both March 2020 and
December 2019. Due to the distinctive nature of each
level 3 trading cash instrument, the interrelationship of
inputs is not necessarily uniform within each product
type.
‰ Trading cash instruments are valued using discounted
cash flows.
Level 3 Rollforward
The table below presents a summary of the changes in fair
value for level 3 trading cash instruments.
Three Months
Ended March
$ in millions 	2020 	2019
Total trading cash instrument assets
Beginning balance 	$1,242 	$1,689
Net realized gains/(losses) 	34 	25
Net unrealized gains/(losses) 	(159) 	(11)
Purchases 	353 	111
Sales 	(268) 	(289)
Settlements 	(153) 	(83)
Transfers into level 3 	342 	341
Transfers out of level 3 	(157) 	(193)
Ending balance 	$1,234 	$1,590
Total trading cash instrument liabilities
Beginning balance 	$ (273) 	$ 	(49)
Net realized gains/(losses) 	– 	–
Net unrealized gains/(losses) 	91 	(63)
Purchases 	26 	18
Sales 	(32) 	(52)
Settlements 	(2) 	8
Transfers into level 3 	(13) 	(24)
Transfers out of level 3 	9 	3
Ending balance 	$ (194) 	$ (159)
In the table above:
‰ Changes in fair value are presented for all trading cash
instruments that are classified in level 3 as of the end of
the period.
‰ Net unrealized gains/(losses) relates to trading cash
instruments that were still held at period-end.
‰ Transfers between levels of the fair value hierarchy are
reported at the beginning of the reporting period in which
they occur. If a trading cash instrument was transferred to
level 3 during a reporting period, its entire gain or loss for
the period is classified in level 3.
‰ For level 3 trading cash instrument assets, increases are
shown as positive amounts, while decreases are shown as
negative amounts. For level 3 trading cash instrument
liabilities, increases are shown as negative amounts, while
decreases are shown as positive amounts.
‰ Level 	3 	trading 	cash 	instruments 	are 	frequently
economically hedged with level 1 and level 2 trading cash
instruments and/or level 1, level 2 or level 3 derivatives.
Accordingly, gains or losses that are classified in level 3
can be partially offset by gains or losses attributable to
level 1 or level 2 trading cash instruments and/or level 1,
level 2 or level 3 derivatives. As a result, gains or losses
included in the level 3 rollforward below do not
necessarily represent the overall impact on the firm’s
results of operations, liquidity or capital resources.
Goldman Sachs March 2020 Form 10-Q 	18

-- 20 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information, by product type, for
assets included in the summary table above.
Three Months
Ended March
$ in millions 	2020 	2019
Loans and securities backed by commercial real estate
Beginning balance 	$ 191 	$ 332
Net realized gains/(losses) 	9 	7
Net unrealized gains/(losses) 	(22) 	(6)
Purchases 	14 	12
Sales 	(6) 	(29)
Settlements 	(50) 	(21)
Transfers into level 3 	7 	89
Transfers out of level 3 	(13) 	(13)
Ending balance 	$ 130 	$ 371
Loans and securities backed by residential real estate
Beginning balance 	$ 231 	$ 348
Net realized gains/(losses) 	1 	3
Net unrealized gains/(losses) 	7 	7
Purchases 	80 	18
Sales 	(23) 	(110)
Settlements 	(13) 	(11)
Transfers into level 3 	61 	22
Transfers out of level 3 	(93) 	(14)
Ending balance 	$ 251 	$ 263
Corporate debt instruments
Beginning balance 	$ 692 	$ 912
Net realized gains/(losses) 	22 	13
Net unrealized gains/(losses) 	(132) 	(11)
Purchases 	238 	60
Sales 	(214) 	(135)
Settlements 	(80) 	(45)
Transfers into level 3 	242 	151
Transfers out of level 3 	(49) 	(156)
Ending balance 	$ 719 	$ 789
Other
Beginning balance 	$ 128 	$ 97
Net realized gains/(losses) 	2 	2
Net unrealized gains/(losses) 	(12) 	(1)
Purchases 	21 	21
Sales 	(25) 	(15)
Settlements 	(10) 	(6)
Transfers into level 3 	32 	79
Transfers out of level 3 	(2) 	(10)
Ending balance 	$ 134 	$ 167
In the table above, other includes U.S. and non-U.S.
government and agency obligations, other debt obligations
and equity securities.
Level 3 Rollforward Commentary
Three Months Ended March 2020. The net realized and
unrealized losses on level 3 trading cash instrument assets of
$125 million (reflecting $34 million of net realized gains
and $159 million of net unrealized losses) for the three
months ended March 2020 included gains/(losses) of
$(4) million reported in investment banking, $(158) million
reported in market making and $37 million reported in
interest income.
The net unrealized losses on level 3 trading cash instrument
assets for the three months ended March 2020 primarily
reflected losses on certain corporate debt instruments,
principally driven by weak corporate performance.
Transfers into level 3 trading cash instrument assets during
the three months ended March 2020 primarily reflected
transfers of certain corporate debt instruments from level 2,
principally due to reduced price transparency as a result of a
lack 	of 	market 	evidence, 	including 	fewer 	market
transactions in these instruments.
The drivers of transfers out of level 3 trading cash
instrument 	assets 	during 	the 	three 	months 	ended
March 2020 were not material.
Three Months Ended March 2019. The net realized and
unrealized gains on level 3 trading cash instrument assets of
$14 million (reflecting $25 million of net realized gains and
$11 million of net unrealized losses) for the three months
ended March 2019 included gains/(losses) of $(26) million
reported in market making and $40 million reported in
interest income.
The drivers of net unrealized losses on level 3 trading cash
instrument assets for the three months ended March 2019
were not material.
Transfers into level 3 trading cash instrument assets during
the three months ended March 2019 primarily reflected
transfers of certain corporate debt instruments and loans
and securities backed by commercial real estate from
level 2, principally due to reduced price transparency as a
result of a lack of market evidence, including fewer market
transactions in these instruments.
Transfers out of level 3 trading cash instrument assets
during the three months ended March 2019 primarily
reflected transfers of certain corporate debt instruments to
level 2, principally due to increased price transparency as a
result of market evidence, including market transactions in
these instruments.
19 	Goldman Sachs March 2020 Form 10-Q

-- 21 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 7.
Derivatives and Hedging Activities
Derivative Activities
Derivatives are instruments that derive their value from
underlying asset prices, indices, reference rates and other
inputs, or a combination of these factors. Derivatives may
be traded on an exchange (exchange-traded) or they may be
privately negotiated contracts, which are usually referred to
as OTC derivatives. Certain of the firm’s OTC derivatives
are 	cleared 	and 	settled 	through 	central 	clearing
counterparties (OTC-cleared), while others are bilateral
contracts between two counterparties (bilateral OTC).
Market Making. As a market maker, the firm enters into
derivative transactions to provide liquidity to clients and to
facilitate the transfer and hedging of their risks. In this role,
the firm typically acts as principal and is required to commit
capital to provide execution, and maintains market-making
positions in response to, or in anticipation of, client
demand.
Risk Management. The firm also enters into derivatives to
actively manage risk exposures that arise from its market-
making and investing and financing activities. The firm’s
holdings and exposures are hedged, in many cases, on either
a portfolio or risk-specific basis, as opposed to an
instrument-by-instrument basis. The offsetting impact of
this economic hedging is reflected in the same business
segment as the related revenues. In addition, the firm may
enter into derivatives designated as hedges under U.S.
GAAP. These derivatives are used to manage interest rate
exposure in certain fixed-rate unsecured long-term and
short-term borrowings, and deposits, and to manage
foreign currency exposure on the net investment in certain
non-U.S. operations.
The firm enters into various types of derivatives, including:
‰ Futures 	and 	Forwards. 	Contracts 	that 	commit
counterparties to purchase or sell financial instruments,
commodities or currencies in the future.
‰ Swaps. 	Contracts 	that 	require 	counterparties 	to
exchange cash flows, such as currency or interest
payment streams. The amounts exchanged are based on
the specific terms of the contract with reference to
specified 	rates, 	financial 	instruments, 	commodities,
currencies or indices.
‰ Options. Contracts in which the option purchaser has
the right, but not the obligation, to purchase from or sell
to the option writer financial instruments, commodities
or currencies within a defined time period for a specified
price.
Derivatives are reported on a net-by-counterparty basis
(i.e., the net payable or receivable for derivative assets and
liabilities for a given counterparty) when a legal right of
setoff exists under an enforceable netting agreement
(counterparty netting). Derivatives are accounted for at fair
value, net of cash collateral received or posted under
enforceable credit support agreements (cash collateral
netting). Derivative assets are included in trading assets and
derivative liabilities are included in trading liabilities.
Realized and unrealized gains and losses on derivatives not
designated as hedges are included in market making (for
derivatives included in the Global Markets segment), and
other principal transactions (for derivatives included in the
remaining 	business 	segments) 	in 	the 	consolidated
statements of earnings. For both the three months ended
March 2020 and March 2019, substantially all of the firm’s
derivatives were included in the Global Markets segment.
Goldman Sachs March 2020 Form 10-Q 	20

-- 22 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The tables below present the gross fair value and the
notional amounts of derivative contracts by major product
type, the amounts of counterparty and cash collateral
netting in the consolidated balance sheets, as well as cash
and 	securities 	collateral 	posted 	and 	received 	under
enforceable credit support agreements that do not meet the
criteria for netting under U.S. GAAP.
As of March 2020 	As of December 2019
$ in millions
Derivative
Assets
Derivative
Liabilities
Derivative
Assets
Derivative
Liabilities
Not accounted for as hedges
Exchange-traded 	$ 	1,233 	$ 	1,815 $ 	476 	$ 	856
OTC-cleared 	16,091 	13,947 	9,958 	8,618
Bilateral OTC 	355,084 	323,742 	266,387 	242,046
Total interest rates 	372,408 	339,504 	276,821 	251,520
OTC-cleared 	1,937 	1,735 	6,551 	6,929
Bilateral OTC 	22,215 	20,639 	14,178 	13,860
Total credit 	24,152 	22,374 	20,729 	20,789
Exchange-traded 	78 	27 	35 	10
OTC-cleared 	1,114 	1,229 	411 	391
Bilateral OTC 	130,426 	130,093 	79,887 	81,613
Total currencies 	131,618 	131,349 	80,333 	82,014
Exchange-traded 	6,926 	6,489 	2,390 	2,272
OTC-cleared 	172 	201 	180 	243
Bilateral OTC 	18,434 	23,466 	8,568 	13,034
Total commodities 	25,532 	30,156 	11,138 	15,549
Exchange-traded 	33,169 	35,127 	13,499 	16,976
Bilateral OTC 	54,380 	54,276 	36,162 	39,531
Total equities 	87,549 	89,403 	49,661 	56,507
Subtotal 	641,259 	612,786 	438,682 	426,379
Accounted for as hedges
OTC-cleared 	4 	– 	– 	–
Bilateral OTC 	1,544 	– 	3,182 	1
Total interest rates 	1,548 	– 	3,182 	1
OTC-cleared 	272 	23 	16 	57
Bilateral OTC 	177 	99 	16 	153
Total currencies 	449 	122 	32 	210
Subtotal 	1,997 	122 	3,214 	211
Total gross fair value 	$ 643,256 	$ 612,908 $ 441,896 	$ 426,590
Offset in the consolidated balance sheets
Exchange-traded 	$ (35,739) $ (35,739) $ (14,159) $ (14,159)
OTC-cleared 	(16,855) 	(16,855) 	(15,565) 	(15,565)
Bilateral OTC 	(438,292) 	(438,292) 	(310,920) 	(310,920)
Counterparty netting 	(490,886) 	(490,886) 	(340,644) 	(340,644)
OTC-cleared 	(1,639) 	(49) 	(1,302) 	(526)
Bilateral OTC 	(76,160) 	(59,934) 	(54,698) 	(41,618)
Cash collateral netting 	(77,799) 	(59,983) 	(56,000) 	(42,144)
Total amounts offset 	$(568,685) $(550,869) $(396,644) $(382,788)
Included in the consolidated balance sheets
Exchange-traded 	$ 	5,667 	$ 	7,719 $ 	2,241 	$ 	5,955
OTC-cleared 	1,096 	231 	249 	147
Bilateral OTC 	67,808 	54,089 	42,762 	37,700
Total 	$ 74,571 	$ 62,039 $ 45,252 	$ 43,802
Not offset in the consolidated balance sheets
Cash collateral 	$ 	(1,447) $ 	(2,971) $ 	(604) $ 	(1,603)
Securities collateral 	(18,357) 	(11,940) 	(14,196) 	(9,252)
Total 	$ 54,767 	$ 47,128 $ 30,452 	$ 32,947
Notional Amounts as of
$ in millions
March
2020
December
2019
Not accounted for as hedges
Exchange-traded 	$ 3,881,459 	$ 4,757,300
OTC-cleared 	21,309,964 	13,440,376
Bilateral OTC 	11,550,666 	11,668,171
Total interest rates 	36,742,089 	29,865,847
OTC-cleared 	536,609 	396,342
Bilateral OTC 	825,708 	707,935
Total credit 	1,362,317 	1,104,277
Exchange-traded 	4,822 	4,566
OTC-cleared 	167,487 	134,060
Bilateral OTC 	6,952,771 	5,926,602
Total currencies 	7,125,080 	6,065,228
Exchange-traded 	239,892 	230,018
OTC-cleared 	2,383 	2,639
Bilateral OTC 	241,849 	243,228
Total commodities 	484,124 	475,885
Exchange-traded 	1,071,077 	910,099
Bilateral OTC 	1,075,007 	1,182,335
Total equities 	2,146,084 	2,092,434
Subtotal 	47,859,694 	39,603,671
Accounted for as hedges
OTC-cleared 	148,644 	123,531
Bilateral OTC 	6,741 	9,714
Total interest rates 	155,385 	133,245
OTC-cleared 	3,734 	4,152
Bilateral OTC 	8,882 	9,247
Total currencies 	12,616 	13,399
Subtotal 	168,001 	146,644
Total notional amounts 	$48,027,695 	$39,750,315
In the tables above:
‰ Gross fair values exclude the effects of both counterparty
netting 	and 	collateral, 	and 	therefore 	are 	not
representative of the firm’s exposure.
‰ Where the firm has received or posted collateral under
credit support agreements, but has not yet determined
such agreements are enforceable, the related collateral has
not been netted.
‰ Notional amounts, which represent the sum of gross long
and short derivative contracts, provide an indication of
the volume of the firm’s derivative activity and do not
represent anticipated losses.
‰ Total gross fair value of derivatives included derivative
assets of $17.15 billion as of March 2020 and $9.15 billion
as 	of 	December 	2019, 	and 	derivative 	liabilities 	of
$20.35 billion as of March 2020 and $14.88 billion as of
December 2019, which are not subject to an enforceable
netting agreement or are subject to a netting agreement that
the firm has not yet determined to be enforceable.
‰ During the first quarter of 2020, consistent with the rules
of a clearing organization, the firm elected to consider its
transactions with that clearing organization as settled each
day. The impact of this change would have been a
reduction in gross credit derivative assets of $3.97 billion
and liabilities of $4.15 billion as of December 2019, and a
corresponding decrease in counterparty and cash collateral
netting, with no impact to the consolidated balance sheets.
21 	Goldman Sachs March 2020 Form 10-Q

-- 23 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Fair Value of Derivatives by Level
The table below presents derivatives on a gross basis by
level and product type, as well as the impact of netting.
$ in millions 	Level 1 	Level 2 	Level 3 	Total
As of March 2020
Assets
Interest rates 	$ 18 $ 373,085 $ 	853 $ 373,956
Credit 	– 	19,560 	4,592 	24,152
Currencies 	– 	131,624 	443 	132,067
Commodities 	– 	24,784 	748 	25,532
Equities 	13 	85,247 	2,289 	87,549
Gross fair value 	31 	634,300 	8,925 	643,256
Counterparty netting in levels 	– 	(488,529) 	(1,544) 	(490,073)
Subtotal 	$ 31 $ 145,771 $ 7,381 $ 153,183
Cross-level counterparty netting 	(813)
Cash collateral netting 	(77,799)
Net fair value 	$ 74,571
Liabilities
Interest rates 	$(32) $(338,885) $ (587) $(339,504)
Credit 	– 	(20,300) 	(2,074) 	(22,374)
Currencies 	– 	(131,089) 	(382) 	(131,471)
Commodities 	– 	(29,796) 	(360) 	(30,156)
Equities 	(17) 	(85,524) 	(3,862) 	(89,403)
Gross fair value 	(49) 	(605,594) 	(7,265) 	(612,908)
Counterparty netting in levels 	– 	488,529 	1,544 	490,073
Subtotal 	$(49) $(117,065) $(5,721) $(122,835)
Cross-level counterparty netting 	813
Cash collateral netting 	59,983
Net fair value 	$ (62,039)
As of December 2019
Assets
Interest rates 	$ 3 $ 279,443 $ 	557 $ 280,003
Credit 	– 	17,204 	3,525 	20,729
Currencies 	– 	80,178 	187 	80,365
Commodities 	– 	10,648 	490 	11,138
Equities 	21 	48,953 	687 	49,661
Gross fair value 	24 	436,426 	5,446 	441,896
Counterparty netting in levels 	– 	(340,325) 	(792) 	(341,117)
Subtotal 	$ 24 $ 96,101 $ 4,654 $ 100,779
Cross-level counterparty netting 	473
Cash collateral netting 	(56,000)
Net fair value 	$ 45,252
Liabilities
Interest rates 	$ (3) $(251,050) $ (468) $(251,521)
Credit 	– 	(19,141) 	(1,648) 	(20,789)
Currencies 	– 	(81,826) 	(398) 	(82,224)
Commodities 	– 	(15,306) 	(243) 	(15,549)
Equities 	(26) 	(53,817) 	(2,664) 	(56,507)
Gross fair value 	(29) 	(421,140) 	(5,421) 	(426,590)
Counterparty netting in levels 	– 	340,325 	792 	341,117
Subtotal 	$(29) $ (80,815) $(4,629) $ (85,473)
Cross-level counterparty netting 	(473)
Cash collateral netting 	42,144
Net fair value 	$ (43,802)
In the table above:
‰ Gross fair values exclude the effects of both counterparty
netting and collateral netting, and therefore are not
representative of the firm’s exposure.
‰ Counterparty netting is reflected in each level to the
extent that receivable and payable balances are netted
within the same level and is included in counterparty
netting in levels. Where the counterparty netting is across
levels, the netting is included in cross-level counterparty
netting.
‰ Derivative assets are shown as positive amounts and
derivative liabilities are shown as negative amounts.
See Note 4 for an overview of the firm’s fair value
measurement policies and the valuation techniques and
significant inputs used to determine the fair value of
derivatives.
Significant Unobservable Inputs
The table below presents the amount of level 3 derivative
assets (liabilities), and ranges, averages and medians of
significant unobservable inputs used to value level 3
derivatives.
Level 3 Assets (Liabilities) and Range of Significant
Unobservable Inputs (Average/Median) as of
$ in millions, except inputs
March
2020
December
2019
Interest rates, net 	$266 	$89
Correlation 	(42)% to 81% (52%/62%) (42)% to 81% (52%/60%)
Volatility (bps) 	31 to 150 (70/61) 	31 to 150 (70/61)
Credit, net 	$2,518 	$1,877
Credit spreads (bps) 	2 to 872 (154/95) 	1 to 559 (96/53)
Upfront credit points 	1 to 95 (32/25) 	2 to 90 (38/32)
Recovery rates 	1% to 70% (35%/38%) 	10% to 60% (31%/25%)
Currencies, net 	$61 	$(211)
Correlation 	20% to 70% (39%/41%) 	20% to 70% (37%/36%)
Commodities, net 	$388 	$247
Volatility 	15% to 187% (45%/42%) 	9% to 57% (26%/25%)
Natural gas spread 	$(1.31) to $1.50
($(0.15)/$(0.09))
$(1.93) to $1.69
($(0.16)/$(0.17))
Oil spread 	$(4.71) to $18.31
($3.92/$1.26)
$(4.86) to $19.77
($9.82/$11.15)
Equities, net 	$(1,573) 	$(1,977)
Correlation 	(70)% to 99% (53%/62%) (70)% to 99% (42%/45%)
Volatility 	2% to 129% (27%/20%) 	2% to 72% (14%/7%)
In the table above:
‰ Derivative assets are shown as positive amounts and
derivative liabilities are shown as negative amounts.
‰ Ranges represent the significant unobservable inputs that
were used in the valuation of each type of derivative.
‰ Averages represent the arithmetic average of the inputs
and are not weighted by the relative fair value or notional
of the respective financial instruments. An average greater
than the median indicates that the majority of inputs are
below the average. For example, the difference between
the average and the median for credit spreads indicates
that the majority of the inputs fall in the lower end of the
range.
Goldman Sachs March 2020 Form 10-Q 	22

-- 24 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
‰ The ranges, averages and medians of these inputs are not
representative of the appropriate inputs to use when
calculating the fair value of any one derivative. For
example, 	the 	highest 	correlation 	for 	interest 	rate
derivatives is appropriate for valuing a specific interest
rate derivative but may not be appropriate for valuing any
other interest rate derivative. Accordingly, the ranges of
inputs do not represent uncertainty in, or possible ranges
of, fair value measurements of level 3 derivatives.
‰ Interest rates, currencies and equities derivatives are
valued using option pricing models, credit derivatives are
valued using option pricing, correlation and discounted
cash flow models, and commodities derivatives are valued
using option pricing and discounted cash flow models.
‰ The fair value of any one instrument may be determined
using multiple valuation techniques. For example, option
pricing models and discounted cash flows models are
typically used together to determine fair value. Therefore,
the level 3 balance encompasses both of these techniques.
‰ Correlation within currencies and equities includes cross-
product type correlation.
‰ Natural gas spread represents the spread per million
British thermal units of natural gas.
‰ Oil spread represents the spread per barrel of oil and
refined products.
Range of Significant Unobservable Inputs
The following provides information about the ranges of
significant unobservable inputs used to value the firm’s
level 3 derivative instruments:
‰ Correlation. Ranges for correlation cover a variety of
underliers both within one product type (e.g., equity
index and equity single stock names) and across product
types (e.g., correlation of an interest rate and a currency),
as well as across regions. Generally, cross-product type
correlation inputs are used to value more complex
instruments and are lower than correlation inputs on
assets within the same derivative product type.
‰ Volatility. 	Ranges 	for 	volatility 	cover 	numerous
underliers across a variety of markets, maturities and
strike prices. For example, volatility of equity indices is
generally lower than volatility of single stocks.
‰ Credit spreads, upfront credit points and recovery
rates. The ranges for credit spreads, upfront credit points
and recovery rates cover a variety of underliers (index and
single names), regions, sectors, maturities and credit
qualities (high-yield and investment-grade). The broad
range of this population gives rise to the width of the
ranges of significant unobservable inputs.
‰ Commodity prices and spreads. The ranges for
commodity 	prices 	and 	spreads cover variability in
products, maturities and delivery locations.
Sensitivity of Fair Value Measurement to Changes
in Significant Unobservable Inputs
The following is a description of the directional sensitivity
of the firm’s level 3 fair value measurements to changes in
significant unobservable inputs, in isolation, as of each
period-end:
‰ Correlation. In general, for contracts where the holder
benefits from the convergence of the underlying asset or
index prices (e.g., interest rates, credit spreads, foreign
exchange rates, inflation rates and equity prices), an
increase in correlation results in a higher fair value
measurement.
‰ Volatility. In general, for purchased options, an increase
in volatility results in a higher fair value measurement.
‰ Credit spreads, upfront credit points and recovery
rates. In general, the fair value of purchased credit
protection increases as credit spreads or upfront credit
points increase or recovery rates decrease. Credit spreads,
upfront credit points and recovery rates are strongly
related to distinctive risk factors of the underlying
reference obligations, which include reference entity-
specific factors, such as leverage, volatility and industry,
market-based risk factors, such as borrowing costs or
liquidity of the underlying reference obligation, and
macroeconomic conditions.
‰ Commodity prices and spreads. In general, for
contracts where the holder is receiving a commodity, an
increase in the spread (price difference from a benchmark
index due to differences in quality or delivery location) or
price results in a higher fair value measurement.
Due to the distinctive nature of each of the firm’s level 3
derivatives, the interrelationship of inputs is not necessarily
uniform within each product type.
23 	Goldman Sachs March 2020 Form 10-Q

-- 25 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Level 3 Rollforward
The table below presents a summary of the changes in fair
value for level 3 derivatives.
Three Months
Ended March
$ in millions 	2020 	2019
Total level 3 derivatives, net
Beginning balance 	$ 	25 	$ 	590
Net realized gains/(losses) 	137 	49
Net unrealized gains/(losses) 	2,305 	(91)
Purchases 	223 	110
Sales 	(413) 	(1,574)
Settlements 	41 	384
Transfers into level 3 	(801) 	(34)
Transfers out of level 3 	143 	(122)
Ending balance 	$1,660 	$ (688)
In the table above:
‰ Changes in fair value are presented for all derivative
assets and liabilities that are classified in level 3 as of the
end of the period.
‰ Net unrealized gains/(losses) relates to instruments that
were still held at period-end.
‰ Transfers between levels of the fair value hierarchy are
reported at the beginning of the reporting period in which
they occur. If a derivative was transferred into level 3
during a reporting period, its entire gain or loss for the
period is classified in level 3.
‰ Positive amounts for transfers into level 3 and negative
amounts for transfers out of level 3 represent net transfers
of derivative assets. Negative amounts for transfers into
level 3 and positive amounts for transfers out of level 3
represent net transfers of derivative liabilities.
‰ A derivative with level 1 and/or level 2 inputs is classified
in level 3 in its entirety if it has at least one significant
level 3 input.
‰ If there is one significant level 3 input, the entire gain or
loss from adjusting only observable inputs (i.e., level 1
and level 2 inputs) is classified in level 3.
‰ Gains or losses that have been classified in level 3
resulting from changes in level 1 or level 2 inputs are
frequently offset by gains or losses attributable to level 1
or level 2 derivatives and/or level 1, level 2 and level 3
trading cash instruments. As a result, gains/(losses)
included in the level 3 rollforward below do not
necessarily represent the overall impact on the firm’s
results of operations, liquidity or capital resources.
The table below presents information, by product type, for
derivatives included in the summary table above.
Three Months
Ended March
$ in millions 	2020 	2019
Interest rates, net
Beginning balance 	$ 	89 	$ (109)
Net realized gains/(losses) 	7 	–
Net unrealized gains/(losses) 	132 	111
Purchases 	1 	2
Sales 	(13) 	(4)
Settlements 	37 	(17)
Transfers into level 3 	11 	(11)
Transfers out of level 3 	2 	9
Ending balance 	$ 	266 	$ 	(19)
Credit, net
Beginning balance 	$ 1,877 	$ 1,672
Net realized gains/(losses) 	(20) 	8
Net unrealized gains/(losses) 	652 	80
Purchases 	53 	42
Sales 	(27) 	(28)
Settlements 	(55) 	(32)
Transfers into level 3 	11 	55
Transfers out of level 3 	27 	77
Ending balance 	$ 2,518 	$ 1,874
Currencies, net
Beginning balance 	$ (211) 	$ 	461
Net realized gains/(losses) 	(6) 	(12)
Net unrealized gains/(losses) 	185 	(131)
Purchases 	– 	2
Sales 	(11) 	(16)
Settlements 	111 	29
Transfers into level 3 	(4) 	(1)
Transfers out of level 3 	(3) 	(303)
Ending balance 	$ 	61 	$ 	29
Commodities, net
Beginning balance 	$ 	247 	$ 	112
Net realized gains/(losses) 	17 	18
Net unrealized gains/(losses) 	197 	15
Purchases 	22 	3
Sales 	(69) 	(6)
Settlements 	(7) 	(12)
Transfers into level 3 	(11) 	(8)
Transfers out of level 3 	(8) 	23
Ending balance 	$ 	388 	$ 	145
Equities, net
Beginning balance 	$(1,977) 	$(1,546)
Net realized gains/(losses) 	139 	35
Net unrealized gains/(losses) 	1,139 	(166)
Purchases 	147 	61
Sales 	(293) 	(1,520)
Settlements 	(45) 	416
Transfers into level 3 	(808) 	(69)
Transfers out of level 3 	125 	72
Ending balance 	$(1,573) 	$(2,717)
Level 3 Rollforward Commentary
Three Months Ended March 2020. The net realized and
unrealized gains on level 3 derivatives of $2.44 billion
(reflecting 	$137 	million 	of 	net 	realized 	gains 	and
$2.31 billion of net unrealized gains) for the three months
ended March 2020 included gains of $2.42 billion reported
in market making and $23 million reported in other
principal transactions.
Goldman Sachs March 2020 Form 10-Q 	24

-- 26 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The net unrealized gains on level 3 derivatives for the three
months ended March 2020 were primarily attributable to
gains on certain equity derivatives (primarily reflecting the
impact of a decrease in equity prices), gains on certain credit
derivatives (primarily reflecting the impact of a decrease in
interest rates and widening of certain credit spreads), gains
on certain commodity derivatives (primarily reflecting the
impact of a decrease in commodity prices), gains on certain
currency derivatives (primarily reflecting the impact of
changes in foreign exchange rates) and gains on certain
interest rate derivatives (primarily reflecting a decrease in
interest rates).
Transfers into level 3 derivatives during the three months
ended March 2020 primarily reflected transfers of certain
equity derivative liabilities from level 2, principally due to
increased significance of certain unobservable inputs used
to value these derivatives.
Transfers out of level 3 derivatives during the three months
ended March 2020 primarily reflected transfers of certain
equity derivative liabilities to level 2, principally due to
increased transparency of certain unobservable volatility
inputs used to value these derivatives.
Three Months Ended March 2019. The net realized and
unrealized losses on level 3 derivatives of $42 million
(reflecting $49 million of net realized gains and $91 million
of net unrealized losses) for the three months ended
March 2019 included losses of $28 million reported in
market making and $14 million reported in other principal
transactions.
The net unrealized losses on level 3 derivatives for the three
months ended March 2019 were primarily attributable to
losses on certain equity derivatives (primarily reflecting the
impact of an increase in equity prices), losses on certain
currency derivatives (primarily reflecting the impact of a
decrease in interest rates), partially offset by gains on
certain interest rate derivatives (primarily reflecting the
impact of a decrease in interest rates and changes in foreign
exchange rates).
The drivers of transfers into level 3 derivatives during the
three months ended March 2019 were not material.
Transfers out of level 3 derivatives during the three months
ended March 2019 primarily reflected transfers of certain
currency derivative assets to level 2, principally due to
certain unobservable inputs no longer being significant to
the valuation of these derivatives, partially offset by
transfers of certain credit derivative liabilities to level 2,
principally due to certain unobservable credit spread inputs
no longer being significant to the valuation of these
derivatives, and transfers of certain equity derivative
liabilities 	to 	level 	2, 	principally 	due 	to 	increased
transparency and reduced significance of volatility and
correlation inputs used to value these derivatives.
OTC Derivatives
The table below presents OTC derivative assets and
liabilities by tenor and major product type.
$ in millions
Less than
1 Year
1 - 5
Years
Greater than
5 Years 	Total
As of March 2020
Assets
Interest rates 	$ 9,971 $21,382 	$70,611 $101,964
Credit 	1,776 	4,342 	4,306 	10,424
Currencies 	21,673 	6,428 	8,945 	37,046
Commodities 	6,741 	2,486 	512 	9,739
Equities 	11,562 	7,238 	3,169 	21,969
Counterparty netting in tenors 	(4,734) 	(5,006) 	(3,722) 	(13,462)
Subtotal 	$46,989 $36,870 	$83,821 $167,680
Cross-tenor counterparty netting 	(20,977)
Cash collateral netting 	(77,799)
Total OTC derivative assets 	$ 68,904
Liabilities
Interest rates 	$ 8,157 $12,908 	$45,859 $ 66,924
Credit 	1,817 	4,433 	2,399 	8,649
Currencies 	17,701 	11,104 	7,700 	36,505
Commodities 	7,790 	2,711 	4,299 	14,800
Equities 	9,567 	7,999 	4,298 	21,864
Counterparty netting in tenors 	(4,734) 	(5,006) 	(3,722) 	(13,462)
Subtotal 	$40,298 $34,149 	$60,833 $135,280
Cross-tenor counterparty netting 	(20,977)
Cash collateral netting 	(59,983)
Total OTC derivative liabilities 	$ 54,320
As of December 2019
Assets
Interest rates 	$ 5,521 $15,183 	$57,394 $ 78,098
Credit 	678 	3,259 	3,183 	7,120
Currencies 	10,236 	5,063 	6,245 	21,544
Commodities 	2,507 	1,212 	302 	4,021
Equities 	7,332 	4,509 	1,294 	13,135
Counterparty netting in tenors 	(3,263) 	(3,673) 	(2,332) 	(9,268)
Subtotal 	$23,011 $25,553 	$66,086 $114,650
Cross-tenor counterparty netting 	(15,639)
Cash collateral netting 	(56,000)
Total OTC derivative assets 	$ 43,011
Liabilities
Interest rates 	$ 3,654 $ 9,113 	$36,470 $ 49,237
Credit 	1,368 	4,052 	1,760 	7,180
Currencies 	12,486 	6,906 	4,036 	23,428
Commodities 	2,796 	1,950 	3,804 	8,550
Equities 	5,755 	7,381 	3,367 	16,503
Counterparty netting in tenors 	(3,263) 	(3,673) 	(2,332) 	(9,268)
Subtotal 	$22,796 $25,729 	$47,105 $ 95,630
Cross-tenor counterparty netting 	(15,639)
Cash collateral netting 	(42,144)
Total OTC derivative liabilities 	$ 37,847
In the table above:
‰ Tenor is based on remaining contractual maturity.
‰ Counterparty netting within the same product type and
tenor category is included within such product type and
tenor category.
‰ Counterparty netting across product types within the
same tenor category is included in counterparty netting in
tenors. Where the counterparty netting is across tenor
categories, 	the 	netting 	is 	included 	in 	cross-tenor
counterparty netting.
25 	Goldman Sachs March 2020 Form 10-Q

-- 27 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Credit Derivatives
The firm enters into a broad array of credit derivatives to
facilitate client transactions and to manage the credit risk
associated with market-making and investing and financing
activities. Credit derivatives are actively managed based on
the firm’s net risk position. Credit derivatives are generally
individually negotiated contracts and can have various
settlement and payment conventions. Credit events include
failure to pay, bankruptcy, acceleration of indebtedness,
restructuring, repudiation and dissolution of the reference
entity.
The 	firm 	enters 	into 	the 	following 	types 	of 	credit
derivatives:
‰ Credit Default Swaps. Single-name credit default swaps
protect the buyer against the loss of principal on one or
more bonds, loans or mortgages (reference obligations) in
the event the issuer of the reference obligations suffers a
credit event. The buyer of protection pays an initial or
periodic premium to the seller and receives protection for
the period of the contract. If there is no credit event, as
defined in the contract, the seller of protection makes no
payments to the buyer. If a credit event occurs, the seller
of protection is required to make a payment to the buyer,
calculated according to the terms of the contract.
‰ Credit Options. In a credit option, the option writer
assumes the obligation to purchase or sell a reference
obligation at a specified price or credit spread. The option
purchaser buys the right, but does not assume the
obligation, to sell the reference obligation to, or purchase
it from, the option writer. The payments on credit options
depend either on a particular credit spread or the price of
the reference obligation.
‰ Credit 	Indices, 	Baskets 	and 	Tranches. 	Credit
derivatives may reference a basket of single-name credit
default swaps or a broad-based index. If a credit event
occurs in one of the underlying reference obligations, the
protection seller pays the protection buyer. The payment
is typically a pro-rata portion of the transaction’s total
notional amount based on the underlying defaulted
reference obligation. In certain transactions, the credit
risk of a basket or index is separated into various portions
(tranches), each having different levels of subordination.
The most junior tranches cover initial defaults and once
losses exceed the notional amount of these junior
tranches, any excess loss is covered by the next most
senior tranche.
‰ Total Return Swaps. A total return swap transfers the
risks relating to economic performance of a reference
obligation from the protection buyer to the protection
seller. Typically, the protection buyer receives a floating
rate of interest and protection against any reduction in
fair value of the reference obligation, and the protection
seller receives the cash flows associated with the reference
obligation, plus any increase in the fair value of the
reference obligation.
The firm economically hedges its exposure to written credit
derivatives primarily by entering into offsetting purchased
credit derivatives with identical underliers. Substantially all
of the firm’s purchased credit derivative transactions are
with financial institutions and are subject to stringent
collateral thresholds. In addition, upon the occurrence of a
specified trigger event, the firm may take possession of the
reference obligations underlying a particular written credit
derivative, and consequently may, upon liquidation of the
reference obligations, recover amounts on the underlying
reference obligations in the event of default.
As of March 2020, written credit derivatives had a total
gross notional amount of $657.12 billion and purchased
credit derivatives had a total gross notional amount of
$705.20 billion, for total net notional purchased protection
of $48.08 billion. As of December 2019, written credit
derivatives 	had 	a 	total 	gross 	notional 	amount 	of
$522.57 billion and purchased credit derivatives had a total
gross notional amount of $581.76 billion, for total net
notional purchased protection of $59.19 billion. The firm’s
written and purchased credit derivatives primarily consist
of credit default swaps.
Goldman Sachs March 2020 Form 10-Q 	26

-- 28 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The 	table 	below 	presents 	information 	about 	credit
derivatives.
Credit Spread on Underlier (basis points)
$ in millions 	0 - 250
251 -
500
501 -
1,000
Greater
than
1,000 	Total
As of March 2020
Maximum Payout/Notional Amount of Written Credit Derivatives by Tenor
Less than 1 year 	$167,856 $ 3,283 $17,312 $ 4,882 $193,333
1 – 5 years 	303,456 	25,507 	16,341 	17,346 	362,650
Greater than 5 years 	91,017 	5,570 	3,038 	1,509 	101,134
Total 	$562,329 $34,360 $36,691 $23,737 $657,117
Maximum Payout/Notional Amount of Purchased Credit Derivatives
Offsetting 	$476,787 $29,983 $24,949 $21,639 $553,358
Other 	$127,244 $ 6,841 $12,957 $ 4,801 $151,843
Fair Value of Written Credit Derivatives
Asset 	$ 	3,833 $ 	246 $ 	30 $ 	51 $ 	4,160
Liability 	4,333 	1,939 	3,304 	8,237 	17,813
Net asset/(liability) 	$ 	(500) $ (1,693) $ (3,274) $ (8,186) $ (13,653)
As of December 2019
Maximum Payout/Notional Amount of Written Credit Derivatives by Tenor
Less than 1 year 	$143,566 $ 7,155 $ 	759 $ 2,953 $154,433
1 – 5 years 	292,444 	10,125 	5,482 	8,735 	316,786
Greater than 5 years 	48,109 	2,260 	427 	554 	51,350
Total 	$484,119 $19,540 $ 6,668 $12,242 $522,569
Maximum Payout/Notional Amount of Purchased Credit Derivatives
Offsetting 	$395,127 $14,492 $ 5,938 $10,543 $426,100
Other 	$149,092 $ 2,617 $ 1,599 $ 2,354 $155,662
Fair Value of Written Credit Derivatives
Asset 	$ 13,103 $ 	446 $ 	160 $ 	202 $ 13,911
Liability 	1,239 	448 	372 	3,490 	5,549
Net asset/(liability) 	$ 11,864 $ 	(2) $ 	(212) $ (3,288) $ 	8,362
In the table above:
‰ Fair values exclude the effects of both netting of
receivable 	balances 	with 	payable 	balances 	under
enforceable netting agreements, and netting of cash
received or posted under enforceable credit support
agreements, and therefore are not representative of the
firm’s credit exposure.
‰ Tenor is based on remaining contractual maturity.
‰ The credit spread on the underlier, together with the tenor
of the contract, are indicators of payment/performance
risk. The firm is less likely to pay or otherwise be required
to perform where the credit spread and the tenor are
lower.
‰ Offsetting purchased credit derivatives represent the
notional amount of purchased credit derivatives that
economically 	hedge 	written 	credit 	derivatives 	with
identical underliers.
‰ Other purchased credit derivatives represent the notional
amount of all other purchased credit derivatives not
included in offsetting.
Impact of Credit and Funding Spreads on Derivatives
The firm realizes gains or losses on its derivative contracts.
These gains or losses include credit valuation adjustments
(CVA) relating to uncollateralized derivative assets and
liabilities, which represents the gains or losses (including
hedges) attributable to the impact of changes in credit
exposure, counterparty credit spreads, liability funding
spreads (which includes the firm’s own credit), probability
of default and assumed recovery. These gains or losses also
include funding valuation adjustments (FVA) relating to
uncollateralized derivative assets, which represents the
gains or losses (including hedges) attributable to the impact
of changes in expected funding exposures and funding
spreads.
The table below presents information about CVA and FVA.
Three Months
Ended March
$ in millions 	2020 	2019
CVA, net of hedges 	$ 	271 	$ 	(163)
FVA, net of hedges 	(759) 	234
Total 	$ 	(488) 	$ 	71
Bifurcated Embedded Derivatives
The table below presents the fair value and the notional
amount of derivatives that have been bifurcated from their
related borrowings.
As of
$ in millions
March
2020
December
2019
Fair value of assets 	$ 1,361 	$ 1,148
Fair value of liabilities 	1,715 	1,717
Net liability 	$ 	354 	$ 	569
Notional amount 	$11,280 	$11,003
In the table above, derivatives that have been bifurcated
from their related borrowings are recorded at fair value and
primarily consist of interest rate, equity and commodity
products. These derivatives are included in unsecured short-
and long-term borrowings with the related borrowings.
Derivatives with Credit-Related Contingent Features
Certain of the firm’s derivatives have been transacted under
bilateral agreements with counterparties who may require
the firm to post collateral or terminate the transactions
based on changes in the firm’s credit ratings. The firm
assesses the impact of these bilateral agreements by
determining the collateral or termination payments that
would occur assuming a downgrade by all rating agencies.
A downgrade by any one rating agency, depending on the
agency’s relative ratings of the firm at the time of the
downgrade, may have an impact which is comparable to
the impact of a downgrade by all rating agencies.
27 	Goldman Sachs March 2020 Form 10-Q

-- 29 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information about net derivative
liabilities under bilateral agreements (excluding collateral
posted), the fair value of collateral posted and additional
collateral or termination payments that could have been
called by counterparties in the event of a one- or two-notch
downgrade in the firm’s credit ratings.
As of
$ in millions
March
2020
December
2019
Net derivative liabilities under bilateral agreements $49,450 	$32,800
Collateral posted 	$42,925 	$28,510
Additional collateral or termination payments:
One-notch downgrade 	$ 	364 	$ 	358
Two-notch downgrade 	$ 	922 	$ 1,268
Hedge Accounting
The firm applies hedge accounting for (i) certain interest
rate swaps used to manage the interest rate exposure of
certain fixed-rate unsecured long-term and short-term
borrowings and certain fixed-rate certificates of deposit and
(ii) certain foreign currency forward contracts and foreign
currency-denominated 	debt 	used 	to 	manage 	foreign
currency exposures on the firm’s net investment in certain
non-U.S. operations.
To qualify for hedge accounting, the hedging instrument
must be highly effective at reducing the risk from the
exposure 	being 	hedged. 	Additionally, 	the 	firm 	must
formally document the hedging relationship at inception
and assess the hedging relationship at least on a quarterly
basis to ensure the hedging instrument continues to be
highly effective over the life of the hedging relationship.
Fair Value Hedges
The firm designates certain interest rate swaps as fair value
hedges of certain fixed-rate unsecured long-term and short-
term debt and fixed-rate certificates of deposit. These
interest rate swaps hedge changes in fair value attributable
to the designated benchmark interest rate (e.g., London
Interbank Offered Rate (LIBOR) or Overnight Index Swap
Rate), effectively converting a substantial portion of fixed-
rate obligations into floating-rate obligations.
The firm applies a statistical method that utilizes regression
analysis when assessing the effectiveness of its fair value
hedging relationships in achieving offsetting changes in the
fair values of the hedging instrument and the risk being
hedged (i.e., interest rate risk). An interest rate swap is
considered highly effective in offsetting changes in fair value
attributable to changes in the hedged risk when the
regression analysis results in a coefficient of determination
of 80% or greater and a slope between 80% and 125%.
For qualifying fair value hedges, gains or losses on
derivatives are included in interest expense. The change in
fair value of the hedged item attributable to the risk being
hedged is reported as an adjustment to its carrying value
(hedging adjustment) and is also included in interest
expense. When a derivative is no longer designated as a
hedge, any remaining difference between the carrying value
and par value of the hedged item is amortized to interest
expense over the remaining life of the hedged item using the
effective 	interest 	method. 	See 	Note 	23 	for 	further
information about interest income and interest expense.
The table below presents the gains/(losses) from interest
rate derivatives accounted for as hedges and the related
hedged borrowings and deposits, and total interest expense.
Three Months
Ended March
$ in millions 	2020 	2019
Interest rate hedges 	$ 	6,586 	$ 1,256
Hedged borrowings and deposits 	$ (6,679) 	$ (1,351)
Interest expense 	$ 	3,437 	$ 4,379
In the table above, the difference between gains/(losses)
from interest rate hedges and hedged borrowings and
deposits was primarily due to the amortization of prepaid
credit spreads resulting from the passage of time.
The table below presents the carrying value of the hedged
items designated in a hedging relationship and the related
cumulative hedging adjustment (increase/(decrease)) from
current and prior hedging relationships included in such
carrying values.
$ in millions
Carrying
Value
Cumulative
Hedging
Adjustment
As of March 2020
Deposits 	$ 19,660 	$ 	783
Unsecured short-term borrowings 	$ 	7,171 	$ 	61
Unsecured long-term borrowings 	$103,057 	$12,527
As of December 2019
Deposits 	$ 19,634 	$ 	200
Unsecured short-term borrowings 	$ 	6,008 	$ 	28
Unsecured long-term borrowings 	$ 87,874 	$ 7,292
In the table above, cumulative hedging adjustment included
$3.81 billion as of March 2020 and $3.48 billion as of
December 2019 of hedging adjustments from prior hedging
relationships that were de-designated and substantially all
were related to unsecured long-term borrowings.
In addition, cumulative hedging adjustments for items no
longer 	designated 	in 	a 	hedging 	relationship 	were
$1.25 billion as of March 2020 and $425 million as of
December 2019 and substantially all were related to
unsecured long-term borrowings.
Goldman Sachs March 2020 Form 10-Q 	28

-- 30 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Net Investment Hedges
The firm seeks to reduce the impact of fluctuations in
foreign exchange rates on its net investments in certain
non-U.S. operations through the use of foreign currency
forward contracts and foreign currency-denominated debt.
For foreign currency forward contracts designated as
hedges, the effectiveness of the hedge is assessed based on
the overall changes in the fair value of the forward contracts
(i.e., based on changes in forward rates). For foreign
currency-denominated debt designated as a hedge, the
effectiveness of the hedge is assessed based on changes in
spot rates. For qualifying net investment hedges, all gains or
losses on the hedging instruments are included in currency
translation.
The table below presents the gains/(losses) from net
investment hedging.
Three Months
Ended March
$ in millions 	2020 	2019
Hedges:
Foreign currency forward contract 	$756 	$14
Foreign currency-denominated debt 	$ (21) 	$31
Gains or losses on individual net investments in non-U.S.
operations are reclassified to earnings from accumulated
other 	comprehensive 	income/(loss) 	when 	such 	net
investments are sold or substantially liquidated. The gross
and net gains and losses on hedges and the related net
investments in non-U.S. operations reclassified to earnings
from accumulated other comprehensive income/(loss) were
not material for both the three months ended March 2020
and March 2019.
The firm had designated $3.52 billion as of March 2020
and $3.05 billion as of December 2019 of foreign currency-
denominated debt, included in unsecured long-term and
short-term borrowings, as hedges of net investments in
non-U.S. subsidiaries.
Note 8.
Investments
Investments includes debt instruments and equity securities
that are accounted for at fair value and are generally held by
the 	firm 	in 	connection 	with 	its 	long-term 	investing
activities. In addition, investments includes debt securities
classified as available-for-sale and held-to-maturity that are
generally held in connection with the firm’s asset-liability
management activities. Investments also consists of equity
securities that are accounted for under the equity method.
The table below presents information about investments.
As of
$ in millions
March
2020
December
2019
Equity securities, at fair value 	$21,221 	$22,163
Debt instruments, at fair value 	23,145 	16,570
Available-for-sale securities, at fair value 	18,289 	19,094
Investments, at fair value 	62,655 	57,827
Held-to-maturity securities 	5,756 	5,825
Equity method investments 	283 	285
Total investments 	$68,694 	$63,937
Equity Securities and Debt Instruments, at Fair Value
Equity securities and debt instruments, at fair value are
accounted for at fair value either under the fair value option
or in accordance with other U.S. GAAP, and the related fair
value gains and losses are recognized in earnings.
Equity Securities, at Fair Value. Equity securities, at fair
value consists of the firm’s public and private equity-related
investments in corporate and real estate entities.
The 	table 	below 	presents 	information 	about 	equity
securities, at fair value.
As of
$ in millions
March
2020
December
2019
Equity securities, at fair value 	$21,221 	$22,163
Equity Type
Public equity 	10% 	11%
Private equity 	90% 	89%
Total 	100% 	100%
Asset Class
Corporate 	77% 	79%
Real estate 	23% 	21%
Total 	100% 	100%
Region
Americas 	46% 	50%
EMEA 	19% 	17%
Asia 	35% 	33%
Total 	100% 	100%
29 	Goldman Sachs March 2020 Form 10-Q

-- 31 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In the table above:
‰ Equity securities, at fair value included investments
accounted for at fair value under the fair value option
where the firm would otherwise apply the equity method
of accounting of $8.04 billion as of March 2020 and
$8.23 billion as of December 2019. Gains recognized by
the firm as a result of changes in the fair value of equity
securities for which the fair value option was elected was
$77 million for the three months ended March 2020 and
$165 million for the three months ended March 2019.
These gains are included in other principal transactions in
the consolidated statements of earnings.
‰ Equity securities, at fair value included $2.71 billion as of
March 2020 and $3.22 billion as of December 2019 of
investments in funds that are measured at NAV.
‰ EMEA represents Europe, Middle East and Africa.
Debt Instruments, at Fair Value. Debt instruments, at
fair 	value 	primarily 	includes 	mezzanine, 	senior 	and
distressed debt.
The 	table 	below 	presents 	information 	about 	debt
instruments, at fair value.
As of
$ in millions
March
2020
December
2019
Corporate debt securities 	$ 9,923 	$10,838
Securities backed by real estate 	2,560 	2,619
Money market instruments 	9,332 	1,681
Other 	1,330 	1,432
Total 	$23,145 	$16,570
In the table above:
‰ Money 	market 	instruments 	primarily 	includes
commercial paper, certificates of deposit and time
deposits. The increase in money market instruments from
December 2019 to March 2020 was primarily related to
the firm’s purchase of commercial paper and certificates
of deposit from affiliated and non-affiliated money
market funds. See Note 22 for further information about
purchases by Goldman Sachs Bank USA (GS Bank USA)
from two affiliated money market funds.
‰ Other included $840 million as of March 2020 and
$983 million as of December 2019 of investments in
credit funds that are measured at NAV.
Investments in Funds at Net Asset Value Per Share.
Equity securities and debt instruments, at fair value include
investments in funds that are measured at NAV of the
investment fund. The firm uses NAV to measure the fair
value of fund investments when (i) the fund investment does
not have a readily determinable fair value and (ii) the NAV
of the investment fund is calculated in a manner consistent
with the measurement principles of investment company
accounting, including measurement of the investments at
fair value.
Substantially all of the firm’s investments in funds at NAV
consist of investments in firm-sponsored private equity,
credit, real estate and hedge funds where the firm co-invests
with third-party investors.
Private equity funds primarily invest in a broad range of
industries 	worldwide, 	including 	leveraged 	buyouts,
recapitalizations, 	growth 	investments 	and 	distressed
investments. Credit funds generally invest in loans and
other fixed income instruments and are focused on
providing private high-yield capital for leveraged and
management 	buyout 	transactions, 	recapitalizations,
financings, refinancings, acquisitions and restructurings for
private 	equity 	firms, 	private 	family 	companies 	and
corporate 	issuers. 	Real 	estate 	funds 	invest 	globally,
primarily in real estate companies, loan portfolios, debt
recapitalizations and property. Private equity, credit and
real estate funds are closed-end funds in which the firm’s
investments are generally not eligible for redemption.
Distributions will be received from these funds as the
underlying assets are liquidated or distributed, the timing of
which is uncertain.
The firm also invests in hedge funds, primarily multi-
disciplinary hedge funds that employ a fundamental
bottom-up investment approach across various asset classes
and strategies. The firm’s investments in hedge funds
primarily include interests where the underlying assets are
illiquid in nature, and proceeds from redemptions will not
be received until the underlying assets are liquidated or
distributed, the timing of which is uncertain.
Private equity, hedge and real estate funds described above
are primarily “covered funds” as defined in the Volcker
Rule of the U.S. Dodd-Frank Wall Street Reform and
Consumer Protection Act (Dodd-Frank Act). The Board of
Governors of the Federal Reserve System (FRB) extended
the conformance period to July 2022 for the firm’s
investments in, and relationships with, certain legacy
“illiquid funds” (as defined in the Volcker Rule) that were
in place prior to December 2013. This extension is
applicable to substantially all of the firm’s remaining
investments in, and relationships with, such covered funds.
Substantially all of the credit funds described above are not
covered funds.
Goldman Sachs March 2020 Form 10-Q 	30

-- 32 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents the fair value of investments in
funds at NAV and the related unfunded commitments.
$ in millions
Fair Value of
Investments
Unfunded
Commitments
As of March 2020
Private equity funds 	$2,285 	$ 753
Credit funds 	840 	730
Hedge funds 	106 	–
Real estate funds 	314 	194
Total 	$3,545 	$1,677
As of December 2019
Private equity funds 	$2,767 	$ 765
Credit funds 	983 	820
Hedge funds 	125 	–
Real estate funds 	331 	196
Total 	$4,206 	$1,781
Available-for-Sale Securities
Available-for-sale securities are accounted for at fair value,
and the related unrealized fair value gains and losses are
included in accumulated other comprehensive income/
(loss).
The 	table 	below 	presents 	information 	about
available-for-sale securities by tenor.
$ in millions
Amortized
Cost
Fair
Value
Weighted
Average
Yield
As of March 2020
Less than 5 years 	$14,038 	$14,472 	1.53%
Greater than 5 years 	3,505 	3,817 	1.85%
Total 	$17,543 	$18,289 	1.59%
As of December 2019
Less than 5 years 	$14,063 	$14,041 	1.53%
Greater than 5 years 	4,974 	5,053 	2.10%
Total 	$19,037 	$19,094 	1.68%
In the table above:
‰ Available-for-sale securities consists of U.S. government
obligations that were classified in level 1 of the fair value
hierarchy as of both March 2020 and December 2019.
‰ The firm sold available-for-sale securities of $1.45 billion
during 	the 	three 	months 	ended 	March 	2020 	and
$4.96 billion during the three months ended March 2019.
The realized gains on sales of such securities were
$265 million for the three months ended March 2020 and
$36 million for the three months ended March 2019, and
were included in the consolidated statements of earnings.
‰ The gross unrealized gains included in accumulated other
comprehensive income/(loss) were $746 million as of
March 2020 and $137 million as of December 2019. The
gross unrealized losses included in accumulated other
comprehensive income/(loss) were not material as of
December 2019.
‰ Beginning in January 2020, available-for-sale securities
are reviewed to determine if an allowance for credit losses
should be recorded in the consolidated statements of
earnings. The firm considers various factors in such
determination, including market conditions, changes in
issuer credit ratings, severity of the unrealized losses, and
the intent and ability to hold the security until recovery.
See Note 3 for further information about the adoption of
CECL. Prior to January 2020, such securities were
reviewed for other-than-temporary impairment. The firm
did not record any provision for credit losses on such
securities during the three months ended March 2020 and
there was no other-than-temporary impairment during
the year ended December 2019.
Fair Value of Investments by Level
The table below presents investments accounted for at fair
value by level within the fair value hierarchy.
$ in millions 	Level 1 	Level 2 	Level 3 	Total
As of March 2020
Government and agency obligations:
U.S. 	$18,289 $ 	– $ 	– $18,289
Non-U.S. 	– 	23 	– 	23
Corporate debt securities 	54 	2,720 	7,149 	9,923
Securities backed by real estate 	– 	1,785 	775 	2,560
Money market instruments 	29 	9,303 	– 	9,332
Other debt obligations 	– 	39 	428 	467
Equity securities 	236 	7,224 	11,056 	18,516
Subtotal 	$18,608 $21,094 $19,408 $59,110
Investments in funds at NAV 	3,545
Total investments 	$62,655
As of December 2019
Government and agency obligations:
U.S. 	$19,094 $ 	– $ 	– $19,094
Non-U.S. 	– 	36 	– 	36
Corporate debt securities 	48 	7,325 	3,465 	10,838
Securities backed by real estate 	– 	2,024 	595 	2,619
Money market instruments 	732 	949 	– 	1,681
Other debt obligations 	– 	94 	319 	413
Equity securities 	251 	7,786 	10,903 	18,940
Subtotal 	$20,125 $18,214 $15,282 $53,621
Investments in funds at NAV 	4,206
Total investments 	$57,827
See Note 4 for an overview of the firm’s fair value
measurement policies and the valuation techniques and
significant inputs used to determine the fair value of
investments.
31 	Goldman Sachs March 2020 Form 10-Q

-- 33 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Significant Unobservable Inputs
The table below presents the amount of level 3 investments,
and 	ranges 	and 	weighted 	averages 	of 	significant
unobservable inputs used to value such investments.
Level 3 Assets and Range of Significant Unobservable
Inputs (Weighted Average) as of
$ in millions
March
2020
December
2019
Corporate debt securities
Level 3 assets 	$7,149 	$3,465
Yield 	4.6% to 25.2% (11.8%) 	5.5% to 29.8% (12.0%)
Recovery rate 	40.0% to 100.0% (65.8%) 25.0% to 100.0% (68.5%)
Duration (years) 	1.5 to 8.0 (4.0) 	2.9 to 5.9 (5.0)
Multiples 	0.6x to 39.7x (7.4x) 	0.6x to 24.4x (7.0x)
Securities backed by real estate
Level 3 assets 	$775 	$595
Yield 	10.0% to 20.3% (15.8%) 	9.4% to 20.3% (16.0%)
Recovery rate 	25.0% to 35.0% (33.5%) 	33.1% to 34.4% (33.5%)
Duration (years) 	0.4 to 3.7 (2.3) 	0.4 to 3.0 (0.9)
Other debt obligations
Level 3 assets 	$428 	$319
Yield 	3.2% to 6.0% (4.2%) 	3.4% to 5.2% (4.5%)
Duration (years) 	3.7 to 9.8 (6.8) 	4.0 to 8.0 (6.7)
Equity securities
Level 3 assets 	$11,056 	$10,903
Multiples 	0.5x to 23.8x (8.0x) 	0.8x to 36.0x (8.0x)
Discount rate/yield 	4.9% to 20.3% (14.0%) 	2.1% to 20.3% (13.4%)
Capitalization rate 	3.7% to 16.0% (5.9%) 	3.6% to 15.1% (6.1%)
In the table above:
‰ Ranges represent the significant unobservable inputs that
were used in the valuation of each type of investment.
‰ Weighted averages are calculated by weighting each input
by the relative fair value of the investment.
‰ The ranges and weighted averages of these inputs are not
representative of the appropriate inputs to use when
calculating the fair value of any one investment. For
example, the highest multiple for private equity securities
is appropriate for valuing a specific private equity security
but may not be appropriate for valuing any other private
equity security. Accordingly, the ranges of inputs do not
represent uncertainty in, or possible ranges of, fair value
measurements of level 3 investments.
‰ Increases in yield, discount rate, capitalization rate or
duration used in the valuation of level 3 investments
would have resulted in a lower fair value measurement,
while increases in recovery rate or multiples would have
resulted in a higher fair value measurement as of both
March 2020 and December 2019. Due to the distinctive
nature of each level 3 investment, the interrelationship of
inputs is not necessarily uniform within each product
type.
‰ Corporate debt securities, securities backed by real estate
and other debt obligations are valued using discounted
cash flows, and equity securities are valued using market
comparables and discounted cash flows.
‰ The fair value of any one instrument may be determined
using multiple valuation techniques. For example, market
comparables and discounted cash flows may be used
together to determine fair value. Therefore, the level 3
balance encompasses both of these techniques.
Level 3 Rollforward
The table below presents a summary of the changes in fair
value for level 3 investments.
Three Months
Ended March
$ in millions 	2020 	2019
Beginning balance 	$15,282 	$13,548
Net realized gains/(losses) 	75 	35
Net unrealized gains/(losses) 	(1,284) 	239
Purchases 	348 	217
Sales 	(197) 	(37)
Settlements 	(325) 	(232)
Transfers into level 3 	6,480 	967
Transfers out of level 3 	(971) 	(461)
Ending balance 	$19,408 	$14,276
In the table above:
‰ Changes in fair value are presented for all investments
that are classified in level 3 as of the end of the period.
‰ Net unrealized gains/(losses) relates to investments that
were still held at period-end.
‰ Transfers between levels of the fair value hierarchy are
reported at the beginning of the reporting period in which
they occur. If an investment was transferred to level 3
during a reporting period, its entire gain or loss for the
period is classified in level 3.
‰ For level 3 investments, increases are shown as positive
amounts, while decreases are shown as negative amounts.
Goldman Sachs March 2020 Form 10-Q 	32

-- 34 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information, by product type, for
investments included in the summary table above.
Three Months
Ended March
$ in millions 	2020 	2019
Corporate debt securities
Beginning balance 	$ 3,465 	$ 2,540
Net realized gains/(losses) 	50 	11
Net unrealized gains/(losses) 	(465) 	50
Purchases 	69 	86
Sales 	(174) 	–
Settlements 	(166) 	(42)
Transfers into level 3 	4,394 	260
Transfers out of level 3 	(24) 	(214)
Ending balance 	$ 7,149 	$ 2,691
Securities backed by real estate
Beginning balance 	$ 	595 	$ 	457
Net realized gains/(losses) 	6 	2
Net unrealized gains/(losses) 	(72) 	7
Purchases 	52 	–
Settlements 	(12) 	(33)
Transfers into level 3 	206 	–
Transfers out of level 3 	– 	(22)
Ending balance 	$ 	775 	$ 	411
Equity securities
Beginning balance 	$10,903 	$10,335
Net realized gains/(losses) 	17 	22
Net unrealized gains/(losses) 	(766) 	182
Purchases 	227 	112
Sales 	(23) 	(36)
Settlements 	(145) 	(157)
Transfers into level 3 	1,790 	707
Transfers out of level 3 	(947) 	(225)
Ending balance 	$11,056 	$10,940
Other debt obligations
Beginning balance 	$ 	319 	$ 	216
Net realized gains/(losses) 	2 	–
Net unrealized gains/(losses) 	19 	–
Purchases 	– 	19
Sales 	– 	(1)
Settlements 	(2) 	–
Transfers into level 3 	90 	–
Ending balance 	$ 	428 	$ 	234
Level 3 Rollforward Commentary
Three Months Ended March 2020. The net realized and
unrealized losses on level 3 investments of $1.21 billion
(reflecting 	$75 	million 	of 	net 	realized 	gains 	and
$1.28 billion of net unrealized losses) for the three months
ended March 2020 included gains/(losses) of $(1.29) billion
reported in other principal transactions and $77 million
reported in interest income.
The net unrealized losses on level 3 investments for the three
months ended March 2020 primarily reflected losses on
certain private equity securities and corporate debt securities,
principally driven by weak corporate performance.
Transfers into level 3 investments during the three months
ended March 2020 primarily reflected transfers of certain
corporate debt securities and private equity securities from
level 2, principally due to certain unobservable yield and
duration inputs becoming significant to the valuation of
these instruments and as a result of a lack of market
evidence, including fewer transactions in these instruments.
Transfers out of level 3 investments during the three
months ended March 2020 primarily reflected transfers of
certain private equity securities to level 2, principally due to
increased price transparency as a result of market evidence,
including market transactions in these instruments.
Three Months Ended March 2019. The net realized and
unrealized gains on level 3 investments of $274 million
(reflecting 	$35 	million 	of 	net 	realized 	gains 	and
$239 million of net unrealized gains) for the three months
ended March 2019 included gains of $227 million reported
in other principal transactions and $47 million reported in
interest income.
The net unrealized gains on level 3 investments for the three
months ended March 2019 primarily reflected gains on
certain private equity securities, principally driven by
company-specific events and corporate performance.
Transfers into level 3 investments during the three months
ended March 2019 primarily reflected transfers of certain
private equity securities and corporate debt from level 2,
principally due to reduced price transparency as a result of a
lack of market evidence, including fewer transactions in
these instruments.
Transfers out of level 3 investments during the three
months ended March 2019 primarily reflected transfers of
certain 	private 	equity 	securities 	and 	corporate 	debt
securities to level 2, principally due to increased price
transparency as a result of market evidence, including
market transactions in these instruments.
33 	Goldman Sachs March 2020 Form 10-Q

-- 35 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Held-to-Maturity Securities
Held-to-maturity securities are accounted for at amortized
cost.
The 	table 	below 	presents 	information 	about
held-to-maturity securities by type and tenor.
$ in millions
Amortized
Cost
Fair
Value
Weighted
Average
Yield
As of March 2020
Less than 5 years 	$3,531 	$3,751 	2.40%
Greater than 5 years 	1,524 	1,680 	2.25%
Total U.S. government obligations 	5,055 	5,431 	2.35%
Less than 5 years 	5 	5 	3.91%
Greater than 5 years 	696 	688 	1.62%
Total securities backed by real estate 	701 	693 	1.64%
Total held-to-maturity securities 	$5,756 	$6,124 	2.27%
As of December 2019
Less than 5 years 	$3,534 	$3,613 	2.40%
Greater than 5 years 	1,534 	1,576 	2.25%
Total U.S. government obligations 	5,068 	5,189 	2.35%
Less than 5 years 	6 	6 	4.16%
Greater than 5 years 	751 	769 	1.67%
Total securities backed by real estate 	757 	775 	1.69%
Total held-to-maturity securities 	$5,825 	$5,964 	2.27%
In the table above:
‰ Substantially all of the securities backed by real estate
consist of securities backed by residential real estate.
‰ As these securities are not accounted for at fair value, they
are not included in the firm’s fair value hierarchy in
Notes 4 through 10. Had these securities been included in
the 	firm’s 	fair 	value 	hierarchy, 	U.S. 	government
obligations would have been classified in level 1 and
substantially all securities backed by real estate would
have been classified in level 2 of the fair value hierarchy as
of both March 2020 and December 2019.
‰ The gross unrealized gains were $395 million as of
March 2020 and $141 million as of December 2019. The
gross unrealized losses were not material as of both
March 2020 and December 2019.
‰ Beginning in January 2020, held-to-maturity securities
are reviewed to determine if an allowance for credit loss
should be recorded in the consolidated statements of
earnings. The firm considers various factors in such
determination, including market conditions, changes in
issuer credit ratings, historical credit losses and sovereign
guarantees. See Note 3 for further information about the
adoption of CECL. Prior to January 2020, such securities
were reviewed for other-than-temporary impairment. The
firm did not record any provision for credit losses on such
securities during the three months ended March 2020 and
there was no other-than-temporary impairment during
the year ended December 2019.
Note 9.
Loans
Loans include (i) loans held for investment that are
accounted for at amortized cost net of allowance for loan
losses or at fair value under the fair value option and
(ii) loans held for sale that are accounted for at the lower of
cost or fair value. Interest on loans is recognized over the
life of the loan and is recorded on an accrual basis.
The table below presents information about loans.
$ in millions
Amortized
Cost
Fair
Value
Held For
Sale 	Total
As of March 2020
Loan Type
Corporate 	$ 63,697 	$ 2,915 	$1,918 	$ 68,530
Wealth management 	21,183 	7,834 	– 	29,017
Commercial real estate 	14,165 	2,005 	660 	16,830
Residential real estate 	3,911 	474 	28 	4,413
Consumer:
Installment 	4,826 	– 	– 	4,826
Credit cards 	2,081 	– 	– 	2,081
Other 	4,472 	601 	551 	5,624
Total loans, gross 	114,335 	13,829 	3,157 	131,321
Allowance for loan losses 	(2,868) 	– 	– 	(2,868)
Total loans 	$111,467 	$13,829 	$3,157 	$128,453
As of December 2019
Loan Type
Corporate 	$ 41,129 	$ 3,224 	$1,954 	$ 46,307
Wealth management 	20,116 	7,824 	– 	27,940
Commercial real estate 	13,258 	1,876 	2,609 	17,743
Residential real estate 	6,132 	792 	34 	6,958
Consumer:
Installment 	4,747 	– 	– 	4,747
Credit cards 	1,858 	– 	– 	1,858
Other 	3,396 	670 	726 	4,792
Total loans, gross 	90,636 	14,386 	5,323 	110,345
Allowance for loan losses 	(1,441) 	– 	– 	(1,441)
Total loans 	$ 89,195 	$14,386 	$5,323 	$108,904
The following is a description of the loan types in the table
above:
‰ Corporate. 	Corporate 	loans 	includes 	term 	loans,
revolving lines of credit, letter of credit facilities and
bridge loans, and are principally used for operating and
general corporate purposes, or in connection with
acquisitions. 	Corporate 	loans 	may 	be 	secured 	or
unsecured, depending on the loan purpose, the risk profile
of the borrower and other factors.
‰ Wealth 	Management. 	Wealth 	management 	loans
includes loans extended to private bank clients, including
wealth management and other clients. These loans are
used to finance investments in both financial and
nonfinancial assets, bridge cash flow timing gaps or
provide liquidity for other needs. Substantially all of such
loans are secured by securities, residential real estate,
commercial real estate or other assets.
Goldman Sachs March 2020 Form 10-Q 	34

-- 36 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
‰ Commercial Real Estate. Commercial real estate loans
includes loans extended by the firm (other than to private
bank clients) that are directly or indirectly secured by
hotels, retail stores, multifamily housing complexes and
commercial and industrial properties. Commercial real
estate loans also includes loans extended to clients who
warehouse assets that are directly or indirectly backed by
commercial real estate. In addition, commercial real
estate includes loans purchased by the firm.
‰ Residential Real Estate. Residential real estate loans
primarily includes loans extended by the firm to clients
(other than private bank clients) who warehouse assets
that are directly or indirectly secured by residential real
estate and loans purchased by the firm.
‰ Installment. Installment loans are unsecured and are
originated by the firm.
‰ Credit Cards. Credit card loans are loans made pursuant
to revolving lines of credit issued to consumers by the firm.
‰ Other. Other loans primarily includes loans extended to
clients who warehouse assets that are directly or indirectly
secured by consumer loans, including auto loans and
private student loans. Other loans also includes unsecured
consumer and credit card loans purchased by the firm.
Loans accounted for at amortized cost included PCI loans
with a carrying value of $1.62 billion (outstanding
principal balance of $3.23 billion and accretable yield of
$220 million) as of December 2019, which were secured by
commercial and residential real estate. In January 2020, the
firm elected the fair value option for these PCI loans in
accordance with ASU No. 2016-13. These loans were
primarily transferred to trading assets. See Note 3 for
further information about adoption of this ASU.
Credit Quality
Risk Assessment. The firm’s risk assessment process
includes evaluating the credit quality of its loans. For
corporate loans and a majority of wealth management, real
estate and other loans, the firm performs credit reviews
which include initial and ongoing analyses of its borrowers,
resulting in an internal credit rating. A credit review is an
independent analysis of the capacity and willingness of a
borrower to meet its financial obligations and is performed
on an annual basis or more frequently if circumstances
change that indicate that a review may be necessary. The
determination of internal credit ratings also incorporates
assumptions with respect to the nature of and outlook for
the borrower’s industry and the economic environment.
The table below presents gross loans by an internally
determined public rating agency equivalent or other credit
metrics and the concentration of secured and unsecured
loans.
$ in millions
Investment-
Grade
Non-Investment-
Grade
Other/
Unrated 	Total
As of March 2020
Accounting Method
Amortized cost 	$40,637 	$64,397 $ 9,301 $114,335
Fair value 	2,386 	4,640 	6,803 	13,829
Held for sale 	257 	2,044 	856 	3,157
Total 	$43,280 	$71,081 $16,960 $131,321
Loan Type
Corporate 	$18,972 	$49,050 $ 	508 $ 68,530
Wealth management 	20,393 	4,275 	4,349 	29,017
Real estate:
Commercial 	478 	14,179 	2,173 	16,830
Residential 	259 	2,875 	1,279 	4,413
Consumer:
Installment 	– 	– 	4,826 	4,826
Credit cards 	– 	– 	2,081 	2,081
Other 	3,178 	702 	1,744 	5,624
Total 	$43,280 	$71,081 $16,960 $131,321
Secured 	67% 	90% 	54% 	78%
Unsecured 	33% 	10% 	46% 	22%
Total 	100% 	100% 	100% 	100%
As of December 2019
Accounting Method
Amortized cost 	$30,266 	$51,222 $ 9,148 $ 90,636
Fair value 	2,844 	5,174 	6,368 	14,386
Held for sale 	323 	4,368 	632 	5,323
Total 	$33,433 	$60,764 $16,148 $110,345
Loan Type
Corporate 	$10,507 	$35,509 $ 	291 $ 46,307
Wealth management 	20,001 	3,576 	4,363 	27,940
Real estate:
Commercial 	306 	15,997 	1,440 	17,743
Residential 	244 	4,600 	2,114 	6,958
Consumer:
Installment 	– 	– 	4,747 	4,747
Credit cards 	– 	– 	1,858 	1,858
Other 	2,375 	1,082 	1,335 	4,792
Total 	$33,433 	$60,764 $16,148 $110,345
Secured 	83% 	91% 	54% 	83%
Unsecured 	17% 	9% 	46% 	17%
Total 	100% 	100% 	100% 	100%
35 	Goldman Sachs March 2020 Form 10-Q

-- 37 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In the table above:
‰ Substantially all of the other/unrated wealth management
loans consists of loans backed by residential real estate,
and real estate and other loans primarily consists of
purchased real estate-backed, consumer and credit card
loans. The firm’s risk assessment process for these loans
includes 	reviewing 	certain 	key 	metrics, 	such 	as
loan-to-value ratio, delinquency status, collateral values,
expected cash flows, the Fair Isaac Corporation (FICO)
credit score and other risk factors.
‰ Installment 	and 	credit 	card 	loans 	represent 	loans
originated by the firm. An important credit-quality
indicator for such loans is the FICO credit score, which
measures a borrower’s creditworthiness by considering
factors such as payment and credit history. FICO credit
scores are refreshed by the firm to assess the updated
creditworthiness of the borrower.
The table below presents gross installment and credit card
loans and the concentration by refreshed FICO credit score.
As of
$ in millions
March
2020
December
2019
Installment, gross 	$4,826 	$4,747
Credit cards, gross 	2,081 	1,858
Total 	$6,907 	$6,605
Refreshed FICO credit score
Greater than or equal to 660 	82% 	85%
Less than 660 	18% 	15%
Total 	100% 	100%
In March 2020, in response to the global outbreak of the
coronavirus (COVID-19) pandemic, the firm announced a
customer 	assistance 	program providing borrowers of
installment and credit card loans the flexibility to defer a
payment for up to two months at no cost. The impact of
this program was not material to the firm’s results for the
three months ended March 2020.
The firm also assigns a regulatory risk rating to its loans
based on the definitions provided by the U.S. federal bank
regulatory agencies. Total loans included 91% of loans as
of both March 2020 and December 2019 that were rated
pass/non-criticized.
Vintage. The table below presents gross loans accounted
for at amortized cost (excluding originated installment and
credit card loans) by an internally determined public rating
agency equivalent or other credit metrics and by origination
year for term loans.
As of March 2020
$ in millions
Investment-
Grade
Non-Investment-
Grade
Other/
Unrated 	Total
2020 	$ 1,151 	$ 2,522 	$ 	– $ 	3,673
2019 	1,648 	8,081 	18 	9,747
2018 	2,383 	4,277 	– 	6,660
2017 	883 	3,977 	– 	4,860
2016 	165 	1,626 	– 	1,791
2015 or earlier 	435 	2,648 	– 	3,083
Revolving 	11,617 	22,240 	26 	33,883
Corporate 	$18,282 	$45,371 	$ 	44 $ 63,697
2020 	$ 	172 	$ 	45 	$ 	– $ 	217
2019 	532 	398 	– 	930
2018 	393 	90 	– 	483
2017 	400 	75 	– 	475
2016 	30 	65 	– 	95
2015 or earlier 	540 	208 	– 	748
Revolving 	16,663 	1,557 	15 	18,235
Wealth management 	$18,730 	$ 2,438 	$ 	15 $ 21,183
2020 	$ 	– 	$ 	632 	$ 	64 $ 	696
2019 	57 	1,870 	27 	1,954
2018 	195 	2,484 	19 	2,698
2017 	18 	1,718 	25 	1,761
2016 	– 	180 	12 	192
2015 or earlier 	– 	589 	691 	1,280
Revolving 	– 	5,584 	– 	5,584
Commercial real estate 	$ 	270 	$13,057 	$ 838 $ 14,165
2020 	$ 	– 	$ 	92 	$ 	18 $ 	110
2019 	– 	707 	251 	958
2018 	– 	169 	316 	485
2017 	179 	95 	169 	443
2016 	– 	524 	– 	524
2015 or earlier 	– 	– 	70 	70
Revolving 	79 	1,242 	– 	1,321
Residential real estate 	$ 	258 	$ 2,829 	$ 824 $ 	3,911
2020 	$ 	– 	$ 	22 	$ 480 $ 	502
2019 	– 	45 	57 	102
2018 	– 	53 	13 	66
2017 	– 	19 	5 	24
2016 	– 	1 	– 	1
Revolving 	3,097 	562 	118 	3,777
Other 	$ 3,097 	$ 	702 	$ 673 $ 	4,472
Total 	$40,637 	$64,397 	$2,394 $107,428
In the table above, revolving loans which converted to term
loans were not material as of March 2020.
Goldman Sachs March 2020 Form 10-Q 	36

-- 38 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents gross originated installment loans
by origination year and credit card revolving loans.
$ in millions
As of
March 2020
2020 	$ 723
2019 	2,043
2018 	1,686
2017 	355
2016 	19
Revolving 	2,081
Total 	$6,907
Credit Concentrations. The table below presents the
concentration of gross loans by region.
$ in millions
Carrying
Value Americas EMEA 	Asia 	Total
As of March 2020
Corporate 	$ 68,530 	67% 	26% 	7% 100%
Wealth management 	29,017 	88% 	9% 	3% 100%
Commercial real estate 	16,830 	69% 	21% 10% 100%
Residential real estate 	4,413 	87% 	11% 	2% 100%
Consumer:
Installment 	4,826 	100% 	– 	– 100%
Credit cards 	2,081 	100% 	– 	– 100%
Other 	5,624 	87% 	12% 	1% 100%
Total 	$131,321 	75% 	19% 	6% 100%
As of December 2019
Corporate 	$ 46,307 	60% 	31% 	9% 100%
Wealth management 	27,940 	88% 	9% 	3% 100%
Commercial real estate 	17,743 	69% 	21% 10% 100%
Residential real estate 	6,958 	90% 	9% 	1% 100%
Consumer:
Installment 	4,747 	100% 	– 	– 100%
Credit cards 	1,858 	100% 	– 	– 100%
Other 	4,792 	87% 	12% 	1% 100%
Total 	$110,345 	73% 	21% 	6% 100%
The table below presents the concentration of gross
corporate loans by industry.
As of
$ in millions
March
2020
December
2019
Corporate, gross 	$68,530 $46,307
Industry
Consumer, Retail & Healthcare 	17% 	15%
Diversified Industrials 	22% 	17%
Financial Institutions 	9% 	10%
Funds 	6% 	9%
Natural Resources & Utilities 	11% 	12%
Real Estate 	8% 	7%
Technology, Media & Telecommunications 	18% 	17%
Other (including Special Purpose Vehicles) 	9% 	13%
Total 	100% 	100%
The table below presents the firm’s credit exposure from
originated installment and credit card loans and the
concentration by the five most concentrated U.S. states.
As of
$ in millions
March
2020
December
2019
Installment 	$4,826 	$4,747
California 	12% 	12%
Texas 	9% 	9%
New York 	7% 	7%
Florida 	7% 	7%
Illinois 	4% 	4%
Other 	61% 	61%
Total 	100% 	100%
Credit Cards 	$2,081 	$1,858
California 	20% 	21%
Texas 	9% 	9%
New York 	8% 	8%
Florida 	8% 	8%
Illinois 	4% 	4%
Other 	51% 	50%
Total 	100% 	100%
Nonaccrual and Past Due Loans. Loans accounted for at
amortized cost (other than credit card loans) are placed on
nonaccrual status when it is probable that the firm will not
collect all principal and interest due under the contractual
terms, regardless of the delinquency status or if a loan is
past due for 90 days or more, unless the loan is both well
collateralized and in the process of collection. At that time,
all accrued but uncollected interest is reversed against
interest income and interest subsequently collected is
recognized on a cash basis to the extent the loan balance is
deemed collectible. Otherwise, all cash received is used to
reduce the outstanding loan balance. A loan is considered
past due when a principal or interest payment has not been
made according to its contractual terms. Credit card loans
are not placed on nonaccrual status and accrue interest
until the loan is paid in full or is charged-off.
In certain circumstances, the firm may also modify the
original terms of a loan agreement by granting a concession
to a borrower experiencing financial difficulty. Such
modifications are considered troubled debt restructurings
and typically include interest rate reductions, payment
extensions and modification of loan covenants.
37 	Goldman Sachs March 2020 Form 10-Q

-- 39 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information about past due loans.
$ in millions 	30-89 days
90 days
or more 	Total
As of March 2020
Corporate 	$ 66 	$172 	$238
Wealth management 	20 	16 	36
Commercial real estate 	127 	91 	218
Residential real estate 	11 	23 	34
Consumer:
Installment 	65 	23 	88
Credit cards 	35 	39 	74
Other 	11 	1 	12
Total 	$335 	$365 	$700
Past due loans divided by gross loans at amortized cost 	0.6%
As of December 2019
Corporate 	$197 	$ 42 	$239
Wealth management 	13 	15 	28
Commercial real estate 	54 	123 	177
Residential real estate 	19 	18 	37
Consumer:
Installment 	71 	29 	100
Credit cards 	35 	4 	39
Other 	6 	1 	7
Total 	$395 	$232 	$627
Past due loans divided by gross loans at amortized cost 	0.7%
The table below presents information about nonaccrual
loans.
As of
$ in millions
March
2020
December
2019
Corporate 	$1,622 	$1,122
Wealth management 	53 	52
Commercial real estate 	155 	175
Residential real estate 	156 	143
Installment 	35 	38
Total 	$2,021 	$1,530
Nonaccrual loans divided by gross loans at
amortized cost 	1.8% 	1.7%
In the table above:
‰ Nonaccrual 	loans 	included 	$502 	million 	as 	of
March 2020 and $429 million as of December 2019 of
loans that were 30 days or more past due.
‰ Loans that were 90 days or more past due and still
accruing were not material as of both March 2020 and
December 2019.
‰ Nonaccrual 	loans 	included 	$302 	million 	as 	of
March 2020 and $251 million as of December 2019 of
corporate loans that were modified in a troubled debt
restructuring. The firm’s lending commitments related to
these loans were not material as of both March 2020 and
December 2019. Installment loans that were modified in
a troubled debt restructuring were not material as of both
March 2020 and December 2019.
Allowance for Credit Losses
The firm’s allowance for credit losses consists of the
allowance for losses on loans and lending commitments
accounted for at amortized cost. Loans and lending
commitments accounted for at fair value or accounted for
at the lower of cost or fair value are not subject to an
allowance for credit losses.
The firm adopted ASU No. 2016-13 in January 2020,
which 	replaced 	the 	incurred 	credit 	loss 	model 	for
recognizing credit losses with the CECL model. As a result,
the firm’s allowance for credit losses effective January 2020
reflects management’s estimate of credit losses over the
remaining expected life of such loans and also considers
forecasts 	of 	future 	economic 	conditions. 	Prior 	to
January 2020, the allowance for credit losses reflected
probable incurred credit losses. See Note 3 for further
information about the adoption of CECL.
To determine the allowance for credit losses, the firm
classifies its loans and lending commitments accounted for
at amortized cost into wholesale and consumer portfolios.
Prior to January 2020, the firm also had PCI loans which
were classified as a separate portfolio. These portfolios
represent the level at which the firm has developed and
documented its methodology to determine the allowance
for credit losses. The allowance for credit losses is measured
on a collective basis for loans that exhibit similar risk
characteristics using a modeled approach and asset-specific
basis for loans that do not share similar risk characteristics.
Under CECL, the allowance for loan losses takes into
account the weighted average of a range of forecasts of
future economic conditions over the expected life of the
loan. These forecasts include baseline, favorable and
adverse economic scenarios. The allowance for loan losses
also 	includes 	qualitative 	components 	which 	allow
management to reflect the uncertain nature of economic
forecasting and account for model imprecision.
Management’s estimate of loan losses entails judgment about
loan collectability at the reporting dates, and there are
uncertainties inherent in those judgments. While management
uses the best information available to determine this estimate,
future adjustments to the allowance may be necessary based
on, among other things, changes in the economic environment
or 	variances 	between 	actual 	results 	and 	the 	original
assumptions used.
Goldman Sachs March 2020 Form 10-Q 	38

-- 40 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The 	table 	below 	presents 	gross 	loans 	and 	lending
commitments accounted for at amortized cost by portfolio.
As of
March 2020 	December 2019
$ in millions 	Loans
Lending
Commitments 	Loans
Lending
Commitments
Wholesale
Corporate 	$ 63,697 	$107,403 $41,129 	$127,226
Wealth management 	21,183 	2,441 	20,116 	2,198
Commercial real estate 	14,165 	2,886 	12,803 	3,207
Residential real estate 	3,911 	1,293 	4,965 	759
Other 	4,472 	3,021 	3,396 	3,029
Consumer
Installment 	4,826 	10 	4,747 	12
Credit cards 	2,081 	16,447 	1,858 	13,669
PCI 	– 	– 	1,622 	–
Total 	$114,335 	$133,501 $90,636 	$150,100
In the table above, wholesale loans included $1.99 billion
as of March 2020 and $1.49 billion as of December 2019 of
nonaccrual loans for which the allowance for credit losses
was measured on an asset-specific basis. The allowance for
credit losses on these loans was $327 million as of
March 2020 and $207 million as of December 2019. These
loans included $543 million as of March 2020 and
$754 million as of December 2019 of loans which did not
require a reserve as the loan was deemed to be recoverable.
See 	Note 	18 	for 	further information about lending
commitments.
The following is a description of the methodology used to
calculate the allowance for credit losses:
Wholesale. The allowance for credit losses for wholesale
loans and lending commitments that exhibit similar risk
characteristics is measured on a collective basis and is
calculated 	using 	a 	modeled 	approach. 	These 	models
determine the probability of default and loss given default
based on various risk factors, including internal credit
ratings, industry default and loss data, contractual maturity,
current macroeconomic indicators, the borrower’s capacity
to meet its financial obligations, the borrower’s country of
risk and industry, loan seniority and collateral type. For
lending commitments, the methodology also considers
probability of drawdowns or funding. In addition, for loans
backed by real estate, risk factors include the loan-to-value
ratio, debt service ratio and home price index. Under CECL,
the allowance for loan losses for wholesale loans also takes
into account the weighted average of a range of forecasts of
future macroeconomic indicators over the expected life of the
loan for a period of three years before reverting to historical
average probability of default using a non-linear modeled
approach. Key macroeconomic inputs to the forecast model
include regional GDP, unemployment rates, credit spreads,
commercial 	and 	industrial 	delinquency 	rates 	and
commodities prices. In addition, the allowance for loan losses
includes a qualitative component.
The allowance for loan losses for wholesale loans that do
not share similar risk characteristics, such as nonaccrual
loans or loans in a troubled debt restructuring, is measured
on an asset-specific basis and is calculated using the present
value of expected future cash flows discounted at the loan’s
original effective rate, the observable market price of the
loan or the fair value of the collateral.
Wholesale loans are charged-off against the allowance for
loan losses when deemed to be uncollectible.
Consumer. The allowance for credit losses for consumer
loans that exhibit similar risk characteristics is measured on
a collective basis and is calculated using a modeled
approach. These models classify consumer loans into pools
based 	on 	borrower-related 	and 	exposure-related
characteristics that differentiate a pool’s risk characteristics
from other pools. The factors considered in determining a
pool are generally consistent with the risk characteristics
used for internal credit risk measurement and management
and include key metrics, such as FICO credit scores,
delinquency 	status, 	loan 	vintage and macroeconomic
indicators. Under CECL, the allowance for loan losses for
consumer loans also takes into account the weighted
average of a range of forecasts of future macroeconomic
conditions, such as GDP and unemployment rates, to
predict FICO scores and delinquency status migration over
the expected life of a loan for a period of three years. For
loans with maturities extending beyond three years, the
model reverts to historical average loss rates using a non-
linear modeled approach. In addition, the allowance for
loan losses includes a qualitative component.
The allowance for credit losses for consumer loans in a
troubled debt restructuring is calculated using the present
value of expected future cash flows discounted at the loan’s
original effective rate, the observable market price of the
loan or the fair value of the collateral.
Installment loans are charged-off when they are 120 days
past due. Credit card loans are charged-off when they are
180 days past due.
39 	Goldman Sachs March 2020 Form 10-Q

-- 41 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information about the allowance
for credit losses.
$ in millions 	Wholesale 	Consumer 	PCI 	Total
Three Months Ended March 2020
Allowance for loan losses
Beginning balance, reported 	$ 879 	$ 393 	$ 169 	$1,441
Impact of CECL adoption 	452 	444 	(169) 	727
Beginning balance, adjusted 	1,331 	837 	– 	2,168
Net charge-offs 	(50) 	(81) 	– 	(131)
Provision 	746 	169 	– 	915
Other 	(84) 	– 	– 	(84)
Ending balance 	$1,943 	$ 925 	$ 	– 	$2,868
Allowance for losses on lending commitments
Beginning balance, reported 	$ 361 	$ 	– 	$ 	– 	$ 361
Impact of CECL adoption 	(48) 	– 	– 	(48)
Beginning balance, adjusted 	313 	– 	– 	313
Provision 	22 	– 	– 	22
Ending balance 	$ 335 	$ 	– 	$ 	– 	$ 335
Year Ended December 2019
Allowance for loan losses
Beginning balance 	$ 658 	$ 292 	$ 116 	$1,066
Net charge-offs 	(121) 	(317) 	(52) 	(490)
Provision 	469 	418 	103 	990
Other 	(127) 	– 	2 	(125)
Ending balance 	$ 879 	$ 393 	$ 169 	$1,441
Allowance for losses on lending commitments
Beginning balance 	$ 286 	$ 	– 	$ 	– 	$ 286
Provision 	75 	– 	– 	75
Ending balance 	$ 361 	$ 	– 	$ 	– 	$ 361
In the table above:
‰ The impact of CECL adoption for wholesale and
consumer loans is driven by the fact that the allowance
under CECL covers expected credit losses over the full
expected life of the loan portfolios and also considers
forecasts of expected future economic conditions. The
impact of CECL adoption for PCI loans was as a result of
the firm electing to apply the fair value option for such
loans.
‰ Net charge-offs for wholesale loans were primarily
related to corporate loans for both the three months
ended March 2020 and the year ended December 2019.
Net charge-offs for consumer loans were substantially all
related to installment loans for both the three months
ended March 2020 and the year ended December 2019.
‰ The provision for credit losses for the three months ended
March 2020 on wholesale loans was primarily related to
corporate loans and was driven by growth in the firm’s
wholesale loan portfolio, asset-specific provisions relating
to borrowers in the oil and gas sector and the impact of
the COVID-19 pandemic on the broader economic
outlook. The provision for credit losses for wholesale
loans was substantially all related to corporate loans for
the year ended December 2019.
‰ The provision for credit losses for the three months ended
March 2020 on consumer loans was primarily related to
seasoning of credit card loans. The provision for credit
losses related to consumer loans was primarily related to
installment loans for the year ended December 2019.
‰ Other represents the reduction to the allowance related to
loans and lending commitments transferred to held for
sale.
‰ The allowance for loan losses for wholesale loans was
1.8% as of March 2020 and 1.1% as of December 2019
of total gross wholesale loans accounted for at amortized
cost. The allowance for loan losses for consumer loans
was 13.4% as of March 2020 and 6.0% as of December
2019 of total gross consumer loans accounted for at
amortized cost.
‰ The net charge-off ratio for wholesale loans accounted
for at amortized cost was 0.2% on an annualized basis
for the three months ended March 2020 and 0.2% for the
year ended December 2019. The net charge-off ratio for
consumer loans accounted for at amortized cost was
4.8% on an annualized basis for the three months ended
March 	2020 	and 	6.2% 	for 	the 	year 	ended
December 2019.
Goldman Sachs March 2020 Form 10-Q 	40

-- 42 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Fair Value of Loans by Level
The table below presents loans held for investment
accounted for at fair value under the fair value option by
level within the fair value hierarchy.
$ in millions 	Level 1 	Level 2 	Level 3 	Total
As of March 2020
Loan Type
Corporate 	$ 	– 	$ 1,871 	$1,044 	$ 2,915
Wealth management 	– 	7,773 	61 	7,834
Commercial real estate 	– 	942 	1,063 	2,005
Residential real estate 	– 	214 	260 	474
Other 	– 	276 	325 	601
Total 	$ 	– 	$11,076 	$2,753 	$13,829
As of December 2019
Loan Type
Corporate 	$ 	– 	$ 2,472 	$ 752 	$ 3,224
Wealth management 	– 	7,764 	60 	7,824
Commercial real estate 	– 	1,285 	591 	1,876
Residential real estate 	– 	571 	221 	792
Other 	– 	404 	266 	670
Total 	$ 	– 	$12,496 	$1,890 	$14,386
The gains/(losses) as a result of changes in the fair value of
loans held for investment for which the fair value option
was elected were $(27) million for the three months ended
March 2020 and $102 million for the three months ended
March 2019. These gains/(losses) were included in other
principal transactions.
See Note 4 for an overview of the firm’s fair value
measurement policies and the valuation techniques and
significant inputs used to determine the fair value of loans.
Significant Unobservable Inputs
The table below presents the amount of level 3 loans, and
ranges and weighted averages of significant unobservable
inputs used to value such loans.
Level 3 Assets and Range of Significant Unobservable
Inputs (Weighted Average) as of
$ in millions
March
2020
December
2019
Corporate
Level 3 assets 	$1,044 	$752
Yield 	3.1% to 26.3% (12.5%) 	1.9% to 26.3% (9.5%)
Recovery rate 	15.1% to 85.4% (40.6%) 	13.5% to 78.0% (44.4%)
Duration (years) 	1.7 to 4.3 (3.2) 	3.7 to 5.8 (3.9)
Commercial real estate
Level 3 assets 	$1,063 	$591
Yield 	7.0% to 26.3% (11.2%) 	7.0% to 16.0% (9.3%)
Recovery rate 	6.7% to 65.0% (29.5%) 	5.9% to 85.2% (48.6%)
Duration (years) 	0.3 to 5.9 (3.3) 	0.2 to 5.3 (3.5)
Residential real estate
Level 3 assets 	$260 	$221
Yield 	1.6% to 14.0% (11.9%) 	1.1% to 14.0% (11.5%)
Duration (years) 	1.0 to 5.2 (3.8) 	1.1 to 4.8 (4.0)
Wealth management and other
Level 3 assets 	$386 	$326
Yield 	2.7% to 11.5% (9.6%) 	3.9% to 16.0% (9.9%)
Duration (years) 	1.5 to 5.1 (3.2) 	1.6 to 6.7 (3.7)
In the table above:
‰ Ranges represent the significant unobservable inputs that
were used in the valuation of each type of loan.
‰ Weighted averages are calculated by weighting each input
by the relative fair value of the loan.
‰ The ranges and weighted averages of these inputs are not
representative of the appropriate inputs to use when
calculating the fair value of any one loan. For example,
the highest yield for residential real estate loans is
appropriate for valuing a specific residential real estate
loan but may not be appropriate for valuing any other
residential real estate loan. Accordingly, the ranges of
inputs do not represent uncertainty in, or possible ranges
of, fair value measurements of level 3 loans.
‰ Increases in yield or duration used in the valuation of
level 3 loans would have resulted in a lower fair value
measurement, while increases in recovery rate would have
resulted in a higher fair value measurement as of both
March 2020 and December 2019. Due to the distinctive
nature of each level 3 loan, the interrelationship of inputs
is not necessarily uniform within each product type.
‰ Loans are valued using discounted cash flows.
Level 3 Rollforward
The table below presents a summary of the changes in fair
value for level 3 loans.
Three Months
Ended March
$ in millions 	2020 	2019
Beginning balance 	$1,890 	$1,990
Net realized gains/(losses) 	27 	26
Net unrealized gains/(losses) 	(54) 	1
Purchases 	473 	44
Sales 	(12) 	(3)
Settlements 	(221) 	(124)
Transfers into level 3 	653 	170
Transfers out of level 3 	(3) 	(35)
Ending balance 	$2,753 	$2,069
In the table above:
‰ Changes in fair value are presented for loans that are
classified in level 3 as of the end of the period.
‰ Net unrealized gains/(losses) relates to loans that were
still held at period-end.
‰ Purchases includes originations and secondary purchases.
‰ Transfers between levels of the fair value hierarchy are
reported at the beginning of the reporting period in which
they occur. If a loan was transferred to level 3 during a
reporting period, its entire gain or loss for the period is
classified in level 3.
41 	Goldman Sachs March 2020 Form 10-Q

-- 43 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information, by loan type, for
loans included in the summary table above.
Three Months
Ended March
$ in millions 	2020 	2019
Corporate
Beginning balance 	$ 752 	$659
Net realized gains/(losses) 	10 	2
Net unrealized gains/(losses) 	(11) 	(14)
Purchases 	156 	34
Sales 	(7) 	–
Settlements 	(40) 	(4)
Transfers into level 3 	187 	81
Transfers out of level 3 	(3) 	(32)
Ending balance 	$1,044 	$726
Commercial real estate
Beginning balance 	$ 591 	$677
Net realized gains/(losses) 	17 	7
Net unrealized gains/(losses) 	7 	7
Purchases 	236 	1
Sales 	(5) 	(2)
Settlements 	(115) 	(47)
Transfers into level 3 	332 	–
Transfers out of level 3 	– 	(3)
Ending balance 	$1,063 	$640
Residential real estate
Beginning balance 	$ 221 	$290
Net realized gains/(losses) 	– 	8
Net unrealized gains/(losses) 	(17) 	(2)
Purchases 	42 	9
Sales 	– 	(1)
Settlements 	(27) 	(30)
Transfers into level 3 	41 	–
Ending balance 	$ 260 	$274
Wealth management and other
Beginning balance 	$ 326 	$364
Net realized gains/(losses) 	– 	9
Net unrealized gains/(losses) 	(33) 	10
Purchases 	39 	–
Settlements 	(39) 	(43)
Transfers into level 3 	93 	89
Ending balance 	$ 386 	$429
Level 3 Rollforward Commentary
Three Months Ended March 2020. The net realized and
unrealized losses on level 3 loans of $27 million (reflecting
$27 million of net realized gains and $54 million of net
unrealized losses) for the three months ended March 2020
included gains/(losses) of $(44) million reported in other
principal transactions and $17 million reported in interest
income.
The drivers of the net unrealized losses on level 3 loans for
the three months ended March 2020 were not material.
Transfers into level 3 loans during the three months ended
March 	2020 	primarily 	reflected 	transfer 	of 	certain
commercial real estate loans and corporate loans from
level 2, principally due to reduced price transparency as a
result of a lack of market evidence, including fewer market
transactions in these instruments.
The drivers of transfers out of level 3 loans during the three
months ended March 2020 were not material.
Three Months Ended March 2019. The net realized and
unrealized gains on level 3 loans of $27 million (reflecting
$26 million of net realized gains and $1 million of net
unrealized gains) for the three months ended March 2019
included gains of $13 million reported in other principal
transactions and $14 million reported in interest income.
The drivers of the net unrealized gains on level 3 loans for
the three months ended March 2019 were not material.
The drivers of transfers into and out of level 3 loans during
the three months ended March 2019 were not material.
Estimated Fair Value
The table below presents the estimated fair value of loans
that are not accounted for at fair value and in what level of
the fair value hierarchy they would have been classified if
they had been included in the firm’s fair value hierarchy.
$ in millions
Carrying
Value
Estimated Fair Value
Level 2 	Level 3 	Total
As of March 2020
Amortized cost 	$111,467 $54,658 	$53,979 	$108,637
Held for sale 	$ 	3,157 $ 1,646 	$ 1,564 	$ 	3,210
As of December 2019
Amortized cost 	$ 89,195 $52,091 	$37,095 	$ 89,186
Held for sale 	$ 	5,323 $ 4,157 	$ 1,252 	$ 	5,409
Goldman Sachs March 2020 Form 10-Q 	42

-- 44 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 10.
Fair Value Option
Other Financial Assets and Liabilities at Fair Value
In addition to trading assets and liabilities, and certain
investments and loans, the firm accounts for certain of its
other 	financial 	assets 	and 	liabilities 	at 	fair 	value,
substantially all under the fair value option. The primary
reasons for electing the fair value option are to:
‰ Reflect economic events in earnings on a timely basis;
‰ Mitigate volatility in earnings from using different
measurement attributes (e.g., transfers of financial assets
accounted for as financings are recorded at fair value,
whereas the related secured financing would be recorded
on an accrual basis absent electing the fair value option);
and
‰ Address simplification and cost-benefit considerations
(e.g., accounting for hybrid financial instruments at fair
value in their entirety versus bifurcation of embedded
derivatives and hedge accounting for debt hosts).
Hybrid financial instruments are instruments that contain
bifurcatable embedded derivatives and do not require
settlement by physical delivery of nonfinancial assets (e.g.,
physical commodities). If the firm elects to bifurcate the
embedded 	derivative 	from 	the 	associated 	debt, 	the
derivative is accounted for at fair value and the host
contract is accounted for at amortized cost, adjusted for the
effective portion of any fair value hedges. If the firm does
not elect to bifurcate, the entire hybrid financial instrument
is accounted for at fair value under the fair value option.
Other financial assets and liabilities accounted for at fair
value under the fair value option include:
‰ Repurchase 	agreements 	and 	substantially 	all 	resale
agreements;
‰ Securities borrowed and loaned in FICC financing;
‰ Most other secured financings, including transfers of
assets accounted for as financings and collateralized
central bank financings;
‰ Certain unsecured short- and long-term borrowings,
substantially 	all 	of 	which 	are 	hybrid 	financial
instruments;
‰ Certain customer and other receivables, including certain
margin loans; and
‰ Certain time deposits (deposits with no stated maturity
are not eligible for a fair value option election), including
structured certificates of deposit, which are hybrid
financial instruments.
Fair Value of Other Financial Assets and Liabilities by
Level
The table below presents, by level within the fair value
hierarchy, other financial assets and liabilities at fair value,
substantially all of which are accounted for at fair value
under the fair value option.
$ in millions 	Level 1 	Level 2 	Level 3 	Total
As of March 2020
Assets
Resale agreements 	$ 	– $ 132,333 $ 	– $ 132,333
Securities borrowed 	– 	29,771 	– 	29,771
Customer and other receivables 	– 	53 	– 	53
Total 	$ 	– $ 162,157 $ 	– $ 162,157
Liabilities
Deposits 	$ 	– $ (20,726) $ (3,996) $ (24,722)
Repurchase agreements 	– 	(95,852) 	(12) 	(95,864)
Securities loaned 	– 	(1,148) 	– 	(1,148)
Other secured financings 	– 	(28,761) 	(1,230) 	(29,991)
Unsecured borrowings:
Short-term 	– 	(13,572) 	(5,411) 	(18,983)
Long-term 	– 	(32,637) (10,676) 	(43,313)
Other liabilities 	– 	(2) 	(325) 	(327)
Total 	$ 	– $(192,698) $(21,650) $(214,348)
As of December 2019
Assets
Resale agreements 	$ 	– $ 85,691 $ 	– $ 85,691
Securities borrowed 	– 	26,279 	– 	26,279
Customer and other receivables 	– 	53 	– 	53
Total 	$ 	– $ 112,023 $ 	– $ 112,023
Liabilities
Deposits 	$ 	– $ (13,742) $ (4,023) $ (17,765)
Repurchase agreements 	– 	(117,726) 	(30) (117,756)
Securities loaned 	– 	(714) 	– 	(714)
Other secured financings 	– 	(17,685) 	(386) 	(18,071)
Unsecured borrowings:
Short-term 	– 	(20,300) 	(5,707) 	(26,007)
Long-term 	– 	(32,920) (10,741) 	(43,661)
Other liabilities 	– 	(1) 	(149) 	(150)
Total 	$ 	– $(203,088) $(21,036) $(224,124)
In the table above, other financial assets are shown as
positive amounts and other financial liabilities are shown as
negative amounts.
See Note 4 for an overview of the firm’s fair value
measurement policies and the valuation techniques and
significant inputs used to determine the fair value of other
financial assets and liabilities.
Significant Unobservable Inputs
See 	below 	for 	information 	about 	the 	significant
unobservable inputs used to value level 3 other financial
assets and liabilities at fair value as of both March 2020 and
December 2019.
43 	Goldman Sachs March 2020 Form 10-Q

-- 45 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Other Secured Financings. The ranges and weighted
averages of significant unobservable inputs used to value
level 3 other secured financings are presented below. These
ranges and weighted averages exclude unobservable inputs
that are only relevant to a single instrument, and therefore
are not meaningful.
As of March 2020:
‰ Yield: 2.2% to 4.2% (weighted average: 2.6%)
‰ Duration: 0.4 to 3.8 years (weighted average: 3.3 years)
As of December 2019:
‰ Yield: 3.3% to 4.2% (weighted average: 3.5%)
‰ Duration: 0.6 to 2.1 years (weighted average: 1.0 year)
Generally, increases in yield or duration, in isolation, would
have resulted in a lower fair value measurement as of
period-end. Due to the distinctive nature of each of level 3
other secured financings, the interrelationship of inputs is
not necessarily uniform across such financings. See Note 11
for further information about other secured financings.
Deposits, 	Unsecured 	Borrowings 	and 	Other
Liabilities. 	Substantially 	all 	of 	the 	firm’s 	deposits,
unsecured short- and long-term borrowings, and other
liabilities that are classified in level 3 are hybrid financial
instruments. As the significant unobservable inputs used to
value hybrid financial instruments primarily relate to the
embedded 	derivative 	component 	of 	these 	deposits,
unsecured 	borrowings 	and 	other 	liabilities, 	these
unobservable 	inputs 	are 	incorporated 	in 	the 	firm’s
derivative disclosures in Note 7. See Note 13 for further
information 	about 	deposits, 	Note 	14 	for 	further
information about unsecured borrowings and Note 15 for
further information about other liabilities.
Repurchase Agreements. As of both March 2020 and
December 2019, the firm’s level 3 repurchase agreements
were not material.
Level 3 Rollforward
The table below presents a summary of the changes in fair
value for level 3 other financial liabilities accounted for at
fair value.
Three Months
Ended March
$ in millions 	2020 	2019
Beginning balance 	$(21,036) 	$(19,397)
Net realized gains/(losses) 	(130) 	(79)
Net unrealized gains/(losses) 	3,160 	(1,494)
Issuances 	(7,643) 	(3,036)
Settlements 	5,157 	3,307
Transfers into level 3 	(1,596) 	(571)
Transfers out of level 3 	438 	351
Ending balance 	$(21,650) 	$(20,919)
In the table above:
‰ Changes in fair value are presented for all other financial
liabilities that are classified in level 3 as of the end of the
period.
‰ Net unrealized gains/(losses) relates to other financial
liabilities that were still held at period-end.
‰ Transfers between levels of the fair value hierarchy are
reported at the beginning of the reporting period in which
they occur. If a financial liability was transferred to level 3
during a reporting period, its entire gain or loss for the
period is classified in level 3.
‰ For level 3 other financial liabilities, increases are shown
as negative amounts, while decreases are shown as
positive amounts.
‰ Level 	3 	other 	financial 	liabilities 	are 	frequently
economically hedged with trading assets and liabilities.
Accordingly, gains or losses that are classified in level 3
can be partially offset by gains or losses attributable to
level 1, 2 or 3 trading assets and liabilities. As a result,
gains or losses included in the level 3 rollforward below
do not necessarily represent the overall impact on the
firm’s results of operations, liquidity or capital resources.
Goldman Sachs March 2020 Form 10-Q 	44

-- 46 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information, by the consolidated
balance sheet line items, for liabilities included in the
summary table above.
Three Months
Ended March
$ in millions 	2020 	2019
Deposits
Beginning balance 	$ (4,023) 	$ (3,168)
Net realized gains/(losses) 	(11) 	(1)
Net unrealized gains/(losses) 	117 	(142)
Issuances 	(335) 	(197)
Settlements 	309 	111
Transfers into level 3 	(121) 	(16)
Transfers out of level 3 	68 	62
Ending balance 	$ (3,996) 	$ (3,351)
Repurchase agreements
Beginning balance 	$ 	(30) 	$ 	(29)
Net unrealized gains/(losses) 	3 	(4)
Settlements 	15 	4
Ending balance 	$ 	(12) 	$ 	(29)
Other secured financings
Beginning balance 	$ 	(386) 	$ 	(170)
Net realized gains/(losses) 	(44) 	11
Net unrealized gains/(losses) 	107 	(10)
Issuances 	(14) 	(11)
Settlements 	92 	8
Transfers into level 3 	(985) 	(20)
Ending balance 	$ (1,230) 	$ 	(192)
Unsecured short-term borrowings
Beginning balance 	$ (5,707) 	$ (4,076)
Net realized gains/(losses) 	(11) 	7
Net unrealized gains/(losses) 	1,538 	(425)
Issuances 	(3,954) 	(2,155)
Settlements 	2,718 	1,344
Transfers into level 3 	(270) 	(338)
Transfers out of level 3 	275 	130
Ending balance 	$ (5,411) 	$ (5,513)
Unsecured long-term borrowings
Beginning balance 	$(10,741) 	$(11,823)
Net realized gains/(losses) 	(72) 	(103)
Net unrealized gains/(losses) 	1,571 	(912)
Issuances 	(3,332) 	(666)
Settlements 	2,023 	1,840
Transfers into level 3 	(220) 	(197)
Transfers out of level 3 	95 	159
Ending balance 	$(10,676) 	$(11,702)
Other liabilities
Beginning balance 	$ 	(149) 	$ 	(131)
Net realized gains/(losses) 	8 	7
Net unrealized gains/(losses) 	(176) 	(1)
Issuances 	(8) 	(7)
Ending balance 	$ 	(325) 	$ 	(132)
Level 3 Rollforward Commentary
Three Months Ended March 2020. The net realized and
unrealized gains on level 3 other financial liabilities of
$3.03 billion (reflecting $130 million of net realized losses
and $3.16 billion of net unrealized gains) for the three
months ended March 2020 included gains of $1.99 billion
reported in market making and $64 million reported in
other principal transactions in the consolidated statements
of earnings, and $974 million reported in debt valuation
adjustment 	in 	the 	consolidated 	statements 	of
comprehensive income.
The unrealized gains on level 3 other financial liabilities for
the three months ended March 2020 primarily reflected
gains on certain hybrid financial instruments included in
unsecured long- and short-term borrowings, principally due
to a decrease in global equity prices.
Transfers into level 3 other financial liabilities during the
three months ended March 2020 primarily reflected
transfers of certain other secured financings and hybrid
financial instruments included in unsecured short- and
long-term borrowings from level 2, principally due to
reduced 	price 	transparency 	of 	certain 	volatility 	and
correlation inputs used to value these instruments.
Transfers out of level 3 other financial liabilities during the
three months ended March 2020 primarily reflected
transfers of certain hybrid financial instruments included in
unsecured short- and long-term borrowings to level 2,
principally due to increased price transparency of certain
volatility and correlation inputs used to value these
instruments.
Three Months Ended March 2019. The net realized and
unrealized losses on level 3 other financial liabilities of
$1.57 billion (reflecting $79 million of net realized losses
and $1.49 billion of net unrealized losses) for the three
months ended March 2019 included losses of $1.22 billion
reported in market making and $1 million reported in other
principal transactions in the consolidated statements of
earnings, and $350 million reported in debt valuation
adjustment 	in 	the 	consolidated 	statements 	of
comprehensive income.
The net unrealized losses on level 3 other financial liabilities
for the three months ended March 2019 primarily reflected
losses on certain hybrid financial instruments included in
unsecured 	long-term 	and 	short-term 	borrowings,
principally due to an increase in global equity prices.
Transfers into level 3 other financial liabilities during the
three months ended March 2019 primarily reflected
transfers of certain hybrid financial instruments included in
unsecured short-term and long-term borrowings from
level 2, principally due to reduced transparency of certain
volatility and correlation inputs used to value these
instruments.
45 	Goldman Sachs March 2020 Form 10-Q

-- 47 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Transfers out of level 3 other financial liabilities during the
three months ended March 2019 primarily reflected
transfers of certain hybrid financial instruments included in
unsecured long-term and short-term borrowings to level 2,
principally 	due 	to 	increased 	transparency 	of 	certain
volatility and correlation inputs used to value these
instruments.
Gains and Losses on Other Financial Assets and
Liabilities Accounted for at Fair Value Under the
Fair Value Option
The table below presents the gains and losses recognized in
earnings as a result of the election to apply the fair value
option to certain financial assets and liabilities.
Three Months
Ended March
$ in millions 	2020 	2019
Unsecured short-term borrowings 	$4,481 	$(1,616)
Unsecured long-term borrowings 	992 	(2,229)
Other 	398 	(476)
Total 	$5,871 	$(4,321)
In the table above:
‰ Gains/(losses) were substantially all included in market
making.
‰ Gains/(losses) exclude contractual interest, which is
included in interest income and interest expense, for all
instruments other than hybrid financial instruments. See
Note 23 for further information about interest income
and interest expense.
‰ Gains/(losses) included in unsecured short- and long-term
borrowings were substantially all related to the embedded
derivative component of hybrid financial instruments for
both 	the 	three 	months 	ended 	March 	2020 	and
March 2019. These gains and losses would have been
recognized under other U.S. GAAP even if the firm had
not elected to account for the entire hybrid financial
instrument at fair value.
‰ Other primarily consists of gains/(losses) on customer and
other receivables, deposits, other secured financings and
other liabilities.
‰ Other financial assets and liabilities at fair value are
frequently economically hedged with trading assets and
liabilities. Accordingly, gains or losses on such other
financial assets and liabilities can be partially offset by
gains or losses on trading assets and liabilities. As a result,
gains or losses on other financial assets and liabilities do
not necessarily represent the overall impact on the firm’s
results of operations, liquidity or capital resources.
See Note 8 for information about gains/(losses) on equity
securities and Note 9 for information about gains/(losses)
on loans which are accounted for at fair value under the fair
value option. Gains/(losses) on trading assets and liabilities
accounted for at fair value under the fair value option are
included in market making. See Note 5 for further
information about gains/(losses) from market making.
Long-Term Debt Instruments
The aggregate contractual principal amount of long-term
other secured financings for which the fair value option was
elected exceeded the related fair value by $546 million as of
March 	2020. 	The 	difference 	between 	the 	aggregate
contractual principal amount and the related fair value of
long-term other secured financings for which the fair value
option was elected was not material as of December 2019.
The aggregate contractual principal amount of unsecured
long-term borrowings for which the fair value option was
elected exceeded the related fair value by $823 million as of
March 2020, and the fair value exceeded the aggregate
contractual principal amount by $199 million as of
December 	2019. 	The 	amounts 	above 	include 	both
principal-protected and non-principal-protected long-term
borrowings.
Debt Valuation Adjustment
The firm calculates the fair value of financial liabilities for
which the fair value option is elected by discounting future
cash flows at a rate which incorporates the firm’s credit
spreads.
The table below presents information about the net debt
valuation adjustment (DVA) gains/(losses) on financial
liabilities for which the fair value option was elected.
Three Months
Ended March
$ in millions 	2020 	2019
DVA (pre-tax) 	$3,871 	$(1,889)
DVA (net of tax) 	$2,914 	$(1,417)
In the table above:
‰ DVA (net of tax) is included in debt valuation adjustment
in the consolidated statements of comprehensive income.
‰ The 	gains/(losses) 	reclassified 	to 	earnings 	from
accumulated other comprehensive income/(loss) upon
extinguishment of such financial liabilities were not
material for both the three months ended March 2020
and March 2019.
Goldman Sachs March 2020 Form 10-Q 	46

-- 48 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Loans and Lending Commitments
The table below presents the difference between the
aggregate fair value and the aggregate contractual principal
amount for loans (included in trading assets and loans on
the consolidated balance sheets) for which the fair value
option was elected.
As of
$ in millions
March
2020
December
2019
Performing loans
Aggregate contractual principal in excess of fair value $ 719 	$ 809
Loans on nonaccrual status and/or more than 90 days past due
Aggregate contractual principal in excess of fair value $8,591 	$6,703
Aggregate fair value 	$3,472 	$2,776
In the table above, the aggregate contractual principal
amount of loans on nonaccrual status and/or more than
90 days past due (which excludes loans carried at zero fair
value and considered uncollectible) exceeds the related fair
value primarily because the firm regularly purchases loans,
such as distressed loans, at values significantly below the
contractual principal amounts.
The fair value of unfunded lending commitments for which
the fair value option was elected was a liability of $6 million
as of March 2020 and $24 million as of December 2019,
and the related total contractual amount of these lending
commitments was $2.33 billion as of March 2020 and
$1.55 billion as of December 2019. See Note 18 for further
information about lending commitments.
Impact of Credit Spreads on Loans and Lending
Commitments
The estimated net gain/(loss) attributable to changes in
instrument-specific credit spreads on loans and lending
commitments for which the fair value option was elected
was $(194) million for the three months ended March 2020
and $77 million for the three months ended March 2019.
The firm generally calculates the fair value of loans and
lending commitments for which the fair value option is
elected by discounting future cash flows at a rate which
incorporates the instrument-specific credit spreads. For
floating-rate loans and lending commitments, substantially
all changes in fair value are attributable to changes in
instrument-specific credit spreads, whereas for fixed-rate
loans and lending commitments, changes in fair value are
also attributable to changes in interest rates.
Note 11.
Collateralized Agreements and Financings
Collateralized 	agreements 	are 	resale 	agreements 	and
securities 	borrowed. 	Collateralized 	financings 	are
repurchase agreements, securities loaned and other secured
financings. The firm enters into these transactions in order
to, among other things, facilitate client activities, invest
excess cash, acquire securities to cover short positions and
finance certain firm activities.
Collateralized agreements and financings are presented on a
net-by-counterparty basis when a legal right of setoff exists.
Interest on collateralized agreements, which is included in
interest income, and collateralized financings, which is
included in interest expense, is recognized over the life of
the transaction. See Note 23 for further information about
interest income and interest expense.
The table below presents the carrying value of resale and
repurchase agreements and securities borrowed and loaned
transactions.
As of
$ in millions
March
2020
December
2019
Resale agreements 	$132,333 	$ 85,691
Securities borrowed 	$121,670 	$136,071
Repurchase agreements 	$ 95,864 	$117,756
Securities loaned 	$ 13,869 	$ 14,985
In the table above:
‰ Substantially all resale agreements and all repurchase
agreements are carried at fair value under the fair value
option. See Note 4 for further information about the
valuation techniques and significant inputs used to
determine fair value.
‰ Securities borrowed of $29.77 billion as of March 2020
and $26.28 billion as of December 2019, and securities
loaned 	of 	$1.15 	billion 	as 	of 	March 	2020 	and
$714 million as of December 2019 were at fair value.
Resale and Repurchase Agreements
A resale agreement is a transaction in which the firm
purchases financial instruments from a seller, typically in
exchange for cash, and simultaneously enters into an
agreement to resell the same or substantially the same
financial instruments to the seller at a stated price plus
accrued interest at a future date.
47 	Goldman Sachs March 2020 Form 10-Q

-- 49 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
A repurchase agreement is a transaction in which the firm
sells financial instruments to a buyer, typically in exchange
for cash, and simultaneously enters into an agreement to
repurchase the same or substantially the same financial
instruments from the buyer at a stated price plus accrued
interest at a future date.
Even though repurchase and resale agreements (including
“repos- 	and 	reverses-to-maturity”) 	involve 	the 	legal
transfer of ownership of financial instruments, they are
accounted for as financing arrangements because they
require the financial instruments to be repurchased or
resold before or at the maturity of the agreement. The
financial instruments purchased or sold in resale and
repurchase agreements typically include U.S. government
and agency, and investment-grade sovereign obligations.
The firm receives financial instruments purchased under
resale 	agreements 	and 	makes 	delivery 	of 	financial
instruments sold under repurchase agreements. To mitigate
credit exposure, the firm monitors the market value of these
financial instruments on a daily basis, and delivers or
obtains additional collateral due to changes in the market
value of the financial instruments, as appropriate. For
resale agreements, the firm typically requires collateral with
a fair value approximately equal to the carrying value of the
relevant assets in the consolidated balance sheets.
Securities Borrowed and Loaned Transactions
In a securities borrowed transaction, the firm borrows
securities from a counterparty in exchange for cash or
securities. When the firm returns the securities, the
counterparty returns the cash or securities. Interest is
generally paid periodically over the life of the transaction.
In a securities loaned transaction, the firm lends securities
to a counterparty in exchange for cash or securities. When
the counterparty returns the securities, the firm returns the
cash or securities posted as collateral. Interest is generally
paid periodically over the life of the transaction.
The firm receives securities borrowed and makes delivery of
securities loaned. To mitigate credit exposure, the firm
monitors the market value of these securities on a daily
basis, and delivers or obtains additional collateral due to
changes 	in 	the 	market 	value 	of 	the 	securities, 	as
appropriate. For securities borrowed transactions, the firm
typically requires collateral with a fair value approximately
equal to the carrying value of the securities borrowed
transaction.
Securities borrowed and loaned within FICC financing are
recorded at fair value under the fair value option. See
Note 10 for further information about securities borrowed
and loaned accounted for at fair value.
Securities borrowed and loaned within Equities financing
are recorded based on the amount of cash collateral
advanced or received plus accrued interest. As these
agreements generally can be terminated on demand, they
exhibit little, if any, sensitivity to changes in interest rates.
Therefore, 	the 	carrying 	value 	of 	such 	agreements
approximates fair value. As these agreements are not
accounted for at fair value, they are not included in the
firm’s fair value hierarchy in Notes 4 through 10. Had these
agreements been included in the firm’s fair value hierarchy,
they would have been classified in level 2 as of both
March 2020 and December 2019.
Offsetting Arrangements
The table below presents resale and repurchase agreements
and securities borrowed and loaned transactions included
in the consolidated balance sheets, as well as the amounts
not offset in the consolidated balance sheets.
Assets 	Liabilities
$ in millions
Resale
agreements
Securities
borrowed
Repurchase
agreements
Securities
loaned
As of March 2020
Included in the consolidated balance sheets
Gross carrying value 	$ 199,157 	$ 125,340 	$ 162,688 	$ 17,539
Counterparty netting 	(66,824) 	(3,670) 	(66,824) 	(3,670)
Total 	132,333 	121,670 	95,864 	13,869
Amounts not offset
Counterparty netting 	(7,393) 	(4,043) 	(7,393) 	(4,043)
Collateral 	(121,885) 	(110,661) 	(87,681) 	(9,826)
Total 	$ 	3,055 	$ 	6,966 	$ 	790 	$ 	–
As of December 2019
Included in the consolidated balance sheets
Gross carrying value 	$ 152,982 	$ 140,677 	$ 185,047 	$ 19,591
Counterparty netting 	(67,291) 	(4,606) 	(67,291) 	(4,606)
Total 	85,691 	136,071 	117,756 	14,985
Amounts not offset
Counterparty netting 	(3,058) 	(2,211) 	(3,058) 	(2,211)
Collateral 	(78,528) 	(127,901) 	(114,065) 	(12,614)
Total 	$ 	4,105 	$ 	5,959 	$ 	633 	$ 	160
In the table above:
‰ Substantially all of the gross carrying values of these
arrangements 	are 	subject 	to 	enforceable 	netting
agreements.
‰ Where the firm has received or posted collateral under
credit support agreements, but has not yet determined
such agreements are enforceable, the related collateral has
not been netted.
‰ Amounts not offset includes counterparty netting that
does not meet the criteria for netting under U.S. GAAP
and the fair value of collateral received or posted subject
to enforceable credit support agreements.
Goldman Sachs March 2020 Form 10-Q 	48

-- 50 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Gross Carrying Value of Repurchase Agreements
and Securities Loaned
The table below presents the gross carrying value of
repurchase agreements and securities loaned by class of
collateral pledged.
$ in millions
Repurchase
agreements
Securities
loaned
As of March 2020
Money market instruments 	$ 	719 	$ 	–
U.S. government and agency obligations 	81,270 	–
Non-U.S. government and agency obligations 	61,443 	1,032
Securities backed by commercial real estate 	60 	–
Securities backed by residential real estate 	450 	–
Corporate debt securities 	6,875 	74
State and municipal obligations 	222 	–
Other debt obligations 	1,061 	–
Equity securities 	10,588 	16,433
Total 	$162,688 	$17,539
As of December 2019
Money market instruments 	$ 	158 	$ 	–
U.S. government and agency obligations 	112,903 	–
Non-U.S. government and agency obligations 	55,575 	1,051
Securities backed by commercial real estate 	210 	–
Securities backed by residential real estate 	1,079 	–
Corporate debt securities 	6,857 	122
State and municipal obligations 	242 	–
Other debt obligations 	196 	–
Equity securities 	7,827 	18,418
Total 	$185,047 	$19,591
The table below presents the gross carrying value of
repurchase agreements and securities loaned by maturity.
As of March 2020
$ in millions
Repurchase
agreements
Securities
loaned
No stated maturity and overnight 	$ 42,764 	$13,522
2 - 30 days 	68,223 	–
31 - 90 days 	29,421 	972
91 days - 1 year 	20,504 	3,045
Greater than 1 year 	1,776 	–
Total 	$162,688 	$17,539
In the table above:
‰ Repurchase agreements and securities loaned that are
repayable prior to maturity at the option of the firm are
reflected at their contractual maturity dates.
‰ Repurchase agreements and securities loaned that are
redeemable prior to maturity at the option of the holder
are reflected at the earliest dates such options become
exercisable.
Other Secured Financings
In addition to repurchase agreements and securities loaned
transactions, the firm funds certain assets through the use of
other secured financings and pledges financial instruments
and other assets as collateral in these transactions. These
other secured financings consist of:
‰ Liabilities of consolidated VIEs;
‰ Transfers of assets accounted for as financings rather than
sales 	(e.g., 	pledged 	commodities, 	bank 	loans 	and
mortgage whole loans);
‰ Other structured financing arrangements; and
‰ Collateralized central bank financings.
Other 	secured 	financings 	included 	nonrecourse
arrangements. Nonrecourse other secured financings were
$18.02 billion as of March 2020 and $10.91 billion as of
December 2019.
The firm has elected to apply the fair value option to
substantially all other secured financings because the use of
fair value eliminates non-economic volatility in earnings
that 	would 	arise 	from 	using 	different 	measurement
attributes. See Note 10 for further information about other
secured financings that are accounted for at fair value.
Other secured financings that are not recorded at fair value
are recorded based on the amount of cash received plus
accrued interest, which generally approximates fair value.
As these financings are not accounted for at fair value, they
are not included in the firm’s fair value hierarchy in Notes 4
through 10. Had these financings been included in the
firm’s fair value hierarchy, they would have been primarily
classified 	in 	level 	2 	as 	of 	both 	March 	2020 	and
December 2019.
49 	Goldman Sachs March 2020 Form 10-Q

-- 51 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information about other secured
financings.
$ in millions
U.S.
Dollar
Non-U.S.
Dollar 	Total
As of March 2020
Other secured financings (short-term):
At fair value 	$13,248 	$ 4,725 	$17,973
At amortized cost 	6,123 	– 	6,123
Other secured financings (long-term):
At fair value 	6,665 	5,353 	12,018
At amortized cost 	396 	686 	1,082
Total other secured financings 	$26,432 	$10,764 	$37,196
Other secured financings collateralized by:
Financial instruments 	$19,694 	$ 8,629 	$28,323
Other assets 	$ 6,738 	$ 2,135 	$ 8,873
As of December 2019
Other secured financings (short-term):
At fair value 	$ 2,754 	$ 4,441 	$ 7,195
At amortized cost 	129 	– 	129
Other secured financings (long-term):
At fair value 	7,402 	3,474 	10,876
At amortized cost 	397 	680 	1,077
Total other secured financings 	$10,682 	$ 8,595 	$19,277
Other secured financings collateralized by:
Financial instruments 	$ 4,826 	$ 7,189 	$12,015
Other assets 	$ 5,856 	$ 1,406 	$ 7,262
In the table above:
‰ Short-term other secured financings includes financings
maturing within one year of the financial statement date
and financings that are redeemable within one year of the
financial statement date at the option of the holder.
‰ U.S. 	dollar-denominated 	short-term 	other 	secured
financings at amortized cost had a weighted average
interest rate of 0.32% as of March 2020 and 4.32% as of
December 2019. These rates include the effect of hedging
activities.
‰ U.S. 	dollar-denominated 	long-term 	other 	secured
financings at amortized cost had a weighted average
interest rate of 2.79% as of both March 2020 and
December 2019. These rates include the effect of hedging
activities.
‰ Total other secured financings included $1.48 billion as
of March 2020 and $2.16 billion as of December 2019
related to transfers of financial assets accounted for as
financings 	rather 	than 	sales. 	Such 	financings 	were
collateralized by financial assets of $1.38 billion as of
March 2020 and $2.21 billion as of December 2019, both
primarily included in trading assets.
‰ Other secured financings collateralized by financial
instruments included $24.62 billion as of March 2020
and $9.09 billion as of December 2019 of other secured
financings collateralized by trading assets and loans, and
included 	$3.70 	billion 	as 	of 	March 	2020 	and
$2.93 billion as of December 2019 of other secured
financings collateralized by financial instruments received
as collateral and repledged.
The table below presents other secured financings by
maturity.
$ in millions
As of
March 2020
Other secured financings (short-term) 	$24,096
Other secured financings (long-term):
2021 	3,460
2022 	2,589
2023 	1,606
2024 	1,490
2025 	492
2026 - thereafter 	3,463
Total other secured financings (long-term) 	13,100
Total other secured financings 	$37,196
In the table above:
‰ Long-term other secured financings that are repayable
prior to maturity at the option of the firm are reflected at
their contractual maturity dates.
‰ Long-term other secured financings that are redeemable
prior to maturity at the option of the holder are reflected
at the earliest dates such options become exercisable.
Collateral Received and Pledged
The firm receives cash and securities (e.g., U.S. government
and agency obligations, other sovereign and corporate
obligations, as well as equity securities) as collateral,
primarily in connection with resale agreements, securities
borrowed, derivative transactions and customer margin
loans. The firm obtains cash and securities as collateral on
an upfront or contingent basis for derivative instruments
and collateralized agreements to reduce its credit exposure
to individual counterparties.
In many cases, the firm is permitted to deliver or repledge
financial instruments received as collateral when entering
into 	repurchase 	agreements 	and 	securities 	loaned
transactions, primarily in connection with secured client
financing activities. The firm is also permitted to deliver or
repledge these financial instruments in connection with
other 	secured 	financings, 	collateralized 	derivative
transactions and firm or customer settlement requirements.
Goldman Sachs March 2020 Form 10-Q 	50

-- 52 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The firm also pledges certain trading assets in connection
with repurchase agreements, securities loaned transactions
and other secured financings, and other assets (substantially
all real estate and cash) in connection with other secured
financings to counterparties who may or may not have the
right to deliver or repledge them.
The table below presents financial instruments at fair value
received as collateral that were available to be delivered or
repledged and were delivered or repledged.
As of
$ in millions
March
2020
December
2019
Collateral available to be delivered or repledged $689,662 	$661,490
Collateral that was delivered or repledged 	$557,726 	$558,634
In the table above, collateral available to be delivered or
repledged excluded $14.65 billion as of March 2020 and
$6.15 billion as of December 2019 of securities received
under 	resale 	agreements 	and 	securities 	borrowed
transactions that contractually had the right to be delivered
or repledged, but were segregated for regulatory and other
purposes.
The table below presents information about assets pledged.
As of
$ in millions
March
2020
December
2019
Pledged to counterparties that had the right to deliver or repledge
Trading assets 	$ 59,128 	$ 66,605
Investments 	$ 10,765 	$ 10,968
Pledged to counterparties that did not have the right to deliver or repledge
Trading assets 	$ 92,201 	$ 101,578
Investments 	$ 	8,098 	$ 	849
Loans 	$ 34,933 	$ 	6,628
Other assets 	$ 14,573 	$ 12,337
The firm also segregated securities included in trading
assets and investments of $39.32 billion as of March 2020
and $20.61 billion as of December 2019 for regulatory and
other 	purposes. 	See 	Note 	3 	for 	information 	about
segregated cash.
Note 12.
Other Assets
The table below presents other assets by type.
As of
$ in millions
March
2020
December
2019
Property, leasehold improvements and equipment $23,620 	$21,886
Goodwill and identifiable intangible assets 	4,810 	4,837
Operating lease right-of-use assets 	2,284 	2,360
Income tax-related assets 	1,804 	2,068
Miscellaneous receivables and other 	4,201 	3,731
Total 	$36,719 	$34,882
Property, Leasehold Improvements and Equipment
Property, leasehold improvements and equipment is net of
accumulated depreciation and amortization of $9.23 billion
as of March 2020 and $9.95 billion as of December 2019.
Property, leasehold improvements and equipment included
$6.23 billion as of March 2020 and $6.16 billion as of
December 2019 that the firm uses in connection with its
operations, and $484 million as of March 2020 and
$521 million as of December 2019 of foreclosed real estate
primarily related to distressed loans that were purchased by
the firm. The remainder is held by investment entities,
including VIEs, consolidated by the firm. Substantially all
property and equipment is depreciated on a straight-line
basis 	over 	the 	useful 	life 	of 	the 	asset. 	Leasehold
improvements are amortized on a straight-line basis over
the shorter of the useful life of the improvement or the term
of the lease. Capitalized costs of software developed or
obtained for internal use are amortized on a straight-line
basis over three years.
The firm tests property, leasehold improvements and
equipment for impairment whenever events or changes in
circumstances suggest that an asset’s or asset group’s
carrying value may not be fully recoverable. To the extent
the carrying value of an asset or asset group exceeds the
projected undiscounted cash flows expected to result from
the use and eventual disposal of the asset or asset group, the
firm determines the asset or asset group is impaired and
records an impairment equal to the difference between the
estimated fair value and the carrying value of the asset or
asset group. In addition, the firm will recognize an
impairment prior to the sale of an asset or asset group if the
carrying value of the asset or asset group exceeds its
estimated fair value.
There were no material impairments during both the three
months ended March 2020 and March 2019.
51 	Goldman Sachs March 2020 Form 10-Q

-- 53 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Goodwill and Identifiable Intangible Assets
Goodwill. Goodwill is the cost of acquired companies in
excess of the fair value of net assets, including identifiable
intangible assets, at the acquisition date.
The table below presents the carrying value of goodwill by
reporting unit.
As of
$ in millions
March
2020
December
2019
Investment Banking 	$ 281 	$ 281
Global Markets:
FICC 	269 	269
Equities 	2,508 	2,508
Asset Management 	390 	390
Consumer & Wealth Management:
Consumer banking 	48 	48
Wealth management 	700 	700
Total 	$4,196 	$4,196
Goodwill is assessed for impairment annually in the fourth
quarter or more frequently if events occur or circumstances
change that indicate an impairment may exist. When assessing
goodwill for impairment, first, a qualitative assessment can be
made to determine whether it is more likely than not that the
estimated fair value of a reporting unit is less than its estimated
carrying value. If the results of the qualitative assessment are
not conclusive, a quantitative goodwill test is performed.
Alternatively, a quantitative goodwill test can be performed
without performing a qualitative assessment.
The quantitative goodwill test compares the estimated fair
value of each reporting unit with its estimated net book
value 	(including 	goodwill 	and 	identifiable 	intangible
assets). If the reporting unit’s estimated fair value exceeds
its estimated net book value, goodwill is not impaired. An
impairment is recognized if the estimated fair value of a
reporting unit is less than its estimated net book value.
To estimate the fair value of each reporting unit, other than
Consumer banking, a relative value technique is used
because the firm believes market participants would use this
technique to value these reporting units. The relative value
technique applies observable price-to-earnings multiples or
price-to-book multiples of comparable competitors to
reporting units’ net earnings or net book value. To estimate
the fair value of Consumer banking, a discounted cash flow
valuation approach is used because the firm believes market
participants would use this technique to value that
reporting unit given its early stage of development. The
estimated net carrying value of each reporting unit reflects
an allocation of total shareholders’ equity and represents
the estimated amount of total shareholders’ equity required
to support the activities of the reporting unit under
currently applicable regulatory capital requirements.
In the fourth quarter of 2019, goodwill was tested for
impairment using a quantitative test. The estimated fair
value of each of the reporting units exceeded its respective
net carrying value, and therefore goodwill was not
impaired.
During the first quarter of 2020, the outbreak of the
COVID-19 pandemic broadly impacted the operating
environment, 	notably 	in 	March, 	causing 	a 	sharp
contraction in global economic activity and increased
market volatility, affecting both equity and credit markets.
Due to the significance of this event in relation to the firm’s
businesses, the firm performed a qualitative assessment of
the goodwill in each of its reporting units for impairment.
Multiple factors, including performance indicators, firm
and industry events, macroeconomic indicators and fair
value indicators, were assessed with respect to each of the
firm’s reporting units to determine whether it was more
likely than not that the estimated fair value of any of these
reporting units was less than its estimated carrying value.
The qualitative assessment also considered changes since
the quantitative test performed in the fourth quarter of
2019.
Despite challenges to the firm’s operating environment, net
revenues for the first quarter of 2020 were strong across
three of the firm’s four business segments and their
respective reporting units. Asset Management recorded a
net loss for the quarter, due to the impact of market declines
on the firm’s investments, which was a reflection of the
broader market and not due to a firm-specific issue, which
more than offset fee revenue generated from increased
assets under supervision.
As a result of investor uncertainty and the economic
outlook, fair value indicators in the market were negatively
impacted, as global equity prices significantly declined and
credit spreads widened. This similarly affected fair value
indicators for the firm and publicly traded participants in its
industry. In response to the macroeconomic concerns,
central banks and governments intervened with monetary
and fiscal measures aimed at mitigating the extent of the
contraction in economic activity, as well as market
concerns, and providing liquidity to the financial markets.
There were no other events, entity-specific or otherwise,
that would have had a significant negative impact on the
valuation of the firm’s reporting units.
Based on the qualitative assessment, the firm determined
that it was more likely than not that the estimated fair value
of each of the reporting units exceeded its respective
estimated carrying value, and that the impact of the
COVID-19 pandemic through the end of the first quarter of
2020 was not a triggering event to perform a quantitative
test.
Goldman Sachs March 2020 Form 10-Q 	52

-- 54 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Identifiable Intangible Assets. The table below presents
identifiable intangible assets by reporting unit and type.
As of
$ in millions
March
2020
December
2019
By Reporting Unit
Global Markets:
FICC 	$ 	2 	$ 	3
Asset Management 	257 	265
Consumer & Wealth Management:
Consumer banking 	6 	7
Wealth management 	349 	366
Total 	$ 	614 	$ 	641
By Type
Customer lists
Gross carrying value 	$ 1,427 	$ 1,427
Accumulated amortization 	(1,055) 	(1,044)
Net carrying value 	372 	383
Acquired leases and other
Gross carrying value 	792 	790
Accumulated amortization 	(550) 	(532)
Net carrying value 	242 	258
Total gross carrying value 	2,219 	2,217
Total accumulated amortization 	(1,605) 	(1,576)
Total net carrying value 	$ 	614 	$ 	641
The firm acquired $34 million of intangible assets during
the three months ended March 2020, primarily related to
acquired leases, with a weighted average amortization
period of 8 years. The firm acquired $515 million of
intangible assets during 2019, primarily related to customer
lists, with a weighted average amortization period of
10 years.
Substantially all of the firm’s identifiable intangible assets
have finite useful lives and are amortized over their
estimated useful lives generally using the straight-line
method.
The 	tables 	below 	present 	information 	about 	the
amortization of identifiable intangible assets.
Three Months
Ended March
$ in millions 	2020 	2019
Amortization 	$41 	$43
$ in millions
As of
March 2020
Estimated future amortization
Remainder of 2020 	$84
2021 	$89
2022 	$78
2023 	$72
2024 	$61
2025 	$42
The firm tests intangible assets for impairment whenever
events or changes in circumstances suggest that an asset’s or
asset group’s carrying value may not be fully recoverable.
To the extent the carrying value of an asset or asset group
exceeds the projected undiscounted cash flows expected to
result from the use and eventual disposal of the asset or
asset group, the firm determines the asset or asset group is
impaired and records an impairment equal to the difference
between the estimated fair value and the carrying value of
the asset or asset group. In addition, the firm will recognize
an impairment prior to the sale of an asset or asset group if
the carrying value of the asset or asset group exceeds its
estimated fair value. There were no material impairments
during each of the three months ended March 2020 and
March 2019.
Operating Lease Right-of-Use Assets
The firm enters into operating leases for real estate, office
equipment and other assets, substantially all of which are
used in connection with its operations. For leases longer
than one year, the firm recognizes a right-of-use asset
representing the right to use the underlying asset for the
lease term, and a lease liability representing the liability to
make payments. The lease term is generally determined
based on the contractual maturity of the lease. For leases
where the firm has the option to terminate or extend the
lease, an assessment of the likelihood of exercising the
option is incorporated into the determination of the lease
term. Such assessment is initially performed at the inception
of the lease and is updated if events occur that impact the
original assessment.
An operating lease right-of-use asset is initially determined
based on the operating lease liability, adjusted for initial
direct costs, lease incentives and amounts paid at or prior to
lease commencement. This amount is then amortized over
the lease term. The firm recognized $51 million for the three
months ended March 2020 and $712 million (primarily
related to the firm’s new European headquarters in
London) for the three months ended March 2019 of
right-of-use assets and operating lease liabilities in non-cash
transactions for leases entered into or assumed. See Note 15
for information about operating lease liabilities.
For leases where the firm will derive no economic benefit
from leased space that it has vacated or where the firm has
shortened the term of a lease when space is no longer
needed, the firm will record an impairment or accelerated
amortization of right-of-use assets. There were no material
impairments or accelerated amortizations during each of
the three months ended March 2020 and March 2019.
53 	Goldman Sachs March 2020 Form 10-Q

-- 55 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Miscellaneous Receivables and Other
Miscellaneous receivables and other included:
‰ Investments in qualified affordable housing projects of
$671 million as of March 2020 and $606 million as of
December 2019.
‰ Assets classified as held for sale of $632 million as of
March 2020 and $470 million as of December 2019
related to the firm’s consolidated investments within the
Asset Management segment, substantially all of which
consisted of property and equipment.
Note 13.
Deposits
The table below presents the types and sources of deposits.
$ in millions
Savings and
Demand 	Time 	Total
As of March 2020
Private bank deposits 	$ 56,437 	$ 2,292 	$ 58,729
Consumer deposits 	49,843 	21,784 	71,627
Brokered certificates of deposit 	– 	38,905 	38,905
Deposit sweep programs 	19,082 	– 	19,082
Transaction banking 	6,920 	2,260 	9,180
Other deposits 	– 	22,471 	22,471
Total 	$132,282 	$87,712 	$219,994
As of December 2019
Private bank deposits 	$ 53,726 	$ 2,087 	$ 55,813
Consumer deposits 	44,973 	15,023 	59,996
Brokered certificates of deposit 	– 	39,449 	39,449
Deposit sweep programs 	17,760 	– 	17,760
Transaction banking 	2,291 	235 	2,526
Other deposits 	– 	14,475 	14,475
Total 	$118,750 	$71,269 	$190,019
In the table above:
‰ Substantially all deposits are interest-bearing.
‰ Savings and demand accounts consist of money market
deposit 	accounts, 	negotiable 	order 	of 	withdrawal
accounts and demand deposit accounts that have no
stated maturity or expiration date.
‰ Time deposits included $24.72 billion as of March 2020
and $17.77 billion as of December 2019 of deposits
accounted for at fair value under the fair value option. See
Note 	10 	for 	further 	information 	about 	deposits
accounted for at fair value.
‰ Time deposits had a weighted average maturity of
approximately 1.5 years as of March 2020 and 1.7 years
as of December 2019.
‰ Deposit sweep programs represent long-term contractual
agreements with U.S. broker-dealers who sweep client
cash to FDIC-insured deposits. As of March 2020, the
firm had 12 such deposit sweep program agreements.
‰ Other deposits represent deposits from institutional clients.
‰ Deposits insured by the FDIC were $111.92 billion as of
March 2020 and $103.98 billion as of December 2019.
‰ Deposits 	insured 	by 	the 	U.K.’s 	Financial 	Services
Compensation 	Scheme 	were 	$18.99 	billion 	as 	of
March 2020 and $15.86 billion as of December 2019.
The table below presents the location of deposits.
As of
$ in millions
March
2020
December
2019
U.S. offices 	$168,992 	$150,759
Non-U.S. offices 	51,002 	39,260
Total 	$219,994 	$190,019
In the table above, U.S. deposits were held at GS Bank USA
and substantially all non-U.S. deposits were held at
Goldman Sachs International Bank (GSIB).
The table below presents maturities of time deposits held in
U.S. and non-U.S. offices.
As of March 2020
$ in millions 	U.S. 	Non-U.S. 	Total
Remainder of 2020 	$25,358 	$ 17,200 	$ 42,558
2021 	18,487 	1,356 	19,843
2022 	8,857 	80 	8,937
2023 	6,498 	112 	6,610
2024 	4,393 	115 	4,508
2025 	2,155 	226 	2,381
2026 - thereafter 	2,072 	803 	2,875
Total 	$67,820 	$ 19,892 	$ 87,712
As of March 2020, deposits in U.S. offices included
$14.35 billion and deposits in non-U.S. offices included
$19.52 billion of time deposits in denominations that met
or exceeded the applicable insurance limits, or were
otherwise not covered by insurance.
The firm’s savings and demand deposits are recorded based
on the amount of cash received plus accrued interest, which
approximates fair value. In addition, the firm designates
certain derivatives as fair value hedges to convert a portion
of its time deposits not accounted for at fair value from
fixed-rate obligations into floating-rate obligations. The
carrying value of time deposits not accounted for at fair
value approximated fair value as of both March 2020 and
December 2019. As these savings and demand deposits and
time deposits are not accounted for at fair value, they are
not included in the firm’s fair value hierarchy in Notes 4
through 10. Had these deposits been included in the firm’s
fair value hierarchy, they would have been classified in
level 2 as of both March 2020 and December 2019.
Goldman Sachs March 2020 Form 10-Q 	54

-- 56 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 14.
Unsecured Borrowings
The table below presents information about unsecured
borrowings.
As of
$ in millions
March
2020
December
2019
Unsecured short-term borrowings 	$ 37,148 	$ 48,287
Unsecured long-term borrowings 	225,476 	207,076
Total 	$262,624 	$255,363
Unsecured Short-Term Borrowings
Unsecured short-term borrowings includes the portion of
unsecured long-term borrowings maturing within one year
of the financial statement date and unsecured long-term
borrowings that are redeemable within one year of the
financial statement date at the option of the holder.
The firm accounts for certain hybrid financial instruments
at fair value under the fair value option. See Note 10 for
further 	information 	about 	unsecured 	short-term
borrowings that are accounted for at fair value. In addition,
the firm designates certain derivatives as fair value hedges
to convert a portion of its unsecured short-term borrowings
not accounted for at fair value from fixed-rate obligations
into 	floating-rate 	obligations. 	The 	carrying 	value 	of
unsecured short-term borrowings that are not recorded at
fair value generally approximates fair value due to the
short-term nature of the obligations. As these unsecured
short-term borrowings are not accounted for at fair value,
they are not included in the firm’s fair value hierarchy in
Notes 4 through 10. Had these borrowings been included in
the firm’s fair value hierarchy, substantially all would have
been classified in level 2 as of both March 2020 and
December 2019.
The table below presents information about unsecured
short-term borrowings.
As of
$ in millions
March
2020
December
2019
Current portion of unsecured long-term borrowings $ 22,532 	$ 30,636
Hybrid financial instruments 	12,635 	15,814
Other unsecured short-term borrowings 	1,981 	1,837
Total unsecured short-term borrowings 	$ 37,148 	$ 48,287
Weighted average interest rate 	2.22% 	2.71%
In the table above, the weighted average interest rates for
these borrowings include the effect of hedging activities and
exclude unsecured short-term borrowings accounted for at
fair value under the fair value option. See Note 7 for further
information about hedging activities.
Unsecured Long-Term Borrowings
The table below presents information about unsecured
long-term borrowings.
$ in millions
U.S.
Dollar
Non-U.S.
Dollar 	Total
As of March 2020
Fixed-rate obligations 	$107,774 	$39,008 	$146,782
Floating-rate obligations 	47,041 	31,653 	78,694
Total 	$154,815 	$70,661 	$225,476
As of December 2019
Fixed-rate obligations 	$ 92,846 	$36,185 	$129,031
Floating-rate obligations 	47,850 	30,195 	78,045
Total 	$140,696 	$66,380 	$207,076
In the table above:
‰ Unsecured long-term borrowings consists principally of
senior borrowings, which have maturities extending
through 2067.
‰ Floating-rate 	obligations 	includes 	equity-linked 	and
indexed instruments. Floating interest rates are generally
based on LIBOR or Euro Interbank Offered Rate.
‰ U.S. dollar-denominated debt had interest rates ranging
from 2.00% to 10.04% (with a weighted average rate of
4.22%) as of March 2020 and 2.00% to 10.04% (with a
weighted average rate of 3.82%) as of December 2019.
These rates exclude unsecured long-term borrowings
accounted for at fair value under the fair value option.
‰ Non-U.S. dollar-denominated debt had interest rates
ranging from 0.13% to 13.00% (with a weighted average
rate of 2.30%) as of March 2020 and 0.13% to 13.00%
(with 	a 	weighted 	average 	rate 	of 	2.33%) 	as 	of
December 2019. These rates exclude unsecured long-term
borrowings accounted for at fair value under the fair
value option.
55 	Goldman Sachs March 2020 Form 10-Q

-- 57 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents unsecured long-term borrowings
by maturity.
$ in millions
As of
March 2020
2021 	$ 24,653
2022 	25,114
2023 	28,607
2024 	19,162
2025 	23,720
2026 - thereafter 	104,220
Total 	$225,476
In the table above:
‰ Unsecured long-term borrowings maturing within one
year of the financial statement date and unsecured long-
term borrowings that are redeemable within one year of
the financial statement date at the option of the holder are
excluded as they are included in unsecured short-term
borrowings.
‰ Unsecured long-term borrowings that are repayable prior
to maturity at the option of the firm are reflected at their
contractual maturity dates.
‰ Unsecured long-term borrowings that are redeemable
prior to maturity at the option of the holder are reflected
at the earliest dates such options become exercisable.
‰ Unsecured long-term borrowings included $13.76 billion
of adjustments to the carrying value of certain unsecured
long-term borrowings resulting from the application of
hedge accounting by year of maturity as follows:
$288 million in 2021, $(26) million in 2022, $273 million
in 2023, $762 million in 2024, $915 million in 2025 and
$11.55 billion in 2026 and thereafter.
The firm designates certain derivatives as fair value hedges
to convert a portion of fixed-rate unsecured long-term
borrowings not accounted for at fair value into floating-
rate obligations. See Note 7 for further information about
hedging activities.
The table below presents unsecured long-term borrowings,
after giving effect to such hedging activities.
As of
$ in millions
March
2020
December
2019
Fixed-rate obligations:
At fair value 	$ 	1,385 	$ 	725
At amortized cost 	50,062 	47,577
Floating-rate obligations:
At fair value 	41,928 	42,936
At amortized cost 	132,101 	115,838
Total 	$225,476 	$207,076
In the table above, the aggregate amounts of unsecured
long-term borrowings had weighted average interest rates
of 2.59% (3.82% related to fixed-rate obligations and
2.08% 	related 	to 	floating-rate 	obligations) 	as 	of
March 2020 and 2.87% (3.77% related to fixed-rate
obligations and 2.48% related to floating-rate obligations)
as of December 2019. These rates exclude unsecured long-
term borrowings accounted for at fair value under the fair
value option.
As of both March 2020 and December 2019, the carrying
value of unsecured long-term borrowings for which the
firm did not elect the fair value option approximated fair
value. As these borrowings are not accounted for at fair
value, they are not included in the firm’s fair value
hierarchy in Notes 4 through 10. Had these borrowings
been 	included 	in 	the 	firm’s 	fair 	value 	hierarchy,
substantially all would have been classified in level 2 as of
both March 2020 and December 2019.
Subordinated Borrowings
Unsecured long-term borrowings includes subordinated
debt and junior subordinated debt. Junior subordinated
debt is junior in right of payment to other subordinated
borrowings, 	which 	are 	junior 	to 	senior 	borrowings.
Subordinated debt had maturities ranging from 2021 to
2045 as of both March 2020 and December 2019.
Subordinated debt that matures within one year is included
in unsecured short-term borrowings.
Goldman Sachs March 2020 Form 10-Q 	56

-- 58 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents information about subordinated
borrowings.
$ in millions
Par
Amount
Carrying
Value 	Rate
As of March 2020
Subordinated debt 	$13,797 	$19,199 	3.30%
Junior subordinated debt 	968 	1,499 	2.71%
Total 	$14,765 	$20,698 	3.26%
As of December 2019
Subordinated debt 	$14,041 	$16,980 	3.46%
Junior subordinated debt 	976 	1,328 	2.85%
Total 	$15,017 	$18,308 	3.42%
In the table above, the rate is the weighted average interest
rate for these borrowings (excluding borrowings accounted
for at fair value under the fair value option), including the
effect of fair value hedges used to convert fixed-rate
obligations into floating-rate obligations. See Note 7 for
further information about hedging activities.
Junior Subordinated Debt
In 2004, Group Inc. issued $2.84 billion of junior
subordinated debt to Goldman Sachs Capital I (Trust), a
Delaware statutory trust. The Trust issued $2.75 billion of
guaranteed preferred beneficial interests (Trust Preferred
securities) to third parties and $85 million of common
beneficial interests to Group Inc. As of March 2020, the
outstanding par amount of junior subordinated debt held
by the Trust was $968 million and the outstanding par
amount 	of 	Trust 	Preferred 	securities 	and 	common
beneficial interests issued by the Trust was $939 million
and $29 million, respectively. As of December 2019, the
outstanding par amount of junior subordinated debt held
by the Trust was $976 million and the outstanding par
amount 	of 	Trust 	Preferred 	securities 	and 	common
beneficial interests issued by the Trust was $947 million
and $29 million, respectively.
During the three months ended March 2020, the firm
purchased Trust Preferred securities with a par amount and
a carrying value of $7.9 million and $11.0 million and
delivered these securities, along with $0.2 million of
common beneficial interests, to the Trust in a non-cash
exchange for junior subordinated debt with a par amount
and carrying value of $8.1 million and $12.5 million,
respectively. Following the exchange, these Trust Preferred
securities, 	common 	beneficial 	interests 	and 	junior
subordinated debt were extinguished. The Trust is a
wholly-owned finance subsidiary of the firm for regulatory
and legal purposes but is not consolidated for accounting
purposes.
The 	firm 	pays 	interest 	semi-annually 	on 	the 	junior
subordinated debt at an annual rate of 6.345% and the
debt matures on February 15, 2034. The coupon rate and
the payment dates applicable to the beneficial interests are
the same as the interest rate and payment dates for the
junior subordinated debt. The firm has the right, from time
to time, to defer payment of interest on the junior
subordinated debt, and therefore cause payment on the
Trust’s preferred beneficial interests to be deferred, in each
case up to ten consecutive semi-annual periods. During any
such deferral period, the firm will not be permitted to,
among other things, pay dividends on or make certain
repurchases of its common stock. The Trust is not
permitted to pay any distributions on the common
beneficial interests held by Group Inc. unless all dividends
payable on the preferred beneficial interests have been paid
in full.
The firm has covenanted in favor of the holders of Group
Inc.’s 	6.345% 	junior 	subordinated 	debt 	due
February 15, 2034, that, subject to certain exceptions, the
firm will not redeem or purchase the capital securities
issued by Goldman Sachs Capital II and Goldman Sachs
Capital III (APEX Trusts) or shares of Group Inc.’s
Perpetual 	Non-Cumulative 	Preferred 	Stock, 	Series 	E
(Series E Preferred Stock), Perpetual Non-Cumulative
Preferred Stock, Series F (Series F Preferred Stock) or
Perpetual Non-Cumulative Preferred Stock, Series O, if the
redemption or purchase results in less than $253 million
aggregate liquidation preference of that series outstanding,
prior to specified dates in 2022 for a price that exceeds a
maximum amount determined by reference to the net cash
proceeds that the firm has received from the sale of
qualifying securities.
The APEX Trusts hold Group Inc.’s Series E Preferred
Stock and Series F Preferred Stock. These trusts are
Delaware statutory trusts sponsored by the firm and
wholly-owned 	finance 	subsidiaries 	of 	the 	firm 	for
regulatory and legal purposes but are not consolidated for
accounting purposes.
57 	Goldman Sachs March 2020 Form 10-Q

-- 59 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 15.
Other Liabilities
The table below presents other liabilities by type.
As of
$ in millions
March
2020
December
2019
Compensation and benefits 	$ 3,281 	$ 6,889
Income tax-related liabilities 	3,172 	2,947
Operating lease liabilities 	2,289 	2,385
Noncontrolling interests 	1,122 	1,713
Employee interests in consolidated funds 	71 	81
Accrued expenses and other 	8,359 	7,636
Total 	$18,294 	$21,651
In the table above, accrued expenses and other includes
contract liabilities, which represent consideration received
by the firm in connection with its contracts with clients,
prior to providing the service. As of both March 2020 and
December 2019, the firm’s contract liabilities were not
material.
Operating Lease Liabilities
For leases longer than one year, the firm recognizes a
right-of-use 	asset 	representing 	the 	right 	to 	use 	the
underlying asset for the lease term, and a lease liability
representing the liability to make payments. See Note 12 for
information about operating lease right-of-use assets.
The table below presents information about operating lease
liabilities.
$ in millions
Operating
lease liabilities
As of March 2020
Remainder of 2020 	$ 	247
2021 	307
2022 	266
2023 	233
2024 	218
2025 	192
2026 - thereafter 	2,365
Total undiscounted lease payments 	3,828
Imputed interest 	(1,539)
Total operating lease liabilities 	$ 2,289
Weighted average remaining lease term 	18 years
Weighted average discount rate 	5.07%
As of December 2019
2020 	$ 	384
2021 	308
2022 	268
2023 	235
2024 	219
2025 - thereafter 	2,566
Total undiscounted lease payments 	3,980
Imputed interest 	(1,595)
Total operating lease liabilities 	$ 2,385
Weighted average remaining lease term 	18 years
Weighted average discount rate 	5.02%
In the table above, the weighted average discount rate
represents the firm’s incremental borrowing rate as of
January 2019 for operating leases existing on the date of
adoption of ASU No. 2016-02 and at the lease inception
date for leases entered into subsequent to the adoption of
this ASU.
Operating lease costs were $113 million for the three
months ended March 2020 and $117 million for the three
months ended March 2019. Variable lease costs, which are
included in operating lease costs, were not material for both
the three months ended March 2020 and March 2019.
Operating lease liabilities include obligations for office
space held in excess of current requirements. Operating
lease costs relating to space held for growth is included in
occupancy expenses. Total occupancy expenses for space
held in excess of the firm’s current requirements were not
material for both the three months ended March 2020 and
March 2019.
Lease payments relating to operating lease arrangements
that were signed, but had not yet commenced as of
March 2020, were not material.
Goldman Sachs March 2020 Form 10-Q 	58

-- 60 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 16.
Securitization Activities
The firm securitizes residential and commercial mortgages,
corporate bonds, loans and other types of financial assets
by selling these assets to securitization vehicles (e.g., trusts,
corporate entities and limited liability companies) or
through a resecuritization. The firm acts as underwriter of
the beneficial interests that are sold to investors. The firm’s
residential 	mortgage 	securitizations 	are 	primarily 	in
connection with government agency securitizations.
The firm accounts for a securitization as a sale when it has
relinquished control over the transferred financial assets.
Prior to securitization, the firm generally accounts for assets
pending transfer at fair value and therefore does not
typically recognize significant gains or losses upon the
transfer of assets. Net revenues from underwriting activities
are 	recognized in connection with the sales of the
underlying beneficial interests to investors.
The firm generally receives cash in exchange for the
transferred 	assets 	but 	may 	also 	have 	continuing
involvement with the transferred financial assets, including
ownership of beneficial interests in securitized financial
assets, primarily in the form of debt instruments. The firm
may also purchase senior or subordinated securities issued
by securitization vehicles (which are typically VIEs) in
connection with secondary market-making activities.
The primary risks included in beneficial interests and other
interests from the firm’s continuing involvement with
securitization 	vehicles 	are 	the 	performance 	of 	the
underlying collateral, the position of the firm’s investment
in the capital structure of the securitization vehicle and the
market yield for the security. Interests accounted for at fair
value are classified in level 2 of the fair value hierarchy.
Interests not accounted for at fair value are carried at
amounts that approximate fair value. See Notes 4 through
10 for further information about fair value measurements.
The table below presents the amount of financial assets
securitized and the cash flows received on retained interests
in securitization entities in which the firm had continuing
involvement as of the end of the period.
Three Months
Ended March
$ in millions 	2020 	2019
Residential mortgages 	$3,107 	$3,489
Commercial mortgages 	4,996 	671
Other financial assets 	540 	172
Total financial assets securitized 	$8,643 	$4,332
Retained interests cash flows 	$ 	94 	$ 	93
In the table above, financial assets securitized included
assets of $174 million during the three months ended
March 2020 and $104 million during the three months
ended March 2019, which were securitized in a non-cash
exchange for loans and held-to-maturity securities.
The 	table 	below 	presents 	information 	about
nonconsolidated securitization entities to which the firm
sold assets and had continuing involvement as of the end of
the period.
$ in millions
Outstanding
Principal
Amount
Retained
Interests
Purchased
Interests
As of March 2020
U.S. government agency-issued CMOs 	$14,309 	$ 935 	$14
Other residential mortgage-backed 	23,121 	1,047 	25
Other commercial mortgage-backed 	29,350 	708 	19
Corporate debt and other asset-backed 	3,851 	156 	4
Total 	$70,631 	$2,846 	$62
As of December 2019
U.S. government agency-issued CMOs 	$14,328 	$1,530 	$ 3
Other residential mortgage-backed 	24,166 	1,078 	24
Other commercial mortgage-backed 	25,588 	615 	6
Corporate debt and other asset-backed 	3,612 	149 	–
Total 	$67,694 	$3,372 	$33
59 	Goldman Sachs March 2020 Form 10-Q

-- 61 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In the table above:
‰ CMOs represents collateralized mortgage obligations.
‰ The outstanding principal amount is presented for the
purpose of providing information about the size of the
securitization entities and is not representative of the
firm’s risk of loss.
‰ The firm’s risk of loss from retained or purchased
interests is limited to the carrying value of these interests.
‰ Purchased interests represent senior and subordinated
interests, 	purchased 	in 	connection 	with 	secondary
market-making activities, in securitization entities in
which the firm also holds retained interests.
‰ Substantially all of the total outstanding principal amount
and total retained interests relate to securitizations during
2014 and thereafter.
‰ The fair value of retained interests was $2.84 billion as of
March 2020 and $3.35 billion as of December 2019.
In addition to the interests in the table above, the firm had
other continuing involvement in the form of derivative
transactions 	and 	commitments 	with 	certain
nonconsolidated 	VIEs. 	The 	carrying 	value 	of 	these
derivatives and commitments was a net asset of $94 million
as of March 2020 and $57 million as of December 2019,
and 	the 	notional 	amount 	of 	these 	derivatives 	and
commitments was $1.44 billion as of March 2020 and
$1.20 billion as of December 2019. The notional amounts
of these derivatives and commitments are included in
maximum exposure to loss in the nonconsolidated VIE
table in Note 17.
The table below presents information about the weighted
average key economic assumptions used in measuring the
fair value of mortgage-backed retained interests.
As of
$ in millions
March
2020
December
2019
Fair value of retained interests 	$ 2,681 	$ 3,198
Weighted average life (years) 	5.2 	6.0
Constant prepayment rate 	14.9% 	12.9%
Impact of 10% adverse change 	$ 	(23) 	$ 	(22)
Impact of 20% adverse change 	$ 	(44) 	$ 	(42)
Discount rate 	5.8% 	4.7%
Impact of 10% adverse change 	$ 	(50) 	$ 	(59)
Impact of 20% adverse change 	$ 	(97) 	$ 	(117)
In the table above:
‰ Amounts do not reflect the benefit of other financial
instruments that are held to mitigate risks inherent in
these retained interests.
‰ Changes in fair value based on an adverse variation in
assumptions generally cannot be extrapolated because the
relationship of the change in assumptions to the change in
fair value is not usually linear.
‰ The impact of a change in a particular assumption is
calculated 	independently 	of 	changes 	in 	any 	other
assumption. 	In 	practice, 	simultaneous 	changes 	in
assumptions might magnify or counteract the sensitivities
disclosed above.
‰ The constant prepayment rate is included only for
positions for which it is a key assumption in the
determination of fair value.
‰ The discount rate for retained interests that relate to U.S.
government agency-issued CMOs does not include any
credit loss. Expected credit loss assumptions are reflected
in the discount rate for the remainder of retained
interests.
The firm has other retained interests not reflected in the
table above with a fair value of $156 million and a
weighted average life of 2.9 years as of March 2020, and a
fair value of $149 million and a weighted average life of
3.3 years as of December 2019. Due to the nature and fair
value of certain of these retained interests, the weighted
average assumptions for constant prepayment and discount
rates and the related sensitivity to adverse changes are not
meaningful as of both March 2020 and December 2019.
The firm’s maximum exposure to adverse changes in the
value of these interests is the carrying value of $156 million
as of March 2020 and $149 million as of December 2019.
Goldman Sachs March 2020 Form 10-Q 	60

-- 62 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 17.
Variable Interest Entities
A variable interest in a VIE is an investment (e.g., debt or
equity) or other interest (e.g., derivatives or loans and
lending commitments) that will absorb portions of the
VIE’s expected losses and/or receive portions of the VIE’s
expected residual returns.
The firm’s variable interests in VIEs include senior and
subordinated debt; loans and lending commitments; limited
and general partnership interests; preferred and common
equity; derivatives that may include foreign currency,
equity and/or credit risk; guarantees; and certain of the fees
the firm receives from investment funds. Certain interest
rate, foreign currency and credit derivatives the firm enters
into with VIEs are not variable interests because they
create, rather than absorb, risk.
VIEs generally finance the purchase of assets by issuing debt
and equity securities that are either collateralized by or
indexed to the assets held by the VIE. The debt and equity
securities issued by a VIE may include tranches of varying
levels of subordination. The firm’s involvement with VIEs
includes securitization of financial assets, as described in
Note 16, and investments in and loans to other types of
VIEs, as described below. See Note 3 for the firm’s
consolidation policies, including the definition of a VIE.
VIE Consolidation Analysis
The enterprise with a controlling financial interest in a VIE
is known as the primary beneficiary and consolidates the
VIE. The firm determines whether it is the primary
beneficiary of a VIE by performing an analysis that
principally considers:
‰ Which variable interest holder has the power to direct the
activities of the VIE that most significantly impact the
VIE’s economic performance;
‰ Which variable interest holder has the obligation to
absorb losses or the right to receive benefits from the VIE
that could potentially be significant to the VIE;
‰ The VIE’s purpose and design, including the risks the VIE
was designed to create and pass through to its variable
interest holders;
‰ The VIE’s capital structure;
‰ The terms between the VIE and its variable interest
holders and other parties involved with the VIE; and
‰ Related-party relationships.
The firm reassesses its evaluation of whether an entity is a
VIE when certain reconsideration events occur. The firm
reassesses its determination of whether it is the primary
beneficiary of a VIE on an ongoing basis based on current
facts and circumstances.
VIE Activities
The firm is principally involved with VIEs through the
following business activities:
Mortgage-Backed VIEs. The firm sells residential and
commercial mortgage loans and securities to mortgage-
backed VIEs and may retain beneficial interests in the assets
sold to these VIEs. The firm purchases and sells beneficial
interests issued by mortgage-backed VIEs in connection
with market-making activities. In addition, the firm may
enter into derivatives with certain of these VIEs, primarily
interest rate swaps, which are typically not variable
interests. The firm generally enters into derivatives with
other counterparties to mitigate its risk.
Real Estate, Credit- and Power-Related and Other
Investing VIEs. The firm purchases equity and debt
securities issued by and makes loans to VIEs that hold real
estate, performing and nonperforming debt, distressed
loans, power-related assets and equity securities. The firm
generally does not sell assets to, or enter into derivatives
with, these VIEs.
Corporate Debt and Other Asset-Backed VIEs. The
firm structures VIEs that issue notes to clients, purchases
and sells beneficial interests issued by corporate debt and
other asset-backed VIEs in connection with market-making
activities, and makes loans to VIEs that warehouse
corporate debt. Certain of these VIEs synthetically create
the exposure for the beneficial interests they issue by
entering into credit derivatives with the firm, rather than
purchasing the underlying assets. In addition, the firm may
enter into derivatives, such as total return swaps, with
certain corporate debt and other asset-backed VIEs, under
which the firm pays the VIE a return due to the beneficial
interest holders and receives the return on the collateral
owned by the VIE. The collateral owned by these VIEs is
primarily other asset-backed loans and securities. The firm
generally can be removed as the total return swap
counterparty 	and 	enters 	into 	derivatives 	with 	other
counterparties to mitigate its risk related to these swaps.
The firm may sell assets to the corporate debt and other
asset-backed VIEs it structures.
61 	Goldman Sachs March 2020 Form 10-Q

-- 63 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Principal-Protected Note VIEs. The firm structures VIEs
that issue principal-protected notes to clients. These VIEs
own portfolios of assets, principally with exposure to hedge
funds. Substantially all of the principal protection on the
notes issued by these VIEs is provided by the asset portfolio
rebalancing that is required under the terms of the notes.
The firm enters into total return swaps with these VIEs
under which the firm pays the VIE the return due to the
principal-protected note holders and receives the return on
the assets owned by the VIE. The firm may enter into
derivatives with other counterparties to mitigate its risk.
The firm also obtains funding through these VIEs.
Investments in Funds. The firm makes equity investments
in certain investment fund VIEs it manages and is entitled to
receive fees from these VIEs. The firm has generally not sold
assets to, or entered into derivatives with, these VIEs.
Nonconsolidated VIEs
The table below presents a summary of the nonconsolidated
VIEs in which the firm holds variable interests.
As of
$ in millions
March
2020
December
2019
Total nonconsolidated VIEs
Assets in VIEs 	$128,603 	$128,069
Carrying value of variable interests — assets 	$ 10,390 	$ 	9,526
Carrying value of variable interests — liabilities $ 	877 	$ 	619
Maximum exposure to loss:
Retained interests 	$ 	2,846 	$ 	3,372
Purchased interests 	2,418 	901
Commitments and guarantees 	2,329 	2,697
Derivatives 	8,689 	9,010
Debt and equity 	4,719 	4,806
Total maximum exposure to loss 	$ 21,001 	$ 20,786
In the table above:
‰ The nature of the firm’s variable interests is described in
the rows under maximum exposure to loss.
‰ The firm’s exposure to the obligations of VIEs is generally
limited to its interests in these entities. In certain instances,
the 	firm 	provides 	guarantees, 	including 	derivative
guarantees, to VIEs or holders of variable interests in VIEs.
‰ The maximum exposure to loss excludes the benefit of
offsetting financial instruments that are held to mitigate
the risks associated with these variable interests.
‰ The maximum exposure to loss from retained interests,
purchased interests, and debt and equity is the carrying
value of these interests.
‰ The maximum exposure to loss from commitments and
guarantees, and derivatives is the notional amount, which
does not represent anticipated losses and has not been
reduced by unrealized losses. As a result, the maximum
exposure 	to 	loss 	exceeds 	liabilities 	recorded 	for
commitments and guarantees, and derivatives.
The table below presents information, by principal business
activity, for nonconsolidated VIEs included in the summary
table above.
As of
$ in millions
March
2020
December
2019
Mortgage-backed
Assets in VIEs 	$77,153 	$75,354
Carrying value of variable interests — assets 	$ 3,323 	$ 3,830
Maximum exposure to loss:
Retained interests 	$ 2,690 	$ 3,223
Purchased interests 	631 	607
Commitments and guarantees 	43 	50
Derivatives 	402 	66
Total maximum exposure to loss 	$ 3,766 	$ 3,946
Real estate, credit- and power-related and other investing
Assets in VIEs 	$19,442 	$19,602
Carrying value of variable interests — assets 	$ 3,066 	$ 3,243
Carrying value of variable interests — liabilities 	$ 	3 	$ 	7
Maximum exposure to loss:
Commitments and guarantees 	$ 	944 	$ 1,213
Derivatives 	83 	92
Debt and equity 	3,066 	3,238
Total maximum exposure to loss 	$ 4,093 	$ 4,543
Corporate debt and other asset-backed
Assets in VIEs 	$17,141 	$16,248
Carrying value of variable interests — assets 	$ 3,598 	$ 2,040
Carrying value of variable interests — liabilities 	$ 	874 	$ 	612
Maximum exposure to loss:
Retained interests 	$ 	156 	$ 	149
Purchased interests 	1,787 	294
Commitments and guarantees 	1,294 	1,374
Derivatives 	8,201 	8,849
Debt and equity 	1,250 	1,155
Total maximum exposure to loss 	$12,688 	$11,821
Investments in funds
Assets in VIEs 	$14,867 	$16,865
Carrying value of variable interests — assets 	$ 	403 	$ 	413
Maximum exposure to loss:
Commitments and guarantees 	$ 	48 	$ 	60
Derivatives 	3 	3
Debt and equity 	403 	413
Total maximum exposure to loss 	$ 	454 	$ 	476
Goldman Sachs March 2020 Form 10-Q 	62

-- 64 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
As of both March 2020 and December 2019, the carrying
values of the firm’s variable interests in nonconsolidated
VIEs are included in the consolidated balance sheets as
follows:
‰ Mortgage-backed: Assets were primarily included in
trading assets and loans.
‰ Real estate, credit- and power-related and other investing:
Assets were primarily included in loans and investments
and liabilities were included in trading liabilities and
other liabilities.
‰ Corporate debt and other asset-backed: Assets were
included in trading assets and loans and liabilities were
included in trading liabilities.
‰ Investments 	in 	funds: 	Assets 	were 	included 	in
investments.
Consolidated VIEs
The table below presents a summary of the carrying value
and balance sheet classification of assets and liabilities in
consolidated VIEs.
As of
$ in millions
March
2020
December
2019
Total consolidated VIEs
Assets
Cash and cash equivalents 	$ 148 	$ 112
Trading assets 	1 	27
Investments 	144 	835
Loans 	2,082 	2,392
Other assets 	1,100 	1,084
Total 	$3,475 	$4,450
Liabilities
Other secured financings 	$1,088 	$1,163
Customer and other payables 	9 	9
Trading liabilities 	9 	10
Unsecured short-term borrowings 	46 	48
Unsecured long-term borrowings 	207 	214
Other liabilities 	312 	959
Total 	$1,671 	$2,403
In the table above:
‰ Assets and liabilities are presented net of intercompany
eliminations and exclude the benefit of offsetting financial
instruments that are held to mitigate the risks associated
with the firm’s variable interests.
‰ VIEs in which the firm holds a majority voting interest are
excluded if (i) the VIE meets the definition of a business
and (ii) the VIE’s assets can be used for purposes other
than the settlement of its obligations.
‰ Substantially all assets can only be used to settle
obligations of the VIE.
The table below presents information, by principal business
activity, for consolidated VIEs included in the summary
table above.
As of
$ in millions
March
2020
December
2019
Real estate, credit-related and other investing
Assets
Cash and cash equivalents 	$ 148 	$ 112
Trading assets 	– 	26
Investments 	144 	835
Loans 	2,082 	2,392
Other assets 	1,100 	1,084
Total 	$3,474 	$4,449
Liabilities
Other secured financings 	$ 612 	$ 684
Customer and other payables 	9 	9
Trading liabilities 	9 	10
Other liabilities 	312 	959
Total 	$ 942 	$1,662
Principal-protected notes
Assets
Trading assets 	$ 	1 	$ 	1
Total 	$ 	1 	$ 	1
Liabilities
Other secured financings 	$ 476 	$ 479
Unsecured short-term borrowings 	46 	48
Unsecured long-term borrowings 	207 	214
Total 	$ 729 	$ 741
In the table above:
‰ The majority of the assets in principal-protected notes
VIEs 	are 	intercompany 	and 	are 	eliminated 	in
consolidation.
‰ Creditors and beneficial interest holders of real estate,
credit-related and other investing VIEs do not have
recourse to the general credit of the firm.
63 	Goldman Sachs March 2020 Form 10-Q

-- 65 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 18.
Commitments, Contingencies and Guarantees
Commitments
The table below presents commitments by type.
As of
$ in millions
March
2020
December
2019
Commitment Type
Commercial lending:
Investment-grade 	$ 76,791 	$ 89,276
Non-investment-grade 	51,208 	58,718
Warehouse financing 	7,519 	5,581
Credit cards 	16,447 	13,669
Total lending 	151,965 	167,244
Collateralized agreement 	64,243 	62,093
Collateralized financing 	18,845 	10,193
Letters of credit 	374 	456
Investment 	5,812 	7,879
Other 	9,027 	6,135
Total commitments 	$250,266 	$254,000
The table below presents commitments by expiration.
As of March 2020
$ in millions
Remainder of
2020
2021 -
2022
2023 -
2024
2025 -
Thereafter
Commitment Type
Commercial lending:
Investment-grade 	$ 	8,002 $27,196 $35,485 	$ 6,108
Non-investment-grade 	3,337 	16,676 	20,843 	10,352
Warehouse financing 	927 	5,103 	1,295 	194
Credit cards 	16,447 	– 	– 	–
Total lending 	28,713 	48,975 	57,623 	16,654
Collateralized agreement 	63,747 	496 	– 	–
Collateralized financing 	18,845 	– 	– 	–
Letters of credit 	299 	35 	– 	40
Investment 	1,657 	1,422 	1,059 	1,674
Other 	8,909 	118 	– 	–
Total commitments 	$122,170 $51,046 $58,682 	$18,368
Lending Commitments
The firm’s commercial and warehouse financing lending
commitments are agreements to lend with fixed termination
dates and depend on the satisfaction of all contractual
conditions to borrowing. These commitments are presented
net of amounts syndicated to third parties. The total
commitment amount does not necessarily reflect actual
future cash flows because the firm may syndicate all or
substantial portions of these commitments. In addition,
commitments can expire unused or be reduced or cancelled
at the counterparty’s request. The firm also provides credit
to consumers by issuing credit card lines.
The table below presents information about lending
commitments.
As of
$ in millions
March
2020
December
2019
Held for investment 	$133,501 	$150,100
Held for sale 	15,419 	15,245
At fair value 	3,045 	1,899
Total 	$151,965 	$167,244
In the table above:
‰ Held for investment lending commitments are accounted
for at amortized cost. The carrying value of lending
commitments was a liability of $460 million (including
allowance for losses of $335 million) as of March 2020
and $527 million (including allowance for losses of
$361 million) as of December 2019. The estimated fair
value of such lending commitments was a liability of
$5.89 billion as of March 2020 and $3.05 billion as of
December 2019. Had these lending commitments been
carried at fair value and included in the fair value
hierarchy, 	$3.29 	billion 	as 	of 	March 	2020 	and
$1.78 billion as of December 2019 would have been
classified in level 2, and $2.60 billion as of March 2020
and $1.27 billion as of December 2019 would have been
classified in level 3.
‰ Held for sale lending commitments are accounted for at
the lower of cost or fair value. The carrying value of
lending commitments held for sale was a liability of
$196 million as of March 2020 and $60 million as of
December 2019. The estimated fair value of such lending
commitments approximates the carrying value. Had these
lending commitments been included in the fair value
hierarchy, they would have been primarily classified in
level 2 as of both March 2020 and December 2019.
‰ Gains or losses related to lending commitments at fair
value, if any, are generally recorded net of any fees in
other principal transactions.
Goldman Sachs March 2020 Form 10-Q 	64

-- 66 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Commercial Lending. The firm’s commercial lending
commitments were primarily extended to investment-grade
corporate borrowers. Such commitments primarily included
$88.61 billion as of March 2020 and $102.50 billion as of
December 2019, related to relationship lending activities
(principally used for operating and general corporate
purposes) and $26.69 billion as of March 2020 and
$33.47 billion as of December 2019, related to other
investment 	banking 	activities 	(generally 	extended 	for
contingent acquisition financing and are often intended to be
short-term in nature, as borrowers often seek to replace them
with other funding sources). The firm also extends lending
commitments in connection with other types of corporate
lending, as well as commercial real estate financing. See
Note 9 for further information about funded loans.
Sumitomo Mitsui Financial Group, Inc. (SMFG) provides
the firm with credit loss protection on certain approved
loan commitments (primarily investment-grade commercial
lending commitments). The notional amount of such loan
commitments was $4.05 billion as of March 2020 and
$5.74 billion as of December 2019. The credit loss
protection on loan commitments provided by SMFG is
generally limited to 95% of the first loss the firm realizes on
such commitments, up to a maximum of approximately
$950 million. In addition, subject to the satisfaction of
certain conditions, upon the firm’s request, SMFG will
provide protection for 70% of additional losses on such
commitments, up to a maximum of $750 million, of which
no protection had been provided as of March 2020 and
December 2019. The firm also uses other financial
instruments to mitigate credit risks related to certain
commitments not covered by SMFG. These instruments
primarily include credit default swaps that reference the
same or similar underlying instrument or entity, or credit
default swaps that reference a credit index.
Warehouse Financing. The firm provides financing to
clients who warehouse financial assets. These arrangements
are secured by the warehoused assets, primarily consisting
of residential real estate, consumer and corporate loans.
Credit Cards. The firm’s credit card lending commitments
represents credit card lines issued by the firm to consumers.
These credit card lines are cancelable by the firm.
Collateralized 	Agreement 	Commitments/
Collateralized Financing Commitments
Collateralized agreement commitments includes forward
starting resale and securities borrowing agreements, and
collateralized financing commitments includes forward
starting repurchase and secured lending agreements that
settle at a future date, generally within three business days.
Collateralized 	agreement 	commitments 	also 	includes
transactions where the firm has entered into commitments
to 	provide 	contingent 	financing 	to 	its 	clients 	and
counterparties 	through 	resale 	agreements. 	The 	firm’s
funding of these commitments depends on the satisfaction
of all contractual conditions to the resale agreement and
these commitments can expire unused.
Letters of Credit
The firm has commitments under letters of credit issued by
various banks which the firm provides to counterparties in
lieu of securities or cash to satisfy various collateral and
margin deposit requirements.
Investment Commitments
Investment commitments includes commitments to invest in
private equity, real estate and other assets directly and
through funds that the firm raises and manages. Investment
commitments included $2.00 billion as of March 2020 and
$2.06 billion as of December 2019, related to commitments
to 	invest 	in 	funds 	managed 	by 	the 	firm. 	If 	these
commitments are called, they would be funded at market
value on the date of investment.
Contingencies
Legal Proceedings. See Note 27 for information about
legal 	proceedings, 	including 	certain 	mortgage-related
matters.
Certain Mortgage-Related Contingencies. During the
period 2005 through 2008 in connection with both sales
and securitizations of loans, the firm provided loan-level
representations 	and/or 	assigned 	the 	loan-level
representations from the party from whom the firm
purchased the loans.
Based on the large number of defaults in residential
mortgages, including those sold or securitized by the firm,
there is a potential for repurchase claims. However, the
firm is not in a position to make a meaningful estimate of
that exposure at this time. The firm’s exposure to claims for
repurchase of residential mortgage loans based on alleged
breaches of representations will depend on a number of
factors, such as the extent to which these claims are made
within the statute of limitations, taking into consideration
the agreements to toll the statute of limitations the firm
entered into with trustees representing certain trusts.
65 	Goldman Sachs March 2020 Form 10-Q

-- 67 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Other Contingencies. In connection with the sale of
Metro International Trade Services (Metro), the firm
agreed to provide indemnities to the buyer, which primarily
relate to fundamental representations and warranties, and
potential liabilities for legal or regulatory proceedings
arising out of the conduct of Metro’s business while the
firm owned it.
In connection with the settlement agreement with the
Residential Mortgage-Backed Securities Working Group of
the U.S. Financial Fraud Enforcement Task Force, the firm
agreed to provide $1.80 billion in consumer relief by
January 	2021. 	As 	of 	March 	2020, 	approximately
$1.55 billion of such relief was provided. This relief was
provided 	in 	the 	form 	of 	principal 	forgiveness 	for
underwater 	homeowners 	and 	distressed 	borrowers;
financing for construction, rehabilitation and preservation
of affordable housing; and support for debt restructuring,
foreclosure prevention and housing quality improvement
programs, as well as land banks.
Guarantees
The 	table 	below 	presents 	derivatives 	that 	meet 	the
definition 	of 	a 	guarantee, 	securities 	lending
indemnifications and certain other financial guarantees.
$ in millions 	Derivatives
Securities
lending
indemnifications
Other
financial
guarantees
As of March 2020
Carrying Value of Net Liability $ 	7,973 	$ 	– 	$ 	58
Maximum Payout/Notional Amount by Period of Expiration
Remainder of 2020 	$ 65,570 	$16,978 	$1,648
2021 - 2022 	72,282 	– 	1,930
2023 - 2024 	22,395 	– 	2,853
2025 - thereafter 	35,303 	– 	192
Total 	$195,550 	$16,978 	$6,623
As of December 2019
Carrying Value of Net Liability 	$ 	3,817 	$ 	– 	$ 	27
Maximum Payout/Notional Amount by Period of Expiration
2020 	$ 91,814 	$17,891 	$2,044
2021 - 2022 	76,693 	– 	1,714
2023 - 2024 	19,377 	– 	2,219
2025 - thereafter 	36,317 	– 	149
Total 	$224,201 	$17,891 	$6,126
In the table above:
‰ The maximum payout is based on the notional amount of
the contract and does not represent anticipated losses.
‰ Amounts exclude certain commitments to issue standby
letters of credit that are included in lending commitments.
See the tables in “Commitments” above for a summary of
the firm’s commitments.
‰ The carrying value for derivatives included derivative assets
of $1.67 billion as of March 2020 and $1.56 billion as of
December 2019, and derivative liabilities of $9.64 billion
as of March 2020 and $5.38 billion as of December 2019.
Derivative Guarantees. The firm enters into various
derivatives that meet the definition of a guarantee under
U.S. GAAP, including written equity and commodity put
options, written currency contracts and interest rate caps,
floors and swaptions. These derivatives are risk managed
together with derivatives that do not meet the definition of
a guarantee, and therefore the amounts in the table above
do not reflect the firm’s overall risk related to derivative
activities. Disclosures about derivatives are not required if
they may be cash settled and the firm has no basis to
conclude it is probable that the counterparties held the
underlying instruments at inception of the contract. The
firm has concluded that these conditions have been met for
certain 	large, 	internationally 	active 	commercial 	and
investment 	bank 	counterparties, 	central 	clearing
counterparties, 	hedge 	funds 	and 	certain 	other
counterparties. Accordingly, the firm has not included such
contracts in the table above. See Note 7 for information
about credit derivatives that meet the definition of a
guarantee, which are not included in the table above.
Derivatives are accounted for at fair value and therefore the
carrying value is considered the best indication of payment/
performance risk for individual contracts. However, the
carrying values in the table above exclude the effect of
counterparty and cash collateral netting.
Securities Lending Indemnifications. The firm, in its
capacity as an agency lender, indemnifies most of its
securities lending customers against losses incurred in the
event that borrowers do not return securities and the
collateral held is insufficient to cover the market value of
the securities borrowed. Collateral held by the lenders in
connection with securities lending indemnifications was
$17.56 billion as of March 2020 and $19.14 billion as of
December 2019. Because the contractual nature of these
arrangements requires the firm to obtain collateral with a
market value that exceeds the value of the securities lent to
the borrower, there is minimal performance risk associated
with these guarantees.
Goldman Sachs March 2020 Form 10-Q 	66

-- 68 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Other Financial Guarantees. In the ordinary course of
business, the firm provides other financial guarantees of the
obligations of third parties (e.g., standby letters of credit
and 	other 	guarantees 	to 	enable 	clients 	to 	complete
transactions 	and 	fund-related 	guarantees). 	These
guarantees represent obligations to make payments to
beneficiaries if the guaranteed party fails to fulfill its
obligation under a contractual arrangement with that
beneficiary.
Guarantees of Securities Issued by Trusts. The firm has
established trusts, including Goldman Sachs Capital I, the
APEX Trusts and other entities, for the limited purpose of
issuing securities to third parties, lending the proceeds to
the firm and entering into contractual arrangements with
the firm and third parties related to this purpose. The firm
does not consolidate these entities. See Note 14 for further
information about the transactions involving Goldman
Sachs Capital I and the APEX Trusts.
The firm effectively provides for the full and unconditional
guarantee of the securities issued by these entities. Timely
payment by the firm of amounts due to these entities under
the guarantee, borrowing, preferred stock and related
contractual 	arrangements 	will 	be 	sufficient 	to 	cover
payments due on the securities issued by these entities.
Management 	believes 	that 	it 	is 	unlikely 	that 	any
circumstances will occur, such as nonperformance on the
part of paying agents or other service providers, that would
make it necessary for the firm to make payments related to
these entities other than those required under the terms of
the guarantee, borrowing, preferred stock and related
contractual arrangements and in connection with certain
expenses incurred by these entities.
Indemnities and Guarantees of Service Providers. In
the ordinary course of business, the firm indemnifies and
guarantees certain service providers, such as clearing and
custody 	agents, 	trustees 	and 	administrators, 	against
specified potential losses in connection with their acting as
an agent of, or providing services to, the firm or its
affiliates.
The firm may also be liable to some clients or other parties
for losses arising from its custodial role or caused by acts or
omissions 	of 	third-party 	service 	providers, 	including
sub-custodians and third-party brokers. In certain cases, the
firm has the right to seek indemnification from these third-
party service providers for certain relevant losses incurred
by the firm. In addition, the firm is a member of payment,
clearing and settlement networks, as well as securities
exchanges around the world that may require the firm to
meet the obligations of such networks and exchanges in the
event of member defaults and other loss scenarios.
In connection with the firm’s prime brokerage and clearing
businesses, the firm agrees to clear and settle on behalf of its
clients the transactions entered into by them with other
brokerage firms. The firm’s obligations in respect of such
transactions are secured by the assets in the client’s account,
as well as any proceeds received from the transactions
cleared and settled by the firm on behalf of the client. In
connection with joint venture investments, the firm may
issue loan guarantees under which it may be liable in the
event of fraud, misappropriation, environmental liabilities
and certain other matters involving the borrower.
The firm is unable to develop an estimate of the maximum
payout 	under 	these 	guarantees 	and 	indemnifications.
However, management believes that it is unlikely the firm
will have to make any material payments under these
arrangements, and no material liabilities related to these
guarantees and indemnifications have been recognized in
the consolidated balance sheets as of both March 2020 and
December 2019.
Other 	Representations, 	Warranties 	and
Indemnifications. The firm provides representations and
warranties to counterparties in connection with a variety of
commercial transactions and occasionally indemnifies them
against potential losses caused by the breach of those
representations and warranties. The firm may also provide
indemnifications protecting against changes in or adverse
application of certain U.S. tax laws in connection with
ordinary-course transactions, such as securities issuances,
borrowings or derivatives.
In addition, the firm may provide indemnifications to some
counterparties to protect them in the event additional taxes
are owed or payments are withheld, due either to a change
in or an adverse application of certain non-U.S. tax laws.
These indemnifications generally are standard contractual
terms and are entered into in the ordinary course of
business. Generally, there are no stated or notional
amounts included in these indemnifications, and the
contingencies triggering the obligation to indemnify are not
expected to occur. The firm is unable to develop an estimate
of the maximum payout under these guarantees and
indemnifications. However, management believes that it is
unlikely the firm will have to make any material payments
under these arrangements, and no material liabilities related
to 	these 	arrangements 	have 	been 	recognized 	in 	the
consolidated balance sheets as of both March 2020 and
December 2019.
67 	Goldman Sachs March 2020 Form 10-Q

-- 69 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Guarantees 	of 	Subsidiaries. 	Group 	Inc. 	fully 	and
unconditionally guarantees the securities issued by GS
Finance Corp., a wholly-owned finance subsidiary of the
firm. Group Inc. has guaranteed the payment obligations of
Goldman Sachs & Co. LLC (GS&Co.) and GS Bank USA,
subject to certain exceptions. In addition, Group Inc. has
provided a guarantee to GS Bank USA related to assets that
GS Bank USA has acquired from certain subsidiaries and
affiliated funds of Group Inc., and Group Inc. has provided
a guarantee to Goldman Sachs International (GSI) related
to agreements that GSI has entered into with certain of its
counterparties.
Group Inc. guarantees many of the obligations of its other
consolidated subsidiaries on a transaction-by-transaction
basis, as negotiated with counterparties. Group Inc. is
unable to develop an estimate of the maximum payout
under its subsidiary guarantees; however, because these
obligations 	are 	also 	obligations 	of 	consolidated
subsidiaries, Group Inc.’s liabilities as guarantor are not
separately disclosed.
Note 19.
Shareholders’ Equity
Common Equity
As of both March 2020 and December 2019, the firm had
4.00 billion authorized shares of common stock and
200 million authorized shares of nonvoting common stock,
each with a par value of $0.01 per share.
The firm’s share repurchase program is intended to help
maintain the appropriate level of common equity. The
share repurchase program is effected primarily through
regular 	open-market 	purchases 	(which 	may 	include
repurchase plans designed to comply with Rule 10b5-1 and
accelerated share repurchases), the amounts and timing of
which are determined primarily by the firm’s current and
projected 	capital 	position, 	and 	capital 	deployment
opportunities, but which may also be influenced by general
market conditions and the prevailing price and trading
volumes of the firm’s common stock. Prior to repurchasing
common stock, the firm must receive confirmation that the
FRB does not object to such capital action.
The table below presents information about common stock
repurchases.
Three Months
Ended March
in millions, except per share amounts 	2020 	2019
Common share repurchases 	8.2 	6.3
Average cost per share 	$236.35 	$197.08
Total cost of common share repurchases 	$ 1,928 	$ 1,250
Pursuant to the terms of certain share-based compensation
plans, employees may remit shares to the firm or the firm
may 	cancel 	share-based 	awards 	to 	satisfy 	statutory
employee tax withholding requirements. Under these plans,
during the three months ended March 2020, 3,476 shares
were remitted with a total value of $0.9 million and the
firm cancelled 3.3 million share-based awards with a total
value of $803 million.
The table below presents common stock dividends declared.
Three Months
Ended March
2020 	2019
Dividends declared per common share 	$1.25 	$0.80
On April 14, 2020, the Board of Directors of Group Inc.
declared a dividend of $1.25 per common share to be paid
on June 29, 2020 to common shareholders of record on
June 1, 2020.
Preferred Equity
The tables below present information about the perpetual
preferred stock issued and outstanding as of March 2020.
Series
Shares
Authorized
Shares
Issued
Shares
Outstanding
Depositary Shares
Per Share
A 	50,000 	30,000 	29,999 	1,000
C 	25,000 	8,000 	8,000 	1,000
D 	60,000 	54,000 	53,999 	1,000
E 	17,500 	7,667 	7,667 	N/A
F 	5,000 	1,615 	1,615 	N/A
J 	46,000 	40,000 	40,000 	1,000
K 	32,200 	28,000 	28,000 	1,000
M 	80,000 	80,000 	80,000 	25
N 	31,050 	27,000 	27,000 	1,000
O 	26,000 	26,000 	26,000 	25
P 	66,000 	60,000 	60,000 	25
Q 	20,000 	20,000 	20,000 	25
R 	24,000 	24,000 	24,000 	25
S 	14,000 	14,000 	14,000 	25
Total 	496,750 	420,282 	420,280
Series 	Earliest Redemption Date
Liquidation
Preference
Redemption
Value
($ in millions)
A 	Currently redeemable 	$ 25,000 	$ 	750
C 	Currently redeemable 	$ 25,000 	200
D 	Currently redeemable 	$ 25,000 	1,350
E 	Currently redeemable 	$100,000 	767
F 	Currently redeemable 	$100,000 	161
J 	May 10, 2023 	$ 25,000 	1,000
K 	May 10, 2024 	$ 25,000 	700
M 	May 10, 2020 	$ 25,000 	2,000
N 	May 10, 2021 	$ 25,000 	675
O 	November 10, 2026 	$ 25,000 	650
P 	November 10, 2022 	$ 25,000 	1,500
Q 	August 10, 2024 	$ 25,000 	500
R 	February 10, 2025 	$ 25,000 	600
S 	February 10, 2025 	$ 25,000 	350
Total 	$11,203
Goldman Sachs March 2020 Form 10-Q 	68

-- 70 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In the tables above:
‰ All shares have a par value of $0.01 per share and, where
applicable, each share is represented by the specified
number of depositary shares.
‰ The earliest redemption date represents the date on which
each 	share 	of 	non-cumulative 	Preferred 	Stock 	is
redeemable at the firm’s option.
‰ Prior to redeeming preferred stock, the firm must receive
confirmation that the FRB does not object to such action.
‰ In January 2020, the firm issued 14,000 shares of Series S
4.40% 	Fixed-Rate 	Reset 	Non-Cumulative 	Preferred
Stock (Series S Preferred Stock).
‰ The redemption price per share for Series A through F and
Series Q through S Preferred Stock is the liquidation
preference plus declared and unpaid dividends. The
redemption price per share for Series J through P
Preferred Stock is the liquidation preference plus accrued
and unpaid dividends. Each share of Series E and Series F
Preferred Stock is redeemable at the firm’s option, subject
to certain covenant restrictions governing the firm’s
ability to redeem the preferred stock without issuing
common stock or other instruments with equity-like
characteristics. See Note 14 for information about the
replacement capital covenants applicable to the Series E
and Series F Preferred Stock.
‰ All series of preferred stock are pari passu and have a
preference over the firm’s common stock on liquidation.
‰ The firm’s ability to declare or pay dividends on, or
purchase, redeem or otherwise acquire, its common stock
is subject to certain restrictions in the event that the firm
fails to pay or set aside full dividends on the preferred
stock for the latest completed dividend period.
In the first quarter of 2020, the firm redeemed the
remaining 14,000 outstanding shares of its Series L 5.70%
Non-Cumulative Preferred Stock (Series L Preferred Stock)
with a redemption value of $350 million ($25,000 per
share), plus accrued and unpaid dividends. The difference
between the redemption value and net carrying value at the
time of this redemption was $1 million, which was recorded
as an addition to preferred stock dividends in 2020.
In 2019, the firm redeemed 38,000 shares of its outstanding
Series L Preferred Stock with a redemption value of
$950 million ($25,000 per share), plus accrued and unpaid
dividends. In addition, in 2019, the firm redeemed the
remaining 6,000 outstanding shares of its Series B 6.20%
Non-Cumulative Preferred Stock (Series B Preferred Stock)
with a redemption value of $150 million ($25,000 per
share). The difference between the redemption value and
net carrying value at the time of these redemptions was
$9 million, which was recorded as an addition to preferred
stock dividends in 2019.
The table below presents the dividend rates of perpetual
preferred stock as of March 2020.
Series 	Per Annum Dividend Rate
A 	3 month LIBOR + 0.75%, with floor of 3.75%, payable quarterly
C 	3 month LIBOR + 0.75%, with floor of 4.00%, payable quarterly
D 	3 month LIBOR + 0.67%, with floor of 4.00%, payable quarterly
E 	3 month LIBOR + 0.7675%, with floor of 4.00%, payable quarterly
F 	3 month LIBOR + 0.77%, with floor of 4.00%, payable quarterly
J 	5.50% to, but excluding, May 10, 2023;
3 month LIBOR + 3.64% thereafter, payable quarterly
K 	6.375% to, but excluding, May 10, 2024;
3 month LIBOR + 3.55% thereafter, payable quarterly
M 	5.375%, payable semi-annually, from issuance date to, but excluding,
May 10, 2020; 3 month LIBOR + 3.922%, payable quarterly, thereafter
N 	6.30%, payable quarterly
O 	5.30%, payable semi-annually, from issuance date to, but excluding,
November 10, 2026; 3 month LIBOR + 3.834%, payable quarterly, thereafter
P 	5.00%, payable semi-annually, from issuance date to, but excluding,
November 10, 2022; 3 month LIBOR + 2.874%, payable quarterly, thereafter
Q 	5.50%, payable semi-annually, from issuance date to, but excluding,
August 10, 2024; 5 year treasury rate + 3.623%, payable semi-annually, thereafter
R 	4.95%, payable semi-annually, from issuance date to, but excluding,
February 10, 2025; 5 year treasury rate + 3.224%, payable semi-annually, thereafter
S 	4.40%, payable semi-annually, from issuance date to, but excluding,
February 10, 2025; 5 year treasury rate + 2.85%, payable semi-annually thereafter
In the table above, dividends on each series of preferred
stock are payable in arrears for the periods specified.
The 	table 	below 	presents 	preferred 	stock 	dividends
declared.
2020 	2019
Series 	per share 	$ in millions 	per share 	$ in millions
Three Months Ended March
A 	$ 234.38 	$ 7 	$234.38 	$ 7
B 	$ 	– 	– 	$387.50 	2
C 	$ 250.00 	2 	$250.00 	2
D 	$ 250.00 	13 	$250.00 	13
E 	$1,011.11 	7 	$977.78 	7
F 	$1,011.11 	2 	$977.78 	2
J 	$ 343.75 	14 	$343.75 	14
K 	$ 398.44 	11 	$398.44 	11
L 	$ 361.54 	4 	$ 	– 	–
N 	$ 393.75 	11 	$393.75 	11
Q 	$ 889.93 	18 	$ 	– 	–
Total 	$89 	$69
69 	Goldman Sachs March 2020 Form 10-Q

-- 71 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
On April 6, 2020, Group Inc. declared dividends of $236.98
per share of Series A Preferred Stock, $252.78 per share of
Series C Preferred Stock, $252.78 per share of Series D
Preferred Stock, $343.75 per share of Series J Preferred Stock,
$398.44 per share of Series K Preferred Stock, $671.88 per
share of Series M Preferred Stock, $393.75 per share of
Series N Preferred Stock, $662.50 per share of Series O
Preferred Stock and $625.00 per share of Series P Preferred
Stock to be paid on May 11, 2020 to preferred shareholders of
record on April 26, 2020. In addition, the firm declared
dividends of $1,011.11 per share of Series E Preferred Stock
and Series F Preferred Stock to be paid on June 1, 2020 to
preferred shareholders of record on May 16, 2020.
Accumulated Other Comprehensive Income/(Loss)
The table below presents changes in the accumulated other
comprehensive income/(loss), net of tax, by type.
$ in millions
Beginning
balance
Other
comprehensive
income/(loss)
adjustments,
net of tax
Ending
balance
Three Months Ended March 2020
Currency translation 	$ (616) 	$ 	(17) $ (633)
Debt valuation adjustment 	(572) 	2,914 	2,342
Pension and postretirement liabilities 	(342) 	7 	(335)
Available-for-sale securities 	46 	517 	563
Total 	$(1,484) 	$ 3,421 $1,937
Three Months Ended March 2019
Currency translation 	$ (621) 	$ 	4 $ (617)
Debt valuation adjustment 	1,507 	(1,417) 	90
Pension and postretirement liabilities 	(81) 	(7) 	(88)
Available-for-sale securities 	(112) 	114 	2
Total 	$ 	693 	$(1,306) $ (613)
Note 20.
Regulation and Capital Adequacy
The FRB is the primary regulator of Group Inc., a bank
holding company (BHC) under the U.S. Bank Holding
Company Act of 1956 and a financial holding company
under amendments to this Act. The firm is subject to
consolidated regulatory capital requirements which are
calculated in accordance with the regulations of the FRB
(Capital Framework).
The capital requirements are expressed as risk-based capital
and leverage ratios that compare measures of regulatory
capital to risk-weighted assets (RWAs), average assets and
off-balance sheet exposures. Failure to comply with these
capital requirements could result in restrictions being
imposed by the firm’s regulators and could limit the firm’s
ability to repurchase shares, pay dividends and make certain
discretionary compensation payments. The firm’s capital
levels are also subject to qualitative judgments by the
regulators about components of capital, risk weightings and
other factors. Furthermore, certain of the firm’s subsidiaries
are subject to separate regulations and capital requirements.
Capital Framework
The regulations under the Capital Framework are largely
based on the Basel Committee on Banking Supervision’s
(Basel Committee) capital framework for strengthening
international 	capital 	standards 	(Basel 	III) 	and 	also
implement certain provisions of the Dodd-Frank Act.
Under the Capital Framework, the firm is an “Advanced
approach” banking organization and has been designated
as a global systemically important bank (G-SIB).
The capital requirements calculated in accordance with the
Capital Framework include the minimum risk-based capital
and leverage ratios. In addition, the risk-based capital
requirements 	include 	the 	capital 	conservation 	buffer,
countercyclical capital buffer and the G-SIB surcharge, all
of which must consist entirely of capital that qualifies as
Common Equity Tier 1 (CET1) capital.
The firm calculates its CET1 capital, Tier 1 capital and
Total capital ratios in accordance with (i) the Standardized
approach and market risk rules set out in the Capital
Framework (together, the Standardized Capital Rules) and
(ii) the Advanced approach and market risk rules set out in
the Capital Framework (together, the Advanced Capital
Rules). The lower of each risk-based capital ratio calculated
in (i) and (ii) is the ratio against which the firm’s compliance
with its risk-based capital requirements is assessed. Under
the Capital Framework, the firm is also subject to leverage
requirements which consist of a minimum Tier 1 leverage
ratio and a minimum supplementary leverage ratio (SLR),
as well as the SLR buffer.
Consolidated Regulatory Risk-Based Capital and
Leverage Ratios
The table below presents the risk-based capital and leverage
requirements.
Requirements
Risk-based capital requirements
CET1 capital ratio 	9.5%
Tier 1 capital ratio 	11.0%
Total capital ratio 	13.0%
Leverage requirements
Tier 1 leverage ratio 	4.0%
SLR 	5.0%
In the table above:
‰ The CET1 capital ratio requirement includes a minimum
of 4.5%, the Tier 1 capital ratio requirement includes a
minimum 	of 	6.0% 	and 	the 	Total 	capital 	ratio
requirement 	includes 	a 	minimum 	of 	8.0%. 	The
requirements also include the capital conservation buffer
of 2.5%, the G-SIB surcharge of 2.5% (Method 2) and
the countercyclical capital buffer, which the FRB has set
to zero percent.
Goldman Sachs March 2020 Form 10-Q 	70

-- 72 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
‰ The G-SIB surcharge is updated annually based on
financial data from the prior year and is generally
applicable for the following year. The G-SIB surcharge is
calculated using two methodologies, the higher of which
is reflected in the firm’s risk-based capital requirements.
The first calculation (Method 1) is based on the Basel
Committee’s methodology which, among other factors,
relies upon measures of the size, activity and complexity
of each G-SIB. The second calculation (Method 2) uses
similar inputs but includes a measure of reliance on short-
term wholesale funding.
‰ The Tier 1 leverage ratio requirement is a minimum of
4%. The SLR requirement of 5% includes a minimum of
3% and a 2% buffer applicable to G-SIBs.
The table below presents information about risk-based
capital ratios.
$ in millions 	Standardized 	Advanced
As of March 2020
CET1 capital 	$ 74,550 	$ 74,550
Tier 1 capital 	$ 85,589 	$ 85,589
Tier 2 capital 	$ 15,131 	$ 13,470
Total capital 	$100,720 	$ 99,059
RWAs 	$594,484 	$605,926
CET1 capital ratio 	12.5% 	12.3%
Tier 1 capital ratio 	14.4% 	14.1%
Total capital ratio 	16.9% 	16.3%
As of December 2019
CET1 capital 	$ 74,850 	$ 74,850
Tier 1 capital 	$ 85,440 	$ 85,440
Tier 2 capital 	$ 14,925 	$ 13,473
Total capital 	$100,365 	$ 98,913
RWAs 	$563,575 	$544,653
CET1 capital ratio 	13.3% 	13.7%
Tier 1 capital ratio 	15.2% 	15.7%
Total capital ratio 	17.8% 	18.2%
In the table above:
‰ The lower of the Standardized or Advanced ratio is the
ratio against which the firm’s compliance with the capital
requirements is assessed under the risk-based Capital
Rules, and therefore, the Advanced ratios applied to the
firm as of March 2020 and the Standardized ratios
applied to the firm as of December 2019.
‰ As permitted by the FRB, the firm has elected to
temporarily delay the estimated effects of adopting CECL
on 	regulatory 	capital 	until 	January 	2022 	and 	to
subsequently phase-in the effects through January 2025.
In addition, during 2020 and 2021, the firm has elected to
increase regulatory capital by 25% of the increase in the
allowance for credit losses since January 1, 2020, as
permitted by the rules issued by the FRB. The impact of
this increase will also be phased in over the three-year
transition period. Reflecting the full impact of CECL as of
March 2020 would not have had a material impact on the
firm’s Advanced risk-based capital ratios.
‰ The FRB permits banking organizations to exclude assets
acquired in connection with their participation in the
Federal Reserve’s Money Market Mutual Fund Liquidity
Facility (MMLF) from their calculation of risk-based
capital and leverage ratios. The firm has opted to exclude
such assets from the calculations of these ratios as of
March 2020.
The table below presents information about leverage ratios.
For the Three Months
Ended or as of
$ in millions
March
2020
December
2019
Tier 1 capital 	$ 	85,589 	$ 	85,440
Average total assets 	$1,048,847 	$ 983,909
Deductions from Tier 1 capital 	(4,887) 	(5,275)
Average adjusted total assets 	1,043,960 	978,634
Average off-balance sheet exposures 	394,906 	396,833
Total leverage exposure 	$1,438,866 	$1,375,467
Tier 1 leverage ratio 	8.2% 	8.7%
SLR 	5.9% 	6.2%
In the table above:
‰ Average total assets represents the average daily assets for
the quarter adjusted for the impact of CECL transition
and exclusion of assets acquired in connection with the
firm’s participation in the Federal Reserve’s MMLF.
‰ Average 	off-balance 	sheet 	exposures 	represents 	the
monthly average and consists of derivatives, securities
financing transactions, commitments and guarantees.
‰ Tier 1 leverage ratio is calculated as Tier 1 capital divided
by average adjusted total assets.
‰ SLR is calculated as Tier 1 capital divided by total
leverage exposure.
71 	Goldman Sachs March 2020 Form 10-Q

-- 73 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Risk-Based Capital. The table below presents information
about risk-based capital.
As of
$ in millions
March
2020
December
2019
Common shareholders’ equity 	$ 81,176 	$ 79,062
Impact of CECL transition 	819 	–
Deduction for goodwill 	(3,528) 	(3,529)
Deduction for identifiable intangible assets 	(584) 	(604)
Other adjustments 	(3,333) 	(79)
CET1 capital 	74,550 	74,850
Preferred stock 	11,203 	11,203
Deduction for investments in covered funds 	(157) 	(610)
Other adjustments 	(7) 	(3)
Tier 1 capital 	$ 85,589 	$ 85,440
Standardized Tier 2 and Total capital
Tier 1 capital 	$ 85,589 	$ 85,440
Qualifying subordinated debt 	12,820 	12,847
Junior subordinated debt 	188 	284
Allowance for credit losses 	2,174 	1,802
Other adjustments 	(51) 	(8)
Standardized Tier 2 capital 	15,131 	14,925
Standardized Total capital 	$100,720 	$100,365
Advanced Tier 2 and Total capital
Tier 1 capital 	$ 85,589 	$ 85,440
Standardized Tier 2 capital 	15,131 	14,925
Allowance for credit losses 	(2,174) 	(1,802)
Other adjustments 	513 	350
Advanced Tier 2 capital 	13,470 	13,473
Advanced Total capital 	$ 99,059 	$ 98,913
In the table above:
‰ Impact of CECL transition represents the impact of
adoption as of January 1, 2020 and the impact of
increasing regulatory capital by 25% of the increase in
allowance for credit losses since January 1, 2020. The
allowance for credit losses within Standardized and
Advanced Tier 2 capital also reflects the impact of these
adjustments.
‰ Deduction for goodwill was net of deferred tax liabilities
of $668 million as of March 2020 and $667 million as of
December 2019.
‰ Deduction for identifiable intangible assets was net of
deferred tax liabilities of $30 million as of March 2020
and $37 million as of December 2019.
‰ Deduction for investments in covered funds represents the
firm’s aggregate investments in applicable covered funds,
excluding investments that are subject to an extended
conformance period. See Note 8 for further information
about the Volcker Rule.
‰ Other adjustments within CET1 capital and Tier 1 capital
primarily 	include 	credit 	valuation 	adjustments 	on
derivative liabilities, the overfunded portion of the firm’s
defined benefit pension plan obligation net of associated
deferred tax liabilities, disallowed deferred tax assets,
debt valuation adjustments and other required credit risk-
based deductions. Other adjustments within Advanced
Tier 2 capital include eligible credit reserves.
‰ Qualifying subordinated debt is subordinated debt issued
by Group Inc. with an original maturity of five years or
greater. The outstanding amount of subordinated debt
qualifying for Tier 2 capital is reduced upon reaching a
remaining maturity of five years. See Note 14 for further
information about the firm’s subordinated debt.
‰ Junior subordinated debt is debt issued to a Trust. As of
March 2020, 20% of this debt was included in Tier 2
capital and 80% was phased out of regulatory capital. As
of December 2019, 30% of this debt was included in
Tier 2 capital and 70% was phased out of regulatory
capital. Junior subordinated debt is reduced by the
amount of Trust Preferred securities purchased by the
firm and will be fully phased out of Tier 2 capital by 2022
at a rate of 10% per year. See Note 14 for further
information about the firm’s junior subordinated debt
and Trust Preferred securities.
Goldman Sachs March 2020 Form 10-Q 	72

-- 74 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents changes in CET1 capital, Tier 1
capital and Tier 2 capital.
$ in millions 	Standardized Advanced
Three Months Ended March 2020
CET1 capital
Beginning balance 	$ 74,850 	$74,850
Change in:
Common shareholders’ equity 	2,114 	2,114
Impact of CECL transition 	819 	819
Deduction for goodwill 	1 	1
Deduction for identifiable intangible assets 	20 	20
Other adjustments 	(3,254) 	(3,254)
Ending balance 	$ 74,550 	$74,550
Tier 1 capital
Beginning balance 	$ 85,440 	$85,440
Change in:
CET1 capital 	(300) 	(300)
Deduction for investments in covered funds 	453 	453
Other adjustments 	(4) 	(4)
Ending balance 	85,589 	85,589
Tier 2 capital
Beginning balance 	14,925 	13,473
Change in:
Qualifying subordinated debt 	(27) 	(27)
Junior subordinated debt 	(96) 	(96)
Allowance for credit losses 	372 	–
Other adjustments 	(43) 	120
Ending balance 	15,131 	13,470
Total capital 	$100,720 	$99,059
Year Ended December 2019
CET1 capital
Beginning balance 	$ 73,116 	$73,116
Change in:
Common shareholders’ equity 	80 	80
Deduction for goodwill 	(432) 	(432)
Deduction for identifiable intangible assets 	(307) 	(307)
Other adjustments 	2,393 	2,393
Ending balance 	$ 74,850 	$74,850
Tier 1 capital
Beginning balance 	$ 83,702 	$83,702
Change in:
CET1 capital 	1,734 	1,734
Deduction for investments in covered funds 	5 	5
Other adjustments 	(1) 	(1)
Ending balance 	85,440 	85,440
Tier 2 capital
Beginning balance 	14,926 	13,743
Change in:
Qualifying subordinated debt 	(300) 	(300)
Junior subordinated debt 	(158) 	(158)
Allowance for credit losses 	449 	–
Other adjustments 	8 	188
Ending balance 	14,925 	13,473
Total capital 	$100,365 	$98,913
RWAs. RWAs are calculated in accordance with both the
Standardized and Advanced Capital Rules.
Credit Risk
Credit 	RWAs 	are 	calculated 	based 	on 	measures 	of
exposure, 	which 	are 	then 	risk 	weighted 	under 	the
Standardized and Advanced Capital Rules:
‰ The Standardized Capital Rules apply prescribed risk-
weights, 	which 	depend 	largely 	on 	the 	type 	of
counterparty. The exposure measure for derivatives and
securities financing transactions are based on specific
formulas which take certain factors into consideration.
‰ Under the Advanced Capital Rules, the firm computes
risk-weights for wholesale and retail credit exposures in
accordance with the Advanced Internal Ratings-Based
approach. The exposure measures for derivatives and
securities financing transactions are computed utilizing
internal models.
‰ For both Standardized and Advanced credit RWAs, the
risk-weights for securitizations and equities are based on
specific required formulaic approaches.
73 	Goldman Sachs March 2020 Form 10-Q

-- 75 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Market Risk
RWAs for market risk in accordance with the Standardized
and Advanced Capital Rules are generally consistent.
Market RWAs are calculated based on measures of
exposure which include the following:
‰ Value-at-Risk (VaR) is the potential loss in value of
trading 	assets 	and 	liabilities, 	as 	well 	as 	certain
investments, 	loans, 	and 	other 	financial 	assets 	and
liabilities accounted for at fair value, due to adverse
market movements over a defined time horizon with a
specified confidence level.
For both risk management purposes and regulatory
capital calculations, the firm uses a single VaR model
which captures risks including those related to interest
rates, equity prices, currency rates and commodity
prices. 	However, 	VaR 	used 	for 	regulatory 	capital
requirements 	(regulatory 	VaR) 	differs 	from 	risk
management VaR due to different time horizons and
confidence levels (10-day and 99% for regulatory VaR
vs. one-day and 95% for risk management VaR), as well
as differences in the scope of positions on which VaR is
calculated. In addition, the daily net revenues used to
determine 	risk 	management 	VaR 	exceptions 	(i.e.,
comparing the daily net revenues to the VaR measure
calculated as of the end of the prior business day) include
intraday 	activity, 	whereas 	the 	Capital 	Framework
requires that intraday activity be excluded from daily net
revenues when calculating regulatory VaR exceptions.
Intraday activity includes bid/offer net revenues, which
are more likely than not to be positive by their nature.
As a result, there may be differences in the number of
VaR exceptions and the amount of daily net revenues
calculated for regulatory VaR compared to the amounts
calculated for risk management VaR.
The firm’s positional losses observed on a single day
exceeded its 99% one-day regulatory VaR on six occasions
during the three months ended March 2020 and exceeded
its 99% one-day VaR on one occasion during the year
ended December 2019. There was no change in the VaR
multiplier used to calculate Market RWAs;
‰ Stressed VaR is the potential loss in value of trading assets
and liabilities, as well as certain investments, loans, and
other financial assets and liabilities accounted for at fair
value, during a period of significant market stress;
‰ Incremental 	risk 	is 	the 	potential 	loss 	in 	value 	of
non-securitized positions due to the default or credit
migration of issuers of financial instruments over a
one-year time horizon;
‰ Comprehensive risk is the potential loss in value, due to
price risk and defaults, within the firm’s credit correlation
positions; and
‰ Specific risk is the risk of loss on a position that could
result from factors other than broad market movements,
including event risk, default risk and idiosyncratic risk.
The 	standardized 	measurement 	method 	is 	used 	to
determine specific risk RWAs, by applying supervisory
defined risk-weighting factors after applicable netting is
performed.
Operational Risk
Operational RWAs are only required to be included under
the Advanced Capital Rules. The firm utilizes an internal
risk-based model to quantify Operational RWAs.
The table below presents information about RWAs.
$ in millions 	Standardized 	Advanced
As of March 2020
Credit RWAs
Derivatives 	$134,778 	$104,638
Commitments, guarantees and loans 	189,300 	148,986
Securities financing transactions 	59,729 	12,515
Equity investments 	50,881 	52,999
Other 	74,574 	82,753
Total Credit RWAs 	509,262 	401,891
Market RWAs
Regulatory VaR 	13,465 	13,465
Stressed VaR 	45,608 	45,608
Incremental risk 	5,088 	5,088
Comprehensive risk 	2,186 	2,186
Specific risk 	18,875 	18,875
Total Market RWAs 	85,222 	85,222
Total Operational RWAs 	– 	118,813
Total RWAs 	$594,484 	$605,926
As of December 2019
Credit RWAs
Derivatives 	$120,906 	$ 72,631
Commitments, guarantees and loans 	179,740 	134,456
Securities financing transactions 	65,867 	13,834
Equity investments 	56,814 	61,892
Other 	75,660 	78,266
Total Credit RWAs 	498,987 	361,079
Market RWAs
Regulatory VaR 	8,933 	8,933
Stressed VaR 	30,911 	30,911
Incremental risk 	4,308 	4,308
Comprehensive risk 	1,393 	1,191
Specific risk 	19,043 	19,043
Total Market RWAs 	64,588 	64,386
Total Operational RWAs 	– 	119,188
Total RWAs 	$563,575 	$544,653
In the table above:
‰ Securities financing transactions represents resale and
repurchase agreements and securities borrowed and
loaned transactions.
‰ Other includes receivables, certain debt securities, cash
and cash equivalents and other assets.
Goldman Sachs March 2020 Form 10-Q 	74

-- 76 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents changes in RWAs.
$ in millions 	Standardized 	Advanced
Three Months Ended March 2020
RWAs
Beginning balance 	$563,575 	$544,653
Credit RWAs
Change in:
Derivatives 	13,872 	32,007
Commitments, guarantees and loans 	9,560 	14,530
Securities financing transactions 	(6,138) 	(1,319)
Equity investments 	(5,933) 	(8,893)
Other 	(1,086) 	4,487
Change in Credit RWAs 	10,275 	40,812
Market RWAs
Change in:
Regulatory VaR 	4,532 	4,532
Stressed VaR 	14,697 	14,697
Incremental risk 	780 	780
Comprehensive risk 	793 	995
Specific risk 	(168) 	(168)
Change in Market RWAs 	20,634 	20,836
Change in Operational RWAs 	– 	(375)
Ending balance 	$594,484 	$605,926
Year Ended December 2019
RWAs
Beginning balance 	$547,910 	$558,111
Credit RWAs
Change in:
Derivatives 	(1,605) 	(9,670)
Commitments, guarantees and loans 	19,435 	(8,900)
Securities financing transactions 	(496) 	(4,425)
Equity investments 	3,251 	6,738
Other 	5,064 	8,585
Change in Credit RWAs 	25,649 	(7,672)
Market RWAs
Change in:
Regulatory VaR 	1,151 	1,151
Stressed VaR 	2,959 	2,959
Incremental risk 	(6,161) 	(6,161)
Comprehensive risk 	(1,377) 	(1,579)
Specific risk 	(6,556) 	(6,556)
Change in Market RWAs 	(9,984) 	(10,186)
Change in Operational RWAs 	– 	4,400
Ending balance 	$563,575 	$544,653
RWAs Rollforward Commentary
Three Months Ended March 2020. Standardized Credit
RWAs as of March 2020 increased by $10.28 billion
compared with December 2019, primarily reflecting an
increase in derivatives, principally due to increased exposure,
and an increase in commitments, guarantees and loans,
principally due to increased lending activity. This increase
was 	partially 	offset 	by 	decreased 	securities 	financing
transactions and equity investments, primarily due to
reduced exposures. Standardized Market RWAs as of
March 2020 increased by $20.63 billion compared with
December 2019, primarily reflecting an increase in stressed
VaR, principally due to increased risk exposures, and an
increase in regulatory VaR, principally due to market
volatility.
Advanced Credit RWAs as of March 2020 increased by
$40.81 billion compared with December 2019, primarily
reflecting an increase in derivatives, principally due to
increased exposure including the impact of higher levels of
volatility and counterparty credit risk, and an increase in
commitments, guarantees and loans, principally due to
increased lending activity. This increase was partially offset
by decreased equity investments, primarily due to reduced
exposures. Advanced Market RWAs as of March 2020
increased 	by 	$20.84 	billion 	compared 	with
December 2019, primarily reflecting an increase in stressed
VaR, principally due to increased risk exposures, and an
increase in regulatory VaR, principally due to market
volatility. Advanced Operational RWAs as of March 2020
were 	essentially 	unchanged 	compared 	with
December 2019.
Year Ended December 2019. Standardized Credit RWAs
as of December 2019 increased by $25.65 billion compared
with December 2018, primarily reflecting an increase in
commitments, guarantees and loans, principally due to an
increase in lending activity, and an increase in other credit
RWAs, principally due to the recognition of operating lease
right-of-use assets upon adoption of ASU No. 2016-02 and
an increase in corporate debt exposures. Standardized
Market 	RWAs 	as 	of 	December 	2019 	decreased 	by
$9.98 billion compared with December 2018, primarily
reflecting a decrease in specific risk, principally due to
reduced exposures, and a decrease in incremental risk,
principally due to reduced exposures and changes in risk
measurements.
Advanced Credit RWAs as of December 2019 decreased by
$7.67 billion compared with December 2018. Beginning in
the fourth quarter of 2019, the firm made changes to the
calculation of the loss given default for certain wholesale
exposures which resulted in a decrease in credit RWAs,
primarily in commitments, guarantees and loans and
derivatives. This decrease was partially offset by an increase
in other credit RWAs, principally due to the recognition of
operating lease right-of-use assets upon adoption of ASU
No. 2016-02 and an increase in corporate debt exposures.
Advanced Market RWAs as of December 2019 decreased
by 	$10.19 	billion 	compared 	with 	December 	2018,
primarily reflecting a decrease in specific risk, principally
due to reduced exposures, and a decrease in incremental
risk, principally due to reduced exposures and changes in
risk measurements. Advanced Operational RWAs as of
December 2019 increased by $4.40 billion compared with
December 2018, associated with litigation and regulatory
proceedings.
75 	Goldman Sachs March 2020 Form 10-Q

-- 77 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Bank Subsidiaries
Regulatory Capital Ratios. GS Bank USA, the firm’s
primary U.S. bank subsidiary, is an FDIC-insured, New
York State-chartered bank and a member of the Federal
Reserve System, is supervised and regulated by the FRB, the
FDIC, the New York State Department of Financial
Services and the Consumer Financial Protection Bureau,
and is subject to regulatory capital requirements that are
calculated in substantially the same manner as those
applicable to BHCs. For purposes of assessing the adequacy
of its capital, GS Bank USA calculates its risk-based capital
and leverage ratios in accordance with the regulatory
capital requirements applicable to state member banks.
Those requirements are based on the Capital Framework
described above. GS Bank USA is an Advanced approach
banking organization under the Capital Framework.
Under the regulatory framework for prompt corrective
action applicable to GS Bank USA, in order to meet the
quantitative requirements for being a “well-capitalized”
depository institution, GS Bank USA must also meet the
“well-capitalized” requirements in the table below.
GS Bank USA’s capital levels and prompt corrective action
classification are also subject to qualitative judgments by
the regulators about components of capital, risk weightings
and other factors. Failure to comply with these capital
requirements, including a breach of the buffers described
above, could result in restrictions being imposed by GS
Bank USA’s regulators.
Similar to the firm, GS Bank USA is required to calculate
each of the CET1 capital, Tier 1 capital and Total capital
ratios in accordance with both the Standardized and
Advanced Capital Rules. The lower of each risk-based
capital ratio calculated in accordance with the Standardized
and Advanced Capital Rules is the ratio against which GS
Bank 	USA’s 	compliance 	with 	its 	risk-based 	capital
requirements is assessed.
The table below presents GS Bank USA’s risk-based capital,
leverage and “well-capitalized” requirements.
Requirements
“Well-capitalized”
Requirements
Risk-based capital requirements
CET1 capital ratio 	7.0% 	6.5%
Tier 1 capital ratio 	8.5% 	8.0%
Total capital ratio 	10.5% 	10.0%
Leverage requirements
Tier 1 leverage ratio 	4.0% 	5.0%
SLR 	3.0% 	6.0%
In the table above:
‰ The CET1 capital ratio requirement includes a minimum
of 4.5%, the Tier 1 capital ratio requirement includes a
minimum 	of 	6.0% 	and 	the 	Total 	capital 	ratio
requirement 	includes 	a 	minimum 	of 	8.0%. 	The
requirements also include the capital conservation buffer
of 2.5% and the countercyclical capital buffer, which the
FRB has set to zero percent.
‰ The “well-capitalized” requirements are the binding
requirements for leverage ratios.
The table below presents information about GS Bank USA’s
risk-based capital ratios.
$ in millions 	Standardized 	Advanced
As of March 2020
CET1 capital 	$ 29,760 	$ 29,760
Tier 1 capital 	$ 29,760 	$ 29,760
Tier 2 capital 	$ 	5,710 	$ 	4,644
Total capital 	$ 35,470 	$ 34,404
RWAs 	$272,752 	$164,238
CET1 capital ratio 	10.9% 	18.1%
Tier 1 capital ratio 	10.9% 	18.1%
Total capital ratio 	13.0% 	20.9%
As of December 2019
CET1 capital 	$ 29,176 	$ 29,176
Tier 1 capital 	$ 29,176 	$ 29,176
Tier 2 capital 	$ 	5,293 	$ 	4,486
Total capital 	$ 34,469 	$ 33,662
RWAs 	$258,541 	$135,596
CET1 capital ratio 	11.3% 	21.5%
Tier 1 capital ratio 	11.3% 	21.5%
Total capital ratio 	13.3% 	24.8%
In the table above:
‰ The lower of the Standardized or Advanced ratio is the ratio
against which GS Bank USA’s compliance with the capital
requirements is assessed under the risk-based Capital Rules,
and therefore, the Standardized ratios applied to GS Bank
USA as of both March 2020 and December 2019.
‰ As permitted by the FRB, GS Bank USA has elected to
temporarily delay the estimated effects of adopting CECL on
regulatory capital until January 2022 and to subsequently
phase-in the effects through January 2025. In addition,
during 2020 and 2021, GS Bank USA has elected to increase
regulatory capital by 25% of the increase in the allowance
for credit losses since January 1, 2020, as permitted by the
rules issued by the FRB. The impact of this increase will also
be phased in over the three-year transition period. Reflecting
the full impact of CECL as of March 2020 would not have
had a material impact on GS Bank USA’s Standardized risk-
based capital ratios.
Goldman Sachs March 2020 Form 10-Q 	76

-- 78 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
‰ The Standardized risk-based capital ratios and the
Advanced risk-based capital ratios both decreased from
December 2019 to March 2020, primarily due to an
increase in Credit RWAs and Market RWAs.
The table below presents information about GS Bank USA’s
leverage ratios.
For the Three Months
Ended or as of
$ in millions
March
2020
December
2019
Tier 1 capital 	$ 29,760 	$ 29,176
Average adjusted total assets 	$243,007 	$220,974
Total leverage exposure 	$425,724 	$413,852
Tier 1 leverage ratio 	12.2% 	13.2%
SLR 	7.0% 	7.0%
In the table above:
‰ Tier 1 leverage ratio is calculated as Tier 1 capital divided
by average adjusted total assets.
‰ SLR is calculated as Tier 1 capital divided by total
leverage exposure.
The firm’s principal non-U.S. bank subsidiary, GSIB, is a
wholly-owned 	credit 	institution, 	regulated 	by 	the
Prudential Regulation Authority and the Financial Conduct
Authority and is subject to regulatory capital requirements.
As of both March 2020 and December 2019, GSIB was in
compliance with its regulatory capital requirements.
Other. The deposits of GS Bank USA are insured by the
FDIC to the extent provided by law. The FRB requires that
GS Bank USA maintain cash reserves with the Federal
Reserve Bank of New York. The amount deposited by GS
Bank USA at the Federal Reserve Bank of New York was
$34.16 billion as of March 2020 and $50.55 billion as of
December 2019, which exceeded required reserve amounts
by $34.16 billion as of March 2020 and $50.29 billion as of
December 2019.
Restrictions on Payments
Group Inc. may be limited in its ability to access capital held
at certain subsidiaries as a result of regulatory, tax or other
constraints. 	These 	limitations 	include 	provisions 	of
applicable law and regulations and other regulatory
restrictions that limit the ability of those subsidiaries to
declare 	and 	pay 	dividends 	without 	prior 	regulatory
approval (e.g., dividends that may be paid by GS Bank USA
are limited to the lesser of the amounts calculated under a
recent earnings test and an undivided profits test) even if the
relevant 	subsidiary 	would 	satisfy 	the 	equity 	capital
requirements applicable to it after giving effect to the
dividend. For example, the FRB, the FDIC and the New
York State Department of Financial Services have authority
to prohibit or to limit the payment of dividends by the
banking organizations they supervise (including GS Bank
USA) if, in the regulator’s opinion, payment of a dividend
would constitute an unsafe or unsound practice in light of
the financial condition of the banking organization.
In addition, subsidiaries not subject to separate regulatory
capital requirements may hold capital to satisfy local tax
and legal guidelines, rating agency requirements (for
entities with assigned credit ratings) or internal policies,
including policies concerning the minimum amount of
capital a subsidiary should hold based on its underlying
level of risk.
Group 	Inc.’s 	equity 	investment 	in 	subsidiaries 	was
$95.59 billion as of March 2020 and $95.68 billion as of
December 2019, of which Group Inc. was required to
maintain 	$63.09 	billion 	as 	of 	March 	2020 	and
$57.58 billion as of December 2019, of minimum equity
capital in its regulated subsidiaries in order to satisfy the
regulatory requirements of such subsidiaries.
Group 	Inc.’s 	capital 	invested 	in 	certain 	non-U.S.
subsidiaries 	is 	exposed 	to 	foreign 	exchange 	risk,
substantially 	all 	of 	which 	is 	managed 	through 	a
combination of derivatives and non-U.S. denominated debt.
See Note 7 for information about the firm’s net investment
hedges used to hedge this risk.
77 	Goldman Sachs March 2020 Form 10-Q

-- 79 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 21.
Earnings Per Common Share
Basic earnings per common share (EPS) is calculated by
dividing net earnings to common by the weighted average
number of common shares outstanding and RSUs for which
the delivery of the underlying common stock is not subject
to satisfaction of future service or performance conditions
(collectively, 	basic 	shares). 	Diluted 	EPS 	includes 	the
determinants of basic EPS and, in addition, reflects the
dilutive effect of the common stock deliverable for RSUs for
which the delivery of the underlying common stock is
subject to satisfaction of future service or performance
conditions.
The table below presents information about basic and
diluted EPS.
Three Months
Ended March
in millions, except per share amounts 	2020 	2019
Net earnings to common 	$1,123 	$2,182
Weighted average basic shares 	358.0 	379.8
Effect of dilutive RSUs 	3.1 	2.6
Weighted average diluted shares 	361.1 	382.4
Basic EPS 	$ 3.12 	$ 5.73
Diluted EPS 	$ 3.11 	$ 5.71
In the table above:
‰ Net 	earnings 	to 	common 	represents 	net 	earnings
applicable to common shareholders, which is calculated
as net earnings less preferred stock dividends.
‰ Unvested share-based awards that have non-forfeitable
rights to dividends or dividend equivalents are treated as a
separate class of securities under the two-class method.
Distributed earnings allocated to these securities reduce
net earnings to common to calculate basic EPS. The
impact of applying this methodology was a reduction in
basic EPS of $0.02 for both the three months ended
March 2020 and March 2019.
‰ Diluted EPS does not include antidilutive RSUs of
0.1 million for the three months ended March 2020 and
0.2 million for the three months ended March 2019.
Note 22.
Transactions with Affiliated Funds
The firm has formed nonconsolidated investment funds
with third-party investors. As the firm generally acts as the
investment manager for these funds, it is entitled to receive
management fees and, in certain cases, advisory fees or
incentive fees from these funds. Additionally, the firm
invests alongside the third-party investors in certain funds.
The tables below present information about affiliated funds.
Three Months
Ended March
$ in millions 	2020 	2019
Fees earned from funds 	$ 921 	$ 706
As of
$ in millions
March
2020
December
2019
Fees receivable from funds 	$ 877 	$ 780
Aggregate carrying value of interests in funds 	$4,031 	$5,490
The firm may periodically determine to waive certain
management 	fees 	on 	selected 	money 	market 	funds.
Management fees waived were $12 million for the three
months ended March 2020 and $10 million for the three
months ended March 2019.
The Volcker Rule restricts the firm from providing financial
support to covered funds (as defined in the rule) after the
expiration of the conformance period. As a general matter, in
the ordinary course of business, the firm does not expect to
provide additional voluntary financial support to any
covered funds, but may choose to do so with respect to funds
that are not subject to the Volcker Rule. However, any such
support is not expected to be material to the results of
operations of the firm.
In March 2020, GS Bank USA and unaffiliated entities
purchased certificates of deposit and commercial paper from
two money market funds managed by the firm. These funds
are not covered funds under the Volcker Rule. GS Bank
USA’s purchase price of $1.84 billion represented the fair
value of these securities, which also closely approximated
their face values. These purchases were made to promote
liquidity in the short-term credit markets and to increase the
funds’ weekly liquid assets. These securities are included
within investments in the consolidated balance sheets. Group
Inc. has provided a guarantee to GS Bank USA in connection
with these securities. See Note 18 for information about
guarantees provided by Group Inc. to subsidiaries. In
addition, the firm had an outstanding guarantee, as
permitted under the Volcker Rule, on behalf of its funds of
$87 million as of both March 2020 and December 2019. The
firm has voluntarily provided this guarantee in connection
with a financing agreement with a third-party lender
executed by one of the firm’s real estate funds that is not
covered by the Volcker Rule. As of and during March 2020
and December 2019, except as noted above, the firm has not
provided any additional financial support to its affiliated
funds.
In addition, in the ordinary course of business, the firm may
also engage in other activities with its affiliated funds,
including, among others, securities lending, trade execution,
market-making, 	custody, 	and 	acquisition 	and 	bridge
financing. See Note 18 for information about the firm’s
investment commitments related to these funds.
Goldman Sachs March 2020 Form 10-Q 	78

-- 80 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Note 23.
Interest Income and Interest Expense
Interest is recorded over the life of the instrument on an
accrual basis based on contractual interest rates.
The table below presents sources of interest income and
interest expense.
Three Months
Ended March
$ in millions 	2020 	2019
Deposits with banks 	$ 205 	$ 377
Collateralized agreements 	534 	1,304
Trading assets 	1,573 	1,388
Investments 	471 	395
Loans 	1,316 	1,319
Other interest 	651 	814
Total interest income 	4,750 	5,597
Deposits 	818 	857
Collateralized financings 	448 	669
Trading liabilities 	314 	366
Short-term borrowings 	141 	142
Long-term borrowings 	1,105 	1,384
Other interest 	611 	961
Total interest expense 	3,437 	4,379
Net interest income 	$1,313 	$1,218
In the table above:
‰ Collateralized agreements includes rebates paid and
interest income on securities borrowed.
‰ Loans excludes interest on loans held for sale that are
accounted for at the lower of cost or fair value. Such
interest is included within other interest.
‰ Other 	interest 	income 	includes 	interest 	income 	on
customer debit balances, other interest-earning assets and
loans held for sale that are accounted for at the lower of
cost or fair value.
‰ Collateralized 	financings 	consists 	of 	repurchase
agreements and securities loaned.
‰ Short- and long-term borrowings include both secured
and unsecured borrowings.
‰ Other interest expense includes rebates received on other
interest-bearing 	liabilities 	and 	interest 	expense 	on
customer credit balances.
Note 24.
Income Taxes
Provision for Income Taxes
Income taxes are provided for using the asset and liability
method under which deferred tax assets and liabilities are
recognized for temporary differences between the financial
reporting and tax bases of assets and liabilities. The firm
reports interest expense related to income tax matters in
provision for taxes and income tax penalties in other
expenses.
Deferred Income Taxes
Deferred income taxes reflect the net tax effects of
temporary differences between the financial reporting and
tax 	bases 	of 	assets 	and 	liabilities. 	These 	temporary
differences result in taxable or deductible amounts in future
years and are measured using the tax rates and laws that
will be in effect when such differences are expected to
reverse. Valuation allowances are established to reduce
deferred tax assets to the amount that more likely than not
will be realized and primarily relate to the ability to utilize
losses in various tax jurisdictions. Tax assets are included in
other assets and tax liabilities are included in other
liabilities.
Unrecognized Tax Benefits
The firm recognizes tax positions in the consolidated
financial statements only when it is more likely than not
that the position will be sustained on examination by the
relevant taxing authority based on the technical merits of
the position. A position that meets this standard is
measured at the largest amount of benefit that will more
likely than not be realized on settlement. A liability is
established for differences between positions taken in a tax
return 	and 	amounts 	recognized 	in 	the 	consolidated
financial statements.
Regulatory Tax Examinations
The firm is subject to examination by the U.S. Internal
Revenue Service (IRS) and other taxing authorities in
jurisdictions 	where 	the 	firm 	has 	significant 	business
operations, such as the United Kingdom, Japan, Hong
Kong and various states, such as New York. The tax years
under examination vary by jurisdiction. The firm does not
expect completion of these audits to have a material impact
on the firm’s financial condition, but it may be material to
operating results for a particular period, depending, in part,
on the operating results for that period.
79 	Goldman Sachs March 2020 Form 10-Q

-- 81 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents the earliest tax years that remain
subject to examination by major jurisdiction.
Jurisdiction
As of
March 2020
U.S. Federal 	2011
New York State and City 	2011
United Kingdom 	2017
Japan 	2014
Hong Kong 	2013
U.S. Federal examinations of 2011 and 2012 began in
2013. The firm has been accepted into the Compliance
Assurance Process program by the IRS for each of the tax
years from 2013 through 2020. This program allows the
firm to work with the IRS to identify and resolve potential
U.S. Federal tax issues before the filing of tax returns. The
2013 through 2018 tax years remain subject to post-filing
review.
New York State and City examinations (excluding GS Bank
USA) of 2011 through 2014 began in 2017. New York
State and City examinations for GS Bank USA have been
completed through 2014.
All years including and subsequent to the years in the table
above 	remain 	open 	to 	examination 	by 	the 	taxing
authorities. 	The 	firm 	believes 	that 	the 	liability 	for
unrecognized tax benefits it has established is adequate in
relation to the potential for additional assessments.
Note 25.
Business Segments
The firm reports its activities in the following four business
segments: Investment Banking, Global Markets, Asset
Management and Consumer & Wealth Management. See
Note 1 for information about the firm’s business segments.
Compensation and benefits expenses in the firm’s segments
reflect, among other factors, the overall performance of the
firm, as well as the performance of individual businesses.
Consequently, pre-tax margins in one segment of the firm’s
business may be significantly affected by the performance
of the firm’s other business segments.
The firm allocates assets (including allocations of global
core liquid assets and cash, secured client financing and
other assets), revenues and expenses among the four
business segments. Due to the integrated nature of these
segments, estimates and judgments are made in allocating
certain assets, revenues and expenses. The allocation
process is based on the manner in which management
currently views the performance of the segments.
The allocation of common shareholders’ equity and
preferred stock dividends to each segment is based on the
estimated amount of equity required to support the
activities of the segment under relevant regulatory capital
requirements.
Net earnings for each segment is calculated by applying the
firmwide tax rate to each segment’s pre-tax earnings.
Management believes that this allocation provides a
reasonable representation of each segment’s contribution to
consolidated net earnings to common, return on average
common equity and total assets. Transactions between
segments are based on specific criteria or approximate
third-party rates.
Goldman Sachs March 2020 Form 10-Q 	80

-- 82 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Segment Results
The table below presents a summary of the firm’s segment
results.
Three Months
Ended March
$ in millions 	2020 	2019
Investment Banking
Non-interest revenues 	$ 2,046 	$ 1,627
Net interest income 	138 	119
Total net revenues 	2,184 	1,746
Provision for credit losses 	622 	86
Operating expenses 	1,169 	1,005
Pre-tax earnings 	$ 	393 	$ 	655
Net earnings 	$ 	354 	$ 	543
Net earnings to common 	$ 	343 	$ 	535
Average common equity 	$ 11,308 	$11,496
Return on average common equity 	12.1% 	18.6%
Global Markets
Non-interest revenues 	$ 4,652 	$ 3,483
Net interest income 	511 	557
Total net revenues 	5,163 	4,040
Provision for credit losses 	68 	3
Operating expenses 	2,847 	2,748
Pre-tax earnings 	$ 2,248 	$ 1,289
Net earnings 	$ 2,023 	$ 1,068
Net earnings to common 	$ 1,964 	$ 1,020
Average common equity 	$ 39,797 	$40,705
Return on average common equity 	19.7% 	10.0%
Asset Management
Non-interest revenues 	$ 	(267) 	$ 1,646
Net interest income 	171 	147
Total net revenues 	(96) 	1,793
Provision for credit losses 	79 	13
Operating expenses 	1,198 	1,103
Pre-tax earnings/(loss) 	$ (1,373) 	$ 	677
Net earnings/(loss) 	$ (1,236) 	$ 	559
Net earnings/(loss) to common 	$ (1,250) 	$ 	549
Average common equity 	$ 21,156 	$20,365
Return on average common equity 	(23.6)% 	10.8%
Consumer & Wealth Management
Non-interest revenues 	$ 	999 	$ 	833
Net interest income 	493 	395
Total net revenues 	1,492 	1,228
Provision for credit losses 	168 	122
Operating expenses 	1,244 	1,008
Pre-tax earnings 	$ 	80 	$ 	98
Net earnings 	$ 	72 	$ 	81
Net earnings to common 	$ 	66 	$ 	78
Average common equity 	$ 7,002 	$ 5,859
Return on average common equity 	3.8% 	5.3%
Total
Non-interest revenues 	$ 7,430 	$ 7,589
Net interest income 	1,313 	1,218
Total net revenues 	8,743 	8,807
Provision for credit losses 	937 	224
Operating expenses 	6,458 	5,864
Pre-tax earnings 	$ 1,348 	$ 2,719
Net earnings 	$ 1,213 	$ 2,251
Net earnings to common 	$ 1,123 	$ 2,182
Average common equity 	$ 79,263 	$78,425
Return on average common equity 	5.7% 	11.1%
In the table above:
‰ Revenues and expenses directly associated with each
segment are included in determining pre-tax earnings.
‰ Net revenues in the firm’s segments include allocations of
interest income and expense to specific positions in
relation to the cash generated by, or funding requirements
of, such positions. Net interest is included in segment net
revenues as it is consistent with how management assesses
segment performance.
‰ Overhead expenses not directly allocable to specific
segments are allocated ratably based on direct segment
expenses.
The table below presents depreciation and amortization
expense by segment.
Three Months
Ended March
$ in millions 	2020 	2019
Investment Banking 	$ 	39 	$ 	29
Global Markets 	133 	147
Asset Management 	170 	137
Consumer & Wealth Management 	95 	55
Total 	$ 	437 	$ 	368
Segment Assets
The table below presents assets by segment.
As of
$ in millions
March
2020
December
2019
Investment Banking 	$ 105,059 	$ 92,009
Global Markets 	800,476 	725,060
Asset Management 	92,636 	92,102
Consumer & Wealth Management 	91,585 	83,797
Total 	$1,089,756 	$992,968
The table below presents gross loans by segment and loan
type.
As of
$ in millions
March
2020
December
2019
Corporate 	$ 	48,121 	$ 27,035
Investment Banking 	48,121 	27,035
Corporate 	12,881 	11,852
Real estate 	12,787 	15,671
Other 	4,873 	3,756
Global Markets 	30,541 	31,279
Corporate 	7,528 	7,420
Real estate 	8,456 	9,030
Other 	751 	1,036
Asset Management 	16,735 	17,486
Wealth management 	29,017 	27,940
Installment 	4,826 	4,747
Credit cards 	2,081 	1,858
Consumer & Wealth Management 	35,924 	34,545
Total 	$ 131,321 	$110,345
81 	Goldman Sachs March 2020 Form 10-Q

-- 83 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The table below presents the allowance for loan losses by
segment.
As of
$ in millions
March
2020
December
2019
Investment Banking 	$1,174 	$ 470
Global Markets 	269 	168
Asset Management 	489 	385
Consumer & Wealth Management 	936 	418
Total 	$2,868 	$1,441
See Note 9 for further information about loans.
Geographic Information
Due to the highly integrated nature of international
financial markets, the firm manages its businesses based on
the 	profitability 	of 	the 	enterprise 	as 	a 	whole. 	The
methodology for allocating profitability to geographic
regions 	is 	dependent 	on 	estimates 	and 	management
judgment because a significant portion of the firm’s
activities require cross-border coordination in order to
facilitate the needs of the firm’s clients. Geographic results
are generally allocated as follows:
‰ Investment Banking: location of the client and investment
banking team.
‰ Global Markets: FICC and Equities intermediation:
location of the market-making desk; FICC and Equities
financing (excluding prime brokerage financing): location
of the desk; prime brokerage financing: location of the
primary market for the underlying security.
‰ Asset Management (excluding Equity investments and
Lending and debt investments): location of the sales team;
Equity investments: location of the investment; Lending
and debt investments: location of the client.
‰ Consumer & Wealth Management: Wealth management:
location of the sales team; Consumer banking: location of
the client.
The table below presents total net revenues and pre-tax
earnings by geographic region.
$ in millions 	2020 	2019
Three Months Ended March
Americas 	$5,171 	59% 	$5,245 	60%
EMEA 	2,108 	24% 	2,459 	28%
Asia 	1,464 	17% 	1,103 	12%
Total net revenues 	$8,743 	100% 	$8,807 	100%
Americas 	$ 551 	41% 	$1,488 	55%
EMEA 	436 	32% 	911 	33%
Asia 	361 	27% 	320 	12%
Total pre-tax earnings 	$1,348 	100% 	$2,719 	100%
In the table above:
‰ Results in Americas were primarily attributable to the
U.S.
‰ Asia includes Australia and New Zealand.
Note 26.
Credit Concentrations
The firm’s concentrations of credit risk arise from its
market making, client facilitation, investing, underwriting,
lending 	and 	collateralized 	transactions, 	and 	cash
management activities, and may be impacted by changes in
economic, industry or political factors. These activities
expose 	the 	firm 	to 	many 	different 	industries 	and
counterparties, and may also subject the firm to a
concentration of credit risk to a particular central bank,
counterparty, borrower or issuer, including sovereign
issuers, or to a particular clearing house or exchange. The
firm seeks to mitigate credit risk by actively monitoring
exposures and obtaining collateral from counterparties as
deemed appropriate.
The firm measures and monitors its credit exposure based
on amounts owed to the firm after taking into account risk
mitigants that the firm considers when determining credit
risk. Such risk mitigants include netting and collateral
arrangements 	and 	economic 	hedges, 	such 	as 	credit
derivatives, futures and forward contracts. Netting and
collateral agreements permit the firm to offset receivables
and payables with such counterparties and/or enable the
firm to obtain collateral on an upfront or contingent basis.
The table below presents the credit concentrations included
in trading cash instruments and investments.
As of
$ in millions
March
2020
December
2019
U.S. government and agency obligations 	$162,690 	$167,097
Percentage of total assets 	14.9% 	16.8%
Non-U.S. government and agency obligations $ 47,457 	$ 44,875
Percentage of total assets 	4.4% 	4.5%
Goldman Sachs March 2020 Form 10-Q 	82

-- 84 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
In addition, the firm had $64.10 billion as of March 2020
and $96.97 billion as of December 2019 of cash deposits
held 	at 	central 	banks 	(included 	in 	cash 	and 	cash
equivalents), of which $34.16 billion as of March 2020 and
$50.55 billion as of December 2019 was held at the Federal
Reserve Bank of New York.
As of both March 2020 and December 2019, the firm did
not have credit exposure to any other counterparty that
exceeded 2% of total assets.
Collateral obtained by the firm related to derivative assets is
principally cash and is held by the firm or a third-party
custodian. Collateral obtained by the firm related to resale
agreements 	and 	securities 	borrowed 	transactions 	is
primarily U.S. government and agency obligations and
non-U.S. government and agency obligations. See Note 11
for further information about collateralized agreements and
financings.
The table below presents U.S. government and agency
obligations 	and 	non-U.S. 	government 	and 	agency
obligations 	that 	collateralize 	resale 	agreements 	and
securities borrowed transactions.
As of
$ in millions
March
2020
December
2019
U.S. government and agency obligations 	$80,136 	$49,396
Non-U.S. government and agency obligations 	$72,573 	$55,889
In the table above:
‰ Non-U.S. government and agency obligations primarily
consists of securities issued by the governments of Japan,
France, the U.K. and Germany.
‰ Given that the firm’s primary credit exposure on such
transactions is to the counterparty to the transaction, the
firm would be exposed to the collateral issuer only in the
event of counterparty default.
Note 27.
Legal Proceedings
The firm is involved in a number of judicial, regulatory and
arbitration proceedings (including those described below)
concerning matters arising in connection with the conduct
of the firm’s businesses. Many of these proceedings are in
early stages, and many of these cases seek an indeterminate
amount of damages.
Under ASC 450, an event is “reasonably possible” if “the
chance of the future event or events occurring is more than
remote but less than likely” and an event is “remote” if “the
chance of the future event or events occurring is slight.”
Thus, references to the upper end of the range of reasonably
possible loss for cases in which the firm is able to estimate a
range of reasonably possible loss mean the upper end of the
range of loss for cases for which the firm believes the risk of
loss is more than slight.
With respect to matters described below for which
management 	has 	been 	able 	to 	estimate 	a 	range 	of
reasonably possible loss where (i) actual or potential
plaintiffs have claimed an amount of money damages,
(ii) the firm is being, or threatened to be, sued by purchasers
in a securities offering and is not being indemnified by a
party that the firm believes will pay the full amount of any
judgment, or (iii) the purchasers are demanding that the
firm repurchase securities, management has estimated the
upper end of the range of reasonably possible loss as being
equal to (a) in the case of (i), the amount of money damages
claimed, (b) in the case of (ii), the difference between the
initial sales price of the securities that the firm sold in such
offering and the estimated lowest subsequent price of such
securities prior to the action being commenced and (c) in
the case of (iii), the price that purchasers paid for the
securities less the estimated value, if any, as of March 2020
of the relevant securities, in each of cases (i), (ii) and (iii),
taking into account any other factors believed to be relevant
to the particular matter or matters of that type. As of the
date hereof, the firm has estimated the upper end of the
range of reasonably possible aggregate loss for such matters
and 	for 	any 	other 	matters 	described 	below 	where
management 	has 	been 	able 	to 	estimate 	a 	range 	of
reasonably possible aggregate loss to be approximately
$3.2 billion in excess of the aggregate reserves for such
matters.
83 	Goldman Sachs March 2020 Form 10-Q

-- 85 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Management is generally unable to estimate a range of
reasonably possible loss for matters other than those
included in the estimate above, including where (i) actual or
potential plaintiffs have not claimed an amount of money
damages, except in those instances where management can
otherwise determine an appropriate amount, (ii) matters
are in early stages, (iii) matters relate to regulatory
investigations or reviews, except in those instances where
management can otherwise determine an appropriate
amount, (iv) there is uncertainty as to the likelihood of a
class being certified or the ultimate size of the class, (v) there
is uncertainty as to the outcome of pending appeals or
motions, (vi) there are significant factual issues to be
resolved, and/or (vii) there are novel legal issues presented.
For example, the firm’s potential liabilities with respect to
the 	investigations 	and 	reviews 	described 	below 	in
“Regulatory 	Investigations 	and 	Reviews 	and 	Related
Litigation” generally are not included in management’s
estimate 	of 	reasonably 	possible 	loss. 	However,
management does not believe, based on currently available
information, that the outcomes of such other matters will
have a material adverse effect on the firm’s financial
condition, though the outcomes could be material to the
firm’s 	operating 	results 	for 	any 	particular 	period,
depending, in part, upon the operating results for such
period. 	See 	Note 	18 	for 	further 	information 	about
mortgage-related contingencies.
1Malaysia Development Berhad (1MDB)-Related
Matters
The 	firm 	has 	received 	subpoenas 	and 	requests 	for
documents and information from various governmental
and regulatory bodies and self-regulatory organizations as
part of investigations and reviews relating to financing
transactions 	and 	other 	matters 	involving 	1MDB, 	a
sovereign wealth fund in Malaysia. Subsidiaries of the firm
acted 	as 	arrangers 	or 	purchasers 	of 	approximately
$6.5 billion of debt securities of 1MDB.
On November 1, 2018, the U.S. Department of Justice
(DOJ) unsealed a criminal information and guilty plea by
Tim Leissner, a former participating managing director of
the firm, and an indictment against Ng Chong Hwa, a
former managing director of the firm, and Low Taek Jho.
Leissner pleaded guilty to a two-count criminal information
charging him with conspiring to launder money and
conspiring to violate the U.S. Foreign Corrupt Practices
Act’s (FCPA) anti-bribery and internal accounting controls
provisions. Low and Ng were charged in a three-count
indictment 	with 	conspiring 	to 	launder 	money 	and
conspiring to violate the FCPA’s anti-bribery provisions.
On August 28, 2018, Leissner’s guilty plea was accepted by
the U.S. District Court for the Eastern District of New York
and Leissner was adjudicated guilty on both counts. Ng was
also charged in this indictment with conspiring to violate
the FCPA’s internal accounting controls provisions. The
charging 	documents 	state, 	among 	other 	things, 	that
Leissner 	and 	Ng 	participated 	in 	a 	conspiracy 	to
misappropriate 	proceeds 	of 	the 	1MDB 	offerings 	for
themselves and to pay bribes to various government
officials to obtain and retain 1MDB business for the firm.
The plea and charging documents indicate that Leissner and
Ng knowingly and willfully circumvented the firm’s system
of internal accounting controls, in part by repeatedly lying
to control personnel and internal committees that reviewed
these offerings. The indictment of Ng and Low alleges that
the firm’s system of internal accounting controls could be
easily circumvented and that the firm’s business culture,
particularly 	in 	Southeast 	Asia, 	at 	times 	prioritized
consummation of deals ahead of the proper operation of its
compliance functions. On May 6, 2019, Ng pleaded not
guilty to the DOJ’s criminal charges. On February 4, 2020,
the FRB disclosed that Andrea Vella, a former participating
managing director whom the DOJ had previously referred
to as an unindicted co-conspirator, had agreed, without
admitting or denying the FRB’s allegations, to a consent
order that prohibited him from participating in the banking
industry. No other penalties were imposed by the consent
order.
Goldman Sachs March 2020 Form 10-Q 	84

-- 86 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
On December 17, 2018, the Attorney General of Malaysia
filed criminal charges in Malaysia against GSI, as the
arranger of three offerings of debt securities of 1MDB,
aggregating 	approximately 	$6.5 	billion 	in 	principal
amount, for alleged disclosure deficiencies in the offering
documents relating to, among other things, the use of
proceeds for the debt securities, as well as against Goldman
Sachs 	(Asia) 	LLC 	(GS 	Asia) 	and 	Goldman 	Sachs
(Singapore) PTE (GS Singapore). Criminal charges have
also been filed against Leissner, Low, Ng and Jasmine Loo
Ai Swan. In a related press release, the Attorney General of
Malaysia indicated that prosecutors in Malaysia will seek
criminal fines against the accused in excess of $2.7 billion
plus the $600 million of fees received in connection with the
debt offerings. On August 9, 2019, the Attorney General of
Malaysia announced that criminal charges had also been
filed against seventeen current and former directors of GSI,
GS Asia and GS Singapore.
The Malaysia Securities Commission issued notices to show
cause against Goldman Sachs (Malaysia) Sdn Bhd (GS
Malaysia) in December 2018 and March 2019 that
(i) allege possible violations of Malaysian securities laws
and (ii) indicate that the Malaysia Securities Commission is
considering whether to revoke GS Malaysia’s license to
conduct corporate finance and fund management activities
in Malaysia.
The firm has received multiple demands, beginning in
November 	2018, 	from 	alleged 	shareholders 	under
Section 220 of the Delaware General Corporation Law for
books and records relating to, among other things, the
firm’s involvement with 1MDB and the firm’s compliance
procedures. On December 13, 2019, an alleged shareholder
filed a lawsuit in the Court of Chancery of the State of
Delaware seeking books and records relating to, among
other things, the firm’s involvement with 1MDB and the
firm’s compliance procedures. The parties have agreed to
stay proceedings pending resolution of the books and
records demand.
On February 19, 2019, a purported shareholder derivative
action relating to 1MDB was filed in the U.S. District Court
for the Southern District of New York against Group Inc.
and the directors at the time and a former chairman and
chief executive officer of the firm. The amended complaint
filed on July 12, 2019, which seeks unspecified damages,
disgorgement and injunctive relief, alleges breaches of
fiduciary duties, including in connection with alleged
insider trading by certain current and former directors,
unjust 	enrichment 	and 	violations 	of 	the 	anti-fraud
provisions of the Exchange Act, including in connection
with 	Group 	Inc.’s 	common 	stock 	repurchases 	and
solicitation of proxies. Defendants moved to dismiss this
action on September 12, 2019.
Beginning in March 2019, the firm has also received
demands from alleged shareholders to investigate and
pursue claims against certain current and former directors
and executive officers based on their oversight and public
disclosures regarding 1MDB and related internal controls.
On November 21, 2018, a summons with notice was filed
in New York Supreme Court, County of New York, by
International 	Petroleum 	Investment 	Company, 	which
guaranteed certain debt securities issued by 1MDB, and its
subsidiary Aabar Investments PJS. The summons with
notice makes unspecified claims relating to 1MDB and
seeks unspecified compensatory and punitive damages and
other relief against Group Inc., GSI, GS Asia, GS Singapore,
GS Malaysia, Leissner, Ng, and Vella, as well as individuals
(who are not current or former employees of the firm)
previously associated with the plaintiffs.
On December 20, 2018, a putative securities class action
lawsuit was filed in the U.S. District Court for the Southern
District of New York against Group Inc. and certain former
officers of the firm alleging violations of the anti-fraud
provisions of the Exchange Act with respect to Group Inc.’s
disclosures concerning 1MDB and seeking unspecified
damages. The plaintiffs filed the second amended complaint
on October 28, 2019, which the defendants moved to
dismiss on January 9, 2020.
The firm is cooperating with the DOJ and all other
governmental and regulatory investigations relating to
1MDB. The firm is also engaged in discussions with certain
governmental and regulatory authorities with respect to
potential resolution of their investigations and proceedings.
There can be no assurance that the discussions will lead to
resolution of any of those matters. Any such resolution, as
well as proceedings by the DOJ or other governmental or
regulatory authorities, could result in the imposition of
significant fines, penalties and other sanctions against the
firm, including restrictions on the firm’s activities.
Mortgage-Related Matters
Beginning in April 2010, a number of purported securities
law class actions were filed in the U.S. District Court for the
Southern District of New York challenging the adequacy of
Group Inc.’s public disclosure of, among other things, the
firm’s activities in the collateralized debt obligation market,
and the firm’s conflict of interest management.
85 	Goldman Sachs March 2020 Form 10-Q

-- 87 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
The 	consolidated 	amended 	complaint 	filed 	on
July 25, 2011, which names as defendants Group Inc. and
certain current and former officers and employees of Group
Inc. and its affiliates, generally alleges violations of Sections
10(b) and 20(a) of the Exchange Act and seeks unspecified
damages. 	The 	defendants 	have 	moved 	for 	summary
judgment. On April 7, 2020, the Second Circuit Court of
Appeals affirmed the district court’s August 14, 2018 grant
of class certification.
Beginning on February 15, 2019, a summons with notice
and a complaint were filed against Goldman Sachs
Mortgage Company and GS Mortgage Securities Corp. by
U.S. Bank National Association, as trustee for two
residential 	mortgage-backed 	securitization 	trusts 	that
issued $1.7 billion of securities, and the cases are pending in
the U.S. District Court for the Southern District of New
York. The summons with notice and complaint generally
allege that mortgage loans in the trusts failed to conform to
applicable representations and warranties and seek specific
performance or, alternatively, compensatory damages and
other relief. Defendants moved to dismiss the complaint on
September 23, 2019.
The firm continues to receive requests for information,
including from certain regulators, relating to mortgage-
related activities.
Director Compensation-Related Litigation
On May 9, 2017, Group Inc. and certain of its current and
former directors were named as defendants in a purported
direct and derivative shareholder action in the Court of
Chancery of the State of Delaware (a similar purported
derivative action, filed in June 2015, alleging excessive
director compensation over the period 2012 to 2014 was
voluntarily 	dismissed 	without 	prejudice 	in
December 2016). The complaint alleges that excessive
compensation has been paid to the non-employee director
defendants since 2015, and that certain disclosures in
connection with soliciting shareholder approval of the
stock incentive plans were deficient. The complaint asserts
claims for breaches of fiduciary duties and seeks, among
other things, rescission or in some cases rescissory damages,
disgorgement, and shareholder votes on several matters. On
October 23, 2018, the court declined to approve the
parties’ proposed settlement. On May 31, 2019, the court
dismissed the disclosure-related claims, but permitted the
non-employee director compensation claim to proceed. The
parties have filed a proposed settlement with the Delaware
court, which is subject to court approval. As part of the
proposed settlement, the firm has agreed to certain changes
to its Non-Employee Director Compensation Program.
Currencies-Related Litigation
GS&Co. and Group Inc. are among the defendants named
in putative class actions filed in the U.S. District Court for
the 	Southern 	District 	of 	New 	York 	beginning 	in
September 2016 on behalf of putative indirect purchasers of
foreign exchange instruments. On August 5, 2019, the
plaintiffs filed a third consolidated amended complaint
generally alleging a conspiracy to manipulate the foreign
currency exchange markets, asserting claims under various
state antitrust laws and state consumer protection laws and
seeking treble damages in an unspecified amount. In
February 	2020, 	the 	parties 	reached 	a 	settlement 	in
principle, subject to documentation and court approval.
The firm has reserved the full amount of its proposed
contribution to the settlement.
GS&Co. and Group Inc. are among the defendants named
in an action filed in the U.S. District Court for the Southern
District of New York on November 7, 2018 by certain
direct purchasers of foreign exchange instruments that
opted out of a class settlement reached with, among others,
GS&Co. and Group Inc. The second amended complaint,
filed on June 11, 2019, generally alleges that the defendants
violated federal antitrust law and state common law in
connection with an alleged conspiracy to manipulate the
foreign currency exchange markets and seeks declaratory
and injunctive relief, as well as unspecified amounts of
compensatory, 	punitive, 	treble 	and 	other 	damages.
Defendants moved to dismiss on July 25, 2019.
Financial Advisory Services
Group Inc. and certain of its affiliates are from time to time
parties 	to 	various 	civil 	litigation 	and 	arbitration
proceedings and other disputes with clients and third
parties relating to the firm’s financial advisory activities.
These 	claims 	generally 	seek, 	among 	other 	things,
compensatory damages and, in some cases, punitive
damages, and in certain cases allege that the firm did not
appropriately disclose or deal with conflicts of interest.
Goldman Sachs March 2020 Form 10-Q 	86

-- 88 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Underwriting Litigation
Firm affiliates are among the defendants in a number of
proceedings in connection with securities offerings. In these
proceedings, including those described below, the plaintiffs
assert class action or individual claims under federal and
state securities laws and in some cases other applicable
laws, allege that the offering documents for the securities
that they purchased contained material misstatements and
omissions, and generally seek compensatory and rescissory
damages 	in 	unspecified 	amounts. 	Certain 	of 	these
proceedings involve additional allegations.
Adeptus Health Inc. GS&Co. is among the underwriters
named as defendants in several putative securities class
actions, filed beginning in October 2016 and consolidated
in the U.S. District Court for the Eastern District of Texas.
In addition to the underwriters, the defendants include
certain former directors and officers of Adeptus Health Inc.
(Adeptus), 	as 	well 	as 	Adeptus’ 	sponsor. 	As 	to 	the
underwriters, 	the 	consolidated 	complaint, 	filed 	on
November 21, 2017, relates to the $124 million June 2014
initial 	public 	offering, 	the 	$154 	million 	May 	2015
secondary equity offering, the $411 million July 2015
secondary equity offering, and the $175 million June 2016
secondary 	equity 	offering. 	GS&Co. 	underwrote
1.69 million shares of common stock in the June 2014
initial public offering representing an aggregate offering
price of approximately $37 million, 962,378 shares of
common stock in the May 2015 offering representing an
aggregate offering price of approximately $61 million,
1.76 million shares of common stock in the July 2015
offering 	representing 	an 	aggregate 	offering 	price 	of
approximately $185 million, and all the shares of common
stock in the June 2016 offering representing an aggregate
offering 	price 	of 	approximately 	$175 	million. 	On
April 19, 2017, Adeptus filed for Chapter 11 bankruptcy.
On January 9, 2020, the court preliminarily approved a
settlement among the parties. The firm has reserved the full
amount of its proposed contribution to the settlement.
SunEdison, Inc. GS&Co. is among the underwriters
named as defendants in several putative class actions and
individual actions filed beginning in March 2016 relating to
the August 2015 public offering of $650 million of
SunEdison, Inc. (SunEdison) convertible preferred stock.
The 	defendants 	also 	include 	certain 	of 	SunEdison’s
directors and officers. On April 21, 2016, SunEdison filed
for Chapter 11 bankruptcy. The pending cases were
transferred to the U.S. District Court for the Southern
District of New York and on March 17, 2017, plaintiffs in
the putative class action filed a consolidated amended
complaint. GS&Co., as underwriter, sold 138,890 shares of
SunEdison convertible preferred stock in the offering,
representing an aggregate offering price of approximately
$139 million. On April 10, 2018 and April 17, 2018,
certain plaintiffs in the individual actions filed amended
complaints. The defendants have reached a settlement with
certain plaintiffs in the individual actions and a settlement
of 	the 	class 	action, 	which 	the 	court 	approved 	on
October 25, 2019. The firm has paid the full amount of its
contribution to the settlement. Defendants moved to
dismiss 	the 	remaining 	individual 	actions 	on
December 18, 2019.
Valeant Pharmaceuticals International, Inc. GS&Co.
and Goldman Sachs Canada Inc. (GS Canada) are among
the 	underwriters 	and 	initial 	purchasers 	named 	as
defendants in a putative class action filed on March 2, 2016
in the Superior Court of Quebec, Canada. In addition to the
underwriters and initial purchasers, the defendants include
Valeant 	Pharmaceuticals 	International, 	Inc. 	(Valeant),
certain directors and officers of Valeant and Valeant’s
auditor. As to GS&Co. and GS Canada, the complaint
relates to the June 2013 public offering of $2.3 billion of
common stock, the June 2013 Rule 144A offering of
$3.2 billion principal amount of senior notes, and the
November 2013 Rule 144A offering of $900 million
principal amount of senior notes. The complaint asserts
claims under the Quebec Securities Act and the Civil Code
of Quebec. On August 29, 2017, the court certified a class
that includes only non-U.S. purchasers in the offerings.
Defendants’ motion for leave to appeal the certification was
denied on November 30, 2017.
GS&Co. and GS Canada, as sole underwriters, sold
5,334,897 shares of common stock in the June 2013
offering to non-U.S. purchasers representing an aggregate
offering price of approximately $453 million and, as initial
purchasers, had a proportional share of sales to non-U.S.
purchasers of approximately CAD14.2 million in principal
amount 	of 	senior 	notes 	in 	the 	June 	2013 	and
November 2013 Rule 144A offerings.
87 	Goldman Sachs March 2020 Form 10-Q

-- 89 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Snap Inc. GS&Co. is among the underwriters named as
defendants in putative securities class actions pending in
California Superior Court, County of Los Angeles, and the
U.S. District Court for the Central District of California
beginning in May 2017, relating to Snap Inc.’s $3.91 billion
March 2017 initial public offering. In addition to the
underwriters, the defendants include Snap Inc. and certain
of 	its 	officers 	and 	directors. 	GS&Co. 	underwrote
57,040,000 shares of common stock representing an
aggregate offering price of approximately $970 million.
The underwriter defendants, including GS&Co., were
voluntarily dismissed from the district court action on
September 18, 2018. In the district court action, defendants
moved for summary judgment on December 19, 2019,
following the court’s November 20, 2019 order approving
plaintiffs’ motion for class certification. The state court
actions have been stayed. On January 17, 2020, the parties
reached a settlement in principle that would resolve all
actions, subject to documentation and court approval.
Sea Limited. GS Asia is among the underwriters named as
defendants in a putative securities class action filed on
November 1, 2018 in New York Supreme Court, County of
New 	York, 	relating 	to 	Sea 	Limited’s 	$989 	million
October 2017 initial public offering of American depositary
shares. In addition to the underwriters, the defendants
include Sea Limited and certain of its officers and directors.
GS Asia underwrote 28,026,721 American depositary
shares 	representing 	an 	aggregate 	offering 	price 	of
approximately $420 million. On January 25, 2019, the
plaintiffs filed an amended complaint. Defendants moved
to dismiss on March 26, 2019.
Altice USA, Inc. GS&Co. is among the underwriters
named as defendants in putative securities class actions
pending in New York Supreme Court, County of Queens,
and the U.S. District Court for the Eastern District of New
York beginning in June 2018, relating to Altice USA, Inc.’s
(Altice) $2.15 billion June 2017 initial public offering. In
addition to the underwriters, the defendants include Altice
and 	certain 	of 	its 	officers 	and 	directors. 	GS&Co.
underwrote 	12,280,042 	shares 	of 	common 	stock
representing an aggregate offering price of approximately
$368 million. On May 10, 2019, plaintiffs in the district
court filed an amended complaint, and on June 27, 2019,
plaintiffs in the state court action filed a consolidated
amended complaint. On July 23, 2019, defendants moved
to dismiss the amended complaint in the state court action.
On October 14, 2019, defendants moved to dismiss the
complaint in the district court action.
Camping World Holdings, Inc. GS&Co. is among the
underwriters named as defendants in several putative
securities class actions pending in the U.S. District Court for
the Northern District of Illinois, New York Supreme Court,
County of New York, and the Circuit Court of Cook
County, 	Illinois, 	Chancery 	Division, 	beginning 	in
December 2018. In addition to the underwriters, the
defendants 	include 	Camping 	World 	Holdings, 	Inc.
(Camping World) and certain of its officers and directors,
as well as certain of its stockholders. As to the underwriters,
the complaints relate to three offerings of Camping World
common stock, a $261 million October 2016 initial public
offering, a $303 million May 2017 offering and a
$310 million October 2017 offering. GS&Co. underwrote
4,267,214 shares of common stock in the October 2016
initial public offering representing an aggregate offering
price of approximately $94 million, 4,557,286 shares of
common stock in the May 2017 offering representing an
aggregate offering price of approximately $126 million and
3,525,348 shares of common stock in the October 2017
offering 	representing 	an 	aggregate 	offering 	price 	of
approximately $143 million. GS&Co. and the other
defendants moved to dismiss the Illinois state court action
on April 19, 2019 and the Illinois district court action on
May 17, 2019. The Illinois state court action has been
stayed pending resolution of the motions to dismiss in the
Illinois district court action. On April 7, 2020, the Illinois
district court preliminarily approved a settlement among
the parties to the Illinois district court action, which would
resolve this action without any contribution by GS&Co.
On April 22, 2020, the New York state court granted in
part and denied in part the underwriter defendants’ motion
to dismiss with leave to amend.
Alnylam Pharmaceuticals, Inc. GS&Co. is among the
underwriters named as defendants in a putative securities
class action filed on September 12, 2019 in New York
Supreme Court, County of New York, relating to Alnylam
Pharmaceuticals, 	Inc.’s 	(Alnylam) 	$805 	million
November 2017 public offering of common stock. In
addition to the underwriters, the defendants include
Alnylam and certain of its officers and directors. GS&Co.
underwrote 	2,576,000 	shares 	of 	common 	stock
representing an aggregate offering price of approximately
$322 million. On December 20, 2019, defendants moved to
dismiss the amended complaint filed on November 7, 2019.
Goldman Sachs March 2020 Form 10-Q 	88

-- 90 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Uber 	Technologies, 	Inc. 	GS&Co. 	is 	among 	the
underwriters named as defendants in several putative
securities class actions filed beginning in September 2019 in
California Superior Court, County of San Francisco and the
U.S. District Court for the Northern District of California,
relating to Uber Technologies, Inc.’s (Uber) $8.1 billion
May 2019 initial public offering. In addition to the
underwriters, the defendants include Uber and certain of its
officers and directors. GS&Co. underwrote 35,864,408
shares of common stock representing an aggregate offering
price of approximately $1.6 billion. On February 11, 2020,
plaintiffs in the state court action filed a consolidated
amended complaint. On March 3, 2020, plaintiffs in the
district court action filed an amended complaint.
Venator 	Materials 	PLC. 	GS&Co. 	is 	among 	the
underwriters named as defendants in putative securities
class actions in Texas District Court, Dallas County, New
York Supreme Court, New York County, and the U.S.
District Court for the Southern District of Texas, filed
beginning in February 2019, relating to Venator Materials
PLC’s (Venator) $522 million August 2017 initial public
offering and $534 million December 2017 secondary equity
offering. In addition to the underwriters, the defendants
include Venator, certain of its officers and directors and
certain 	of 	its 	shareholders. 	GS&Co. 	underwrote
6,351,347 shares of common stock in the August 2017
initial public offering representing an aggregate offering
price of approximately $127 million and 5,625,768 shares
of common stock in the December 2017 secondary equity
offering 	representing 	an 	aggregate 	offering 	price 	of
approximately $127 million. On January 21, 2020, the
Texas Court of Appeals reversed the Texas District Court
and 	dismissed 	the 	claims 	against 	the 	underwriter
defendants, including GS&Co., in the Texas state court
action 	for 	lack 	of 	personal 	jurisdiction. 	On
February 18, 2020, defendants moved to dismiss the
consolidated complaint in the federal action.
XP Inc. GS&Co. is among the underwriters named as
defendants in putative securities class actions pending in
New York Supreme Court, County of New York, and the
U.S. District Court for the Eastern District of York, filed
beginning March 19, 2020, relating to XP Inc.’s (XP)
$2.3 billion December 2019 initial public offering. In
addition to the underwriters, the defendants include XP,
certain of its officers and directors and certain of its
shareholders. GS&Co. underwrote 19,326,218 shares of
common stock in the December 2019 initial public offering
representing an aggregate offering price of approximately
$522 million.
Investment Management Services
Group Inc. and certain of its affiliates are parties to various
civil litigation and arbitration proceedings and other
disputes with clients relating to losses allegedly sustained as
a result of the firm’s investment management services.
These claims generally seek, among other things, restitution
or other compensatory damages and, in some cases,
punitive damages.
Securities Lending Antitrust Litigation
Group Inc. and GS&Co. are among the defendants named
in a putative antitrust class action and three individual
actions relating to securities lending practices filed in the
U.S. District Court for the Southern District of New York
beginning in August 2017. The complaints generally assert
claims under federal and state antitrust law and state
common law in connection with an alleged conspiracy
among the defendants to preclude the development of
electronic platforms for securities lending transactions. The
individual 	complaints 	also assert claims for tortious
interference with business relations and under state trade
practices law and, in the second and third individual
actions, unjust enrichment under state common law. The
complaints seek declaratory and injunctive relief, as well as
unspecified amounts of compensatory, treble, punitive and
other damages. Group Inc. was voluntarily dismissed from
the putative class action on January 26, 2018. Defendants’
motion to dismiss the class action complaint was denied on
September 27, 2018. Defendants moved to dismiss the
second 	individual 	action 	on 	December 	21, 	2018.
Defendants’ motion to dismiss the first individual action
was granted on August 7, 2019.
89 	Goldman Sachs March 2020 Form 10-Q

-- 91 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Interest Rate Swap Antitrust Litigation
Group Inc., GS&Co., GSI, GS Bank USA and Goldman
Sachs Financial Markets, L.P. (GSFM) are among the
defendants named in a putative antitrust class action
relating to the trading of interest rate swaps, filed in
November 2015 and consolidated in the U.S. District Court
for the Southern District of New York. The same Goldman
Sachs entities also are among the defendants named in two
antitrust actions relating to the trading of interest rate
swaps, 	commenced 	in 	April 	2016 	and 	June 	2018,
respectively, in the U.S. District Court for the Southern
District of New York by three operators of swap execution
facilities and certain of their affiliates. These actions have
been consolidated for pretrial proceedings. The complaints
generally assert claims under federal antitrust law and state
common law in connection with an alleged conspiracy
among the defendants to preclude exchange trading of
interest rate swaps. The complaints in the individual actions
also assert claims under state antitrust law. The complaints
seek declaratory and injunctive relief, as well as treble
damages in an unspecified amount. Defendants moved to
dismiss the class and the first individual action and the
district court dismissed the state common law claims
asserted by the plaintiffs in the first individual action and
otherwise limited the state common law claim in the
putative class action and the antitrust claims in both actions
to the period from 2013 to 2016. On November 20, 2018,
the court granted in part and denied in part the defendants’
motion to dismiss the second individual action, dismissing
the state common law claims for unjust enrichment and
tortious interference, but denying dismissal of the federal
and state antitrust claims. On March 13, 2019, the court
denied the plaintiffs’ motion in the putative class action to
amend their complaint to add allegations related to 2008-
2012 conduct, but granted the motion to add limited
allegations from 2013-2016, which the plaintiffs added in a
fourth 	consolidated 	amended 	complaint 	filed 	on
March 22, 2019. The plaintiffs in the putative class action
moved for class certification on March 7, 2019.
GSE Bonds Antitrust Litigation
GS&Co. is among the dealers named as defendants in
numerous putative antitrust class actions relating to debt
securities issued by Federal National Mortgage Association,
Federal Home Loan Mortgage Corporation, Federal Farm
Credit Banks Funding Corporation and Federal Home
Loan Banks (collectively, the GSEs), filed beginning in
February 2019 and consolidated in the U.S. District Court
for 	the 	Southern 	District 	of 	New 	York. 	The 	third
consolidated 	amended 	complaint, 	filed 	on
September 10, 2019, asserts claims under federal antitrust
law in connection with an alleged conspiracy among the
defendants to manipulate the secondary market for debt
securities 	issued 	by 	the 	GSEs. 	The 	complaint 	seeks
declaratory and injunctive relief, as well as treble damages
in unspecified amounts. On December 12, 2019, the court
preliminarily approved a settlement between the firm and
class plaintiffs. The firm has reserved the full amount of its
contribution 	to 	the 	settlement. 	Beginning 	in
September 2019, the State of Louisiana and the City of
Baton Rouge filed complaints in the U.S. District Court for
the 	Middle 	District 	of 	Louisiana 	against 	the 	class
defendants and a number of dealers alleging the same
claims as in the class action. In January 2020, the State of
Louisiana and City of Baton Rouge voluntarily dismissed
their actions with prejudice against GS&Co. in favor of
participating in the class settlement.
Variable 	Rate 	Demand 	Obligations 	Antitrust
Litigation
GS&Co. is among the defendants named in a putative class
action 	relating 	to 	variable 	rate 	demand 	obligations
(VRDOs), filed beginning in February 2019 under separate
complaints and consolidated in the U.S. District Court for
the Southern District of New York. The consolidated
amended complaint, filed on May 31, 2019, generally
asserts claims under federal antitrust law and state common
law in connection with an alleged conspiracy among the
defendants to manipulate the market for VRDOs. The
complaint seeks declaratory and injunctive relief, as well as
unspecified amounts of compensatory, treble and other
damages. Defendants moved to dismiss on July 30, 2019.
Goldman Sachs March 2020 Form 10-Q 	90

-- 92 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
Commodities-Related Litigation
GSI is among the defendants named in putative class actions
relating to trading in platinum and palladium, filed beginning
on November 25, 2014 and most recently amended on
May 15, 2017, in the U.S. District Court for the Southern
District of New York. The amended complaint generally
alleges that the defendants violated federal antitrust laws and
the Commodity Exchange Act in connection with an alleged
conspiracy to manipulate a benchmark for physical platinum
and palladium prices and seek declaratory and injunctive
relief, as well as treble damages in an unspecified amount. On
March 29, 2020, the court granted the defendants’ motions
to dismiss and for reconsideration, resulting in the dismissal
of all claims. Plaintiffs have been granted leave to replead.
GS&Co., GSI, J. Aron & Company and Metro, a
previously consolidated subsidiary of Group Inc. that was
sold in the fourth quarter of 2014, are among the
defendants in a number of putative class and individual
actions filed beginning on August 1, 2013 and consolidated
in the U.S. District Court for the Southern District of New
York. The complaints generally allege violations of federal
antitrust laws and state laws in connection with the storage
of aluminum and aluminum trading. The complaints seek
declaratory, injunctive and other equitable relief, as well as
unspecified monetary damages, including treble damages.
In December 2016, the district court granted defendants’
motions to dismiss as to all remaining claims. Certain
plaintiffs subsequently appealed in December 2016. On
August 27, 2019, the Second Circuit vacated the district
court’s dismissals and remanded the case to district court
for further proceedings.
Group Inc., GS&Co., GSI, J. Aron & Company and Metro
are 	among 	the 	defendants 	in 	an 	action 	filed 	on
February 27, 2020 in the High Court of Justice, Business
and Property Courts of England and Wales. The particulars
of claim seeks unspecified compensatory and exemplary
damages based on alleged violations of U.K. and E.U.
competition laws in connection with the storage and
trading of aluminum.
U.S. Treasury Securities Litigation
GS&Co. is among the primary dealers named as defendants
in several putative class actions relating to the market for
U.S. Treasury securities, filed beginning in July 2015 and
consolidated in the U.S. District Court for the Southern
District of New York. GS&Co. is also among the primary
dealers named as defendants in a similar individual action
filed in the U.S. District Court for the Southern District of
New York on August 25, 2017. The consolidated class
action complaint, filed on December 29, 2017, generally
alleges that the defendants violated antitrust laws in
connection with an alleged conspiracy to manipulate the
when-issued 	market 	and 	auctions 	for 	U.S. 	Treasury
securities and that certain defendants, including GS&Co.,
colluded to preclude trading of U.S. Treasury securities on
electronic trading platforms in order to impede competition
in the bidding process. The individual action alleges a
similar conspiracy regarding manipulation of the when-
issued market and auctions, as well as related futures and
options in violation of the Commodity Exchange Act. The
complaints seek declaratory and injunctive relief, treble
damages 	in 	an 	unspecified 	amount 	and 	restitution.
Defendants moved to dismiss on February 23, 2018.
Corporate Bonds Antitrust Litigation
Group Inc. and GS&Co. are among the dealers named as
defendants in a putative class action relating to the
secondary market for odd-lot corporate bonds, filed on
April 21, 2020 in the U.S. District Court for the Southern
District of New York. The complaint asserts claims under
federal antitrust law in connection with alleged anti-
competitive conduct by the defendants in the secondary
market 	for 	odd-lots 	of 	corporate 	bonds, 	and 	seeks
declaratory and injunctive relief, as well as unspecified
monetary damages, including treble and punitive damages
and restitution.
Employment-Related Matters
On September 15, 2010, a putative class action was filed in
the U.S. District Court for the Southern District of New
York by three female former employees. The complaint, as
subsequently 	amended, 	alleges 	that 	Group 	Inc. 	and
GS&Co. have systematically discriminated against female
employees in respect of compensation, promotion and
performance evaluations. The complaint alleges a class
consisting of all female employees employed at specified
levels in specified areas by Group Inc. and GS&Co. since
July 2002, and asserts claims under federal and New York
City discrimination laws. The complaint seeks class action
status, 	injunctive 	relief 	and 	unspecified 	amounts 	of
compensatory, punitive and other damages.
91 	Goldman Sachs March 2020 Form 10-Q

-- 93 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Notes to Consolidated Financial Statements
(Unaudited)
On March 30, 2018, the district court certified a damages
class as to the plaintiffs’ disparate impact and treatment
claims. On September 4, 2018, the Second Circuit Court of
Appeals denied defendants’ petition for interlocutory
review of the district court’s class certification decision and
subsequently denied defendants’ petition for rehearing. On
September 27, 2018, plaintiffs advised the district court
that they would not seek to certify a class for injunctive and
declaratory relief. On March 26, 2020, the Magistrate
Judge in the district court granted in part a motion to
compel arbitration as to class members who are parties to
certain agreements with Group Inc. and/or GS&Co. in
which 	they 	agreed 	to 	arbitrate 	employment-related
disputes. On April 16, 2020, plaintiffs submitted objections
to the Magistrate Judge’s order and defendants submitted
conditional objections in the event that the district judge
overturns any portion of the Magistrate Judge’s order.
Regulatory Investigations and Reviews and Related
Litigation
Group Inc. and certain of its affiliates are subject to a
number of other investigations and reviews by, and in some
cases have received subpoenas and requests for documents
and 	information 	from, 	various 	governmental 	and
regulatory bodies and self-regulatory organizations and
litigation and shareholder requests relating to various
matters relating to the firm’s businesses and operations,
including:
‰ The public offering process;
‰ The 	firm’s 	investment 	management 	and 	financial
advisory services;
‰ Conflicts of interest;
‰ Research practices, including research independence and
interactions between research analysts and other firm
personnel, including investment banking personnel, as
well as third parties;
‰ Transactions involving government-related financings
and other matters, municipal securities, including wall-
cross procedures and conflict of interest disclosure with
respect to state and municipal clients, the trading and
structuring 	of 	municipal 	derivative 	instruments 	in
connection 	with 	municipal 	offerings, 	political
contribution rules, municipal advisory services and the
possible impact of credit default swap transactions on
municipal issuers;
‰ Credit 	cards, 	unsecured 	installment 	and 	residential
mortgage lending and servicing, and compliance with
related consumer laws;
‰ The offering, auction, sales, trading and clearance of
corporate 	and 	government 	securities, 	currencies,
commodities and other financial products and related
sales and other communications and activities, as well as
the firm’s supervision and controls relating to such
activities, including compliance with applicable short sale
rules, 	algorithmic, 	high-frequency 	and 	quantitative
trading, the firm’s U.S. alternative trading system (dark
pool), futures trading, options trading, when-issued
trading, transaction reporting, technology systems and
controls, 	securities 	lending 	practices, 	trading 	and
clearance of credit derivative instruments and interest rate
swaps, commodities activities and metals storage, private
placement 	practices, 	allocations 	of 	and 	trading 	in
securities, and trading activities and communications in
connection with the establishment of benchmark rates,
such as currency rates;
‰ Compliance with the FCPA;
‰ The firm’s hiring and compensation practices;
‰ The firm’s system of risk management and controls; and
‰ Insider trading, the potential misuse and dissemination of
material nonpublic information regarding corporate and
governmental developments and the effectiveness of the
firm’s insider trading controls and information barriers.
The firm is cooperating with all such governmental and
regulatory investigations and reviews.
Goldman Sachs March 2020 Form 10-Q 	92

-- 94 of 356 --

Report 	of 	Independent 	Registered 	Public
Accounting Firm
To the Board of Directors and the Shareholders of The
Goldman Sachs Group, Inc.:
Results of Review of Interim Financial Statements
We have reviewed the accompanying consolidated balance
sheet 	of 	The 	Goldman 	Sachs 	Group, 	Inc. 	and 	its
subsidiaries (the Company) as of March 31, 2020, the
related consolidated statements of earnings, comprehensive
income, changes in shareholders’ equity and cash flows for
the three month periods ended March 31, 2020 and 2019,
including the related notes (collectively referred to as the
“interim financial statements”). Based on our reviews, we
are not aware of any material modifications that should be
made to the accompanying interim financial statements for
them to be in conformity with accounting principles
generally accepted in the United States of America.
We have previously audited, in accordance with the
standards of the Public Company Accounting Oversight
Board (United States) (PCAOB), the consolidated balance
sheet of the Company as of December 31, 2019, and the
related consolidated statements of earnings, comprehensive
income, changes in shareholders’ equity and cash flows for
the year then ended (not presented herein), and in our
report 	dated 	February 	20, 	2020, 	we 	expressed 	an
unqualified 	opinion 	on 	those 	consolidated 	financial
statements. In our opinion, the information set forth in the
accompanying 	consolidated 	balance 	sheet 	as 	of
December 31, 2019 is fairly stated in all material respects in
relation to the consolidated balance sheet from which it has
been derived.
Basis for Review Results
These interim financial statements are the responsibility of
the Company’s management. We are a public accounting
firm registered with the PCAOB and are required to be
independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission
and the PCAOB. We conducted our review in accordance
with the standards of the PCAOB. A review of interim
financial information consists principally of applying
analytical procedures and making inquiries of persons
responsible for financial and accounting matters. It is
substantially less in scope than an audit conducted in
accordance with the standards of the PCAOB, the objective
of which is the expression of an opinion regarding the
financial statements taken as a whole. Accordingly, we do
not express such an opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
April 30, 2020
93 	Goldman Sachs March 2020 Form 10-Q

-- 95 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Statistical Disclosures
Distribution of Assets, Liabilities and Shareholders’
Equity
The tables below present information about average
balances, interest and average interest rates.
Average Balance for
the Three Months
Ended March
$ in millions 	2020 	2019
Assets
U.S. 	$ 	41,249 	$ 52,559
Non-U.S. 	54,102 	51,998
Total deposits with banks 	95,351 	104,557
U.S. 	137,105 	171,446
Non-U.S. 	123,218 	131,874
Total collateralized agreements 	260,323 	303,320
U.S. 	195,854 	132,752
Non-U.S. 	117,488 	106,227
Total trading assets 	313,342 	238,979
U.S. 	43,979 	35,102
Non-U.S. 	17,435 	13,581
Total investments 	61,414 	48,683
U.S. 	88,534 	85,073
Non-U.S. 	17,066 	10,534
Total loans 	105,600 	95,607
U.S. 	50,888 	39,685
Non-U.S. 	43,570 	33,832
Total other interest-earning assets 	94,458 	73,517
Total interest-earning assets 	930,488 	864,663
Cash and due from banks 	12,232 	9,222
Other non-interest-earning assets 	105,947 	80,581
Total assets 	$1,048,667 	$954,466
Liabilities
U.S. 	$ 153,771 	$126,643
Non-U.S. 	45,418 	32,572
Total interest-bearing deposits 	199,189 	159,215
U.S. 	88,223 	52,995
Non-U.S. 	36,884 	36,312
Total collateralized financings 	125,107 	89,307
U.S. 	27,626 	32,475
Non-U.S. 	47,948 	47,087
Total trading liabilities 	75,574 	79,562
U.S. 	34,241 	32,877
Non-U.S. 	18,399 	16,000
Total short-term borrowings 	52,640 	48,877
U.S. 	197,063 	208,876
Non-U.S. 	27,294 	29,114
Total long-term borrowings 	224,357 	237,990
U.S. 	128,285 	128,337
Non-U.S. 	65,702 	54,984
Total other interest-bearing liabilities 	193,987 	183,321
Total interest-bearing liabilities 	870,854 	798,272
Non-interest-bearing deposits 	6,325 	4,933
Other non-interest-bearing liabilities 	81,022 	61,633
Total liabilities 	958,201 	864,838
Shareholders’ equity
Preferred stock 	11,203 	11,203
Common stock 	79,263 	78,425
Total shareholders’ equity 	90,466 	89,628
Total liabilities and shareholders’ equity 	$1,048,667 	$954,466
Percentage of interest-earning assets and interest-bearing liabilities
attributable to non-U.S. operations
Assets 	40.07% 	40.25%
Liabilities 	27.75% 	27.07%
Interest for the
Three Months
Ended March
$ in millions 	2020 	2019
Assets
U.S. 	$ 151 	$ 296
Non-U.S. 	54 	81
Total deposits with banks 	205 	377
U.S. 	440 	1,175
Non-U.S. 	94 	129
Total collateralized agreements 	534 	1,304
U.S. 	1,067 	869
Non-U.S. 	506 	519
Total trading assets 	1,573 	1,388
U.S. 	334 	290
Non-U.S. 	137 	105
Total investments 	471 	395
U.S. 	1,123 	1,167
Non-U.S. 	193 	152
Total loans 	1,316 	1,319
U.S. 	453 	562
Non-U.S. 	198 	252
Total other interest-earning assets 	651 	814
Total interest-earning assets 	$4,750 	$5,597
Liabilities
U.S. 	$ 685 	$ 758
Non-U.S. 	133 	99
Total interest-bearing deposits 	818 	857
U.S. 	400 	591
Non-U.S. 	48 	78
Total collateralized financings 	448 	669
U.S. 	105 	158
Non-U.S. 	209 	208
Total trading liabilities 	314 	366
U.S. 	135 	136
Non-U.S. 	6 	6
Total short-term borrowings 	141 	142
U.S. 	1,074 	1,369
Non-U.S. 	31 	15
Total long-term borrowings 	1,105 	1,384
U.S. 	452 	1,237
Non-U.S. 	159 	(276)
Total other interest-bearing liabilities 	611 	961
Total interest-bearing liabilities 	$3,437 	$4,379
Net interest income
U.S. 	$ 717 	$ 110
Non-U.S. 	596 	1,108
Net interest income 	$1,313 	$1,218
Goldman Sachs March 2020 Form 10-Q 	94

-- 96 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Statistical Disclosures
Annualized
Average Rate for
the Three Months
Ended March
2020 	2019
Assets
U.S. 	1.47% 	2.34%
Non-U.S. 	0.40% 	0.65%
Total deposits with banks 	0.86% 	1.50%
U.S. 	1.29% 	2.84%
Non-U.S. 	0.31% 	0.41%
Total collateralized agreements 	0.83% 	1.78%
U.S. 	2.19% 	2.72%
Non-U.S. 	1.73% 	2.03%
Total trading assets 	2.02% 	2.41%
U.S. 	3.05% 	3.43%
Non-U.S. 	3.16% 	3.21%
Total investments 	3.08% 	3.37%
U.S. 	5.10% 	5.69%
Non-U.S. 	4.55% 	5.98%
Total loans 	5.01% 	5.72%
U.S. 	3.58% 	5.87%
Non-U.S. 	1.83% 	3.09%
Total other interest-earning assets 	2.77% 	4.59%
Total interest-earning assets 	2.05% 	2.68%
Liabilities
U.S. 	1.79% 	2.48%
Non-U.S. 	1.18% 	1.26%
Total interest-bearing deposits 	1.65% 	2.23%
U.S. 	1.82% 	4.63%
Non-U.S. 	0.52% 	0.89%
Total collateralized financings 	1.44% 	3.11%
U.S. 	1.53% 	2.02%
Non-U.S. 	1.75% 	1.83%
Total trading liabilities 	1.67% 	1.91%
U.S. 	1.59% 	1.72%
Non-U.S. 	0.13% 	0.16%
Total short-term borrowings 	1.08% 	1.21%
U.S. 	2.19% 	2.72%
Non-U.S. 	0.46% 	0.21%
Total long-term borrowings 	1.98% 	2.41%
U.S. 	1.42% 	4.00%
Non-U.S. 	0.97% 	(2.08)%
Total other interest-bearing liabilities 	1.27% 	2.17%
Total interest-bearing liabilities 	1.59% 	2.28%
Interest rate spread 	0.46% 	0.40%
U.S. 	0.52% 	0.09%
Non-U.S. 	0.64% 	1.32%
Net yield on interest-earning assets 	0.57% 	0.58%
In the tables above:
‰ Assets, liabilities and interest are classified as U.S. and
non-U.S. based on the location of the legal entity in which
the assets and liabilities are held.
‰ Derivative instruments and commodities are included in
other non-interest-earning assets and other non-interest-
bearing liabilities.
‰ Total other interest-earning assets primarily consists of
receivables from customers and counterparties.
‰ Collateralized financings consists of securities sold under
agreements to repurchase and securities loaned.
‰ Substantially all of the total other interest-bearing
liabilities 	consists 	of 	payables 	to 	customers 	and
counterparties.
‰ Interest rates for borrowings include the effects of interest
rate swaps accounted for as hedges.
‰ Total loans exclude loans held for sale that are accounted
for at the lower of cost or fair value. Such loans are
included within other interest-earning assets.
‰ Total short- and long-term borrowings include both
secured and unsecured borrowings.
95 	Goldman Sachs March 2020 Form 10-Q

-- 97 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Item 2. 	Management’s Discussion and
Analysis 	of 	Financial 	Condition 	and
Results of Operations
Introduction
The Goldman Sachs Group, Inc. (Group Inc. or parent
company), a Delaware corporation, together with its
consolidated subsidiaries, is a leading global investment
banking, securities and investment management firm that
provides a wide range of financial services to a substantial
and diversified client base that includes corporations,
financial 	institutions, 	governments 	and 	individuals.
Founded in 1869, we are headquartered in New York and
maintain offices in all major financial centers around the
world. We report our activities in four business segments:
Investment Banking, Global Markets, Asset Management,
and Consumer & Wealth Management. See “Results of
Operations” for further information about our business
segments.
When we use the terms “we,” “us” and “our,” we mean
Group Inc. and its consolidated subsidiaries. When we use
the term “our subsidiaries,” we mean the consolidated
subsidiaries of Group Inc.
This Management’s Discussion and Analysis of Financial
Condition and Results of Operations should be read in
conjunction with our Annual Report on Form 10-K for the
year ended December 31, 2019. References to “the 2019
Form 10-K” are to our Annual Report on Form 10-K for
the year ended December 31, 2019. References to “this
Form 10-Q” are to our Quarterly Report on Form 10-Q for
the quarterly period ended March 31, 2020. All references
to “the consolidated financial statements” or “Statistical
Disclosures” are to Part I, Item 1 of this Form 10-Q. The
consolidated 	financial 	statements 	are 	unaudited. 	All
references to March 2020 and March 2019 refer to our
periods ended, or the dates, as the context requires,
March 31, 2020 and March 31, 2019, respectively. All
references 	to 	December 	2019 	refer 	to 	the 	date
December 31, 2019. Any reference to a future year refers to
a year ending on December 31 of that year. Beginning in the
fourth quarter of 2019, we changed our business segments
and balance sheet presentation to better reflect the nature of
our 	activities. 	Reclassifications 	have 	been 	made 	to
previously reported amounts to conform to the current
presentation. See Note 2 to the consolidated financial
statements in Part II, Item 8 of the 2019 Form 10-K for
further information.
Executive Overview
In response to the global outbreak of the coronavirus
(COVID-19) pandemic, we are harnessing our resources,
experience and network to help where we can, working
with public and private clients to partner on initiatives with
a focus on community assistance, economic support for
businesses, and serving our clients and customers. Through
the first quarter of 2020, we have announced a number of
important initiatives to support our employees, clients and
the broader public during this crisis, reinforcing our core
values 	of 	partnership, 	client 	service, 	integrity 	and
excellence:
Employees and Vendors
‰ Activated our global Business Continuity Planning (BCP)
strategy, with approximately 98% of global employees
working remotely.
‰ Extended 10 days of family leave to our people globally to
care for family members due to COVID-19-related illness
or childcare needs.
‰ Introduced telemedicine benefit to employees and covered
dependents and waived all costs for 2020.
‰ Provided access to global patient advocacy teams to help
employees and their families gain access to appropriate
care for COVID-19.
‰ Partnered with our vendors to ensure that workers
dedicated to us continue to receive their full pay and
benefits, even if their shifts are temporarily reduced or
eliminated.
‰ Launched virtual volunteer opportunities for our people
to support their communities remotely.
‰ Honoring the full financial commitment to our 2,800
summer interns who will have a truncated program.
Goldman Sachs March 2020 Form 10-Q 	96

-- 98 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Clients
‰ Announced a COVID-19 Customer Assistance Program,
giving consumers the flexibility to defer a Marcus loan or
Apple Card payment for up to two months at no cost and
access funds in Marcus certificates of deposit early with
no penalty.
‰ Leveraging 	our 	digital 	banking 	model 	to 	provide
uninterrupted customer service, including rapid response
times through virtual call centers.
‰ Continuing to provide savings products with attractive
interest rates.
‰ Led more than $15 billion of “Fight COVID-19” bonds.
‰ Funded $19 billion of loans to corporate clients.
‰ Bookrunner on more than $200 billion of total investment-
grade issuance during the first quarter of 2020.
‰ Working in partnership with central banks, governments
and regulators to support financial system.
Communities
‰ Announced an approximate $550 million commitment to
COVID-19 	relief 	efforts 	through 	mid-April 	2020,
including (i) $500 million of emergency loan capital for
underserved 	small 	businesses 	through 	Community
Development Financial Institutions (CDFIs) and other
mission-driven lenders across the U.S.; (ii) $25 million in
grants to CDFIs and mission-driven lending partners to
enable them to hire necessary staff and set up additional
operations; (iii) $30 million COVID-19 relief effort; and
(iv) 	city/state-specific 	COVID-19 	public-private
partnerships in New York, Texas, Ohio, Rhode Island,
Chicago and Baltimore.
‰ Launched a U.S. Small Business Resource Center and
emergency coaching sessions to 10,000 Small Businesses
and 10,000 Women graduates.
‰ Donated over 2.5 million surgical masks and 700,000
N95 masks across the U.S. and Europe.
‰ Working with the National Health Service to deliver
technical and data support related to the spread of
COVID-19.
During the first quarter of 2020, we successfully executed on
our BCP strategy amid the COVID-19 pandemic, providing
clients with advice, execution and liquidity. As for our
financial 	performance, 	we 	generated 	net 	earnings 	of
$1.21 billion for the first quarter of 2020, a decrease of 46%,
compared with $2.25 billion for the first quarter of 2019.
Diluted earnings per common share was $3.11 for the first
quarter of 2020, a decrease of 46%, compared with $5.71
for the first quarter of 2019. Annualized return on average
common shareholders’ equity (ROE) was 5.7% for the first
quarter of 2020, compared with 11.1% for the first quarter
of 2019. Book value per common share was $228.21 as of
March 2020, 4.4% higher compared with December 2019.
Net revenues were $8.74 billion for the first quarter of
2020, essentially unchanged compared with the first
quarter of 2019. Net revenues in Asset Management were
significantly lower, due to significant net losses in Lending
and debt investments and net losses in Equity investments,
reflecting the impact of macroeconomic uncertainty and the
challenging 	operating 	environment 	on 	asset 	prices.
However, fees earned from our institutional and third-party
distribution 	asset 	management 	clients 	were 	higher
compared with the first quarter of 2019. The decrease in
Asset 	Management 	revenues 	was 	largely 	offset 	by
significantly higher net revenues in both Fixed Income,
Currency and Commodities (FICC) and Equities within
Global Markets, driven by strong activity as we extended
balance sheet and liquidity to clients during volatile market
conditions. In addition, net revenues were significantly
higher in Investment Banking, reflecting gains on hedges
related to our relationship lending activities, and in
Consumer & Wealth Management, reflecting strength in
both Consumer banking and Wealth management as we
continued to advise our clients and accelerated growth in
consumer deposits.
Provision for credit losses was $937 million for the first
quarter of 2020, compared with $224 million for the first
quarter of 2019, reflecting the challenging economic
environment, loan growth and the impact of accounting for
credit losses under the Current Expected Credit Losses
(CECL) standard. See Note 3 to the consolidated financial
statements 	for 	further 	information 	about 	ASU
No. 2016-13, “Financial Instruments — Credit Losses
(Topic 326) — Measurement of Credit Losses on Financial
Instruments.”
Operating expenses were $6.46 billion for the first quarter
of 2020, 10% higher than the first quarter of 2019,
primarily due to significantly higher brokerage, clearing,
exchange and distribution fees, net provisions for litigation
and regulatory proceedings, and expenses related to
consolidated 	investments. 	Our 	efficiency 	ratio 	(total
operating expenses divided by total net revenues) for the
first quarter of 2020 was 73.9%, compared with 66.6% for
the first quarter of 2019.
We 	returned 	$2.38 	billion 	of 	capital 	to 	common
shareholders during the first quarter of 2020, including
$1.93 	billion 	of 	common 	share 	repurchases 	and
$449 	million 	of 	common 	stock 	dividends. 	As 	of
March 2020, our Common Equity Tier 1 (CET1) capital
ratio as calculated in accordance with the Advanced Capital
Rules was 12.3% and as calculated in accordance with the
Standardized Capital Rules was 12.5%. See Note 20 to the
consolidated financial statements for further information
about our capital ratios.
97 	Goldman Sachs March 2020 Form 10-Q

-- 99 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Business Environment
The 	beginning 	of 	the 	first 	quarter 	of 	2020 	was
characterized by favorable market conditions, reflecting
continued 	economic 	growth 	and 	strong 	consumer
sentiment. However, in March, the spread of COVID-19
across the globe and the dramatic measures taken to
contain it, including the temporary closures of non-essential
businesses and stay-at-home requirements, caused a sharp
contraction in global economic activity, high levels of
volatility across most financial assets and global markets,
an unprecedented decline in global equity prices, and a
significant widening of credit spreads. Global central banks
responded quickly with accommodative monetary policy by
reducing policy interest rates and increasing large scale asset
purchases, and the establishment of a number of facilities to
support the functioning of markets and to provide liquidity
to the market. In addition, governments globally intervened
with fiscal policy to mitigate the impact, including the
Coronavirus Aid, Relief, and Economic Security (CARES)
Act in the U.S., which aimed to provide economic relief to
businesses and individuals.
The beginning of the second quarter of 2020 continued to
be impacted by the COVID-19 pandemic, reflecting
continued 	declines 	in 	recent 	economic 	indicators,
particularly in advanced economies, and a historic increase
in initial jobless claims in the U.S. To alleviate the economic
impact, global central banks continued their quantitative
easing, while signaling that they would do more if needed,
and 	the 	U.S. 	government 	approved 	additional 	fiscal
measures to support small businesses and individuals. This
intervention helped equity prices recover and credit spreads
tighten moderately compared with the end of the first
quarter of 2020. However, the pace of industry-wide
announced mergers and acquisitions activity has slowed,
volatility in the equity markets, although declining, has
remained elevated, and commodities markets experienced
significant turmoil, as oil prices declined significantly due to
an unprecedented surplus in net supply. See “Results of
Operations — Segment Operating Results” for further
information about the operating environment for each of
our business segments.
Critical Accounting Policies
Fair Value
Fair Value Hierarchy. Trading assets and liabilities, certain
investments and loans, and certain other financial assets and
liabilities, are included in our consolidated balance sheets at
fair value (i.e., marked-to-market), with related gains or
losses generally recognized in our consolidated statements of
earnings. The use of fair value to measure financial
instruments is fundamental to our risk management practices
and is our most critical accounting policy.
The fair value of a financial instrument is the amount that
would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the
measurement date. We measure certain financial assets and
liabilities as a portfolio (i.e., based on its net exposure to
market and/or credit risks). In determining fair value, the
hierarchy 	under 	U.S. 	generally 	accepted 	accounting
principles (U.S. GAAP) gives (i) the highest priority to
unadjusted quoted prices in active markets for identical,
unrestricted assets or liabilities (level 1 inputs), (ii) the next
priority to inputs other than level 1 inputs that are
observable, either directly or indirectly (level 2 inputs), and
(iii) the lowest priority to inputs that cannot be observed in
market activity (level 3 inputs). In evaluating the significance
of a valuation input, we consider, among other factors, a
portfolio’s net risk exposure to that input. Assets and
liabilities are classified in their entirety based on the lowest
level of input that is significant to their fair value
measurement.
The fair values for substantially all of our financial assets and
liabilities are based on observable prices and inputs and are
classified in levels 1 and 2 of the fair value hierarchy. Certain
level 2 and level 3 financial assets and liabilities may require
appropriate valuation adjustments that a market participant
would require to arrive at fair value for factors, such as
counterparty and our credit quality, funding risk, transfer
restrictions, liquidity and bid/offer spreads.
Instruments classified in level 3 of the fair value hierarchy are
those which require one or more significant inputs that are
not observable. Level 3 financial assets represented 2.8% as
of March 2020 and 2.3% as of December 2019, of our total
assets. See Notes 4 through 10 to the consolidated financial
statements for further information about level 3 financial
assets, including changes in level 3 financial assets and
related fair value measurements. Absent evidence to the
contrary, instruments classified in level 3 of the fair value
hierarchy are initially valued at transaction price, which is
considered to be the best initial estimate of fair value.
Subsequent 	to 	the 	transaction 	date, 	we 	use 	other
methodologies to determine fair value, which vary based on
the type of instrument. Estimating the fair value of level 3
financial instruments requires judgments to be made. These
judgments include:
‰ Determining the appropriate valuation methodology and/
or model for each type of level 3 financial instrument;
‰ Determining model inputs based on an evaluation of all
relevant empirical market data, including prices evidenced
by market transactions, interest rates, credit spreads,
volatilities and correlations; and
‰ Determining appropriate valuation adjustments, including
those related to illiquidity or counterparty credit quality.
Regardless of the methodology, valuation inputs and
assumptions are only changed when corroborated by
substantive evidence.
Goldman Sachs March 2020 Form 10-Q 	98

-- 100 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Controls Over Valuation of Financial Instruments.
Market 	makers 	and 	investment 	professionals 	in 	our
revenue-producing units are responsible for pricing our
financial 	instruments. 	Our 	control 	infrastructure 	is
independent 	of 	the 	revenue-producing 	units 	and 	is
fundamental 	to 	ensuring 	that 	all 	of 	our 	financial
instruments are appropriately valued at market-clearing
levels. In the event that there is a difference of opinion in
situations where estimating the fair value of financial
instruments requires judgment (e.g., calibration to market
comparables or trade comparison, as described below), the
final valuation decision is made by senior managers in
independent risk oversight and control functions. This
independent price verification is critical to ensuring that our
financial instruments are properly valued.
Price Verification. All financial instruments at fair value
classified in levels 1, 2 and 3 of the fair value hierarchy are
subject to our independent price verification process. The
objective of price verification is to have an informed and
independent opinion with regard to the valuation of financial
instruments under review. Instruments that have one or more
significant inputs which cannot be corroborated by external
market data are classified in level 3 of the fair value
hierarchy. 	Price 	verification 	strategies utilized by our
independent risk oversight and control functions include:
‰ Trade Comparison. Analysis of trade data (both internal
and external, where available) is used to determine the
most relevant pricing inputs and valuations.
‰ External Price Comparison. Valuations and prices are
compared to pricing data obtained from third parties (e.g.,
brokers 	or 	dealers, 	IHS 	Markit, 	Bloomberg, 	IDC,
TRACE). Data obtained from various sources is compared
to ensure consistency and validity. When broker or dealer
quotations or third-party pricing vendors are used for
valuation or price verification, greater priority is generally
given to executable quotations.
‰ Calibration to Market Comparables. Market-based
transactions are used to corroborate the valuation of
positions 	with 	similar 	characteristics, 	risks 	and
components.
‰ Relative Value Analyses. Market-based transactions
are analyzed to determine the similarity, measured in
terms of risk, liquidity and return, of one instrument
relative to another or, for a given instrument, of one
maturity relative to another.
‰ Collateral Analyses. Margin calls on derivatives are
analyzed to determine implied values, which are used to
corroborate our valuations.
‰ Execution of Trades. Where appropriate, market-
making desks are instructed to execute trades in order to
provide evidence of market-clearing levels.
‰ Backtesting. 	Valuations 	are 	corroborated 	by
comparison to values realized upon sales.
See Note 4 to the consolidated financial statements for
further information about fair value measurements.
Review of Net Revenues. Independent risk oversight and
control functions ensure adherence to our pricing policy
through a combination of daily procedures, including the
explanation and attribution of net revenues based on the
underlying factors. Through this process, we independently
validate net revenues, identify and resolve potential fair
value or trade booking issues on a timely basis and seek to
ensure that risks are being properly categorized and
quantified.
Review of Valuation Models. Our independent model
risk 	management 	group 	(Model 	Risk), 	consisting 	of
quantitative professionals who are separate from model
developers, performs an independent model review and
validation process of our valuation models. New or
changed models are reviewed and approved prior to
implementation. Models are reviewed annually to assess the
impact of any changes in the product or market and any
market 	developments 	in 	pricing 	theories. 	See 	“Risk
Management — Model Risk Management” for further
information about the review and validation of our
valuation models.
Allowance for Credit Losses
We estimate and record an allowance for credit losses
related to our loans held for investment and accounted for
at amortized cost. We adopted ASU No. 2016-13 in
January 2020, which replaced the probable incurred credit
loss model for recognizing credit losses with the current
expected credit losses (CECL) model. As a result, our
allowance for credit losses effective January 2020, reflects
our estimate of credit losses over the remaining expected life
of such loans and also takes into account forecasts of future
economic conditions. See Note 3 to the consolidated
financial statements for further information about adoption
of ASU No. 2016-13. To determine the allowance for credit
losses, we classify our loans into wholesale and retail
portfolios. These portfolios represent the level at which we
have developed and documented our methodology to
determine the allowance for credit losses. The allowance for
credit losses is measured on a collective basis for loans that
exhibit 	similar 	risk 	characteristics 	using 	a 	modeled
approach and asset-specific basis for loans that do not share
similar risk characteristics. The determination of allowance
for credit losses entails significant judgment on various risk
factors, including industry default and loss data, current
macroeconomic indicators, borrower’s capacity to meet its
financial obligations, borrower’s country of risk, loan
seniority and collateral type. In addition, for loans backed
by real estate, risk factors include loan-to-value ratio, debt
service ratio and home price index. Risk factors for
installment and credit card loans include Fair Isaac
Corporation (FICO) credit scores and delinquency status.
99 	Goldman Sachs March 2020 Form 10-Q

-- 101 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Our estimate of credit losses entails judgment about
collectability 	at 	the 	reporting 	dates, 	and 	there 	are
uncertainties inherent in those judgments. While we use the
best information available to determine this estimate, future
adjustments to the allowance may be necessary based on,
among other things, changes in the economic environment
or variances between actual results and the original
assumptions used. Loans are charged off against the
allowance for loan losses when deemed to be uncollectible.
We also record an allowance for losses on lending
commitments which are held for investment and accounted
for at amortized cost. Such allowance is determined using
the same methodology as the allowance for loan losses,
while also taking into consideration the probability of
drawdowns or funding, and is included in other liabilities.
See Note 9 to the consolidated financial statements for
further information about the allowance for credit losses.
Use of Estimates
U.S. GAAP requires us to make certain estimates and
assumptions. In addition to the estimates we make in
connection with fair value measurements and the allowance
for credit losses on loans and lending commitments held for
investment and accounted for at amortized cost, the use of
estimates and assumptions is also important in determining
discretionary compensation accruals, the accounting for
goodwill and identifiable intangible assets, provisions for
losses that may arise from litigation and regulatory
proceedings (including governmental investigations), and
provisions for losses that may arise from tax audits.
A substantial portion of our compensation and benefits
represents discretionary compensation, which is finalized at
year-end. We believe the most appropriate way to allocate
estimated year-end discretionary compensation among
interim periods is in proportion to the net revenues earned
in such periods. In addition to the level of net revenues, our
overall compensation expense in any given year is also
influenced by, among other factors, overall financial
performance, prevailing labor markets, business mix, the
structure of our share-based compensation programs and
the external environment.
Goodwill is assessed for impairment annually in the fourth
quarter or more frequently if events occur or circumstances
change that indicate an impairment may exist. When
assessing goodwill for impairment, first, a qualitative
assessment can be made to determine whether it is more
likely than not that the estimated fair value of a reporting
unit is less than its estimated carrying value. If the results of
the qualitative assessment are not conclusive, a quantitative
goodwill test is performed. Alternatively, a quantitative
goodwill test can be performed without performing a
qualitative assessment.
Estimating the fair value of our reporting units requires
judgment. Critical inputs to the fair value estimates include
projected earnings and allocated equity. There is inherent
uncertainty in the projected earnings. The estimated
carrying value of each reporting unit reflects an allocation
of total shareholders’ equity and represents the estimated
amount of total shareholders’ equity required to support
the 	activities 	of 	the 	reporting 	unit 	under 	currently
applicable regulatory capital requirements. See Note 12 to
the 	consolidated 	financial 	statements 	for 	further
information about goodwill. If we experience a prolonged
or severe period of weakness in the business environment,
financial markets, our performance or our common stock
price, or additional increases in capital requirements, our
goodwill could be impaired in the future.
Identifiable intangible assets are tested for impairment
whenever events or changes in circumstances suggest that
an asset’s or asset group’s carrying value may not be fully
recoverable. Judgment is required to evaluate whether
indications of potential impairment have occurred, and to
test intangible assets for impairment, if required. An
impairment is recognized if the total of the estimated
undiscounted cash flows relating to the asset or asset group
is less than the corresponding carrying value. See Note 12
to 	the 	consolidated 	financial 	statements 	for 	further
information about identifiable intangible assets.
We also estimate and provide for potential losses that may
arise out of litigation and regulatory proceedings to the
extent that such losses are probable and can be reasonably
estimated. In addition, we estimate the upper end of the
range of reasonably possible aggregate loss in excess of the
related reserves for litigation and regulatory proceedings
where we believe the risk of loss is more than slight. See
Notes 18 and 27 to the consolidated financial statements for
information about certain judicial, litigation and regulatory
proceedings. Significant judgment is required in making these
estimates 	and 	our 	final 	liabilities 	may 	ultimately 	be
materially different. Our total estimated liability in respect of
litigation and regulatory proceedings is determined on a
case-by-case basis and represents an estimate of probable
losses after considering, among other factors, the progress of
each case, proceeding or investigation, our experience and
the experience of others in similar cases, proceedings or
investigations, and the opinions and views of legal counsel.
In accounting for income taxes, we recognize tax positions
in the financial statements only when it is more likely than
not that the position will be sustained on examination by
the relevant taxing authority based on the technical merits
of the position. See Note 24 to the consolidated financial
statements for further information about income taxes.
Goldman Sachs March 2020 Form 10-Q 100

-- 102 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Recent Accounting Developments
See Note 3 to the consolidated financial statements for
information about Recent Accounting Developments.
Results of Operations
The composition of our net revenues has varied over time as
financial markets and the scope of our operations have
changed. The composition of net revenues can also vary over
the shorter term due to fluctuations in U.S. and global
economic and market conditions. See “Risk Factors” in
Part II, Item 1A of this Form 10-Q and in Part I, Item 1A of
the 2019 Form 10-K for further information about the
impact of economic and market conditions on our results of
operations.
Financial Overview
The table below presents an overview of our financial
results and selected financial ratios.
Three Months
Ended March
$ in millions, except per share amounts 	2020 	2019
Net revenues 	$8,743 $8,807
Pre-tax earnings 	$1,348 $2,719
Net earnings 	$1,213 $2,251
Net earnings to common 	$1,123 $2,182
Diluted earnings per common share 	$ 3.11 $ 5.71
Annualized ROE 	5.7% 11.1%
Annualized ROTE 	6.0% 11.7%
Annualized net earnings to average total assets 	0.5% 	0.9%
Annualized return on average total shareholders’ equity 	5.4% 10.0%
Average equity to average assets 	8.6% 	9.4%
Dividend payout ratio 	40.2% 14.0%
In the table above:
‰ Net 	earnings 	to 	common 	represents 	net 	earnings
applicable to common shareholders, which is calculated
as net earnings less preferred stock dividends.
‰ Average equity to average assets is calculated by dividing
average total shareholders’ equity by average total assets.
‰ Dividend payout ratio is calculated by dividing dividends
declared per common share by diluted earnings per
common share.
‰ Annualized ROE is calculated by dividing annualized net
earnings to common by average monthly common
shareholders’ equity. Tangible common shareholders’
equity is calculated as total shareholders’ equity less
preferred stock, goodwill and identifiable intangible
assets. Annualized return on average tangible common
shareholders’ equity (ROTE) is calculated by dividing
annualized net earnings to common by average monthly
tangible common shareholders’ equity. We believe that
tangible common shareholders’ equity is meaningful
because it is a measure that we and investors use to assess
capital adequacy and that ROTE is meaningful because it
measures the performance of businesses consistently,
whether they were acquired or developed internally.
Tangible common shareholders’ equity and ROTE are
non-GAAP measures and may not be comparable to
similar non-GAAP measures used by other companies.
Annualized return on average total shareholders’ equity is
calculated by dividing annualized net earnings by average
monthly total shareholders’ equity.
The table below presents our average equity and the
reconciliation of average common shareholders’ equity
to average tangible common shareholders’ equity.
Average for the
Three Months
Ended March
$ in millions 	2020 	2019
Total shareholders’ equity 	$ 90,466 	$ 89,628
Preferred stock 	(11,203) 	(11,203)
Common shareholders’ equity 	$ 79,263 	$ 78,425
Goodwill and identifiable intangible assets 	(4,821) 	(4,096)
Tangible common shareholders’ equity 	$ 74,442 	$ 74,329
Net Revenues
The table below presents our net revenues by line item.
Three Months
Ended March
$ in millions 	2020 	2019
Investment banking 	$ 1,742 	$ 1,618
Investment management 	1,768 	1,436
Commissions and fees 	1,020 	745
Market making 	3,682 	2,723
Other principal transactions 	(782) 	1,067
Total non-interest revenues 	7,430 	7,589
Interest income 	4,750 	5,597
Interest expense 	3,437 	4,379
Net interest income 	1,313 	1,218
Total net revenues 	$ 8,743 	$ 8,807
In the table above:
‰ Investment banking consists of revenues (excluding net
interest) 	from 	financial 	advisory 	and 	underwriting
assignments. 	These 	activities 	are 	included 	in 	our
Investment Banking segment.
101 Goldman Sachs March 2020 Form 10-Q

-- 103 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
‰ Investment management consists of revenues (excluding
net interest) from providing asset management services
across all major asset classes to a diverse set of asset
management clients (included in our Asset Management
segment), as well as asset management services, wealth
advisory services and certain transaction services for
wealth management clients (included in our Consumer &
Wealth Management segment).
‰ Commissions 	and 	fees 	consists 	of 	revenues 	from
executing and clearing client transactions on major stock,
options and futures exchanges worldwide, as well as
over-the-counter (OTC) transactions. These activities are
included in our Global Markets and Consumer & Wealth
Management segments.
‰ Market making consists of revenues (excluding net interest)
from client execution activities related to making markets in
interest 	rate 	products, 	credit 	products, 	mortgages,
currencies, 	commodities 	and 	equity 	products. 	These
activities are included in our Global Markets segment.
‰ Other 	principal 	transactions 	consists 	of 	revenues
(excluding net interest) from our equity investing activities,
including revenues related to our consolidated investments
(included in our Asset Management segment), and lending
activities (included across our four segments).
Operating Environment. The beginning of the first quarter
of 2020 was characterized by favorable market conditions,
reflecting continued economic growth and strong consumer
sentiment. However, in March, the spread of COVID-19
across the globe caused a sharp contraction in global economic
activity, high levels of volatility across most financial assets
and global markets, an unprecedented decline in global equity
prices, and a significant widening of credit spreads. Market-
making activities operated in an environment characterized by
strong client activity and higher levels of volatility compared
with the fourth quarter of 2019, as clients reacted to the
significant decline in near-term global economic activity and
the accommodative monetary policies set by global central
banks. Investment banking activities reflected decreases in
industry-wide 	announced 	and 	completed 	mergers 	and
acquisitions activity and industry-wide equity underwriting
transactions, while industry-wide investment-grade activity
increased. Credit spreads widened during the first quarter of
2020 and global equity markets were lower compared with
the end of the fourth quarter of 2019.
If the COVID-19 pandemic persists, it may lead to a decline
in market-making activity levels, continued declines in
investment banking transaction levels, global equity markets
and assets under supervision, and the further widening of
credit spreads. As a result, net revenues and the provision for
credit losses would likely be negatively impacted. See
“Segment Operating Results” for information about the
operating environment and material trends and uncertainties
that may impact our results of operations.
Three Months Ended March 2020 versus March 2019
Net revenues in the consolidated statements of earnings
were $8.74 billion for the first quarter of 2020, essentially
unchanged compared with the first quarter of 2019,
reflecting 	significant 	net 	losses 	in 	other 	principal
transactions, largely offset by significantly higher market
marking revenues, investment management revenues and
commissions and fees, and higher investment banking
revenues and net interest income.
Non-Interest Revenues. Investment banking revenues in
the consolidated statements of earnings were $1.74 billion
for the first quarter of 2020, 8% higher than the first
quarter 	of 	2019. 	Revenues 	in 	underwriting 	were
significantly higher, due to significantly higher revenues in
equity underwriting, primarily from initial public offerings
and convertible offerings, and in debt underwriting, driven
by 	asset-backed and leveraged finance activity. This
increase was partially offset by lower revenues in financial
advisory, reflecting a decrease in industry-wide completed
mergers and acquisitions transactions.
Investment management revenues in the consolidated
statements of earnings were $1.77 billion for the first
quarter of 2020, 23% higher than the first quarter of 2019,
due to significantly higher incentive fees, driven by
harvesting, 	and 	higher 	management 	and 	other 	fees
(including the impact of the consolidation of United Capital
Financial Partners, Inc. (United Capital)), reflecting the
impact of higher average assets under supervision, partially
offset by a lower average effective fee due to shifts in the
mix of client assets and strategies.
Commissions and fees in the consolidated statements of
earnings were $1.02 billion for the first quarter of 2020,
37% higher than the first quarter of 2019, reflecting an
increase in our listed cash equity, options and futures
volumes, generally consistent with market volumes.
Market making revenues in the consolidated statements of
earnings were $3.68 billion for the first quarter of 2020,
35% higher than the first quarter of 2019, primarily due to
significantly higher revenues in interest rate products,
equity products and currencies, and higher revenues in
commodities and credit products, partially offset by
significantly lower results in mortgages.
Other principal transactions revenues in the consolidated
statements of earnings were $(782) million for the first
quarter of 2020, compared with $1.07 billion for the first
quarter of 2019, reflecting significant net losses across debt
securities, as well as significant mark-to-market net losses
from investments in public equities and significantly lower
net gains from investments in private equities. These
decreases were partially offset by significantly higher
revenues related to relationship lending activities, reflecting
the impact of changes in credit spreads on hedges.
Goldman Sachs March 2020 Form 10-Q 102

-- 104 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Net 	Interest 	Income. 	Net 	interest 	income 	in 	the
consolidated statements of earnings was $1.31 billion for
the first quarter of 2020, 8% higher than the first quarter of
2019, reflecting a decrease in interest expense primarily
related 	to 	other 	interest-bearing 	liabilities, 	long-term
borrowings, collateralized financing and deposits as a result
of lower interest rates, partially offset by the impact of
higher average balances for deposits. The decrease in
interest expense is partially offset by a decrease in interest
income primarily related to collateralized agreements,
deposits with banks and other interest-earning assets
reflecting the impact of lower interest rates, partially offset
by trading assets reflecting an impact of higher average
balances. See “Statistical Disclosures — Distribution of
Assets, Liabilities and Shareholders’ Equity” for further
information about our sources of net interest income.
Provision for Credit Losses
Provision for credit losses consists of provision for credit
losses 	on 	loans 	and 	lending 	commitments 	held 	for
investment and accounted for at amortized cost. See Note 9
to 	the 	consolidated 	financial 	statements 	for 	further
information about the provision for credit losses.
The table below presents our provision for credit losses.
Three Months
Ended March
$ in millions 	2020 	2019
Provision for credit losses 	$937 	$224
Three Months Ended March 2020 versus March 2019.
Provision for credit losses in the consolidated statements of
earnings was $937 million for the first quarter of 2020,
compared with $224 million for the first quarter of 2019,
primarily due to significantly higher provisions related to
corporate loans reflecting continued pressure in the energy
sector and the impact of the COVID-19 pandemic on the
broader economic environment. In addition, the first
quarter of 2020 included provisions related to growth in
corporate loans and credit card loans, and the impact of
accounting for credit losses under the CECL standard. See
Note 3 to the consolidated financial statements for further
information about ASU No. 2016-13.
Operating Expenses
Our 	operating 	expenses 	are 	primarily 	influenced 	by
compensation, headcount and levels of business activity.
Compensation and benefits includes salaries, estimated
year-end 	discretionary 	compensation, 	amortization 	of
equity 	awards 	and 	other 	items 	such 	as 	benefits.
Discretionary compensation is significantly impacted by,
among other factors, the level of net revenues, overall
financial performance, prevailing labor markets, business
mix, 	the 	structure 	of 	our 	share-based 	compensation
programs and the external environment.
The table below presents our operating expenses by line
item and headcount.
Three Months
Ended March
$ in millions 	2020 	2019
Compensation and benefits 	$ 3,235 $ 3,259
Brokerage, clearing, exchange and distribution fees 	975 	762
Market development 	153 	184
Communications and technology 	321 	286
Depreciation and amortization 	437 	368
Occupancy 	238 	225
Professional fees 	347 	298
Other expenses 	752 	482
Total operating expenses 	$ 6,458 $ 5,864
Headcount at period-end 	38,500 	35,900
Three Months Ended March 2020 versus March 2019.
Operating expenses in the consolidated statements of
earnings were $6.46 billion for the first quarter of 2020,
10% higher than the first quarter of 2019. Our efficiency
ratio (total operating expenses divided by total net
revenues) for the first quarter of 2020 was 73.9%,
compared with 66.6% for the first quarter of 2019.
The increase in operating expenses compared with the first
quarter of 2019 was primarily due to significantly higher
brokerage, 	clearing, 	exchange 	and 	distribution 	fees
(reflecting an increase in activity levels), net provisions for
litigation and regulatory proceedings, and expenses related
to 	consolidated 	investments, 	including 	impairments
(increase was primarily in depreciation and amortization,
occupancy and other expenses). In addition, technology
expenses and professional fees were higher. The first
quarter of 2020 also included higher expenses related to
our credit card activities (increases were primarily in
professional fees and other expenses) and the impact of the
consolidation 	of 	United 	Capital. 	Compensation 	and
benefits expenses were essentially unchanged, while market
development expenses were lower.
Net provisions for litigation and regulatory proceedings for
the first quarter of 2020 were $184 million compared with
$37 million for the first quarter of 2019.
As of March 2020, headcount was essentially unchanged
compared with the end of 2019.
103 Goldman Sachs March 2020 Form 10-Q

-- 105 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Provision for Taxes
The effective income tax rate for the first quarter of 2020
was 10.0%, down from the full year tax rate of 20.0% for
2019, primarily due to tax benefits on the settlement of
employee share-based awards and the impact of lower
pre-tax earnings on permanent tax benefits in the first
quarter of 2020.
The CARES Act was enacted on March 27, 2020. The
CARES Act includes retroactive and prospective provisions
enacted to provide income tax relief and liquidity to
businesses affected by the COVID-19 pandemic. The
legislation includes corporate income tax provisions that
temporarily allow for the carryback of net operating losses
and remove limitations on the use of loss carryforwards,
increase interest expense deduction limitations and allow
accelerated 	depreciation 	deductions 	on 	certain 	asset
improvements. The CARES Act did not have a material
impact on our effective tax rate for the first quarter of 2020.
The U.S. Internal Revenue Service and the U.S. Department
of 	the 	Treasury 	have 	released 	final 	and 	proposed
regulations relating to the implementation of Global
Intangible Low Taxed Income and Base Erosion and Anti-
Abuse Tax. These final and proposed regulations did not
have a material impact on our effective tax rate for the first
quarter of 2020.
On March 19, 2020, the U.K. government published
Finance Bill 2019-21 (Finance Bill). The Finance Bill
includes a repeal of a previously enacted two percentage
point decrease in the corporate income tax rate that was
scheduled to become effective April 1, 2020. Following
Royal Assent, the Finance Bill will be enacted as Finance
Act 2020. The impact of this legislation on our provision
for income taxes and income tax assets and liabilities will be
recognized upon enactment. We do not expect this
legislation to have a material impact on our effective tax
rate for 2020.
Based on the first quarter of 2020, we expect our 2020 tax
rate to be below 20%, excluding the impact of any
non-deductible litigation.
Segment Assets and Operating Results
Segment Assets. The table below presents assets by
segment.
As of
$ in millions
March
2020
December
2019
Investment Banking 	$ 105,059 	$ 92,009
Global Markets 	800,476 	725,060
Asset Management 	92,636 	92,102
Consumer & Wealth Management 	91,585 	83,797
Total 	$1,089,756 	$992,968
The allocation process for segment assets is based on the
activities of these segments. The allocation of assets
includes allocation of global core liquid assets (GCLA)
(which consists of unencumbered, highly liquid securities
and cash), which is generally included within cash and cash
equivalents, collateralized agreements and trading assets on
our balance sheet. Due to the integrated nature of these
segments, estimates and judgments are made in allocating
these assets. See “Risk Management — Liquidity Risk
Management” for further information about our GCLA.
Segment Operating Results. The table below presents
our segment operating results.
Three Months
Ended March
$ in millions 	2020 	2019
Investment Banking
Net revenues 	$ 	2,184 	$ 	1,746
Provision for credit losses 	622 	86
Operating expenses 	1,169 	1,005
Pre-tax earnings 	$ 	393 	$ 	655
Net earnings to common 	$ 	343 	$ 	535
Average common equity 	$ 	11,308 	$ 11,496
Return on average common equity 	12.1% 	18.6%
Global Markets
Net revenues 	$ 	5,163 	$ 	4,040
Provision for credit losses 	68 	3
Operating expenses 	2,847 	2,748
Pre-tax earnings 	$ 	2,248 	$ 	1,289
Net earnings to common 	$ 	1,964 	$ 	1,020
Average common equity 	$ 	39,797 	$ 40,705
Return on average common equity 	19.7% 	10.0%
Asset Management
Net revenues 	$ 	(96) 	$ 	1,793
Provision for credit losses 	79 	13
Operating expenses 	1,198 	1,103
Pre-tax earnings/(loss) 	$ 	(1,373) 	$ 	677
Net earnings/(loss) to common 	$ 	(1,250) 	$ 	549
Average common equity 	$ 	21,156 	$ 20,365
Return on average common equity 	(23.6)% 	10.8%
Consumer & Wealth Management
Net revenues 	$ 	1,492 	$ 	1,228
Provision for credit losses 	168 	122
Operating expenses 	1,244 	1,008
Pre-tax earnings 	$ 	80 	$ 	98
Net earnings to common 	$ 	66 	$ 	78
Average common equity 	$ 	7,002 	$ 	5,859
Return on average common equity 	3.8% 	5.3%
Total net revenues 	$ 	8,743 	$ 	8,807
Total provision for credit losses 	937 	224
Total operating expenses 	6,458 	5,864
Total pre-tax earnings 	$ 	1,348 	$ 	2,719
Net earnings to common 	$ 	1,123 	$ 	2,182
Average common equity 	$ 	79,263 	$ 78,425
Return on average common equity 	5.7% 	11.1%
Goldman Sachs March 2020 Form 10-Q 104

-- 106 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Net revenues in our segments include allocations of interest
income and expense to specific positions in relation to the
cash generated by, or funding requirements of, such
positions. See Note 25 to the consolidated financial
statements for further information about our business
segments.
The allocation of common shareholders’ equity and
preferred stock dividends to each segment is based on the
estimated amount of equity required to support the
activities of the segment under relevant regulatory capital
requirements. Net earnings for each segment is calculated
by applying the firmwide tax rate to each segment’s pre-tax
earnings.
Compensation and benefits expenses within our segments
reflect, among other factors, our overall performance, as
well 	as 	the 	performance 	of 	individual 	businesses.
Consequently, pre-tax margins in one segment of our
business may be significantly affected by the performance
of our other business segments. A description of segment
operating results follows.
Investment Banking
Investment Banking generates revenues from the following:
‰ Financial 	advisory. 	Includes 	strategic 	advisory
assignments with respect to mergers and acquisitions,
divestitures, corporate defense activities, restructurings
and spin-offs.
‰ Underwriting. Includes public offerings and private
placements, including local and cross-border transactions
and acquisition financing, of a wide range of securities
and other financial instruments, including loans.
‰ Corporate 	lending. 	Includes 	lending 	to 	corporate
clients, including middle-market lending, relationship
lending and acquisition financing.
The table below presents our Investment Banking assets.
As of
$ in millions
March
2020
December
2019
Cash and cash equivalents 	$ 15,425 	$25,301
Collateralized agreements 	21,305 	13,376
Customer and other receivables 	3,469 	3,576
Trading assets 	15,585 	20,737
Investments 	696 	854
Loans 	46,947 	26,565
Other assets 	1,632 	1,600
Total assets 	$105,059 	$92,009
The table below presents our Investment Banking operating
results.
Three Months
Ended March
$ in millions 	2020 	2019
Financial advisory 	$ 	781 	$ 	874
Equity underwriting 	378 	262
Debt underwriting 	583 	482
Underwriting 	961 	744
Corporate lending 	442 	128
Net revenues 	2,184 	1,746
Provision for credit losses 	622 	86
Operating expenses 	1,169 	1,005
Pre-tax earnings 	393 	655
Provision for taxes 	39 	112
Net earnings 	354 	543
Preferred stock dividends 	11 	8
Net earnings to common 	$ 	343 	$ 	535
Average common equity 	$11,308 	$11,496
Return on average common equity 	12.1% 	18.6%
The table below presents our financial advisory and
underwriting transaction volumes.
Three Months
Ended March
$ in billions 	2020 	2019
Announced mergers and acquisitions 	$ 	245 	$ 	393
Completed mergers and acquisitions 	$ 	196 	$ 	372
Equity and equity-related offerings 	$ 	12 	$ 	16
Debt offerings 	$ 	91 	$ 	70
In the table above:
‰ Volumes are per Dealogic.
‰ Announced and completed mergers and acquisitions
volumes are based on full credit to each of the advisors in
a transaction. Equity and equity-related offerings and
debt offerings are based on full credit for single book
managers and equal credit for joint book managers.
Transaction volumes may not be indicative of net
revenues in a given period. In addition, transaction
volumes for prior periods may vary from amounts
previously reported due to the subsequent withdrawal or
a change in the value of a transaction.
‰ Equity and equity-related offerings includes Rule 144A
and public common stock offerings, convertible offerings
and rights offerings.
‰ Debt offerings includes non-convertible preferred stock,
mortgage-backed securities, asset-backed securities and
taxable municipal debt. Includes publicly registered and
Rule 144A issues and excludes leveraged loans.
105 Goldman Sachs March 2020 Form 10-Q

-- 107 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Operating Environment. During the first quarter of 2020,
investment banking activity was negatively impacted by the
economic uncertainty related to the COVID-19 pandemic.
Industry-wide 	announced 	and 	completed 	mergers 	and
acquisitions activity decreased compared with the fourth
quarter of 2019. In underwriting, industry-wide equity
underwriting transactions decreased, reflecting a decline in
initial public offerings, and industry-wide debt underwriting
activity reflected a decrease in acquisition-related financing,
but a significant increase in investment-grade activity, all
compared with the fourth quarter of 2019. In credit markets,
spreads widened, particularly towards the end of the quarter,
and corporate clients borrowed under revolving lines of credit
to address liquidity needs. In the future, if industry-wide
mergers and acquisitions transactions, equity underwriting
transactions or debt underwriting transactions continue to
decline, or credit spreads tighten, net revenues in Investment
Banking would likely be negatively impacted. In addition, a
continued deterioration in the creditworthiness of borrowers
would negatively impact the provision for credit losses.
Three Months Ended March 2020 versus March 2019.
Net revenues in Investment Banking were $2.18 billion for
the first quarter of 2020, 25% higher than the first quarter
of 2019, reflecting significantly higher net revenues in
Corporate lending and Underwriting, partially offset by
lower net revenues in Financial advisory.
The increase in Corporate lending net revenues was due to
significantly higher net revenues related to relationship
lending activities, reflecting the impact of changes in credit
spreads on hedges. The first quarter of 2020 included
approximately $375 million of net gains related to these
hedges. The increase in Underwriting net revenues was due
to significantly higher net revenues in Equity underwriting,
primarily from initial public offerings and convertible
offerings, and in Debt underwriting, driven by asset-backed
and leveraged finance activity. The decrease in Financial
advisory net revenues reflected a decrease in industry-wide
completed mergers and acquisitions transactions.
Provision for credit losses was $622 million for the first
quarter of 2020, compared with $86 million for the first
quarter of 2019, primarily due to draws on committed
corporate lines, continued pressure in the energy sector, and
the impact of the COVID-19 pandemic on the broader
economic environment. In addition, the first quarter of 2020
included the impact of accounting for credit losses under the
CECL standard. See Note 3 to the consolidated financial
statements for further information about ASU No. 2016-13.
Operating expenses were $1.17 billion for the first quarter
of 2020, 16% higher than the first quarter of 2019,
primarily due to higher net provisions for litigation and
regulatory proceedings. Pre-tax earnings were $393 million
for the first quarter of 2020, 40% lower than the first
quarter of 2019.
As of March 2020, our investment banking transaction
backlog decreased compared with December 2019, due to
lower estimated net revenues from potential advisory
transactions and potential debt underwriting transactions,
particularly 	from 	acquisition-related 	financing. 	These
decreases were partially offset by higher estimated net
revenues from potential equity underwriting transactions,
primarily from secondary and initial public offerings.
Our investment banking transaction backlog represents an
estimate of our future net revenues from investment
banking transactions where we believe that future revenue
realization is more likely than not. We believe changes in
our investment banking transaction backlog may be a
useful indicator of client activity levels which, over the long
term, impact our net revenues. However, the time frame for
completion and corresponding revenue recognition of
transactions in our backlog varies based on the nature of
the assignment, as certain transactions may remain in our
backlog for longer periods of time, which we expect to
occur in light of the impact of the COVID-19 pandemic on
mergers and acquisitions. In addition, our transaction
backlog 	is 	subject 	to 	certain 	limitations, 	such 	as
assumptions about the likelihood that individual client
transactions will occur in the future. Transactions may be
cancelled or modified, and transactions not included in the
estimate may also occur.
Global Markets
Our Global Markets segment consists of:
FICC. FICC generates revenues from intermediation and
financing activities.
‰ FICC intermediation. Includes client execution activities
related to making markets in both trading cash and
derivative instruments, as detailed below.
Interest Rate Products. Government bonds (including
inflation-linked 	securities) 	across 	maturities, 	other
government-backed securities, and interest rate swaps,
options and other derivatives.
Credit Products. Investment-grade corporate securities,
high-yield securities, credit derivatives, exchange-traded
funds 	(ETFs), 	bank 	and 	bridge 	loans, 	municipal
securities, emerging market and distressed debt, and trade
claims.
Mortgages. Commercial mortgage-related securities,
loans 	and 	derivatives, 	residential 	mortgage-related
securities, 	loans 	and 	derivatives 	(including 	U.S.
government 	agency-issued 	collateralized 	mortgage
obligations and other securities and loans), and other
asset-backed securities, loans and derivatives.
Currencies. Currency options, spot/forwards and other
derivatives on G-10 currencies and emerging-market
products.
Goldman Sachs March 2020 Form 10-Q 106

-- 108 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Commodities. Commodity derivatives and, to a lesser
extent, physical commodities, involving crude oil and
petroleum products, natural gas, base, precious and other
metals, 	electricity, 	coal, 	agricultural 	and 	other
commodity products.
For further information about market-making activities,
see “Market-Making Activities” below.
‰ FICC financing. Includes providing financing to our
clients through securities sold under agreements to
repurchase (repurchase agreements), as well as through
structured 	credit, 	warehouse 	lending 	(including
residential and commercial mortgage lending) and asset-
backed lending, which are typically longer term in nature.
Equities. Equities generates revenues from intermediation
and financing activities.
‰ Equities intermediation. We make markets in equity
securities and equity-related products, including ETFs,
convertible 	securities, 	options, 	futures 	and
over-the-counter (OTC) derivative instruments, on a
global basis. We also structure and make markets in
derivatives 	on 	indices, 	industry 	sectors, 	financial
measures and individual company stocks. Our exchange-
based market-making activities include making markets
in stocks and ETFs, futures and options on major
exchanges 	worldwide. 	In 	addition, 	we 	generate
commissions and fees from executing and clearing
institutional client transactions on major stock, options
and futures exchanges worldwide, as well as OTC
transactions. For further information about market-
making activities, see “Market-Making Activities” below.
‰ Equities financing. Includes prime brokerage and other
equities financing activities, including securities lending,
margin lending and swaps. We earn fees by providing
clearing, settlement and custody services globally. We
provide services that principally involve borrowing and
lending securities to cover institutional clients’ short sales
and borrowing securities to cover our short sales and
otherwise to make deliveries into the market. In addition,
we are an active participant in broker-to-broker securities
lending and third-party agency lending activities. We
provide financing to our clients for their securities trading
activities through margin loans that are collateralized by
securities, cash or other acceptable collateral. In addition,
we execute swap transactions to provide our clients with
exposure to securities and indices.
Market-Making Activities
As a market maker, we facilitate transactions in both liquid
and less liquid markets, primarily for institutional clients,
such as corporations, financial institutions, investment
funds and governments, to assist clients in meeting their
investment objectives and in managing their risks. In this
role, we seek to earn the difference between the price at
which a market participant is willing to sell an instrument
to us and the price at which another market participant is
willing to buy it from us, and vice versa (i.e., bid/offer
spread). In addition, we maintain (i) market-making
positions, typically for a short period of time, in response
to, or in anticipation of, client demand, and (ii) positions to
actively manage our risk exposures that arise from these
market-making activities (collectively, inventory). Our
inventory is recorded in trading assets (long positions) or
trading liabilities (short positions) in our consolidated
balance sheets.
Our 	results 	are 	influenced 	by 	a 	combination 	of
interconnected drivers, including (i) client activity levels and
transactional bid/offer spreads (collectively, client activity),
and (ii) changes in the fair value of our inventory and
interest income and interest expense related to the holding,
hedging and funding of our inventory (collectively, market-
making inventory changes). Due to the integrated nature of
our 	market-making 	activities, 	disaggregation 	of 	net
revenues into client activity and market-making inventory
changes is judgmental and has inherent complexities and
limitations.
The amount and composition of our net revenues vary over
time as these drivers are impacted by multiple interrelated
factors 	affecting 	economic 	and 	market 	conditions,
including volatility and liquidity in the market, changes in
interest rates, currency exchange rates, credit spreads,
equity prices and commodity prices, investor confidence,
and other macroeconomic concerns and uncertainties.
In general, assuming all other market-making conditions
remain constant, increases in client activity levels or bid/
offer spreads tend to result in increases in net revenues, and
decreases tend to have the opposite effect. However,
changes in market-making conditions can materially impact
client activity levels and bid/offer spreads, as well as the fair
value of our inventory. For example, a decrease in liquidity
in the market could have the impact of (i) increasing our
bid/offer spread, (ii) decreasing investor confidence and
thereby decreasing client activity levels, and (iii) widening
of credit spreads on our inventory positions.
107 Goldman Sachs March 2020 Form 10-Q

-- 109 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents our Global Markets assets.
As of
$ in millions
March
2020
December
2019
Cash and cash equivalents 	$ 68,511 	$ 82,819
Collateralized agreements 	207,297 	196,278
Customer and other receivables 	109,941 	63,277
Trading assets 	341,644 	316,242
Investments 	33,774 	25,937
Loans 	30,272 	31,111
Other assets 	9,037 	9,396
Total assets 	$800,476 	$725,060
The table below presents our Global Markets operating
results.
Three Months
Ended March
$ in millions 	2020 	2019
FICC intermediation 	$ 	2,537 	$ 	1,872
FICC financing 	432 	366
FICC 	2,969 	2,238
Equities intermediation 	1,528 	1,161
Equities financing 	666 	641
Equities 	2,194 	1,802
Net revenues 	5,163 	4,040
Provision for credit losses 	68 	3
Operating expenses 	2,847 	2,748
Pre-tax earnings 	2,248 	1,289
Provision for taxes 	225 	221
Net earnings 	2,023 	1,068
Preferred stock dividends 	59 	48
Net earnings to common 	$ 	1,964 	$ 	1,020
Average common equity 	$ 39,797 	$ 40,705
Return on average common equity 	19.7% 	10.0%
In the table above, net revenues for the three months ended
March 2020 included gains of approximately $180 million
(of the total gains of approximately $265 million for the
firm) related to sales of available-for-sale securities, of
which approximately 50% was recorded in each of FICC
and Equities.
The table below presents our Global Markets net revenues
by line item in the consolidated statements of earnings.
$ in millions 	FICC 	Equities
Global
Markets
Three Months Ended March 2020
Market making 	$2,334 	$1,348 	$3,682
Commissions and fees 	– 	980 	980
Other principal transactions 	(20) 	10 	(10)
Net interest income 	655 	(144) 	511
Total net revenues 	$2,969 	$2,194 	$5,163
Three Months Ended March 2019
Market making 	$1,702 	$1,021 	$2,723
Commissions and fees 	– 	714 	714
Other principal transactions 	11 	35 	46
Net interest income 	525 	32 	557
Total net revenues 	$2,238 	$1,802 	$4,040
In the table above:
‰ The difference between commissions and fees and those
in the consolidated statements of earnings represents
commissions and fees included in our Consumer &
Wealth Management segment.
‰ See “Net Revenues” for further information about
market making revenues, commissions and fees, other
principal transactions revenues and net interest income.
See Note 25 to the consolidated financial statements for
net interest income by business segment.
‰ The 	primary 	driver 	of 	net 	revenues 	for 	FICC
intermediation was client activity.
Operating Environment. During the first quarter of 2020,
Global Markets operated in an environment characterized
by strong client activity and higher levels of volatility
compared with the fourth quarter of 2019. The average
daily VIX for the first quarter of 2020 increased to 30 (and
peaked at 83 in March), compared with 14 for the fourth
quarter of 2019. The increase in client activity and volatility
was due to the risks from the COVID-19 pandemic as
clients reacted to the significant decline in near-term global
economic 	activity 	and 	the 	accommodative 	monetary
policies set by global central banks. Global equity markets
decreased during the first quarter of 2020 (with the MSCI
World Index down 22%) and credit spreads widened (with
U.S. investment-grade wider by approximately 150 basis
points 	and 	high-yield 	credit 	spreads 	wider 	by
approximately 375 basis points), both particularly towards
the end of the quarter. If macroeconomic concerns lead to a
decline in activity levels or volatility, net revenues in Global
Markets would likely be negatively impacted.
Three Months Ended March 2020 versus March 2019.
Net revenues in Global Markets were $5.16 billion for the
first quarter of 2020, 28% higher than the first quarter of
2019.
Net revenues in FICC were $2.97 billion, 33% higher than
the first quarter of 2019, due to significantly higher net
revenues in FICC intermediation, reflecting significantly
higher client activity, partially offset by the impact of
challenging market-making conditions on our inventory,
and higher net revenues in FICC financing, driven by
repurchase agreements.
The following provides information about our FICC
intermediation net revenues by business, compared with
results in the first quarter of 2019:
‰ Net revenues in currencies were significantly higher,
driven by higher client activity.
‰ Net revenues in credit products were significantly higher
and commodities were higher, reflecting higher client
activity, partially offset by the impact of challenging
market-making conditions on our inventory.
‰ Net revenues in interest rate products were slightly
higher, reflecting higher client activity, largely offset by
the impact of challenging market-making conditions on
our inventory.
Goldman Sachs March 2020 Form 10-Q 108

-- 110 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
‰ Net revenues in mortgages were significantly lower,
driven by the impact of challenging market-making
conditions on our inventory.
Net revenues in Equities were $2.19 billion, 22% higher
than the first quarter of 2019, due to significantly higher net
revenues in Equities intermediation, driven by derivatives,
and slightly higher net revenues in Equities financing,
reflecting higher average customer balances.
Provision for credit losses was $68 million for the first
quarter of 2020, compared with $3 million for the first
quarter of 2019, reflecting the impact of the COVID-19
pandemic on the broader economic environment.
Operating expenses were $2.85 billion for the first quarter
of 2020, 4% higher than the first quarter of 2019, due to
significantly higher brokerage, clearing, exchange and
distribution fees and higher net provisions for litigation and
regulatory 	proceedings, 	partially 	offset 	by 	decreased
compensation and benefits expenses. Pre-tax earnings were
$2.25 billion for the first quarter of 2020, 74% higher than
the first quarter of 2019.
Asset Management
We manage client assets across a broad range of investment
strategies and asset classes for a diverse set of institutional
clients and a network of third-party distributors around the
world, including equity, fixed income and alternative
investments. We provide investment solutions including
those managed on a fiduciary basis by our portfolio
managers, as well as those managed by a variety of third-
party managers. We offer our investment solutions in a
variety 	of 	structures, 	including 	separately 	managed
accounts, mutual funds, private partnerships and other
comingled vehicles. These solutions begin with identifying
clients’ 	objectives 	and 	continue 	through 	portfolio
construction, 	ongoing 	asset 	allocation 	and 	risk
management and investment realization.
In addition to managing client assets, we invest in
alternative investments across a range of asset classes that
seek to deliver long-term accretive risk-adjusted returns.
Our investing activities, which are typically longer term,
include investments in corporate equity, credit, real estate
and infrastructure assets.
Asset Management generates revenues from the following:
‰ Management and other fees. The majority of revenues
in management and other fees consists of asset-based fees
on client assets that we manage. For further information
about assets under supervision (AUS), see “Assets Under
Supervision” below. The fees that we charge vary by asset
class, distribution channel and the types of services
provided, and are affected by investment performance, as
well as asset inflows and redemptions.
‰ Incentive fees. In certain circumstances, we also receive
incentive fees based on a percentage of a fund’s or a
separately managed account’s return, or when the return
exceeds a specified benchmark or other performance
targets. Such fees include overrides, which consist of the
increased share of the income and gains derived primarily
from our private equity and credit funds when the return
on a fund’s investments over the life of the fund exceeds
certain threshold returns. Incentive fees are recognized
when it is probable that a significant reversal of such fees
will not occur.
‰ Equity investments. Our alternative investing activities
relate to public and private equity investments in
corporate, real estate and infrastructure assets. We also
make 	investments 	through 	consolidated 	investment
entities (CIEs), substantially all of which are engaged in
real estate investment activities.
‰ Lending and debt investments. We invest in corporate
debt and provide financing for real estate and other
assets. These activities include investments in mezzanine
debt, senior debt and distressed debt securities.
The table below presents our Asset Management assets.
As of
$ in millions
March
2020
December
2019
Cash and cash equivalents 	$ 5,336 	$ 6,756
Collateralized agreements 	7,011 	3,433
Customer and other receivables 	1,880 	1,579
Trading assets 	5,035 	5,266
Investments 	34,176 	37,096
Loans 	16,246 	17,101
Other assets 	22,952 	20,871
Total assets 	$92,636 	$92,102
The table below presents our Asset Management operating
results.
Three Months
Ended March
$ in millions 	2020 	2019
Management and other fees 	$ 	640 	$ 	607
Incentive fees 	154 	30
Equity investments 	(22) 	805
Lending and debt investments 	(868) 	351
Net revenues 	(96) 	1,793
Provision for credit losses 	79 	13
Operating expenses 	1,198 	1,103
Pre-tax earnings/(loss) 	(1,373) 	677
Provision/(benefit) for taxes 	(137) 	118
Net earnings/(loss) 	(1,236) 	559
Preferred stock dividends 	14 	10
Net earnings/(loss) to common 	$ (1,250) 	$ 	549
Average common equity 	$ 21,156 	$20,365
Return on average common equity 	(23.6)% 	10.8%
109 Goldman Sachs March 2020 Form 10-Q

-- 111 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Operating Environment. During the first quarter of 2020,
macroeconomic concerns from the COVID-19 pandemic
led to lower global equity prices and wider credit spreads,
particularly in March, compared to the end of the fourth
quarter of 2019, as well as uncertainty in the economic
outlook. If the COVID-19 pandemic persists, asset prices
may continue to decline, credit spreads may continue to
widen, investors may continue to favor asset classes that
typically generate lower fees and investors may withdraw
their assets. As a result, net revenues in Asset Management
would likely continue to be negatively impacted.
Three Months Ended March 2020 versus March 2019.
Net revenues in Asset Management were $(96) million for
the first quarter of 2020, compared with $1.79 billion for
the first quarter of 2019, reflecting significant net losses in
Lending and debt investments and net losses in Equity
investments. These decreases were partially offset by
significantly higher Incentive fees and higher Management
and other fees from our institutional and third-party
distribution asset management clients.
As a result of the challenging operating environment,
Lending and debt investments reflected significant net
losses across debt securities, particularly within our private
credit group and multi-strategy investing portfolios. Equity
investments reflected $484 million in mark-to-market net
losses from investments in public equities partially offset by
$462 million of net gains from investments in private
equities. The results from investments in private equities
included approximately $775 million of net gains from
pending 	and 	completed 	sales 	and 	approximately
$200 million of operating net revenues from CIEs, partially
offset by approximately $500 million of mark-downs. Net
revenues in Equity investments for the first quarter of 2020
included net losses of $573 million from corporate
investments, which were largely offset by net gains of
$551 million from real estate investments.
The increase in Incentive fees was driven by harvesting and
the increase in Management and other fees reflected the
impact of higher average assets under supervision, partially
offset by a lower average effective fee due to shifts in the
mix of client assets and strategies.
Provision for credit losses was $79 million for the first
quarter of 2020, compared with $13 million for the first
quarter of 2019, reflecting the impact of the COVID-19
pandemic on the broader economic environment.
Operating expenses were $1.20 billion for the first quarter
of 2020, 9% higher than the first quarter of 2019, due to
higher 	expenses 	related 	to 	consolidated 	investments,
including impairments. Pre-tax loss was $1.37 billion for
the first quarter of 2020, compared with pre-tax earnings of
$677 million for the first quarter of 2019.
Consumer & Wealth Management
Consumer & Wealth Management helps clients achieve
their individual financial goals by providing a broad range
of wealth advisory and banking services, including financial
planning, investment management, deposit taking, and
lending. Services are offered through our global network of
advisors and via our digital platforms.
Wealth Management. Wealth management provides
tailored wealth advisory services to clients across the wealth
spectrum. We operate globally serving individuals, families,
family offices, and select foundations and endowments.
Our relationships are established directly or introduced
through 	corporations 	that 	sponsor 	financial 	wellness
programs for their employees.
We offer personalized financial planning inclusive of
income 	and 	liability management, compensation and
benefits 	analysis, 	trust 	and 	estate 	structuring, 	tax
optimization, philanthropic giving, and asset protection.
We also provide customized investment advisory solutions,
and offer structuring and execution capabilities in security
and derivative products across all major global markets.
We 	leverage 	a 	broad, 	open-architecture 	investment
platform and our global execution capabilities to help
clients achieve their investment goals. In addition, we offer
clients a full range of private banking services, including a
variety of deposit alternatives and loans that our clients use
to finance investments in both financial and nonfinancial
assets, bridge cash flow timing gaps or provide liquidity and
flexibility for other needs.
Wealth 	management 	generates 	revenues 	from 	the
following:
‰ Management and other fees. Includes fees related to
managing assets, providing investing and wealth advisory
solutions, providing financial planning and counseling
services via our subsidiary, The Ayco Company, L.P., and
executing brokerage transactions for wealth management
clients.
‰ Incentive fees. In certain circumstances, we also receive
incentive fees based on a percentage of a fund’s return, or
when the return exceeds a specified benchmark or other
performance targets. Such fees include overrides, which
consist of the increased share of the income and gains
derived primarily from our private equity and credit funds
when the return on a fund’s investments over the life of
the fund exceeds certain threshold returns. Incentive fees
are recognized when it is probable that a significant
reversal of such fees will not occur.
‰ Private banking and lending. Includes interest income
allocated to deposit-taking and net interest income earned
on lending activities for wealth management clients.
Goldman Sachs March 2020 Form 10-Q 110

-- 112 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Consumer Banking. Our Consumer banking business
issues unsecured loans, through Marcus and credit cards to
finance the purchases of goods or services. We also accept
deposits through Marcus, primarily through Goldman
Sachs Bank USA (GS Bank USA) and Goldman Sachs
International Bank (GSIB), that are used as a source of
funding. These deposits include savings and time deposits
which provide us with a diversified source of funding that
reduces our reliance on wholesale funding.
Consumer banking revenues consist of net interest income
earned on unsecured loans issued to consumers through
Marcus and credit card lending activities, and net interest
income allocated to consumer deposits.
The table below presents our Consumer & Wealth
Management assets.
As of
$ in millions
March
2020
December
2019
Cash and cash equivalents 	$16,217 	$18,670
Collateralized agreements 	18,390 	8,675
Customer and other receivables 	5,637 	6,173
Trading assets 	13,207 	13,087
Investments 	48 	50
Loans 	34,988 	34,127
Other assets 	3,098 	3,015
Total assets 	$91,585 	$83,797
The table below presents our Consumer & Wealth
Management operating results.
Three Months
Ended March
$ in millions 	2020 	2019
Management and other fees 	$ 	959 	$ 	794
Incentive fees 	69 	28
Private banking and lending 	182 	203
Wealth management 	1,210 	1,025
Consumer banking 	282 	203
Net revenues 	1,492 	1,228
Provision for credit losses 	168 	122
Operating expenses 	1,244 	1,008
Pre-tax earnings 	80 	98
Provision for taxes 	8 	17
Net earnings 	72 	81
Preferred stock dividends 	6 	3
Net earnings to common 	$ 	66 	$ 	78
Average common equity 	$ 7,002 	$ 5,859
Return on average common equity 	3.8% 	5.3%
Operating Environment. During the first quarter of 2020,
macroeconomic concerns from the COVID-19 pandemic
led to lower global equity prices, particularly in March,
compared to the end of the fourth quarter of 2019, which
affected the market levels of our long-term assets under
supervision. Our consumer banking activities reflected
continued increases in deposits, while loan balances
remained stable. If the COVID-19 pandemic persists, asset
prices may continue to decline, investors may continue to
favor asset classes that typically generate lower fees,
investors may withdraw their assets and consumers may
withdraw 	their 	deposits 	or 	consumer 	credit 	may
deteriorate. As a result, net revenues and the provision for
credit losses in Consumer & Wealth Management would
likely continue to be negatively impacted.
Three Months Ended March 2020 and March 2019. Net
revenues in Consumer & Wealth Management were
$1.49 billion for the first quarter of 2020, 21% higher than
the first quarter of 2019.
Net revenues in Wealth management were $1.21 billion,
18% higher than the first quarter of 2019, due to
significantly higher Management and other fees (including
the impact of the consolidation of United Capital),
primarily reflecting higher average assets under supervision
and higher transaction volumes, and higher Incentive fees.
Net revenues in Private banking and lending were lower
compared with the first quarter of 2019.
Net revenues in Consumer banking were $282 million,
39% higher than the first quarter of 2019, driven by higher
net interest income, primarily reflecting an increase in
deposit balances and the addition of credit card loans.
Provision for credit losses was $168 million for the first
quarter of 2020, 38% higher than the first quarter of 2019,
as the first quarter of 2020 included provisions related to
credit card loans.
Operating expenses were $1.24 billion for the first quarter
of 2020, 23% higher than the first quarter of 2019,
primarily due to the impact of the consolidation of United
Capital and higher expenses related to our credit card
activities. Pre-tax earnings were $80 million for the first
quarter of 2020, 18% lower than the first quarter of 2019.
111 Goldman Sachs March 2020 Form 10-Q

-- 113 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Assets Under Supervision
Assets under supervision includes our institutional clients’
assets and assets sourced through third-party distributors
(both included in our Asset Management segment), as well
as 	high-net-worth 	clients’ 	assets 	(included 	in 	our
Consumer & Wealth Management segment), where we
earn a fee for managing assets on a discretionary basis. This
includes net assets in our mutual funds, hedge funds, credit
funds, private equity funds, real estate funds, and separately
managed 	accounts 	for 	institutional 	and 	individual
investors. Assets under supervision also include client assets
invested with third-party managers, private bank deposits
and advisory relationships where we earn a fee for advisory
and other services, but do not have investment discretion.
Assets under supervision do not include the self-directed
brokerage assets of our clients.
The table below presents information about our firmwide
period-end assets under supervision by segment, asset class,
distribution channel, region and vehicle.
As of March
$ in billions 	2020 	2019
Segment
Asset Management 	$1,309 	$1,117
Consumer & Wealth Management 	509 	482
Total AUS 	$1,818 	$1,599
Asset Class
Alternative investments 	$ 178 	$ 172
Equity 	335 	335
Fixed income 	771 	717
Total long-term AUS 	1,284 	1,224
Liquidity products 	534 	375
Total AUS 	$1,818 	$1,599
Distribution Channel
Institutional 	$ 657 	$ 620
Wealth management 	509 	482
Third-party distributed 	652 	497
Total AUS 	$1,818 	$1,599
Region
Americas 	$1,396 	$1,183
EMEA 	264 	255
Asia 	158 	161
Total AUS 	$1,818 	$1,599
Vehicle
Separate accounts 	$1,001 	$ 927
Public funds 	622 	510
Private funds and other 	195 	162
Total AUS 	$1,818 	$1,599
In the table above:
‰ Liquidity products includes money market funds and
private bank deposits.
‰ EMEA represents Europe, Middle East and Africa.
Asset classes, such as alternative investment and equity assets,
typically generate higher fees relative to fixed income and
liquidity product assets. The average effective management fee
(which excludes non-asset-based fees) we earned on our
firmwide assets under supervision was 31 basis points for the
three months ended March 2020 and 33 basis points for the
three months ended March 2019. This decrease primarily
reflected shifts in the mix of client assets and strategies.
We earn management fees on client assets that we manage
and also receive incentive fees based on a percentage of a
fund’s or a separately managed account’s return, or when
the 	return 	exceeds 	a 	specified 	benchmark 	or 	other
performance targets. These incentive fees are recognized
when it is probable that a significant reversal of such fees
will not occur. Our estimated unrecognized incentive fees
were $1.58 billion as of March 2020 and $1.63 billion as of
December 2019. Such amounts are based on the completion
of the funds’ financial statements, which is generally one
quarter in arrears. These fees will be recognized, assuming
no decline in fair value, if and when it is probable that a
significant reversal of such fees will not occur, which is
generally 	when 	such 	fees 	are 	no 	longer 	subject 	to
fluctuations in the market value of the assets of the funds.
The table below presents changes in our assets under
supervision.
Three Months
Ended March
$ in billions 	2020 	2019
Asset Management
Beginning balance 	$1,298 	$1,087
Net inflows/(outflows):
Alternative investments 	(1) 	–
Equity 	2 	3
Fixed income 	7 	18
Total long-term AUS net inflows/(outflows) 	8 	21
Liquidity products 	66 	(25)
Total AUS net inflows/(outflows) 	74 	(4)
Net market appreciation/(depreciation) 	(63) 	34
Ending balance 	$1,309 	$1,117
Consumer & Wealth Management
Beginning balance 	$ 561 	$ 455
Net inflows/(outflows):
Alternative investments 	– 	1
Equity 	1 	(4)
Fixed income 	(8) 	2
Total long-term AUS net inflows/(outflows) 	(7) 	(1)
Liquidity products 	6 	3
Total AUS net inflows/(outflows) 	(1) 	2
Net market appreciation/(depreciation) 	(51) 	25
Ending balance 	$ 509 	$ 482
Firmwide
Beginning balance 	$1,859 	$1,542
Net inflows/(outflows):
Alternative investments 	(1) 	1
Equity 	3 	(1)
Fixed income 	(1) 	20
Total long-term AUS net inflows/(outflows) 	1 	20
Liquidity products 	72 	(22)
Total AUS net inflows/(outflows) 	73 	(2)
Net market appreciation/(depreciation) 	(114) 	59
Ending balance 	$1,818 	$1,599
Goldman Sachs March 2020 Form 10-Q 112

-- 114 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents information about our average
monthly firmwide assets under supervision by segment and
asset class.
Average for the
Three Months
Ended March
$ in billions 	2020 	2019
Segment
Asset Management 	$1,295 	$1,102
Consumer & Wealth Management 	546 	474
Total AUS 	$1,841 	$1,576
Asset Class
Alternative investments 	$ 183 	$ 170
Equity 	392 	324
Fixed income 	796 	693
Total long-term AUS 	1,371 	1,187
Liquidity products 	470 	389
Total AUS 	$1,841 	$1,576
In addition to our assets under supervision, we have
discretion over alternative investments where we currently
do not earn management fees (non-fee-earning alternative
assets).
The table below presents information about our assets
under supervision for alternative assets, non-fee-earning
alternative assets and total alternative assets.
$ in billions 	AUS
Non-fee-earning
alternative assets
Total
alternative
assets
As of March 2020
Corporate equity 	$ 80 	$ 40 	$120
Credit 	15 	49 	64
Real estate 	13 	45 	58
Hedge funds and multi-asset 	70 	1 	71
Other 	– 	1 	1
Total 	$178 	$136 	$314
As of March 2019
Corporate equity 	$ 73 	$ 39 	$112
Credit 	12 	45 	57
Real estate 	10 	43 	53
Hedge funds and multi-asset 	77 	1 	78
Other 	– 	1 	1
Total 	$172 	$129 	$301
In the table above:
‰ Substantially all corporate equity is private equity.
‰ Total alternative assets included uncalled capital that is
available for future investing of $31 billion as of
March 2020 and $24 billion as of March 2019.
‰ Non-fee-earning alternative assets primarily includes
investments that we hold on our balance sheet, our
unfunded commitments, unfunded commitments of our
clients (where we do not charge fees on commitments),
credit facilities collateralized by fund assets and employee
funds. Our calculation of non-fee-earning alternative
assets may not be comparable to similar calculations used
by other companies.
The table below presents information about alternative
investments in our Asset Management segment that we
hold on our balance sheet.
$ in billions 	Loans
Debt
securities 	Equity
Other
assets 	Total
As of March 2020
Corporate equity 	$ – 	$ – 	$16 	$ – 	$16
Credit 	8 	10 	– 	– 	18
Real estate 	8 	3 	5 	19 	35
Other 	– 	– 	– 	1 	1
Total 	$16 	$13 	$21 	$20 	$70
As of March 2019
Corporate equity 	$ – 	$ – 	$18 	$ – 	$18
Credit 	6 	8 	– 	– 	14
Real estate 	8 	3 	4 	15 	30
Other 	– 	– 	– 	1 	1
Total 	$14 	$11 	$22 	$16 	$63
In the table above:
‰ Corporate equity includes private equity positions of
$14 billion as of March 2020 and $17 billion as of
March 2019. Corporate equity also includes public equity
positions that converted from private equity upon the
initial public offering of the underlying company of
$2 billion as of March 2020 and $1 billion as of
March 2019.
‰ Other assets represents investments held by CIEs, which
were funded with liabilities of approximately $11 billion
as of March 2020 and $8 billion as of March 2019.
Substantially all such liabilities were nonrecourse, thereby
reducing our equity at risk.
The table below presents information about our equity
investments by vintage.
$ in billions
As of
March 2020
Equity investments 	$21
2013 or earlier 	36%
2014 - 2016 	37%
2017 - thereafter 	27%
Total 	100%
Geographic Data
See Note 25 to the consolidated financial statements for a
summary of our total net revenues and pre-tax earnings by
geographic region.
113 Goldman Sachs March 2020 Form 10-Q

-- 115 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Balance Sheet and Funding Sources
Balance Sheet Management
One of our risk management disciplines is our ability to
manage the size and composition of our balance sheet.
While our asset base changes due to client activity, market
fluctuations and business opportunities, the size and
composition of our balance sheet also reflects factors
including (i) our overall risk tolerance, (ii) the amount of
equity capital we hold and (iii) our funding profile, among
other factors. See “Equity Capital Management and
Regulatory Capital — Equity Capital Management” for
information about our equity capital management process.
Although our balance sheet fluctuates on a day-to-day
basis, our total assets at quarter-end and year-end dates are
generally not materially different from those occurring
within our reporting periods.
In order to ensure appropriate risk management, we seek to
maintain a sufficiently liquid balance sheet and have
processes in place to dynamically manage our assets and
liabilities, 	which 	include 	(i) 	balance 	sheet 	planning,
(ii) balance sheet limits, (iii) monitoring of key metrics and
(iv) scenario analyses.
Balance Sheet Planning. We prepare a balance sheet plan
that combines our projected total assets and composition of
assets with our expected funding sources over a three-year
time horizon. This plan is reviewed quarterly and may be
adjusted in response to changing business needs or market
conditions. The objectives of this planning process are:
‰ To develop our balance sheet projections, taking into
account the general state of the financial markets and
expected business activity levels, as well as regulatory
requirements;
‰ To allow Treasury and our independent risk oversight
and control functions to objectively evaluate balance
sheet limit requests from our revenue-producing units in
the context of our overall balance sheet constraints,
including our liability profile and equity capital levels,
and key metrics; and
‰ To inform the target amount, tenor and type of funding to
raise, based on our projected assets and contractual
maturities.
Treasury and our independent risk oversight and control
functions, along with our revenue-producing units, review
current and prior period information and expectations for
the year to prepare our balance sheet plan. The specific
information reviewed includes asset and liability size and
composition, 	limit 	utilization, 	risk 	and 	performance
measures, and capital usage.
Our consolidated balance sheet plan, including our balance
sheets by business, funding projections and projected key
metrics, is reviewed and approved by the Firmwide Asset
Liability Committee and the Risk Governance Committee.
See “Risk Management — Overview and Structure of Risk
Management” for an overview of our risk management
structure.
Balance Sheet Limits. The Firmwide Asset Liability
Committee and the Risk Governance Committee have the
responsibility to review and approve balance sheet limits.
These limits are set at levels which are close to actual
operating levels, rather than at levels which reflect our
maximum 	risk 	appetite, 	in 	order to ensure prompt
escalation and discussion among our revenue-producing
units, Treasury and our independent risk oversight and
control functions on a routine basis. Requests for changes
in limits are evaluated after giving consideration to their
impact on our key metrics. Compliance with limits is
monitored by our revenue-producing units and Treasury, as
well 	as 	our 	independent 	risk 	oversight 	and 	control
functions.
Monitoring of Key Metrics. We monitor key balance
sheet metrics both by business and on a consolidated basis,
including asset and liability size and composition, limit
utilization and risk measures. We allocate assets to
businesses and review and analyze movements resulting
from new business activity, as well as market fluctuations.
Scenario Analyses. We conduct various scenario analyses
including as part of the Comprehensive Capital Analysis
and Review (CCAR) and U.S. Dodd-Frank Wall Street
Reform and Consumer Protection Act (Dodd-Frank Act)
Stress Tests (DFAST), as well as our resolution and
recovery planning. See “Equity Capital Management and
Regulatory Capital — Equity Capital Management” for
further information about these scenario analyses. These
scenarios cover short- and long-term time horizons using
various macroeconomic and firm-specific assumptions,
based on a range of economic scenarios. We use these
analyses to assist us in developing our longer-term balance
sheet 	management 	strategy, 	including 	the 	level 	and
composition 	of 	assets, 	funding 	and 	equity 	capital.
Additionally, these analyses help us develop approaches for
maintaining appropriate funding, liquidity and capital
across a variety of situations, including a severely stressed
environment.
Goldman Sachs March 2020 Form 10-Q 114

-- 116 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Balance Sheet Analysis and Metrics
As of March 2020, total assets in our consolidated balance
sheets were $1.09 trillion, an increase of $96.79 billion
from December 2019, primarily reflecting increases in
customer 	and 	other 	receivables 	of 	$46.32 	billion,
collateralized agreements of $32.24 billion, trading assets
of $20.14 billion, and loans of $19.55 billion, partially
offset by a decrease in cash and cash equivalents of
$28.06 billion. The increase in customer and other
receivables primarily reflected higher client activity. The net
increase in collateralized agreements reflected the impact of
our activities and our clients’ activities. The increase in
trading assets primarily reflected the impact of interest rate
and currency movements in derivative instruments. The
increase 	in 	loans 	primarily 	reflected 	an 	increase 	in
corporate loans, partially offset by a decrease in residential
real estate loans. The decrease in cash and cash equivalents
primarily reflected our activities.
As of March 2020, total liabilities in our consolidated
balance sheets were $997.38 billion, an increase of
$94.67 billion from December 2019, primarily reflecting
increases in customer and other payables of $38.36 billion,
deposits 	of 	$29.98 	billion 	and 	trading 	liabilities 	of
$27.52 billion. The increase in customer and other payables
primarily reflected higher client activity. The increase in
deposits 	primarily 	reflected 	increases 	in 	consumer,
institutional and transaction banking deposits. The increase
in trading liabilities reflected the impact of interest rate and
currency movements in derivative instruments.
Our 	total 	repurchase 	agreements, 	accounted 	for 	as
collateralized 	financings, 	were 	$95.86 	billion 	as 	of
March 2020 and $117.76 billion as of December 2019,
which were 12% lower as of March 2020 and 32% higher
as of December 2019 than the average daily amount of
repurchase agreements over the respective quarters. As of
March 2020, the decrease in our repurchase agreements
relative 	to 	the 	average 	daily 	amount 	of 	repurchase
agreements during the quarter resulted from lower levels of
our activity and our clients’ activity at the end of the period.
The level of our repurchase agreements fluctuates between
and within periods, primarily due to providing clients with
access to highly liquid collateral, such as liquid government
and agency obligations, through collateralized financing
activities.
The table below presents information about our balance
sheet and leverage ratios.
As of
$ in millions
March
2020
December
2019
Total assets 	$1,089,756 	$992,968
Unsecured long-term borrowings 	$ 225,476 	$207,076
Total shareholders’ equity 	$ 	92,379 	$ 90,265
Leverage ratio 	11.8x 	11.0x
Debt to equity ratio 	2.4x 	2.3x
In the table above:
‰ The leverage ratio equals total assets divided by total
shareholders’ equity and measures the proportion of
equity and debt we use to finance assets. This ratio is
different from the leverage ratios included in Note 20 to
the consolidated financial statements.
‰ The debt-to-equity ratio equals unsecured long-term
borrowings divided by total shareholders’ equity.
The 	table 	below 	presents 	information 	about 	our
shareholders’ equity and book value per common share,
including the reconciliation of common shareholders’
equity to tangible common shareholders’ equity.
As of
$ in millions, except per share amounts
March
2020
December
2019
Total shareholders’ equity 	$ 	92,379 	$ 90,265
Preferred stock 	(11,203) 	(11,203)
Common shareholders’ equity 	81,176 	79,062
Goodwill and identifiable intangible assets 	(4,810) 	(4,837)
Tangible common shareholders’ equity 	$ 	76,366 	$ 74,225
Book value per common share 	$ 	228.21 	$ 218.52
Tangible book value per common share 	$ 	214.69 	$ 205.15
In the table above:
‰ Tangible common shareholders’ equity is calculated as
total shareholders’ equity less preferred stock, goodwill
and identifiable intangible assets. We believe that tangible
common shareholders’ equity is meaningful because it is a
measure that we and investors use to assess capital
adequacy. Tangible common shareholders’ equity is a
non-GAAP measure and may not be comparable to
similar non-GAAP measures used by other companies.
‰ Book value per common share and tangible book value per
common share are based on common shares outstanding
and restricted stock units granted to employees with no
future service requirements and not subject to performance
conditions (collectively, basic shares) of 355.7 million as of
March 2020 and 361.8 million as of December 2019. We
believe that tangible book value per common share
(tangible common shareholders’ equity divided by basic
shares) is meaningful because it is a measure that we and
investors use to assess capital adequacy. Tangible book
value per common share is a non-GAAP measure and may
not be comparable to similar non-GAAP measures used by
other companies.
115 Goldman Sachs March 2020 Form 10-Q

-- 117 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Funding Sources
Our primary sources of funding are deposits, collateralized
financings, unsecured short- and long-term borrowings,
and shareholders’ equity. We seek to maintain broad and
diversified 	funding 	sources 	globally 	across 	products,
programs, markets, currencies and creditors to avoid
funding concentrations.
The table below presents information about our funding
sources.
As of
$ in millions 	March 2020 	December 2019
Deposits 	$219,994 	31% 	$190,019 	28%
Collateralized financings 	146,929 	20% 	152,018 	22%
Unsecured short-term borrowings 	37,148 	5% 	48,287 	7%
Unsecured long-term borrowings 	225,476 	31% 	207,076 	30%
Total shareholders’ equity 	92,379 	13% 	90,265 	13%
Total 	$721,926 	100% 	$687,665 	100%
Our funding is primarily raised in U.S. dollar, Euro, British
pound and Japanese yen. We generally distribute our
funding products through our own sales force and third-
party distributors to a large, diverse creditor base in a
variety of markets in the Americas, Europe and Asia. We
believe that our relationships with our creditors are critical
to our liquidity. Our creditors include banks, governments,
securities lenders, corporations, pension funds, insurance
companies, 	mutual 	funds 	and 	individuals. 	We 	have
imposed various internal guidelines to monitor creditor
concentration across our funding programs.
Deposits. Our deposits provide us with a diversified source of
funding and reduce our reliance on wholesale funding. We
raise deposits, including savings, demand and time deposits,
from consumers and institutional clients, and through internal
and third-party broker-dealers, as well as transaction banking
channels. Our deposits are primarily raised through GS Bank
USA and GSIB. See Note 13 to the consolidated financial
statements for further information about our deposits.
Secured Funding. We fund a significant amount of inventory
and a portion of investments on a secured basis. Secured funding
includes collateralized financings in the consolidated balance
sheets. We may also pledge our inventory and investments as
collateral for securities borrowed under a securities lending
agreement. We also use our own inventory and investments to
cover transactions in which we or our clients have sold securities
that have not yet been purchased. Secured funding is less
sensitive to changes in our credit quality than unsecured
funding, due to our posting of collateral to our lenders.
Nonetheless, we analyze the refinancing risk of our secured
funding activities, taking into account trade tenors, maturity
profiles, counterparty concentrations, collateral eligibility and
counterparty rollover probabilities. We seek to mitigate our
refinancing risk by executing term trades with staggered
maturities, diversifying counterparties, raising excess secured
funding and pre-funding residual risk through our GCLA.
We seek to raise secured funding with a term appropriate
for the liquidity of the assets that are being financed, and we
seek longer maturities for secured funding collateralized by
asset classes that may be harder to fund on a secured basis,
especially during times of market stress. Our secured
funding, 	excluding 	funding 	collateralized 	by 	liquid
government and agency obligations, is primarily executed
for tenors of one month or greater and is primarily executed
through term repurchase agreements and securities loaned
contracts.
The weighted average maturity of our secured funding
included in collateralized financings in the consolidated
balance 	sheets, 	excluding 	funding 	that 	can 	only 	be
collateralized by liquid government and agency obligations
and funding through participation in Federal Reserve
facilities, exceeded 120 days as of March 2020.
Assets that may be harder to fund on a secured basis during
times of market stress include certain financial instruments
in the following categories: mortgage and other asset-
backed 	loans 	and 	securities, 	non-investment-grade
corporate debt securities, equity securities and emerging
market securities. Assets that are classified in level 3 of the
fair value hierarchy are generally funded on an unsecured
basis. See Notes 4 through 10 to the consolidated financial
statements for further information about the classification
of financial instruments in the fair value hierarchy and
“Unsecured Long-Term Borrowings” below for further
information 	about 	the 	use 	of 	unsecured 	long-term
borrowings as a source of funding.
We 	also 	raise 	financing 	through 	other 	types 	of
collateralized financings, such as secured loans and notes.
GS Bank USA has access to funding from the Federal Home
Loan Bank. Our outstanding borrowings against the
Federal Home Loan Bank were $4.03 billion as of
March 2020 and $527 million as of December 2019.
In an effort to mitigate the financial impact of the
COVID-19 pandemic, central banks around the world have
taken aggressive measures to increase liquidity. In the U.S.,
the Federal Reserve has taken a broad set of actions to
support the functioning of financial markets. These actions
by the Federal Reserve include establishing a Primary
Dealer Credit Facility, which permits broker dealers to
borrow against a wide array of collateral, and creating a
Money Market Mutual Fund Liquidity Facility, under
which banks that purchase assets from money market
mutual funds can pledge those assets on a nonrecourse basis
to the Federal Reserve. The banking sector, including us,
has acted in support of the financial system through active
participation in the Federal Reserve’s initiatives.
Goldman Sachs March 2020 Form 10-Q 116

-- 118 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We also have access to funding through the Federal Reserve
discount window. While we do not rely on this funding in
our liquidity planning and stress testing, we accessed the
Federal Reserve discount window during the first quarter of
2020, in line with the commitment announced alongside
the nation’s other large banks. The discount window allows
the 	Federal 	Reserve 	to 	lend 	directly 	to 	depository
institutions to provide liquidity and stability to the banking
system so that they can better serve their individual and
corporate clients.
Unsecured 	Short-Term 	Borrowings. 	A 	significant
portion of our unsecured short-term borrowings was
originally long-term debt that is scheduled to mature within
one year of the reporting date. We use unsecured short-term
borrowings, including U.S. and non-U.S. hybrid financial
instruments, to finance liquid assets and for other cash
management purposes. In light of regulatory developments,
Group Inc. no longer issues debt with an original maturity
of less than one year, other than to its subsidiaries. See
Note 14 to the consolidated financial statements for further
information about our unsecured short-term borrowings.
Unsecured Long-Term Borrowings. Unsecured long-
term borrowings, including structured notes, are raised
through syndicated U.S. registered offerings, U.S. registered
and Rule 144A medium-term note programs, offshore
medium-term note offerings and other debt offerings. We
issue in different tenors, currencies and products to
maximize the diversification of our investor base.
The table below presents our quarterly unsecured long-term
borrowings maturity profile.
$ in millions
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter 	Total
As of March 2020
2021 	$ 	– 	$8,754 	$8,019 	$7,880 	$ 24,653
2022 	$ 6,692 	$6,106 	$6,222 	$6,094 	25,114
2023 	$10,043 	$6,241 	$7,986 	$4,337 	28,607
2024 	$ 6,075 	$4,049 	$6,005 	$3,033 	19,162
2025 	$ 7,038 	$8,044 	$4,418 	$4,220 	23,720
2026 - thereafter 	104,220
Total 	$225,476
The weighted average maturity of our unsecured long-term
borrowings as of March 2020 was approximately eight
years. To mitigate refinancing risk, we seek to limit the
principal amount of debt maturing over the course of any
monthly, quarterly or annual time horizon. We enter into
interest rate swaps to convert a portion of our unsecured
long-term borrowings into floating-rate obligations to
manage our exposure to interest rates. See Note 14 to the
consolidated financial statements for further information
about our unsecured long-term borrowings.
Shareholders’ Equity. Shareholders’ equity is a stable and
perpetual 	source 	of 	funding. 	See 	Note 	19 	to 	the
consolidated financial statements for further information
about our shareholders’ equity.
Equity Capital Management and Regulatory
Capital
Capital adequacy is of critical importance to us. We have in
place a comprehensive capital management policy that
provides a framework, defines objectives and establishes
guidelines to assist us in maintaining the appropriate level
and composition of capital in both business-as-usual and
stressed conditions.
Equity Capital Management
We determine the appropriate amount and composition of
our equity capital by considering multiple factors, including
our current and future regulatory capital requirements, the
results of our capital planning and stress testing process, the
results of resolution capital models and other factors, such
as rating agency guidelines, subsidiary capital requirements,
the business environment and conditions in the financial
markets.
We manage our capital requirements and the levels of our
capital usage principally by setting limits on the balance
sheet and/or limits on risk, in each case at both the firmwide
and business levels.
We principally manage the level and composition of our
equity capital through issuances and repurchases of our
common stock. We may also, from time to time, issue or
repurchase our preferred stock, junior subordinated debt
issued to trusts, and other subordinated debt or other forms
of capital as business conditions warrant. Prior to any
repurchases, we must receive confirmation that the Board
of Governors of the Federal Reserve System (FRB) does not
object to such capital action. See Notes 14 and 19 to the
consolidated financial statements for further information
about our preferred stock, junior subordinated debt issued
to trusts and other subordinated debt.
Capital Planning and Stress Testing Process. As part of
capital planning, we project sources and uses of capital
given a range of business environments, including stressed
conditions. Our stress testing process is designed to identify
and measure material risks associated with our business
activities, including market risk, credit risk and operational
risk, as well as our ability to generate revenues.
117 Goldman Sachs March 2020 Form 10-Q

-- 119 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Our capital planning process incorporates an internal
capital adequacy assessment with the objective of ensuring
that we are appropriately capitalized relative to the risks in
our businesses. We incorporate stress scenarios into our
capital planning process with a goal of holding sufficient
capital to ensure we remain adequately capitalized after
experiencing a severe stress event. Our assessment of capital
adequacy is viewed in tandem with our assessment of
liquidity adequacy and is integrated into our overall risk
management structure, governance and policy framework.
Our stress tests incorporate our internally designed stress
scenarios, including our internally developed severely
adverse scenario, and those required under CCAR and
DFAST, 	and 	are 	designed 	to 	capture 	our 	specific
vulnerabilities and risks. We provide further information
about our stress test processes and a summary of the results
on our website as described in “Available Information.”
As required by the FRB’s CCAR rules, we submit an annual
capital plan for review by the FRB. The purpose of the
FRB’s review is to ensure that we have a robust, forward-
looking capital planning process that accounts for our
unique risks and that permits continued operation during
times of economic and financial stress.
The FRB evaluates us based, in part, on whether we have
the capital necessary to continue operating under the
baseline and severely adverse scenarios provided by the
FRB and those developed internally. This evaluation also
takes into account our process for identifying risk, our
controls and governance for capital planning, and our
guidelines 	for 	making 	capital 	planning 	decisions. 	In
addition, the FRB evaluates our plan to make capital
distributions (i.e., dividend payments and repurchases or
redemptions of stock, subordinated debt or other capital
securities) 	and 	issue 	capital, 	across 	the 	range 	of
macroeconomic scenarios and firm-specific assumptions.
With respect to our 2019 CCAR submission, the FRB
informed us that it did not object to our capital plan, which
includes the return of up to $8.8 billion of capital from the
third quarter of 2019 through the second quarter of 2020
(2019 CCAR cycle). The capital plan provides for up to
$7.0 billion in repurchases of outstanding common stock
and $1.8 billion in total common stock dividends, including
an increase in our common stock dividend from $0.85 to
$1.25 per share in the third quarter of 2019. During the
third and fourth quarters of 2019 and first quarter of 2020,
we returned a total of $6.13 billion of capital, including
stock repurchases of $4.76 billion and common stock
dividends of $1.37 billion. Due to the current market
conditions, we, along with other member banks of the
Financial Services Forum, have voluntarily decided to
temporarily suspend stock repurchases through the end of
the 2019 CCAR cycle, and we will continue to evaluate our
share 	repurchases 	for 	the 	remainder 	of 	2020 	as
circumstances related to the COVID-19 pandemic evolve.
We published a summary of our annual DFAST results in
June 2019. See “Available Information.” We submitted our
2020 CCAR capital plan in April 2020 and expect to
publish a summary of our annual DFAST results in
June 2020. The FRB also conducts its own annual stress
tests and publishes a summary of certain results.
GS Bank USA has its own capital planning process, but was
not required to conduct its annual stress test in 2019.
Goldman Sachs International (GSI) and GSIB also have
their own capital planning and stress testing process, which
incorporates internally designed stress tests and those
required under the Prudential Regulation Authority’s
(PRA) Internal Capital Adequacy Assessment Process.
Goldman Sachs March 2020 Form 10-Q 118

-- 120 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Contingency Capital Plan. As part of our comprehensive
capital management policy, we maintain a contingency
capital plan. Our contingency capital plan provides a
framework for analyzing and responding to a perceived or
actual capital deficiency, including, but not limited to,
identification of drivers of a capital deficiency, as well as
mitigants and potential actions. It outlines the appropriate
communication procedures to follow during a crisis period,
including internal dissemination of information, as well as
timely communication with external stakeholders.
Capital Attribution. We assess each of our businesses’
capital usage based on our internal assessment of risks,
which incorporates an attribution of all of our relevant
regulatory capital requirements. These regulatory capital
requirements are allocated using our attributed equity
framework, which takes into consideration our most
binding capital constraints. Our most binding capital
constraint is based on the results of the FRB’s annual stress
test scenarios which include the Standardized risk-based
capital and leverage ratios. See “Segment Assets and
Operating Results — Segment Operating Results” for
information about our attributed equity by segment.
Share 	Repurchase 	Program. 	We 	use 	our 	share
repurchase program to help maintain the appropriate level
of common equity. The repurchase program is effected
primarily through regular open-market purchases (which
may include repurchase plans designed to comply with
Rule 10b5-1 and accelerated share repurchases), the
amounts and timing of which are determined primarily by
our current and projected capital position and our capital
plan submitted to the FRB as part of CCAR. The amounts
and timing of the repurchases may also be influenced by
general market conditions and the prevailing price and
trading volumes of our common stock.
On July 15, 2019, the Board of Directors of Group Inc.
(Board) 	authorized 	the 	repurchase 	of 	an 	additional
50 million shares of common stock pursuant to our existing
share repurchase program; however, we are only permitted
to make repurchases to the extent that such repurchases
have not been objected to by the FRB. As of March 2020,
the remaining share authorization under our existing
repurchase 	program 	was 	49.7 	million 	shares. 	See
“Unregistered Sales of Equity Securities and Use of
Proceeds” in Part II, Item 2 of this Form 10-Q and Note 19
to 	the 	consolidated 	financial 	statements 	for 	further
information about our share repurchase program, and see
above for information about our capital planning and stress
testing process.
Resolution Capital Models. In connection with our
resolution 	planning 	efforts, 	we 	have 	established 	a
Resolution Capital Adequacy and Positioning framework,
which is designed to ensure that our major subsidiaries (GS
Bank USA, Goldman Sachs & Co. LLC (GS&Co.), GSI,
GSIB, Goldman Sachs Japan Co., Ltd. (GSJCL), Goldman
Sachs Asset Management, L.P. and Goldman Sachs Asset
Management International) have access to sufficient loss-
absorbing capacity (in the form of equity, subordinated
debt and unsecured senior debt) so that they are able to
wind-down following a Group Inc. bankruptcy filing in
accordance with our preferred resolution strategy.
In addition, we have established a triggers and alerts
framework, which is designed to provide the Board with
information needed to make an informed decision on
whether and when to commence bankruptcy proceedings
for Group Inc.
Rating Agency Guidelines
The credit rating agencies assign credit ratings to the
obligations 	of 	Group 	Inc., 	which 	directly 	issues 	or
guarantees substantially all of our senior unsecured debt
obligations. GS&Co. and GSI have been assigned long-term
and short-term issuer ratings by certain credit rating
agencies. GS Bank USA and GSIB have also been assigned
long-term and short-term issuer ratings, as well as ratings
on their long-term and short-term bank deposits. In
addition, credit rating agencies have assigned ratings to
debt obligations of certain other subsidiaries of Group Inc.
The level and composition of our equity capital are among
the many factors considered in determining our credit
ratings. Each agency has its own definition of eligible
capital and methodology for evaluating capital adequacy,
and assessments are generally based on a combination of
factors 	rather 	than 	a 	single 	calculation. 	See 	“Risk
Management — Liquidity Risk Management — Credit
Ratings” for further information about credit ratings of
Group Inc., GS Bank USA, GSIB, GS&Co. and GSI.
119 Goldman Sachs March 2020 Form 10-Q

-- 121 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Consolidated Regulatory Capital
We 	are 	subject 	to 	consolidated 	regulatory 	capital
requirements which are calculated in accordance with the
regulations of the FRB (Capital Framework). Under the
Capital Framework, we are an “Advanced approach”
banking organization and have been designated as a global
systemically important bank (G-SIB).
The capital requirements calculated in accordance with the
Capital Framework include the risk-based capital buffers
and G-SIB surcharge. The risk-based capital buffers,
applicable to us for 2020, include the capital conservation
buffer of 2.5% and the countercyclical capital buffer, which
the FRB has set to zero percent. In addition, the G-SIB
surcharge applicable to us for 2020 is 2.5% based on 2018
financial data and 2.5% for 2021 based on 2019 financial
data. Based on financial data for the three months ended
March 2020, our current estimate is that we are above the
threshold for the 3.0% G-SIB surcharge. We expect that
our G-SIB surcharge may remain above the 3% threshold
over the next three years. This increase would be effective
on January 1 of the year that is one full calendar year after
the increased G-SIB surcharge is finalized. The G-SIB
surcharge and countercyclical buffer in the future may
differ due to additional guidance from our regulators and/
or positional changes. Our target CET1 capital ratio over
the next three years is between 13.0% and 13.5%
(including management buffers). This target reflects, among
other things, our calculations based on the final stress
capital buffer rule. See “Regulatory and Other Matters” for
further information about the final rule.
See Note 20 to the consolidated financial statements for
further information about our risk-based capital ratios and
leverage ratios, and the Capital Framework.
TLAC
We are also subject to the FRB’s TLAC and related
requirements. Failure to comply with the TLAC and related
requirements could result in restrictions being imposed by
the FRB and could limit our ability to repurchase shares,
pay 	dividends 	and 	make 	certain 	discretionary
compensation payments.
The table below presents TLAC and external long-term
debt requirements.
Requirements
TLAC to RWAs 	22.0%
TLAC to leverage exposure 	9.5%
External long-term debt to RWAs 	8.5%
External long-term debt to leverage exposure 	4.5%
In the table above:
‰ The TLAC to RWAs requirement includes (i) the 18%
minimum, (ii) the 2.5% buffer, (iii) the 1.5% G-SIB
surcharge (Method 1) and (iv) the countercyclical capital
buffer, which the FRB has set to zero percent.
‰ The 	TLAC 	to 	leverage 	exposure 	requirement
includes (i) the 7.5% minimum and (ii) the 2.0% leverage
exposure buffer.
‰ The external long-term debt to RWAs requirement
includes (i) the 6% minimum and (ii) the 2.5% G-SIB
surcharge (Method 2).
‰ The external long-term debt to total leverage exposure is
the 4.5% minimum.
The table below presents information about our TLAC and
external long-term debt ratios.
As of
$ in millions
March
2020
December
2019
TLAC 	$ 248,729 $ 236,850
External long-term debt 	$ 150,870 $ 141,770
RWAs 	$ 605,926 $ 563,575
Leverage exposure 	$1,438,866 $1,375,467
TLAC to RWAs 	41.0% 	42.0%
TLAC to leverage exposure 	17.3% 	17.2%
External long-term debt to RWAs 	24.9% 	25.2%
External long-term debt to leverage exposure 	10.5% 	10.3%
In the table above:
‰ TLAC includes common and preferred stock, and eligible
long-term debt issued by Group Inc. Eligible long-term
debt represents unsecured debt, which has a remaining
maturity of at least one year and satisfies additional
requirements.
‰ External long-term debt consists of eligible long-term
debt subject to a haircut if it is due to be paid between one
and two years.
‰ RWAs represent Advanced RWAs as of March 2020 and
Standardized RWAs as of December 2019. In accordance
with the TLAC rules, the higher of Advanced or
Standardized RWAs are used in the calculation of TLAC
and 	external 	long-term 	debt 	ratios 	and 	applicable
requirements.
‰ Leverage exposure consists of average adjusted total
assets and certain off-balance sheet exposures.
See “Business — Regulation” in Part I, Item 1 of the 2019
Form 10-K for further information about TLAC.
Goldman Sachs March 2020 Form 10-Q 120

-- 122 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Subsidiary Capital Requirements
Many of our subsidiaries, including our bank and broker-
dealer subsidiaries, are subject to separate regulation and
capital requirements of the jurisdictions in which they
operate.
Bank Subsidiaries. GS Bank USA is our primary U.S.
banking subsidiary and GSIB is our primary non-U.S.
banking subsidiary. These entities are subject to regulatory
capital requirements. See Note 20 to the consolidated
financial statements for further information about the
regulatory capital requirements of our bank subsidiaries.
U.S. Regulated Broker-Dealer Subsidiaries. GS&Co. is
our primary U.S. regulated broker-dealer subsidiary and is
subject to regulatory capital requirements, including those
imposed by the SEC and the Financial Industry Regulatory
Authority, Inc. In addition, GS&Co. is a registered futures
commission merchant and is subject to regulatory capital
requirements 	imposed 	by 	the 	CFTC, 	the 	Chicago
Mercantile Exchange and the National Futures Association.
Rule 15c3-1 of the SEC and Rule 1.17 of the CFTC specify
uniform minimum net capital requirements, as defined, for
their 	registrants, 	and 	also 	effectively 	require 	that 	a
significant part of the registrants’ assets be kept in relatively
liquid form. GS&Co. has elected to calculate its minimum
capital requirements in accordance with the “Alternative
Net Capital Requirement” as permitted by Rule 15c3-1.
GS&Co. 	had 	regulatory 	net 	capital, 	as 	defined 	by
Rule 15c3-1, of $18.66 billion as of March 2020 and
$20.88 billion as of December 2019, which exceeded the
amount required by $14.26 billion as of March 2020 and
$18.15 billion as of December 2019. In addition to its
alternative minimum net capital requirements, GS&Co. is
also required to hold tentative net capital in excess of
$1 billion and net capital in excess of $500 million in
accordance with the market and credit risk standards of
Appendix E of Rule 15c3-1. GS&Co. is also required to
notify the SEC in the event that its tentative net capital is
less than $5 billion. As of both March 2020 and
December 2019, GS&Co. had tentative net capital and net
capital in excess of both the minimum and the notification
requirements.
Non-U.S. Regulated Broker-Dealer Subsidiaries. Our
principal non-U.S. regulated broker-dealer subsidiaries
include GSI and GSJCL.
GSI, our U.K. broker-dealer, is regulated by the PRA and
the Financial Conduct Authority (FCA). GSI is subject to
the 	capital 	framework 	for 	E.U.-regulated 	financial
institutions 	prescribed 	in 	the 	E.U. 	Fourth 	Capital
Requirements Directive and the E.U. Capital Requirements
Regulation (CRR). These capital regulations are largely
based on Basel III.
The 	table 	below 	presents 	GSI’s 	risk-based 	capital
requirements.
As of
March
2020
December
2019
Risk-based capital requirements
CET1 capital ratio 	8.5% 	8.8%
Tier 1 capital ratio 	10.5% 	10.8%
Total capital ratio 	13.1% 	13.4%
In the table above, the risk-based capital requirements
incorporate capital guidance received from the PRA and
could 	change 	in 	the 	future. 	GSI’s 	future 	capital
requirements may also be impacted by developments, such
as the introduction of risk-based capital buffers.
The table below presents information about GSI’s risk-
based capital ratios.
As of
$ in millions
March
2020
December
2019
Risk-based capital and risk-weighted assets
CET1 capital 	$ 24,475 $ 24,142
Tier 1 capital 	$ 32,776 $ 32,442
Tier 2 capital 	$ 	5,318 $ 	5,374
Total capital 	$ 38,094 $ 37,816
RWAs 	$236,840 $206,669
Risk-based capital ratios
CET1 capital ratio 	10.3% 	11.7%
Tier 1 capital ratio 	13.8% 	15.7%
Total capital ratio 	16.1% 	18.3%
In the table above, CET1 capital, Tier 1 capital and Total
capital as of March 2020 excluded GSI’s undistributed
profits from December 1, 2019 through March 31, 2020, as
such profits have not yet been approved to be included as
regulatory capital by the PRA.
In November 2016, the European Commission proposed
amendments to the CRR to implement a 3% leverage ratio
requirement for certain E.U. financial institutions. This
leverage ratio compares the CRR’s definition of Tier 1
capital to a measure of leverage exposure, defined as the
sum 	of 	certain 	assets 	plus 	certain 	off-balance 	sheet
exposures 	(which 	include 	a 	measure 	of 	derivatives,
securities 	financing 	transactions, 	commitments 	and
guarantees), less Tier 1 capital deductions. The required
leverage ratio is expected to become effective for GSI on
June 28, 2021. GSI had a leverage ratio of 4.3% as of
March 2020 and 4.6% as of December 2019. GSI’s
leverage 	ratio 	as 	of 	March 	2020 	excluded 	GSI’s
undistributed profits from December 1, 2019 through
March 31, 2020, as such profits have not yet been approved
to be included as regulatory capital by the PRA. This
leverage ratio is based on our current interpretation and
understanding of this rule and may evolve as we discuss the
interpretation and application of this rule with GSI’s
regulators.
121 Goldman Sachs March 2020 Form 10-Q

-- 123 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
GSI is also subject to a minimum requirement for own
funds and eligible liabilities issued to affiliates. This
requirement is subject to a transitional period which began
to phase in from January 1, 2019 and will become fully
effective on January 1, 2022. As of March 2020, GSI was in
compliance with this requirement.
GSJCL, our Japanese broker-dealer, is regulated by Japan’s
Financial Services Agency. GSJCL and certain other
non-U.S. 	subsidiaries 	are 	also 	subject 	to 	capital
requirements promulgated by authorities of the countries in
which 	they 	operate. 	As 	of 	both 	March 	2020 	and
December 2019, these subsidiaries were in compliance with
their local capital requirements.
Regulatory and Other Matters
Regulatory Matters
Our businesses are subject to extensive regulation and
supervision worldwide. Regulations have been adopted or
are being considered by regulators and policy makers
worldwide. Given that many of the new and proposed rules
are highly complex, the full impact of regulatory reform
will not be known until the rules are implemented and
market practices develop under the final regulations.
Stress Capital Buffer. In March 2020, the FRB released
the stress capital buffer final rule, and it will begin to apply
on October 1, 2020. In accordance with the final rule, our
Standardized capital ratio requirements will include the
stressed capital buffer, which will be measured as the
difference between the starting and lowest projected CET1
capital ratio in the supervisory severely adverse stress
scenario, as calculated by the FRB, including four quarters
of 	planned 	common 	stock 	dividends, 	subject 	to 	a
2.5% floor. Under the rule, stress leverage requirements, as
calculated by the FRB, have been eliminated.
Leverage Ratios. In April 2020, the FRB released an
interim final rule that provides an option for depository
institution holding companies, such as Group Inc., to
exclude U.S. Treasury securities holdings and deposits at
the Federal Reserve from the calculation of total leverage
exposure beginning April 1, 2020 through March 31, 2021.
We have elected to exclude such instruments from our
calculation of supplementary leverage ratio and TLAC
leverage requirement for the applicable period.
See “Business — Regulation” in Part I, Item 1 of the 2019
Form 10-K for further information about the laws, rules
and regulations and proposed laws, rules and regulations
that apply to us and our operations.
Other Matters
Brexit. In March 2017, the U.K. government commenced
the formal proceedings to withdraw from the E.U.
The E.U. and the U.K. agreed to a withdrawal agreement
(the Withdrawal Agreement), which became effective on
January 	31, 	2020. 	The 	transition 	period 	under 	the
Withdrawal 	Agreement 	will 	last 	until 	the 	end 	of
December 2020 to allow the two sides to negotiate a future
trade agreement. During the transition period, the U.K. will
be treated as if it were a member state of the E.U. and
therefore the existing arrangements between the U.K. and
the E.U. will not change. The Withdrawal Agreement
provides for the possibility of an extension of the transition
period for either one or two more years. However, the U.K.
has pledged not to extend the transition period beyond
December 31, 2020.
Based upon the existing non-E.U. country equivalence
regimes, the E.U. and the U.K. have agreed to complete
their assessments of equivalence by the end of June 2020.
There is significant uncertainty as to the outcome of those
assessments. We are monitoring the ongoing development
related to Brexit and continue to prepare for a scenario
where the U.K. financial services firms will lose access to
E.U. markets on December 31, 2020 (a “hard” Brexit)
while ensuring we remain flexible and well positioned to
allow our clients to benefit from any more favorable
scenarios. Our planning also recognizes that after the end of
the transition period, we can rely on a degree of continuing
access for our U.K. entities pursuant to national cross-
border access regimes in certain jurisdictions (for example,
based on specific licenses or exemptions). See “Regulatory
Matters and Other Developments — Other Developments”
in Part II, Item 7 of the 2019 Form 10-K for further
information about our plan to manage a hard Brexit
scenario.
Replacement of Interbank Offered Rates (IBORs),
including LIBOR. Central banks and regulators in a
number of major jurisdictions (for example, U.S., U.K.,
E.U., Switzerland and Japan) have convened working
groups to find, and implement the transition to, suitable
replacements for IBORs. The FCA, which regulates LIBOR,
has announced that it will not compel panel banks to
contribute to LIBOR after 2021. In addition, in light of
COVID-19, the FCA, alongside the Bank of England and
the members of the Working Group on Sterling Risk-Free
Reference Rates, issued a statement reaffirming that firms
cannot 	rely 	on 	LIBOR 	being published after 2021.
Accordingly, we continue to make progress on our LIBOR
transition program in line with this deadline.
Goldman Sachs March 2020 Form 10-Q 122

-- 124 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We have created a program that focuses on achieving an
orderly transition from IBORs to alternative risk-free
reference rates for us and our clients. As part of this
transition, we continue to actively engage with our
regulators and clients, as well as participate in central bank
and sector working groups. We have issued debt and
deposits linked to the Secured Overnight Financing Rate
(SOFR) and Sterling Overnight Index Average (SONIA)
and have executed SOFR- and SONIA-based derivative
contracts to make markets and facilitate client activities.
Where possible, we continue to execute transactions in the
market to reduce our LIBOR exposures arising from hedges
to our fixed-rate debt issuances and replace with alternative
risk-free 	reference 	rates 	exposures. 	See 	“Regulatory
Matters and Other Developments — Other Developments”
in Part II, Item 7 of the 2019 Form 10-K for further
information about our transition program.
Impact 	of 	COVID-19 	Pandemic. 	The 	COVID-19
pandemic has resulted in governments around the world
implementing a broad suite of measures to help control the
spread of the virus, including, among others, quarantines,
travel restrictions and business curtailments.
In response to the COVID-19 pandemic, we activated and
successfully executed on our BCP strategy. Our priority has
been to safeguard our employees and to seek to ensure
continuity of business operations on behalf of our clients.
We have a central team that manages our COVID-19
response, which is led by our chief administrative officer
and chief medical officer, and includes senior management
within Risk and the chief operating officers across all
regions and businesses. As a result of our BCP plan, nearly
all of our employees are working remotely. Our systems
and infrastructure have continued to support the increased
volumes of activity. We implemented a heightened level of
communication across senior management and among
senior management, the rest of our employees and the
Board of Directors. Real-time information sharing and
decision-making are occurring through a variety of senior
management meetings. Our Management Committee and
other senior leaders have multiple standing meetings on a
daily and weekly basis. Our executive officers have
provided 	regular 	and 	enhanced 	communications 	to
promote connectivity with our clients and employees
worldwide. Furthermore, we have proactively engaged with
our vendors on a regular basis in connection with our
efforts to ensure they continue to meet our criteria for
business continuity.
The adverse impacts of COVID-19 on financial markets has
led central banks to take aggressive steps to increase
liquidity. At the encouragement of the Federal Reserve, the
banking sector, including us, has utilized a variety of
facilities to help clients access financing to support their
businesses. We will continue to evaluate our level of
participation in these facilities and any new facilities or
programs that become available. We have also decided to
temporarily suspend share buybacks through the second
quarter of 2020. As we make capital return decisions
beyond the second quarter of 2020, we will continue to
assess what is needed for reinvestment and to support our
clients. Another action we took during the first quarter of
2020 was the purchase by GS Bank USA of short-term debt
securities, primarily certificates of deposit, from two money
market funds that we manage, which are not covered by the
Volcker 	Rule. 	GS 	Bank 	USA’s 	purchase 	price 	of
$1.84 billion represented the fair value of these securities,
which also closely approximated their face values. These
purchases were made to promote liquidity in the short-term
credit markets and to increase the funds’ weekly liquid
assets.
Our liquidity position during the first quarter of 2020
remained strong. We maintained an average GCLA of
$243 billion for the first quarter of 2020, an increase of
$6 billion compared with the fourth quarter of 2019. Our
deposits increased by $30 billion to $220 billion compared
with December 2019. In addition, we also issued unsecured
vanilla debt of $15.7 billion during the first quarter of 2020.
Our capital ratios declined during the first quarter of 2020,
primarily driven by balance sheet growth to support clients
amid increased activity and demand for risk intermediation,
but remained in excess of our minimum requirements. See
“Balance Sheet and Funding Sources,” “Equity Capital
Management and Regulatory Capital” and “Liquidity Risk
Management” for further information.
The valuation of financial instruments and determination of
the provision for credit losses are more difficult when severe
economic 	and 	market 	shocks 	occur. 	Recent 	market
conditions, characterized by dislocations between asset
prices, higher volatility, reduced price transparency and a
deterioration in the creditworthiness of borrowers have
made it more challenging to determine the fair value of some
of our financial assets and liabilities and the provision for
credit losses. The current circumstances have required
greater use of judgment, and in the case of financial
instruments accounted for at fair value, have contributed to
an increase in level 3 balances. See Note 4 to the consolidated
financial statements for further information about fair value
measurements and Note 9 to the consolidated financial
statements for further information about the provision for
credit losses.
123 Goldman Sachs March 2020 Form 10-Q

-- 125 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
As a result of the dramatic change in the macroeconomic
environment 	since 	we 	last 	performed 	a 	goodwill
impairment test in the fourth quarter of 2019, we assessed
goodwill for impairment as of March 2020 and determined
that it was not impaired. See Note 12 to the consolidated
financial 	statements 	for 	further 	information 	about
goodwill.
Over the latter part of the first quarter of 2020, financial
markets experienced a spike in volatility as concerns over
the spread of COVID-19 intensified. Clients sought to
reduce risk exposures, resulting in a significant increase in
transaction volumes. Our average daily VaR for the first
quarter of 2020 was $81 million, an increase of $26 million
compared to March 2019, reflecting, among other things,
the role that we have played as a risk intermediary for our
clients in the current challenging environment. Throughout
the crisis, our approach to managing market risk levels has
been proactive, involving ongoing review and monitoring
of exposures and risk mitigation opportunities. In addition,
the sharp decline in economic activity as the pandemic
became more acute has increased credit risk in general and
particularly with regard to companies in industries that
have been most severely impacted by the economic
disruption, including oil and gas, gaming and lodging, and
airlines. 	During 	the 	first 	quarter 	of 	2020, 	we 	had
approximately $19 billion in drawdowns on committed
corporate credit lines in our relationship lending business,
which was below the amount that was pre-funded based on
our liquidity models. Given the stresses on clients’ liquidity,
we have elevated our approach to credit risk management,
with an increased focus on monitoring of credit exposures
and management of margin calls and disputes. Our risk
positions remained balanced, controlled and adequately
provisioned for, both in terms of counterparty risk and
sector exposure. See “Market Risk Management” and
“Credit Risk Management” for further information.
Our response to COVID-19 has involved a number of
actions and initiatives aimed at providing support to our
clients, 	employees, 	vendors 	and 	communities. 	See
“Executive Overview” for further information.
The 	COVID-19 	pandemic 	has 	created 	significant
uncertainty regarding the operating environment for the
remainder of 2020 and possibly longer, as the duration and
future course of the pandemic cannot be predicted at this
time. A sustained period of weak economic conditions as a
result of the pandemic would be detrimental to our
businesses as it would negatively affect factors that are
important to our operating performance, such as the level
of client activity, creditworthiness of counterparties and
borrowers, and the amount of our assets under supervision.
We are monitoring the ongoing developments related to
COVID-19 and will take further action as may be required
by government authorities or that we determine are in the
best interests of our employees, clients and counterparties.
For further information about the risks associated with
COVID-19, see “Risk Factors” in Part II, Item 1A.
Off-Balance 	Sheet 	Arrangements 	and
Contractual Obligations
Off-Balance Sheet Arrangements
In the ordinary course of business, we enter into various
types of off-balance sheet arrangements. Our involvement
in these arrangements can take many different forms,
including:
‰ Purchasing or retaining residual and other interests in
special purpose entities, such as mortgage-backed and
other asset-backed securitization vehicles;
‰ Holding senior and subordinated debt, interests in limited
and general partnerships, and preferred and common
stock in other nonconsolidated vehicles;
‰ Entering into interest rate, foreign currency, equity,
commodity and credit derivatives, including total return
swaps; and
‰ Providing guarantees, indemnifications, commitments,
letters of credit and representations and warranties.
We enter into these arrangements for a variety of business
purposes, 	including 	securitizations. 	The 	securitization
vehicles that purchase mortgages, corporate bonds, and
other types of financial assets are critical to the functioning
of several significant investor markets, including the
mortgage-backed 	and 	other 	asset-backed 	securities
markets, since they offer investors access to specific cash
flows and risks created through the securitization process.
We also enter into these arrangements to underwrite client
securitization 	transactions; 	provide 	secondary 	market
liquidity; make investments in performing and nonperforming
debt, distressed loans, power-related assets, equity securities,
real estate and other assets; provide investors with credit-
linked and asset-repackaged notes; and receive or provide
letters of credit to satisfy margin requirements and to facilitate
the clearance and settlement process.
Goldman Sachs March 2020 Form 10-Q 124

-- 126 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents where information about our
various off-balance sheet arrangements may be found in
this Form 10-Q. In addition, see Note 3 to the consolidated
financial 	statements 	for 	information 	about 	our
consolidation policies.
Off-Balance Sheet Arrangement 	Disclosure in Form 10-Q
Variable 	interests 	and 	other
obligations, including contingent
obligations, arising from variable
interests 	in 	nonconsolidated
variable interest entities (VIEs)
See Note 17 to the consolidated
financial statements.
Guarantees, letters of credit, and
lending and other commitments
See Note 18 to the consolidated
financial statements.
Derivatives 	See “Risk Management — Credit
Risk 	Management 	— 	Credit
Exposures — OTC Derivatives”
and Notes 4, 5, 7 and 18 to the
consolidated financial statements.
Contractual Obligations
We have certain contractual obligations which require us to
make future cash payments. These contractual obligations
include our time deposits, secured long-term financings,
unsecured long-term borrowings, interest payments and
operating lease payments.
Our obligations to make future cash payments also include
our commitments and guarantees related to off-balance
sheet arrangements, which are excluded from the table
below. See Note 18 to the consolidated financial statements
for further information about such commitments and
guarantees.
Due to the uncertainty of the timing and amounts that will
ultimately be paid, our liability for unrecognized tax
benefits has been excluded from the table below. See
Note 24 to the consolidated financial statements for further
information about our unrecognized tax benefits.
The table below presents our contractual obligations by
type.
As of
$ in millions
March
2020
December
2019
Time deposits 	$ 32,466 	$ 32,273
Financings and borrowings:
Secured long-term 	$ 13,100 	$ 11,953
Unsecured long-term 	$225,476 	$207,076
Interest payments 	$ 49,992 	$ 47,649
Operating lease payments 	$ 	3,828 	$ 	3,980
The table below presents our contractual obligations by
expiration.
As of March 2020
$ in millions
Remainder
of 2020
2021 -
2022
2023 -
2024
2025 -
Thereafter
Time deposits 	$ 	– $16,092 $11,118 $ 	5,256
Financings and borrowings:
Secured long-term 	$ 	– $ 6,049 $ 3,096 $ 	3,955
Unsecured long-term 	$ 	– $49,767 $47,769 $127,940
Interest payments 	$4,759 $11,646 $ 8,243 $ 25,344
Operating lease payments 	$ 247 $ 	573 $ 	451 $ 	2,557
In the table above:
‰ Obligations maturing within one year of our financial
statement date or redeemable within one year of our
financial statement date at the option of the holders are
excluded as they are treated as short-term obligations. See
Note 14 to the consolidated financial statements for
further information about our short-term borrowings.
‰ Obligations that are repayable prior to maturity at our
option are reflected at their contractual maturity dates
and obligations that are redeemable prior to maturity at
the option of the holders are reflected at the earliest dates
such options become exercisable.
‰ As of March 2020, unsecured long-term borrowings had
maturities extending through 2067, consisted principally
of senior borrowings, and included $13.76 billion of
adjustments to the carrying value of certain unsecured
long-term borrowings resulting from the application of
hedge accounting. See Note 14 to the consolidated
financial statements for further information about our
unsecured long-term borrowings.
‰ As of March 2020, the aggregate contractual principal
amount of long-term other secured financings for which
the fair value option was elected exceeded the related fair
value by $546 million.
‰ As of March 2020, the aggregate contractual principal
amount of unsecured long-term borrowings for which the
fair value option was elected exceeded the related fair
value by $823 million.
‰ Interest payments represents estimated future contractual
interest 	payments 	related 	to 	unsecured 	long-term
borrowings, 	secured 	long-term 	financings 	and 	time
deposits 	based 	on 	applicable 	interest 	rates 	as 	of
March 2020, and includes stated coupons, if any, on
structured notes.
‰ Operating lease payments includes lease commitments for
office space that expire on various dates through 2069.
Certain agreements are subject to periodic escalation
provisions for increases in real estate taxes and other
charges. See Note 15 to the consolidated financial
statements for further information about our operating
lease liabilities.
125 Goldman Sachs March 2020 Form 10-Q

-- 127 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Risk Management
Risks are inherent in our businesses and include liquidity,
market, credit, operational, model, legal, compliance,
conduct, regulatory and reputational risks. Our risks
include the risks across our risk categories, regions or global
businesses, as well as those which have uncertain outcomes
and have the potential to materially impact our financial
results, our liquidity and our reputation. For further
information about our risk management processes, see
“Overview and Structure of Risk Management,” and for
information about our areas of risk, see “Liquidity Risk
Management,” “Market Risk Management,” “Credit Risk
Management,” 	“Operational 	Risk 	Management” 	and
“Model Risk Management” and “Risk Factors” in Part II,
Item 1A of this Form 10-Q and in Part I, Item 1A of the
2019 Form 10-K.
Overview and Structure of Risk Management
Overview
We believe that effective risk management is critical to our
success. Accordingly, we have established an enterprise risk
management framework that employs a comprehensive,
integrated approach to risk management, and is designed to
enable comprehensive risk management processes through
which we identify, assess, monitor and manage the risks we
assume in conducting our activities. Our risk management
structure 	is 	built 	around 	three 	core 	components:
governance, processes and people.
Governance. Risk management governance starts with the
Board, which both directly and through its committees,
including 	its 	Risk 	Committee, 	oversees 	our 	risk
management policies and practices implemented through
the enterprise risk management framework. The Board is
also responsible for the annual review and approval of our
risk 	appetite 	statement. 	The 	risk 	appetite 	statement
describes the levels and types of risk we are willing to accept
or to avoid, in order to achieve our objectives included in
our strategic business plan, while remaining in compliance
with regulatory requirements. The Board reviews our
strategic business plan and is ultimately responsible for
overseeing and providing direction about our strategy and
risk appetite.
The Board receives regular briefings on firmwide risks,
including liquidity risk, market risk, credit risk, operational
risk and model risk from our independent risk oversight
and control functions, including the chief risk officer, and
on compliance risk and conduct risk from Compliance, on
legal and regulatory enforcement matters from the general
counsel, and on other matters impacting our reputation
from the chair of our Firmwide Client and Business
Standards Committee and our Firmwide Reputational Risk
Committee. The chief risk officer reports to our chief
executive officer and to the Risk Committee of the Board.
As part of the review of the firmwide risk portfolio, the
chief risk officer regularly advises the Risk Committee of
the Board of relevant risk metrics and material exposures,
including risk limits and thresholds established in our risk
appetite statement.
The implementation of our risk governance structure and
core risk management processes are overseen by Enterprise
Risk, which reports to our chief risk officer, and is
responsible 	for 	ensuring 	that 	our 	enterprise 	risk
management framework provides the Board, our risk
committees and senior management with a consistent and
integrated approach to managing our various risks in a
manner consistent with our risk appetite.
Our 	revenue-producing 	units, 	as 	well 	as 	Treasury,
Engineering, Human Capital Management, Operations and
Services, are considered our first line of defense. They are
accountable for the outcomes of our risk-generating
activities, as well as for assessing and managing those risks
within our risk appetite.
Our independent risk oversight and control functions are
considered 	our 	second 	line 	of 	defense 	and 	provide
independent assessment, oversight and challenge of the
risks taken by our first line of defense, as well as lead and
participate in risk committees. Independent risk oversight
and 	control 	functions 	include 	Compliance, 	Conflicts
Resolution, Controllers, Credit Risk, Enterprise Risk,
Legal, 	Liquidity 	Risk, 	Market 	Risk, 	Model 	Risk,
Operational Risk and Tax.
Internal Audit is considered our third line of defense and
reports 	to 	the 	Audit 	Committee 	of 	the 	Board 	and
administratively to our chief executive officer. Internal
Audit includes professionals with a broad range of audit
and 	industry 	experience, 	including 	risk 	management
expertise. Internal Audit is responsible for independently
assessing and validating the effectiveness of key controls,
including those within the risk management framework,
and providing timely reporting to the Audit Committee of
the Board, senior management and regulators.
The 	three 	lines 	of 	defense 	structure 	promotes 	the
accountability 	of 	first 	line 	risk 	takers, 	provides 	a
framework for effective challenge by the second line and
empowers independent review from the third line.
Goldman Sachs March 2020 Form 10-Q 126

-- 128 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Processes. We maintain various processes that are critical
components of our risk management framework, including
(i) risk identification and assessment, (ii) risk appetite, limit
and threshold setting, (iii) risk reporting and monitoring,
and (iv) risk decision-making.
‰ Risk Identification and Assessment. We believe that
the identification and assessment of our risks is a critical
step in providing our Board and senior management
transparency and insight into the range and materiality of
our risks. We have a comprehensive data collection
process, including firmwide policies and procedures that
require all employees to report and escalate risk events.
Our approach for risk identification and assessment is
comprehensive across all risk types, is dynamic and
forward-looking to reflect and adapt to our changing risk
profile and business environment, leverages subject
matter expertise, and allows for prioritization of our most
critical risks.
To effectively assess our risks, we maintain a daily
discipline of marking substantially all of our inventory to
current market levels. We carry our inventory at fair
value, with changes in valuation reflected immediately in
our risk management systems and in net revenues. We do
so because we believe this discipline is one of the most
effective tools for assessing and managing risk and that it
provides 	transparent 	and 	realistic 	insight 	into 	our
inventory exposures.
An important part of our risk management process is
firmwide stress testing. It allows us to quantify our
exposure 	to 	tail 	risks, 	highlight 	potential 	loss
concentrations, 	undertake 	risk/reward 	analysis, 	and
assess and mitigate our risk positions. Firmwide stress
tests are performed on a regular basis and are designed to
ensure a comprehensive analysis of our vulnerabilities
and 	idiosyncratic 	risks 	combining 	financial 	and
nonfinancial risks, including, but not limited to, credit,
market, 	liquidity 	and 	funding, 	operational 	and
compliance, strategic, systemic and emerging risks into a
single combined scenario. We also perform ad hoc stress
tests in anticipation of market events or conditions. Stress
tests are also used to assess capital adequacy as part of
our capital planning and stress testing process. See
“Equity Capital Management and Regulatory Capital —
Equity Capital Management” for further information.
‰ Risk Appetite, Limit and Threshold Setting. We apply
a rigorous framework of limits and thresholds to control
and 	monitor 	risk 	across 	transactions, 	products,
businesses and markets. The Board, directly or indirectly
through 	its 	Risk 	Committee, 	approves 	limits 	and
thresholds included in our risk appetite statement at
firmwide, business and product levels. In addition, the
Firmwide Enterprise Risk Committee is responsible for
approving our risk limits framework, subject to the
overall limits approved by the Risk Committee of the
Board, and monitoring these limits.
The Risk Governance Committee is responsible for
approving limits at firmwide, business and product levels.
Certain limits may be set at levels that will require
periodic adjustment, rather than at levels that reflect our
maximum risk appetite. This fosters an ongoing dialogue
about risk among our first and second lines of defense,
committees and senior management, as well as rapid
escalation of risk-related matters. Additionally, through
delegated 	authority 	from 	the 	Risk 	Governance
Committee, Market Risk sets limits at certain product
and desk levels, and Credit Risk sets limits for individual
counterparties, counterparties and their subsidiaries,
industries and countries. Limits are reviewed regularly
and amended on a permanent or temporary basis to
reflect changing market conditions, business conditions
or risk tolerance.
‰ Risk 	Reporting 	and 	Monitoring. 	Effective 	risk
reporting and risk decision-making depends on our
ability to get the right information to the right people at
the right time. As such, we focus on the rigor and
effectiveness of our risk systems, with the objective of
ensuring that our risk management technology systems
provide 	us 	with 	complete, 	accurate 	and 	timely
information. Our risk reporting and monitoring processes
are designed to take into account information about both
existing and emerging risks, thereby enabling our risk
committees and senior management to perform their
responsibilities with the appropriate level of insight into
risk exposures. Furthermore, our limit and threshold
breach processes provide means for timely escalation. We
evaluate changes in our risk profile and our businesses,
including changes in business mix or jurisdictions in
which we operate, by monitoring risk factors at a
firmwide level.
127 Goldman Sachs March 2020 Form 10-Q

-- 129 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
‰ Risk 	Decision-Making. 	Our 	governance 	structure
provides 	the 	protocol 	and 	responsibility 	for
decision-making on risk management issues and ensures
implementation of those decisions. We make extensive
use of risk committees that meet regularly and serve as an
important 	means 	to 	facilitate 	and 	foster 	ongoing
discussions to manage and mitigate risks.
We maintain strong and proactive communication about
risk and we have a culture of collaboration in decision-
making among our first and second lines of defense,
committees and senior management. While our first line
of defense is responsible for management of their risk, we
dedicate extensive resources to our second line of defense
in order to ensure a strong oversight structure and an
appropriate segregation of duties. We regularly reinforce
our strong culture of escalation and accountability across
all functions.
People. Even the best technology serves only as a tool for
helping to make informed decisions in real time about the
risks we are taking. Ultimately, effective risk management
requires our people to interpret our risk data on an ongoing
and timely basis and adjust risk positions accordingly. The
experience of our professionals, and their understanding of
the nuances and limitations of each risk measure, guides us
in assessing exposures and maintaining them within
prudent levels.
We reinforce a culture of effective risk management,
consistent with our risk appetite, in our training and
development programs, as well as in the way we evaluate
performance, and recognize and reward our people. Our
training and development programs, including certain
sessions led by our most senior leaders, are focused on the
importance of risk management, client relationships and
reputational excellence. As part of our annual performance
review process, we assess reputational excellence, including
how an employee exercises good risk management and
reputational judgment, and adheres to our code of conduct
and compliance policies. Our review and reward processes
are 	designed 	to 	communicate 	and 	reinforce 	to 	our
professionals the link between behavior and how people are
recognized, the need to focus on our clients and our
reputation, and the need to always act in accordance with
our highest standards.
Structure
Ultimate oversight of risk is the responsibility of our Board.
The Board oversees risk both directly and through its
committees, including its Risk Committee. We have a series
of committees with specific risk management mandates that
have oversight or decision-making responsibilities for risk
management activities. Committee membership generally
consists of senior managers from both our first and second
lines of defense. We have established procedures for these
committees to ensure that appropriate information barriers
are in place. Our primary risk committees, most of which
also have additional sub-committees or working groups,
are described below. In addition to these committees, we
have other risk committees that provide oversight for
different 	businesses, 	activities, 	products, 	regions 	and
entities. All of our committees have responsibility for
considering the impact of transactions and activities, which
they oversee, on our reputation.
Membership of our risk committees is reviewed regularly
and updated to reflect changes in the responsibilities of the
committee members. Accordingly, the length of time that
members serve on the respective committees varies as
determined by the committee chairs and based on the
responsibilities of the members.
The 	chart 	below 	presents 	an 	overview 	of 	our 	risk
management governance structure.
Corporate Oversight
Board of Directors
Senior Management Oversight
Commiee Oversight
Management Commiee
Firmwide Client and Business
Standards Commiee
Chief Risk Officer
Board Commiees
Chief Execuve Officer
President/Chief Operang Officer
Chief Financial Officer
Firmwide Asset Liability
Commiee
Firmwide Enterprise Risk
Commiee
Director of
Internal Audit
Management Committee. The Management Committee
oversees our global activities. It provides this oversight
directly and through authority delegated to committees it
has established. This committee consists of our most senior
leaders, and is chaired by our chief executive officer. Most
members of the Management Committee are also members
of other committees. The following are the committees that
are principally involved in firmwide risk management.
Goldman Sachs March 2020 Form 10-Q 128

-- 130 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Firmwide Enterprise Risk Committee. The Firmwide
Enterprise Risk Committee is responsible for overseeing all
of our financial and nonfinancial risks. As a part of such
oversight, the committee is responsible for the ongoing
review, approval and monitoring of our enterprise risk
management 	framework, 	as 	well 	as 	our 	risk 	limits
framework. This committee is co-chaired by our chief
financial officer and our chief risk officer, who are
appointed as chairs by our chief executive officer, and
reports to the Management Committee. The following are
the primary committees that report to the Firmwide
Enterprise Risk Committee:
‰ Firmwide 	Risk 	Committee. 	The 	Firmwide 	Risk
Committee is responsible for the ongoing monitoring of
relevant financial risks and related risk limits at the
firmwide, business and product levels. This committee is
co-chaired by the chairs of the Firmwide Enterprise Risk
Committee.
‰ Firmwide New Activity Committee. The Firmwide
New Activity Committee is responsible for reviewing new
activities and for establishing a process to identify and
review previously approved activities that are significant
and that have changed in complexity and/or structure or
present different reputational and suitability concerns
over time to consider whether these activities remain
appropriate. 	This 	committee 	is 	co-chaired 	by 	the
controller and chief accounting officer, and the head of
Operations and Operations Engineering for the Global
Markets Division, who are appointed as chairs by the
chairs of the Firmwide Enterprise Risk Committee.
‰ Firmwide 	Operational 	Risk 	and 	Resilience
Committee. 	The 	Firmwide 	Operational 	Risk 	and
Resilience 	Committee 	is 	responsible 	for 	overseeing
operational risk, and for ensuring our business and
operational 	resilience. 	To 	assist 	the 	Firmwide
Operational Risk and Resilience Committee in carrying
out its mandate, other risk committees with dedicated
oversight for technology-related risks, including cyber
security matters, report into the Firmwide Operational
Risk and Resilience Committee. This committee is
co-chaired by our chief administrative officer and deputy
chief risk officer, who are appointed as chairs by the
chairs of the Firmwide Enterprise Risk Committee.
‰ Firmwide 	Conduct 	Committee. 	The 	Firmwide
Conduct Committee is responsible for the ongoing
approval and monitoring of the frameworks and policies
which govern our conduct risks. Conduct risk is the risk
that our people fail to act in a manner consistent with our
Business Principles and related core values, policies or
codes, or applicable laws or regulations, thereby falling
short in fulfilling their responsibilities to us, our clients,
colleagues, other market participants or the broader
community. 	The 	co-chairs 	of 	this 	committee 	are
appointed by the chairs of the Firmwide Enterprise Risk
Committee.
‰ Risk Governance Committee. The Risk Governance
Committee 	(through 	delegated 	authority 	from 	the
Firmwide Enterprise Risk Committee) is responsible for
the ongoing approval and monitoring of risk frameworks
and policies related to our core risk management
processes, as well as limits, at firmwide, business and
product levels. In addition, this committee reviews the
results of stress tests and scenario analyses. To assist the
Risk Governance Committee in carrying out its mandate,
a number of other risk committees with dedicated
oversight for stress testing, model risks and Volcker Rule
compliance report into the Risk Governance Committee.
This committee is chaired by our chief risk officer, who is
appointed as chair by the chairs of the Firmwide
Enterprise Risk Committee.
Firmwide Client and Business Standards Committee.
The Firmwide Client and Business Standards Committee is
responsible for overseeing relationships with our clients,
client 	service 	and 	experience, 	and 	related 	business
standards, as well as client-related reputational matters.
This committee is chaired by our president and chief
operating officer, who is appointed as chair by the chief
executive 	officer, 	and 	reports 	to 	the 	Management
Committee. This committee periodically provides updates
to, and receives guidance from, the Public Responsibilities
Committee of the Board.
129 Goldman Sachs March 2020 Form 10-Q

-- 131 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The following committees report jointly to the Firmwide
Enterprise Risk Committee and the Firmwide Client and
Business Standards Committee:
‰ Firmwide 	Reputational 	Risk 	Committee. 	The
Firmwide Reputational Risk Committee is responsible for
assessing reputational risks arising from transactions that
have been identified as having potential heightened
reputational risk pursuant to the criteria established by
the 	Firmwide 	Reputational 	Risk 	Committee. 	This
committee is chaired by our president and chief operating
officer, and the vice-chairs are the head of Regulatory
Affairs and the head of Conflicts Resolution, who are
appointed as vice-chairs by the chair of the Firmwide
Reputational 	Risk 	Committee. 	This 	committee
periodically provides updates to, and receives guidance
from, the Public Responsibilities Committee of the Board.
‰ Firmwide 	Suitability 	Committee. 	The 	Firmwide
Suitability Committee is responsible for setting standards
and policies for product, transaction and client suitability
and providing a forum for consistency across functions,
regions and products on suitability assessments. This
committee also reviews suitability matters escalated from
other committees. This committee is co-chaired by our
chief compliance officer, and the co-head of EMEA FICC
sales, who are appointed as chairs by the chair of the
Firmwide Client and Business Standards Committee.
‰ Firmwide 	Investment 	Policy 	Committee. 	The
Firmwide 	Investment 	Policy 	Committee 	reviews,
approves, sets policies, and provides oversight for certain
illiquid principal investments, including review of risk
management and controls for these types of investments.
This committee is co-chaired by the chairman of our
Merchant Banking Division, the head of our Merchant
Banking Division and the chief risk officer, who are
appointed as chairs by our president and chief operating
officer and our chief financial officer.
‰ Firmwide Capital Committee. The Firmwide Capital
Committee provides approval and oversight of debt-
related transactions, including principal commitments of
our capital. This committee aims to ensure that business,
reputational and suitability standards for underwritings
and capital commitments are maintained on a global
basis. This committee is co-chaired by the head of Credit
Risk and a co-head of the Financing Group, who are
appointed as chairs by the chairs of the Firmwide
Enterprise Risk Committee.
‰ Firmwide Commitments Committee. The Firmwide
Commitments Committee reviews our underwriting and
distribution activities with respect to equity and equity-
related product offerings, and sets and maintains policies
and 	procedures 	designed 	to 	ensure 	that 	legal,
reputational, regulatory and business standards are
maintained on a global basis. In addition to reviewing
specific 	transactions, 	this 	committee 	periodically
conducts general strategic reviews of sectors and products
and establishes policies in connection with transaction
practices. This committee is co-chaired by the co-head of
the 	Industrials 	Group 	in 	our 	Investment 	Banking
Division, the chief debt underwriting officer for EMEA,
and a managing director in our Investment Banking
Division, who are appointed as chairs by the chair of the
Firmwide Client and Business Standards Committee.
Firmwide Asset Liability Committee. The Firmwide
Asset Liability Committee reviews and approves the
strategic direction for our financial resources, including
capital, 	liquidity, 	funding 	and 	balance 	sheet. 	This
committee has oversight responsibility for asset liability
management, including interest rate and currency risk,
funds transfer pricing, capital allocation and incentives, and
credit ratings. This committee makes recommendations as
to any adjustments to asset liability management and
financial resource allocation in light of current events, risks,
exposures, and regulatory requirements and approves
related policies. This committee is co-chaired by our chief
financial 	officer 	and 	our 	global 	treasurer, 	who 	are
appointed as chairs by our chief executive officer, and
reports to the Management Committee.
Goldman Sachs March 2020 Form 10-Q 130

-- 132 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Conflicts Management
Conflicts of interest and our approach to dealing with them
are fundamental to our client relationships, our reputation
and our long-term success. The term “conflict of interest”
does not have a universally accepted meaning, and conflicts
can arise in many forms within a business or between
businesses. The responsibility for identifying potential
conflicts, as well as complying with our policies and
procedures, is shared by all of our employees.
We have a multilayered approach to resolving conflicts and
addressing 	reputational 	risk. 	Our 	senior 	management
oversees policies related to conflicts resolution, and, in
conjunction 	with 	Conflicts 	Resolution, 	Legal 	and
Compliance, the Firmwide Client and Business Standards
Committee, and other internal committees, formulates
policies, standards and principles, and assists in making
judgments regarding the appropriate resolution of particular
conflicts. Resolving potential conflicts necessarily depends on
the facts and circumstances of a particular situation and the
application of experienced and informed judgment.
As a general matter, Conflicts Resolution reviews financing
and advisory assignments in Investment Banking and certain
of our investing, lending and other activities. In addition, we
have various transaction oversight committees, such as the
Firmwide Capital, Commitments and Suitability Committees
and other committees that also review new underwritings,
loans, investments and structured products. These groups
and committees work with internal and external counsel and
Compliance to evaluate and address any actual or potential
conflicts. Conflicts Resolution reports to our president and
chief operating officer.
We regularly assess our policies and procedures that address
conflicts of interest in an effort to conduct our business in
accordance with the highest ethical standards and in
compliance with all applicable laws, rules and regulations.
Compliance Risk Management
Compliance risk is the risk of legal or regulatory sanctions,
material financial loss or damage to our reputation arising
from our failure to comply with the requirements of
applicable laws, rules and regulations, and our internal
policies and procedures. Compliance risk is inherent in all
activities through which we conduct our businesses. Our
Compliance Risk Management Program, administered by
Compliance, 	assesses 	our 	compliance, 	regulatory 	and
reputational risk; monitors for compliance with new or
amended laws, rules and regulations; designs and implements
controls, 	policies, 	procedures 	and 	training; 	conducts
independent testing; investigates, surveils and monitors for
compliance risks and breaches; and leads our responses to
regulatory examinations, audits and inquiries. We monitor
and review business practices to assess whether they meet or
exceed minimum regulatory and legal standards in all
markets and jurisdictions in which we conduct business.
Liquidity Risk Management
Overview
Liquidity risk is the risk that we will be unable to fund
ourselves or meet our liquidity needs in the event of firm-
specific, broader industry or market liquidity stress events.
We have in place a comprehensive and conservative set of
liquidity and funding policies. Our principal objective is to
be able to fund ourselves and to enable our core businesses
to continue to serve clients and generate revenues, even
under adverse circumstances.
Treasury, which reports to our chief financial officer, has
primary 	responsibility 	for 	developing, 	managing 	and
executing our liquidity and funding strategy within our risk
appetite.
Liquidity Risk, which is independent of our revenue-
producing units and Treasury, and reports to our chief risk
officer, has primary responsibility for assessing, monitoring
and managing our liquidity risk through firmwide oversight
across our global businesses and the establishment of stress
testing and limits frameworks.
Liquidity Risk Management Principles
We manage liquidity risk according to three principles:
(i) hold sufficient excess liquidity in the form of GCLA to
cover outflows during a stressed period, (ii) maintain
appropriate Asset-Liability Management and (iii) maintain
a viable Contingency Funding Plan.
GCLA. GCLA is liquidity that we maintain to meet a broad
range of potential cash outflows and collateral needs in a
stressed environment. A primary liquidity principle is to
pre-fund our estimated potential cash and collateral needs
during a liquidity crisis and hold this liquidity in the form of
unencumbered, highly liquid securities and cash. We believe
that the securities held in our GCLA would be readily
convertible to cash in a matter of days, through liquidation,
by entering into repurchase agreements or from maturities
of resale agreements, and that this cash would allow us to
meet immediate obligations without needing to sell other
assets or depend on additional funding from credit-sensitive
markets.
Our GCLA reflects the following principles:
‰ The first days or weeks of a liquidity crisis are the most
critical to a company’s survival;
‰ Focus must be maintained on all potential cash and
collateral outflows, not just disruptions to financing
flows. Our businesses are diverse, and our liquidity needs
are determined by many factors, including market
movements, 	collateral 	requirements 	and 	client
commitments, all of which can change dramatically in a
difficult funding environment;
131 Goldman Sachs March 2020 Form 10-Q

-- 133 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
‰ During 	a 	liquidity 	crisis, 	credit-sensitive 	funding,
including unsecured debt, certain deposits and some types
of secured financing agreements, may be unavailable, and
the terms (e.g., interest rates, collateral provisions and
tenor) or availability of other types of secured financing
may change and certain deposits may be withdrawn; and
‰ As a result of our policy to pre-fund liquidity that we
estimate may be needed in a crisis, we hold more
unencumbered 	securities 	and 	have 	larger 	funding
balances than our businesses would otherwise require.
We believe that our liquidity is stronger with greater
balances of highly liquid unencumbered securities, even
though it increases our total assets and our funding costs.
We maintain our GCLA across Group Inc., Goldman Sachs
Funding LLC (Funding IHC) and Group Inc.’s major
broker-dealer and bank subsidiaries, asset types and
clearing agents to provide us with sufficient operating
liquidity to ensure timely settlement in all major markets,
even in a difficult funding environment. In addition to the
GCLA, we maintain cash balances and securities in several
of our other entities, primarily for use in specific currencies,
entities or jurisdictions where we do not have immediate
access to parent company liquidity.
Asset-Liability 	Management. 	Our 	liquidity 	risk
management policies are designed to ensure we have a
sufficient amount of financing, even when funding markets
experience persistent stress. We manage the maturities and
diversity of our funding across markets, products and
counterparties, and seek to maintain a diversified funding
profile with an appropriate tenor, taking into consideration
the characteristics and liquidity profile of our assets.
Our approach to asset-liability management includes:
‰ Conservatively managing the overall characteristics of
our funding book, with a focus on maintaining long-term,
diversified sources of funding in excess of our current
requirements. See “Balance Sheet and Funding Sources —
Funding Sources” for further information;
‰ Actively managing and monitoring our asset base, with
particular focus on the liquidity, holding period and
ability to fund assets on a secured basis. We assess our
funding requirements and our ability to liquidate assets in
a stressed environment while appropriately managing
risk. This enables us to determine the most appropriate
funding products and tenors. See “Balance Sheet and
Funding Sources — Balance Sheet Management” for
further information about our balance sheet management
process and “— Funding Sources — Secured Funding”
for further information about asset classes that may be
harder to fund on a secured basis; and
‰ Raising secured and unsecured financing that has a long
tenor relative to the liquidity profile of our assets. This
reduces the risk that our liabilities will come due in
advance of our ability to generate liquidity from the sale
of our assets. Because we maintain a highly liquid balance
sheet, the holding period of certain of our assets may be
materially shorter than their contractual maturity dates.
Our goal is to ensure that we maintain sufficient liquidity to
fund our assets and meet our contractual and contingent
obligations in normal times, as well as during periods of
market 	stress. 	Through 	our 	dynamic 	balance 	sheet
management process, we use actual and projected asset
balances to determine secured and unsecured funding
requirements. Funding plans are reviewed and approved by
the Firmwide Asset Liability Committee. In addition, our
independent risk oversight and control functions analyze,
and the Firmwide Asset Liability Committee reviews, our
consolidated total capital position (unsecured long-term
borrowings plus total shareholders’ equity) so that we
maintain a level of long-term funding that is sufficient to
meet our long-term financing requirements. In a liquidity
crisis, we would first use our GCLA in order to avoid
reliance on asset sales (other than our GCLA). However, we
recognize that orderly asset sales may be prudent or
necessary in a severe or persistent liquidity crisis.
Subsidiary Funding Policies
The majority of our unsecured funding is raised by Group
Inc., which lends the necessary funds to Funding IHC and
other subsidiaries, some of which are regulated, to meet
their asset financing, liquidity and capital requirements. In
addition, Group Inc. provides its regulated subsidiaries
with 	the 	necessary 	capital 	to 	meet 	their 	regulatory
requirements. The benefits of this approach to subsidiary
funding are enhanced control and greater flexibility to meet
the funding requirements of our subsidiaries. Funding is
also raised at the subsidiary level through a variety of
products, 	including 	deposits, 	secured 	funding 	and
unsecured borrowings.
Our 	intercompany 	funding 	policies 	assume 	that 	a
subsidiary’s funds or securities are not freely available to its
parent, Funding IHC or other subsidiaries unless (i) legally
provided for and (ii) there are no additional regulatory, tax
or other restrictions. In particular, many of our subsidiaries
are subject to laws that authorize regulatory bodies to block
or reduce the flow of funds from those subsidiaries to
Group Inc. or Funding IHC. Regulatory action of that kind
could impede access to funds that Group Inc. needs to make
payments on its obligations. Accordingly, we assume that
the capital provided to our regulated subsidiaries is not
available to Group Inc. or other subsidiaries and any other
financing provided to our regulated subsidiaries is not
available to Group Inc. or Funding IHC until the maturity
of such financing.
Goldman Sachs March 2020 Form 10-Q 132

-- 134 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Group Inc. has provided substantial amounts of equity and
subordinated indebtedness, directly or indirectly, to its
regulated subsidiaries. For example, as of March 2020,
Group Inc. had $33.23 billion of equity and subordinated
indebtedness 	invested 	in 	GS&Co., 	its 	principal 	U.S.
registered broker-dealer; $41.68 billion invested in GSI, a
regulated U.K. broker-dealer; $2.94 billion invested in
GSJCL, a regulated Japanese broker-dealer; $33.87 billion
invested in GS Bank USA, a regulated New York State-
chartered bank; and $4.04 billion invested in GSIB, a
regulated U.K. bank. Group Inc. also provided, directly or
indirectly, 	$117.52 	billion 	of 	unsubordinated 	loans
(including 	secured 	loans 	of 	$55.61 	billion) 	and
$17.01 billion of collateral and cash deposits to these
entities, substantially all of which was to GS&Co., GSI and
GSJCL, as of March 2020. In addition, as of March 2020,
Group Inc. had significant amounts of capital invested in
and loans to its other regulated subsidiaries.
Contingency Funding Plan. We maintain a contingency
funding plan to provide a framework for analyzing and
responding to a liquidity crisis situation or periods of
market stress. Our contingency funding plan outlines a list
of potential risk factors, key reports and metrics that are
reviewed on an ongoing basis to assist in assessing the
severity of, and managing through, a liquidity crisis and/or
market dislocation. The contingency funding plan also
describes 	in 	detail 	our 	potential 	responses 	if 	our
assessments indicate that we have entered a liquidity crisis,
which include pre-funding for what we estimate will be our
potential cash and collateral needs, as well as utilizing
secondary sources of liquidity. Mitigants and action items
to address specific risks which may arise are also described
and assigned to individuals responsible for execution.
The contingency funding plan identifies key groups of
individuals 	and 	their 	responsibilities, 	which 	include
fostering effective coordination, control and distribution of
information, implementing liquidity maintenance activities
and managing internal and external communication, all of
which are critical in the management of a crisis or period of
market stress.
Stress Tests
In order to determine the appropriate size of our GCLA, we
model liquidity outflows over a range of scenarios and time
horizons. One of our primary internal liquidity risk models,
referred to as the Modeled Liquidity Outflow, quantifies our
liquidity risks over a 30-day stress scenario. We also consider
other factors, including, but not limited to, an assessment of
our potential intraday liquidity needs through an additional
internal liquidity risk model, referred to as the Intraday
Liquidity Model, the results of our long-term stress testing
models, our resolution liquidity models and other applicable
regulatory requirements and a qualitative assessment of our
condition, as well as the financial markets. The results of the
Modeled Liquidity Outflow, the Intraday Liquidity Model,
the long-term stress testing models and the resolution
liquidity models are reported to senior management on a
regular basis. We also perform firmwide stress tests. See
“Overview 	and 	Structure 	of 	Risk 	Management” 	for
information about firmwide stress tests.
Modeled Liquidity Outflow. Our Modeled Liquidity
Outflow is based on conducting multiple scenarios that
include combinations of market-wide and firm-specific
stress. These scenarios are characterized by the following
qualitative elements:
‰ Severely challenged market environments, which includes
low consumer and corporate confidence, financial and
political instability, and adverse changes in market values,
including 	potential 	declines 	in 	equity markets and
widening of credit spreads; and
‰ A firm-specific crisis potentially triggered by material losses,
reputational damage, litigation and/or a ratings downgrade.
The following are key modeling elements of our Modeled
Liquidity Outflow:
‰ Liquidity needs over a 30-day scenario;
‰ A 	two-notch 	downgrade 	of 	our 	long-term 	senior
unsecured credit ratings;
‰ Changing conditions in funding markets, which limit our
access to unsecured and secured funding;
‰ No 	support 	from 	additional 	government 	funding
facilities. Although we have access to various central bank
funding programs, we do not assume reliance on
additional sources of funding in a liquidity crisis; and
‰ A 	combination 	of 	contractual 	outflows, 	such 	as
upcoming maturities of unsecured debt, and contingent
outflows, including, but not limited to, the withdrawal of
customer credit balances in our prime brokerage business,
increase in variation margin requirements due to adverse
changes 	in 	the 	value 	of 	our 	exchange-traded 	and
OTC-cleared derivatives, and withdrawals of deposits
that have no contractual maturity.
133 Goldman Sachs March 2020 Form 10-Q

-- 135 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Intraday Liquidity Model. Our Intraday Liquidity Model
measures our intraday liquidity needs using a scenario
analysis characterized by the same qualitative elements as
our Modeled Liquidity Outflow. The model assesses the
risk of increased intraday liquidity requirements during a
scenario where access to sources of intraday liquidity may
become constrained.
Long-Term Stress Testing. We utilize longer-term stress
tests to take a forward view on our liquidity position
through prolonged stress periods in which we experience a
severe liquidity stress and recover in an environment that
continues to be challenging. We are focused on ensuring
conservative asset-liability management to prepare for a
prolonged period of potential stress, seeking to maintain a
diversified funding profile with an appropriate tenor,
taking into consideration the characteristics and liquidity
profile of our assets.
Resolution Liquidity Models. In connection with our
resolution planning efforts, we have established our
Resolution 	Liquidity 	Adequacy 	and 	Positioning
framework, which estimates liquidity needs of our major
subsidiaries in a stressed environment. The liquidity needs
are measured using our Modeled Liquidity Outflow
assumptions and include certain additional inter-affiliate
exposures. We have also established our Resolution
Liquidity Execution Need framework, which measures the
liquidity needs of our major subsidiaries to stabilize and
wind-down following a Group Inc. bankruptcy filing in
accordance with our preferred resolution strategy.
In addition, we have established a triggers and alerts
framework, which is designed to provide the Board with
information needed to make an informed decision on
whether and when to commence bankruptcy proceedings
for Group Inc.
Limits
We use liquidity risk limits at various levels and across
liquidity risk types to manage the size of our liquidity
exposures. Limits are measured relative to acceptable levels
of risk given our liquidity risk tolerance. See “Overview and
Structure of Risk Management” for information about the
limit approval process.
Limits are monitored by Treasury and Liquidity Risk.
Liquidity Risk is responsible for identifying and escalating
to 	senior 	management 	and/or 	the 	appropriate 	risk
committee, on a timely basis, instances where limits have
been exceeded.
GCLA and Unencumbered Metrics
GCLA. Based on the results of our internal liquidity risk
models, described above, as well as our consideration of
other factors, including, but not limited to, a qualitative
assessment of our condition, as well as the financial
markets, we believe our liquidity position as of both
March 2020 and December 2019 was appropriate. We
strictly limit our GCLA to a narrowly defined list of
securities and cash because they are highly liquid, even in a
difficult funding environment. We do not include other
potential sources of excess liquidity in our GCLA, such as
less liquid unencumbered securities or committed credit
facilities.
The table below presents information about our GCLA.
Average for the
Three Months Ended
$ in millions
March
2020
December
2019
Denomination
U.S. dollar 	$158,016 	$150,455
Non-U.S. dollar 	84,730 	86,661
Total 	$242,746 	$237,116
Asset Class
Overnight cash deposits 	$ 70,776 	$ 66,327
U.S. government obligations 	104,600 	99,798
U.S. agency obligations 	12,191 	14,081
Non-U.S. government obligations 	55,179 	56,910
Total 	$242,746 	$237,116
Entity Type
Group Inc. and Funding IHC 	$ 39,001 	$ 39,104
Major broker-dealer subsidiaries 	89,575 	92,835
Major bank subsidiaries 	114,170 	105,177
Total 	$242,746 	$237,116
In the table above:
‰ The 	U.S. 	dollar-denominated 	GCLA 	consists 	of
(i) 	unencumbered 	U.S. 	government 	and 	agency
obligations 	(including 	highly 	liquid 	U.S. 	agency
mortgage-backed obligations), all of which are eligible as
collateral in Federal Reserve open market operations and
(ii) certain overnight U.S. dollar cash deposits.
‰ The non-U.S. dollar-denominated GCLA consists of
non-U.S. government obligations (only unencumbered
German, 	French, 	Japanese 	and 	U.K. 	government
obligations) and certain overnight cash deposits in highly
liquid currencies.
Goldman Sachs March 2020 Form 10-Q 134

-- 136 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We maintain our GCLA to enable us to meet current and
potential liquidity requirements of our parent company,
Group Inc., and its subsidiaries. Our Modeled Liquidity
Outflow and Intraday Liquidity Model incorporate a
requirement for Group Inc., as well as a standalone
requirement for each of our major broker-dealer and bank
subsidiaries. Funding IHC is required to provide the
necessary liquidity to Group Inc. during the ordinary course
of business, and is also obligated to provide capital and
liquidity support to major subsidiaries in the event of our
material financial distress or failure. Liquidity held directly
in each of our major broker-dealer and bank subsidiaries is
intended for use only by that subsidiary to meet its liquidity
requirements and is assumed not to be available to Group
Inc. or Funding IHC unless (i) legally provided for and
(ii) there are no additional regulatory, tax or other
restrictions. In addition, the Modeled Liquidity Outflow
and Intraday Liquidity Model also incorporate a broader
assessment of standalone liquidity requirements for other
subsidiaries and we hold a portion of our GCLA directly at
Group Inc. or Funding IHC to support such requirements.
Other Unencumbered Assets. In addition to our GCLA,
we have a significant amount of other unencumbered cash
and financial instruments, including other government
obligations, high-grade money market securities, corporate
obligations, marginable equities, loans and cash deposits
not included in our GCLA. The fair value of our
unencumbered assets averaged $205.95 billion for the three
months ended March 2020 and $206.01 billion for the
three months ended December 2019. We do not consider
these assets liquid enough to be eligible for our GCLA.
Liquidity Regulatory Framework
As a bank holding company (BHC), we are subject to a
minimum Liquidity Coverage Ratio (LCR) under the LCR
rule approved by the U.S. federal bank regulatory agencies.
The LCR rule requires organizations to maintain an
adequate ratio of eligible high-quality liquid assets (HQLA)
to expected net cash outflows under an acute short-term
liquidity stress scenario. Eligible HQLA excludes HQLA
held by subsidiaries that is in excess of their minimum
requirement and is subject to transfer restrictions. We are
required to maintain a minimum LCR of 100%. We expect
that fluctuations in client activity, business mix and the
market environment will impact our LCR.
The table below presents information about our average
daily LCR.
Average for the
Three Months Ended
$ in millions
March
2020
December
2019
Total HQLA 	$235,620 	$229,029
Eligible HQLA 	$178,530 	$170,371
Net cash outflows 	$136,341 	$134,436
LCR 	131% 	127%
The U.S. federal bank regulatory agencies have issued a
proposed rule that calls for a net stable funding ratio
(NSFR) for large U.S. banking organizations. The proposal
would require banking organizations to ensure they have
access to stable funding over a one-year time horizon and
includes quarterly disclosure of the ratio and a description
of the banking organization’s stable funding sources. We
expect 	that 	we 	will 	be 	compliant 	with 	the 	NSFR
requirement when it is effective.
The following provides information about our subsidiary
liquidity regulatory requirements:
‰ GS Bank USA. GS Bank USA is subject to a minimum
LCR of 100% under the LCR rule approved by the U.S.
federal bank regulatory agencies. As of March 2020, GS
Bank USA’s LCR exceeded the minimum requirement.
The NSFR requirement described above would also apply
to GS Bank USA.
‰ GSI. GSI is subject to a minimum LCR of 100% under
the LCR rule approved by the U.K. regulatory authorities
and the European Commission. GSI’s average monthly
LCR 	for 	the 	trailing 	twelve-month 	period 	ended
March 2020 exceeded the minimum requirement.
‰ Other 	Subsidiaries. 	We 	monitor 	local 	regulatory
liquidity requirements of our subsidiaries to ensure
compliance. 	For 	many 	of 	our 	subsidiaries, 	these
requirements either have changed or are likely to change
in the future due to the implementation of the Basel
Committee on Banking Supervision’s framework for
liquidity risk measurement, standards and monitoring, as
well as other regulatory developments.
The implementation of these rules and any amendments
adopted by the regulatory authorities could impact our
liquidity and funding requirements and practices in the future.
Credit Ratings
We rely on the short- and long-term debt capital markets to
fund a significant portion of our day-to-day operations and
the cost and availability of debt financing is influenced by
our credit ratings. Credit ratings are also important when
we are competing in certain markets, such as OTC
derivatives, and when we seek to engage in longer-term
transactions. See “Risk Factors” in Part I, Item 1A of the
2019 Form 10-K for information about the risks associated
with a reduction in our credit ratings.
135 Goldman Sachs March 2020 Form 10-Q

-- 137 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents the unsecured credit ratings and
outlook of Group Inc.
As of March 2020
DBRS 	Fitch Moody’s 	R&I 	S&P
Short-term debt 	R-1 (middle) 	F1 	P-2 	a-1 	A-2
Long-term debt 	A (high) 	A 	A3 	A 	BBB+
Subordinated debt 	A 	A- 	Baa2 	A- 	BBB-
Trust preferred 	A 	BBB- 	Baa3 	N/A 	BB
Preferred stock 	BBB (high) 	BB+ 	Ba1 	N/A 	BB
Ratings outlook 	Stable Stable 	Stable Stable Stable
In the table above:
‰ The ratings and outlook are by DBRS, Inc. (DBRS), Fitch,
Inc. (Fitch), Moody’s Investors Service (Moody’s), Rating
and Investment Information, Inc. (R&I), and Standard &
Poor’s Ratings Services (S&P).
‰ The ratings for trust preferred relate to the guaranteed
preferred beneficial interests issued by Goldman Sachs
Capital I.
‰ The DBRS, Fitch, Moody’s and S&P ratings for preferred
stock include the APEX issued by Goldman Sachs
Capital II and Goldman Sachs Capital III.
In April 2020, after revising its global rating methodology for
banks, Fitch lowered Group Inc.’s ratings on subordinated
debt (from A- to BBB+) and upgraded preferred stock (from
BB+ to BBB-). In addition, due to COVID-19 uncertainty,
Fitch revised the outlook of Group Inc. from stable to negative.
The table below presents the unsecured credit ratings and
outlook of GS Bank USA, GSIB, GS&Co. and GSI.
As of March 2020
Fitch 	Moody’s 	S&P
GS Bank USA
Short-term debt 	F1 	P-1 	A-1
Long-term debt 	A+ 	A1 	A+
Short-term bank deposits 	F1+ 	P-1 	N/A
Long-term bank deposits 	AA- 	A1 	N/A
Ratings outlook 	Stable 	Stable 	Stable
GSIB
Short-term debt 	F1 	P-1 	A-1
Long-term debt 	A 	A1 	A+
Short-term bank deposits 	F1 	P-1 	N/A
Long-term bank deposits 	A 	A1 	N/A
Ratings outlook 	Stable 	Stable 	Stable
GS&Co.
Short-term debt 	F1 	N/A 	A-1
Long-term debt 	A+ 	N/A 	A+
Ratings outlook 	Stable 	N/A 	Stable
GSI
Short-term debt 	F1 	P-1 	A-1
Long-term debt 	A 	A1 	A+
Ratings outlook 	Stable 	Stable 	Stable
In April 2020, Fitch upgraded GSIB’s and GSI’s ratings on
long-term debt (from A to A+) and GSIB’s long-term bank
deposits (from A to A+). In addition, due to COVID-19
uncertainty, Fitch revised the outlook of GS Bank USA,
GSIB, GS&Co. and GSI from stable to negative.
We believe our credit ratings are primarily based on the
credit rating agencies’ assessment of:
‰ Our 	liquidity, 	market, 	credit 	and 	operational 	risk
management practices;
‰ Our level and variability of earnings;
‰ Our capital base;
‰ Our franchise, reputation and management;
‰ Our corporate governance; and
‰ The external operating and economic environment,
including, in some cases, the assumed level of government
support 	or 	other 	systemic 	considerations, 	such 	as
potential resolution.
Certain of our derivatives have been transacted under
bilateral agreements with counterparties who may require
us to post collateral or terminate the transactions based on
changes in our credit ratings. We manage our GCLA to
ensure we would, among other potential requirements, be
able to make the additional collateral or termination
payments that may be required in the event of a two-notch
reduction in our long-term credit ratings, as well as
collateral that has not been called by counterparties, but is
available to them.
See Note 7 to the consolidated financial statements for
further information about derivatives with credit-related
contingent 	features 	and 	the 	additional 	collateral 	or
termination 	payments 	related 	to 	our 	net 	derivative
liabilities under bilateral agreements that could have been
called by counterparties in the event of a one- or two-notch
downgrade in our credit ratings.
Goldman Sachs March 2020 Form 10-Q 136

-- 138 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Cash Flows
As a global financial institution, our cash flows are complex
and bear little relation to our net earnings and net assets.
Consequently, we believe that traditional cash flow analysis
is less meaningful in evaluating our liquidity position than
the 	liquidity 	and 	asset-liability 	management 	policies
described above. Cash flow analysis may, however, be
helpful in highlighting certain macro trends and strategic
initiatives in our businesses.
Three Months Ended March 2020. Our cash and cash
equivalents decreased by $28.06 billion to $105.49 billion
at the end of the first quarter of 2020, primarily due to net
cash used for operating activities and investing activities,
partially offset by net cash provided by financing activities.
The net cash used for operating activities primarily reflected
an increase in collateralized transactions (an increase in
collateralized agreements and a decrease in collateralized
financings) as a result of our activities and our clients’
activities. 	The 	net 	cash 	used 	for 	investing 	activities
primarily reflected an increase in corporate loans and net
purchases of investments. The net cash provided by
financing activities primarily reflected an increase in
deposits, the issuance of unsecured long-term borrowings
and an increase in other secured financings.
Three Months Ended March 2019. Our cash and cash
equivalents decreased by $42.66 billion to $87.88 billion at
the end of the first quarter of 2019, primarily due to net
cash used for operating activities. The net cash used for
operating activities primarily reflected an increase in
trading assets and collateralized transactions (an increase in
collateralized agreements and a decrease in collateralized
financings) as a result of our activities and our clients’
activities.
Market Risk Management
Overview
Market risk is the risk of loss in the value of our inventory,
investments, loans and other financial assets and liabilities
accounted for at fair value due to changes in market
conditions. We hold such positions primarily for market
making for our clients and for our investing and financing
activities, and therefore, these positions change based on
client demands and our investment opportunities. Since
these positions are accounted for at fair value, they
fluctuate on a daily basis, with the related gains and losses
included in the consolidated statements of earnings. We
employ a variety of risk measures, each described in the
respective 	sections 	below, 	to 	monitor 	market 	risk.
Categories of market risk include the following:
‰ Interest rate risk: results from exposures to changes in the
level, slope and curvature of yield curves, the volatilities
of interest rates, prepayment speeds and credit spreads;
‰ Equity price risk: results from exposures to changes in
prices and volatilities of individual equities, baskets of
equities and equity indices;
‰ Currency rate risk: results from exposures to changes in
spot prices, forward prices and volatilities of currency
rates; and
‰ Commodity price risk: results from exposures to changes
in 	spot 	prices, 	forward 	prices 	and 	volatilities 	of
commodities, such as crude oil, petroleum products,
natural gas, electricity, and precious and base metals.
Market Risk, which is independent of our revenue-
producing units and reports to our chief risk officer, has
primary 	responsibility 	for 	assessing, 	monitoring 	and
managing our market risk through firmwide oversight
across our global businesses.
Managers in revenue-producing units and Market Risk
discuss market information, positions and estimated loss
scenarios on an ongoing basis. Managers in revenue-
producing units are accountable for managing risk within
prescribed limits. These managers have in-depth knowledge
of their positions, markets and the instruments available to
hedge their exposures.
137 Goldman Sachs March 2020 Form 10-Q

-- 139 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Market Risk Management Process
Our process for managing market risk includes the critical
components of our risk management framework described
in the “Overview and Structure of Risk Management,” as
well as the following:
‰ Monitoring compliance with established market risk
limits and reporting our exposures;
‰ Diversifying exposures;
‰ Controlling position sizes; and
‰ Evaluating mitigants, such as economic hedges in related
securities or derivatives.
Our market risk management systems enable us to perform
an independent calculation of Value-at-Risk (VaR) and
stress 	measures, 	capture 	risk 	measures 	at 	individual
position levels, attribute risk measures to individual risk
factors of each position, report many different views of the
risk measures (e.g., by desk, business, product type or
entity) and produce ad hoc analyses in a timely manner.
Risk Measures
We produce risk measures and monitor them against
established market risk limits. These measures reflect an
extensive range of scenarios and the results are aggregated
at product, business and firmwide levels.
We use a variety of risk measures to estimate the size of
potential losses for both moderate and more extreme
market moves over both short- and long-term time
horizons. Our primary risk measures are VaR, which is
used for shorter-term periods, and stress tests. Our risk
reports detail key risks, drivers and changes for each desk
and 	business, 	and 	are 	distributed 	daily 	to 	senior
management of both our revenue-producing units and our
independent risk oversight and control functions.
Value-at-Risk. VaR is the potential loss in value due to
adverse market movements over a defined time horizon
with a specified confidence level. For assets and liabilities
included in VaR, see “Financial Statement Linkages to
Market Risk Measures.” We typically employ a one-day
time horizon with a 95% confidence level. We use a single
VaR model, which captures risks including interest rates,
equity prices, currency rates and commodity prices. As
such, VaR facilitates comparison across portfolios of
different 	risk 	characteristics. 	VaR 	also 	captures 	the
diversification of aggregated risk at the firmwide level.
We are aware of the inherent limitations to VaR and
therefore use a variety of risk measures in our market risk
management process. Inherent limitations to VaR include:
‰ VaR does not estimate potential losses over longer time
horizons where moves may be extreme;
‰ VaR does not take account of the relative liquidity of
different risk positions; and
‰ Previous moves in market risk factors may not produce
accurate predictions of all future market moves.
To comprehensively capture our exposures and relevant
risks in our VaR calculation, we use historical simulations
with full valuation of market factors at the position level by
simultaneously shocking the relevant market factors for
that position. These market factors include spot prices,
credit spreads, funding spreads, yield curves, volatility and
correlation, and are updated periodically based on changes
in the composition of positions, as well as variations in
market conditions. We sample from five years of historical
data to generate the scenarios for our VaR calculation. The
historical data is weighted so that the relative importance of
the data reduces over time. This gives greater importance to
more 	recent 	observations 	and 	reflects 	current 	asset
volatilities, which improves the accuracy of our estimates of
potential loss. As a result, even if our positions included in
VaR were unchanged, our VaR would increase with
increasing market volatility and vice versa.
Given its reliance on historical data, VaR is most effective in
estimating risk exposures in markets in which there are no
sudden fundamental changes or shifts in market conditions.
Our VaR measure does not include:
‰ Positions that are best measured and monitored using
sensitivity measures; and
‰ The impact of changes in counterparty and our own
credit spreads on derivatives, as well as changes in our
own credit spreads on financial liabilities for which the
fair value option was elected.
Goldman Sachs March 2020 Form 10-Q 138

-- 140 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We perform daily backtesting of our VaR model (i.e.,
comparing daily net revenues for positions included in VaR
to the VaR measure calculated as of the prior business day)
at the firmwide level and for each of our businesses and
major regulated subsidiaries.
Stress Testing. Stress testing is a method of determining
the effect of various hypothetical stress scenarios. We use
stress testing to examine risks of specific portfolios, as well
as the potential impact of our significant risk exposures. We
use a variety of stress testing techniques to calculate the
potential loss from a wide range of market moves on our
portfolios, 	including 	firmwide 	stress 	tests, 	sensitivity
analysis and scenario analysis. The results of our various
stress tests are analyzed together for risk management
purposes. 	See 	“Overview 	and 	Structure 	of 	Risk
Management” for information about firmwide stress tests.
Sensitivity analysis is used to quantify the impact of a
market move in a single risk factor across all positions (e.g.,
equity prices or credit spreads) using a variety of defined
market shocks, ranging from those that could be expected
over a one-day time horizon up to those that could take
many months to occur. We also use sensitivity analysis to
quantify the impact of the default of any single entity,
which captures the risk of large or concentrated exposures.
Scenario analysis is used to quantify the impact of a
specified event, including how the event impacts multiple
risk factors simultaneously. For example, for sovereign
stress 	testing 	we 	calculate 	potential 	direct 	exposure
associated with our sovereign positions, as well as the
corresponding 	debt, 	equity 	and 	currency 	exposures
associated with our non-sovereign positions that may be
impacted by the sovereign distress. When conducting
scenario analysis, we often consider a number of possible
outcomes for each scenario, ranging from moderate to
severely adverse market impacts. In addition, these stress
tests are constructed using both historical events and
forward-looking hypothetical scenarios.
Unlike VaR measures, which have an implied probability
because they are calculated at a specified confidence level,
there may not be an implied probability that our stress
testing scenarios will occur. Instead, stress testing is used to
model 	both 	moderate 	and 	more 	extreme 	moves 	in
underlying market factors. When estimating potential loss,
we generally assume that our positions cannot be reduced
or hedged (although experience demonstrates that we are
generally able to do so).
Limits
We use market risk limits at various levels to manage the
size of our market exposures. These limits are set based on
VaR and on a range of stress tests relevant to our exposures.
See “Overview and Structure of Risk Management” for
information about the limit approval process.
Market Risk is responsible for monitoring these limits, and
identifying and escalating to senior management and/or the
appropriate risk committee, on a timely basis, instances
where limits have been exceeded (e.g., due to positional
changes or changes in market conditions, such as increased
volatilities or changes in correlations). Such instances are
remediated by a reduction in the positions we hold and/or a
temporary or permanent increase to the limit.
Metrics
We analyze VaR at the firmwide level and a variety of more
detailed levels, including by risk category, business and
region. Diversification effect in the tables below represents
the difference between total VaR and the sum of the VaRs
for the four risk categories. This effect arises because the
four market risk categories are not perfectly correlated.
The table below presents our average daily VaR.
Three Months Ended
$ in millions
March
2020
December
2019
March
2019
Categories
Interest rates 	$ 60 	$ 49 	$ 43
Equity prices 	41 	24 	29
Currency rates 	18 	11 	12
Commodity prices 	11 	12 	11
Diversification effect 	(49) 	(38) 	(40)
Total 	$ 81 	$ 58 	$ 55
Our average daily VaR increased to $81 million for the first
quarter of 2020 from $58 million for the fourth quarter of
2019, primarily due to increases in the equity prices,
interest rates and currency rates categories, partially offset
by an increase in the diversification effect. The overall
increase was due to increased exposures and higher levels of
volatility.
Our average daily VaR increased to $81 million for the first
quarter of 2020 from $55 million for the first quarter of
2019, due to increases in the interest rates, equity prices and
currency rates categories, partially offset by an increase in
the diversification effect. The overall increase was due to
higher levels of volatility and increased exposures.
139 Goldman Sachs March 2020 Form 10-Q

-- 141 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents our period-end VaR.
As of
$ in millions
March
2020
December
2019
March
2019
Categories
Interest rates 	$ 99 	$ 54 	$ 41
Equity prices 	78 	24 	31
Currency rates 	48 	10 	11
Commodity prices 	16 	10 	12
Diversification effect 	(118) 	(28) 	(38)
Total 	$ 123 	$ 70 	$ 57
Our period-end VaR increased to $123 million as of
March 2020 from $70 million as of December 2019, due to
increases in the equity prices, interest rates, currency rates
and commodity prices categories, partially offset by an
increase in the diversification effect. The overall increase
was primarily due to higher levels of volatility.
Our period-end VaR increased to $123 million as of
March 2020 from $57 million as of March 2019, due to
increases in the interest rates, equity prices, currency rates
and commodity prices categories, partially offset by an
increase in the diversification effect. The overall increase
was primarily due to higher levels of volatility.
During the three months ended March 2020 the firmwide
VaR risk limit was exceeded on 10 occasions primarily due
to higher levels of volatility and was not raised or reduced.
During the year ended December 2019, the firmwide VaR
risk limit was not exceeded, raised or reduced.
The table below presents our high and low VaR.
Three Months Ended
March 2020 	December 2019 	March 2019
$ in millions 	High 	Low 	High 	Low 	High 	Low
Categories
Interest rates 	$ 99 	$46 	$64 	$39 	$52 	$35
Equity prices 	$116 	$23 	$30 	$20 	$38 	$25
Currency rates 	$ 53 	$ 8 	$17 	$ 7 	$20 	$ 7
Commodity prices 	$ 18 	$ 9 	$16 	$ 9 	$16 	$10
Firmwide
VaR 	$195 	$58 	$77 	$48 	$63 	$49
The chart below presents our daily VaR for the three
months ended March 2020.
0
30
120
180
150
60
90
210
Daily VaR	
(in millions)
First Quarter
2020
The table below presents, by number of business days, the
frequency distribution of our daily net revenues for
positions included in VaR.
Three Months
Ended March
$ in millions 	2020 	2019
>$100 	14 	5
$75 - $100 	8 	6
$50 - $75 	5 	10
$25 - $50 	12 	18
$0 - $25 	14 	19
$(25) - $0 	4 	3
$(50) - $(25) 	1 	–
$(75) - $(50) 	2 	–
$(100) - $(75) 	2 	–
Total 	62 	61
Daily net revenues for positions included in VaR are
compared with VaR calculated as of the end of the prior
business day. Net losses incurred on a single day for such
positions exceeded our 95% one-day VaR (i.e., a VaR
exception) on two occasions during the three months ended
March 2020 and did not exceed our 95% one-day VaR
during the three months ended March 2019.
During periods in which we have significantly more positive
net revenue days than net revenue loss days, we expect to
have 	fewer 	VaR 	exceptions 	because, 	under 	normal
conditions, our business model generally produces positive
net revenues. In periods in which our franchise revenues are
adversely affected, we generally have more loss days,
resulting in more VaR exceptions. The daily net revenues
for positions included in VaR used to determine VaR
exceptions reflect the impact of any intraday activity,
including bid/offer net revenues, which are more likely than
not to be positive by their nature.
Goldman Sachs March 2020 Form 10-Q 140

-- 142 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Sensitivity Measures
Certain portfolios and individual positions are not included
in VaR because VaR is not the most appropriate risk
measure. Other sensitivity measures we use to analyze
market risk are described below.
10% Sensitivity Measures. The table below presents our
market risk by asset category for positions accounted for at
fair value, that are not included in VaR.
As of
$ in millions
March
2020
December
2019
March
2019
Equity 	$1,818 	$1,865 	$1,939
Debt 	2,384 	2,368 	2,031
Total 	$4,202 	$4,233 	$3,970
In the table above:
‰ The market risk of these positions is determined by
estimating the potential reduction in net revenues of a
10% decline in the value of these positions.
‰ Equity positions relate to private and restricted public
equity securities, including interests in funds that invest in
corporate equities and real estate and interests in hedge
funds.
‰ Debt positions include interests in funds that invest in
corporate mezzanine and senior debt instruments, loans
backed 	by 	commercial 	and 	residential 	real 	estate,
corporate bank loans and other corporate debt, including
acquired portfolios of distressed loans.
‰ Funded equity and debt positions are included in our
consolidated balance sheets in investments and loans. See
Note 8 to the consolidated financial statements for
further information about investments and Note 9 to the
consolidated financial statements for further information
about loans.
‰ These measures do not reflect the diversification effect
across asset categories or across other market risk
measures.
Credit and Funding Spread Sensitivity on Derivatives
and Financial Liabilities. VaR excludes the impact of
changes in counterparty credit spreads, our own credit
spreads and unsecured funding spreads on derivatives, as
well as changes in our own credit spreads (debt valuation
adjustment) on financial liabilities for which the fair value
option was elected. The estimated sensitivity to a one basis
point increase in credit spreads (counterparty and our own)
and unsecured funding spreads on derivatives (including
hedges) was a loss of $4 million as of March 2020 and
$2 million as of December 2019. In addition, the estimated
sensitivity to a one basis point increase in our own credit
spreads on financial liabilities for which the fair value
option was elected was a gain of $33 million as of
March 2020 and $29 million as of December 2019.
However, the actual net impact of a change in our own
credit spreads is also affected by the liquidity, duration and
convexity (as the sensitivity is not linear to changes in
yields) of those financial liabilities for which the fair value
option was elected, as well as the relative performance of
any hedges undertaken.
Interest 	Rate 	Sensitivity. 	Loans 	accounted 	for 	at
amortized cost were $111.47 billion as of March 2020 and
$89.20 billion as of December 2019, substantially all of
which had floating interest rates. The estimated sensitivity
to a 100 basis point increase in interest rates on such loans
was $872 million as of March 2020 and $681 million as of
December 2019 of additional interest income over a twelve-
month period, which does not take into account the
potential impact of an increase in costs to fund such loans.
See Note 9 to the consolidated financial statements for
further information about loans accounted for at amortized
cost.
Other Market Risk Considerations
As of both March 2020 and December 2019, we had
commitments and held loans for which we have obtained
credit loss protection from Sumitomo Mitsui Financial
Group, Inc. See Note 18 to the consolidated financial
statements for further information about such lending
commitments.
In addition, we make investments in securities that are
accounted for as available-for-sale, held-to-maturity or
under the equity method which are included in investments
in the consolidated balance sheets. See Note 8 to the
consolidated financial statements for further information.
Direct investments in real estate are accounted for at cost
less 	accumulated 	depreciation. 	See 	Note 	12 	to 	the
consolidated financial statements for further information
about other assets.
141 Goldman Sachs March 2020 Form 10-Q

-- 143 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Financial 	Statement 	Linkages 	to 	Market 	Risk
Measures
We employ a variety of risk measures, each described in the
respective sections above, to monitor market risk across the
consolidated balance sheets and consolidated statements of
earnings. The related gains and losses on these positions are
included in market making, other principal transactions,
interest income and interest expense in the consolidated
statements of earnings, and debt valuation adjustment in
the consolidated statements of comprehensive income.
The table below presents certain assets and liabilities in our
consolidated balance sheets and the market risk measures
used to assess those assets and liabilities.
Assets or Liabilities 	Market Risk Measures
Collateralized agreements, at fair value 	VaR
Customer and other receivables, at fair value 	10% Sensitivity Measures
Trading assets 	VaR
Credit Spread Sensitivity
Investments, at fair value 	VaR
10% Sensitivity Measures
Loans 	VaR
10% Sensitivity Measures
Interest Rate Sensitivity
Deposits, at fair value 	VaR
Credit Spread Sensitivity
Collateralized financings, at fair value 	VaR
Trading liabilities 	VaR
Credit Spread Sensitivity
Unsecured short- and long-term
borrowings, at fair value
VaR
Credit Spread Sensitivity
Credit Risk Management
Overview
Credit risk represents the potential for loss due to the
default or deterioration in credit quality of a counterparty
(e.g., an OTC derivatives counterparty or a borrower) or an
issuer of securities or other instruments we hold. Our
exposure 	to 	credit 	risk 	comes 	mostly 	from 	client
transactions in OTC derivatives and loans and lending
commitments. Credit risk also comes from cash placed with
banks, securities financing transactions (i.e., resale and
repurchase 	agreements 	and 	securities 	borrowing 	and
lending activities) and customer and other receivables.
Credit 	Risk, 	which 	is 	independent 	of 	our 	revenue-
producing units and reports to our chief risk officer, has
primary 	responsibility 	for 	assessing, 	monitoring 	and
managing our credit risk through firmwide oversight across
our global businesses. The Risk Governance Committee
reviews and approves credit policies and parameters. In
addition, we hold other positions that give rise to credit risk
(e.g., bonds and secondary bank loans). These credit risks
are captured as a component of market risk measures,
which are monitored and managed by Market Risk. We
also enter into derivatives to manage market risk exposures.
Such derivatives also give rise to credit risk, which is
monitored and managed by Credit Risk.
Credit Risk Management Process
Our process for managing credit risk includes the critical
components of our risk management framework described
in the “Overview and Structure of Risk Management,” as
well as the following:
‰ Monitoring compliance with established credit risk limits
and 	reporting 	our 	credit 	exposures 	and 	credit
concentrations;
‰ Establishing or approving underwriting standards;
‰ Assessing the likelihood that a counterparty will default
on its payment obligations;
‰ Measuring our current and potential credit exposure and
losses resulting from a counterparty default;
‰ Using credit risk mitigants, including collateral and
hedging; and
‰ Maximizing 	recovery 	through 	active 	workout 	and
restructuring of claims.
We also perform credit reviews, which include initial and
ongoing analyses of our counterparties. For substantially all
of our credit exposures, the core of our process is an annual
counterparty 	credit 	review. 	A 	credit 	review 	is 	an
independent analysis of the capacity and willingness of a
counterparty to meet its financial obligations, resulting in
an internal credit rating. The determination of internal
credit ratings also incorporates assumptions with respect to
the nature of and outlook for the counterparty’s industry,
and the economic environment. Senior personnel, with
expertise in specific industries, inspect and approve credit
reviews and internal credit ratings.
Our risk assessment process may also include, where
applicable, reviewing certain key metrics, including, but not
limited to, delinquency status, collateral values, Fair Isaac
Corporation credit scores and other risk factors.
Goldman Sachs March 2020 Form 10-Q 142

-- 144 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Our 	credit 	risk 	management 	systems 	capture 	credit
exposure to individual counterparties and on an aggregate
basis to counterparties and their subsidiaries. These systems
also provide management with comprehensive information
about our aggregate credit risk by product, internal credit
rating, industry, country and region.
Risk Measures
We measure our credit risk based on the potential loss in the
event of non-payment by a counterparty using current and
potential exposure. For derivatives and securities financing
transactions, current exposure represents the amount
presently owed to us after taking into account applicable
netting 	and 	collateral 	arrangements, 	while 	potential
exposure represents our estimate of the future exposure
that could arise over the life of a transaction based on
market movements within a specified confidence level.
Potential exposure also takes into account netting and
collateral 	arrangements. 	For 	loans 	and 	lending
commitments, the primary measure is a function of the
notional amount of the position.
Stress Tests
We conduct regular stress tests to calculate the credit
exposures, including potential concentrations that would
result from applying shocks to counterparty credit ratings
or credit risk factors (e.g., currency rates, interest rates,
equity prices). These shocks cover a wide range of moderate
and more extreme market movements, including shocks to
multiple risk factors, consistent with the occurrence of a
severe market or economic event. In the case of sovereign
default, we estimate the direct impact of the default on our
sovereign credit exposures, changes to our credit exposures
arising from potential market moves in response to the
default, and the impact of credit market deterioration on
corporate borrowers and counterparties that may result
from the sovereign default. Unlike potential exposure,
which is calculated within a specified confidence level,
stress testing does not generally assume a probability of
these events occurring. We also perform firmwide stress
tests. See “Overview and Structure of Risk Management”
for information about firmwide stress tests.
To supplement these regular stress tests, as described above,
we also conduct tailored stress tests on an ad hoc basis in
response to specific market events that we deem significant.
We also utilize these stress tests to estimate the indirect
impact of certain hypothetical events on our country
exposures, such as the impact of credit market deterioration
on corporate borrowers and counterparties along with the
shocks to the risk factors described above. The parameters
of these shocks vary based on the scenario reflected in each
stress test. We review estimated losses produced by the
stress tests in order to understand their magnitude,
highlight potential loss concentrations, and assess and
mitigate our exposures where necessary.
Limits
We use credit risk limits at various levels, as well as
underwriting standards to manage the size and nature of
our credit exposures. Limits for industries and countries are
based on our risk appetite and are designed to allow for
regular monitoring, review, escalation and management of
credit risk concentrations. See “Overview and Structure of
Risk 	Management” 	for 	information 	about 	the 	limit
approval process.
Credit Risk is responsible for monitoring these limits, and
identifying and escalating to senior management and/or the
appropriate risk committee, on a timely basis, instances
where limits have been exceeded.
Risk Mitigants
To reduce our credit exposures on derivatives and securities
financing 	transactions, 	we 	may 	enter 	into 	netting
agreements with counterparties that permit us to offset
receivables and payables with such counterparties. We may
also reduce credit risk with counterparties by entering into
agreements that enable us to obtain collateral from them on
an 	upfront 	or 	contingent 	basis 	and/or 	to terminate
transactions if the counterparty’s credit rating falls below a
specified level. We monitor the fair value of the collateral to
ensure 	that 	our 	credit 	exposures 	are 	appropriately
collateralized. We seek to minimize exposures where there
is 	a 	significant 	positive 	correlation 	between 	the
creditworthiness of our counterparties and the market
value of collateral we receive.
For loans and lending commitments, depending on the
credit quality of the borrower and other characteristics of
the transaction, we employ a variety of potential risk
mitigants. Risk mitigants include collateral provisions,
guarantees, covenants, structural seniority of the bank loan
claims and, for certain lending commitments, provisions in
the legal documentation that allow us to adjust loan
amounts, pricing, structure and other terms as market
conditions change. The type and structure of risk mitigants
employed can significantly influence the degree of credit
risk involved in a loan or lending commitment.
When 	we 	do 	not 	have 	sufficient 	visibility 	into 	a
counterparty’s financial strength or when we believe a
counterparty requires support from its parent, we may
obtain 	third-party 	guarantees 	of 	the 	counterparty’s
obligations. We may also mitigate our credit risk using
credit derivatives or participation agreements.
143 Goldman Sachs March 2020 Form 10-Q

-- 145 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Credit Exposures
As of March 2020, our aggregate credit exposure increased
as compared with December 2019, primarily reflecting an
increase in OTC derivatives, receivables from clearing
organizations 	and 	securities 	financing 	transactions,
partially offset by a decrease in cash deposits with central
banks. The percentage of our credit exposures arising from
non-investment-grade 	counterparties 	(based 	on 	our
internally determined public rating agency equivalents)
increased slightly as compared with December 2019,
primarily reflecting an increase in non-investment-grade
OTC derivatives. Our credit exposure to counterparties
that defaulted during the three months ended March 2020
was higher as compared with our credit exposure to
counterparties that defaulted during the same prior year
period, and such exposure was primarily related to OTC
derivatives. Our credit exposure to counterparties that
defaulted during the three months ended March 2020
remained low, representing less than 0.5% of our total
credit exposure. Estimated losses associated with these
defaults have been recognized in earnings. Our credit
exposures are described further below.
Cash and Cash Equivalents. Our credit exposure on cash
and cash equivalents arises from our unrestricted cash, and
includes both interest-bearing and non-interest-bearing
deposits. To mitigate the risk of credit loss, we place
substantially all of our deposits with highly rated banks and
central banks.
The table below presents our credit exposure from
unrestricted 	cash 	and 	cash 	equivalents, 	and 	the
concentration by industry, region and credit quality.
As of
$ in millions
March
2020
December
2019
Cash and Cash Equivalents 	$76,561 	$110,774
Industry
Financial Institutions 	15% 	12%
Sovereign 	85% 	88%
Total 	100% 	100%
Region
Americas 	51% 	50%
EMEA 	27% 	31%
Asia 	22% 	19%
Total 	100% 	100%
Credit Quality (Credit Rating Equivalent)
AAA 	64% 	66%
AA 	9% 	11%
A 	25% 	22%
BBB 	2% 	1%
Total 	100% 	100%
The table above excludes cash segregated for regulatory
and other purposes of $28.93 billion as of March 2020 and
$22.78 billion as of December 2019.
OTC Derivatives. Our credit exposure on OTC derivatives
arises primarily from our market-making activities. As a
market maker, we enter into derivative transactions to
provide liquidity to clients and to facilitate the transfer and
hedging of their risks. We also enter into derivatives to
manage market risk exposures. We manage our credit
exposure on OTC derivatives using the credit risk process,
measures, limits and risk mitigants described above.
We generally enter into OTC derivatives transactions under
bilateral collateral arrangements that require the daily
exchange of collateral. As credit risk is an essential
component of fair value, we include a credit valuation
adjustment (CVA) in the fair value of derivatives to reflect
counterparty credit risk, as described in Note 7 to the
consolidated financial statements. CVA is a function of the
present value of expected exposure, the probability of
counterparty default and the assumed recovery upon
default.
The table below presents our net credit exposure from OTC
derivatives and the concentration by industry and region.
As of
$ in millions
March
2020
December
2019
OTC derivative assets 	$ 68,904 	$ 43,011
Collateral (not netted under U.S. GAAP) 	(21,002) 	(15,420)
Net credit exposure 	$ 47,902 	$ 27,591
Industry
Consumer, Retail & Healthcare 	4% 	4%
Diversified Industrials 	11% 	7%
Financial Institutions 	14% 	13%
Funds 	21% 	11%
Municipalities & Nonprofit 	7% 	8%
Natural Resources & Utilities 	13% 	15%
Sovereign 	19% 	25%
Technology, Media & Telecommunications 	7% 	9%
Other (including Special Purpose Vehicles) 	4% 	8%
Total 	100% 	100%
Region
Americas 	46% 	44%
EMEA 	42% 	48%
Asia 	12% 	8%
Total 	100% 	100%
In the table above:
‰ OTC derivative assets, included in the consolidated
balance sheets, are reported on a net-by-counterparty
basis (i.e., the net receivable for a given counterparty)
when a legal right of setoff exists under an enforceable
netting 	agreement 	(counterparty 	netting) 	and 	are
accounted for at fair value, net of cash collateral received
under 	enforceable 	credit 	support 	agreements 	(cash
collateral netting).
‰ Collateral represents cash collateral and the fair value of
securities 	collateral, 	primarily 	U.S. 	and 	non-U.S.
government and agency obligations, received under credit
support agreements, that we consider when determining
credit risk, but such collateral is not eligible for netting
under U.S. GAAP.
Goldman Sachs March 2020 Form 10-Q 144

-- 146 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents the distribution of our net credit
exposure from OTC derivatives by tenor.
$ in millions
Investment-
Grade
Non-Investment-
Grade / Unrated 	Total
As of March 2020
Less than 1 year 	$ 37,771 	$ 9,218 	$ 46,989
1 - 5 years 	26,665 	10,205 	36,870
Greater than 5 years 	74,102 	9,719 	83,821
Total 	138,538 	29,142 	167,680
Netting 	(104,415) 	(15,363) 	(119,778)
Net credit exposure 	$ 34,123 	$ 13,779 	$ 47,902
As of December 2019
Less than 1 year 	$ 18,764 	$ 4,247 	$ 23,011
1 - 5 years 	18,674 	6,879 	25,553
Greater than 5 years 	60,190 	5,896 	66,086
Total 	97,628 	17,022 	114,650
Netting 	(78,081) 	(8,978) 	(87,059)
Net credit exposure 	$ 19,547 	$ 8,044 	$ 27,591
In the table above:
‰ Tenor is based on remaining contractual maturity.
‰ Netting 	includes 	counterparty 	netting 	across 	tenor
categories and cash and securities collateral that we
consider 	when 	determining 	credit 	risk 	(including
collateral that is not eligible for netting under U.S.
GAAP). Counterparty netting within the same tenor
category is included within such tenor category.
The tables below present the distribution of our net credit
exposure from OTC derivatives by tenor and internally
determined public rating agency equivalents.
Investment-Grade
$ in millions 	AAA 	AA 	A 	BBB 	Total
As of March 2020
Less than 1 year 	$ 1,498 $ 7,011 $ 18,890 $ 10,372 $ 37,771
1 - 5 years 	766 	4,375 	12,883 	8,641 	26,665
Greater than 5 years 	14,862 	8,795 	26,521 	23,924 	74,102
Total 	17,126 	20,181 	58,294 	42,937 	138,538
Netting 	(10,392) (14,188) (48,097) (31,738) (104,415)
Net credit exposure $ 6,734 $ 5,993 $ 10,197 $ 11,199 $ 34,123
As of December 2019
Less than 1 year 	$ 	326 $ 2,022 $ 10,002 $ 6,414 $ 18,764
1 - 5 years 	669 	3,196 	8,635 	6,174 	18,674
Greater than 5 years 	12,381 	5,770 	22,324 	19,715 	60,190
Total 	13,376 	10,988 	40,961 	32,303 	97,628
Netting 	(8,146) 	(8,273) (35,932) (25,730) 	(78,081)
Net credit exposure 	$ 5,230 $ 2,715 $ 5,029 $ 6,573 $ 19,547
Non-Investment-Grade / Unrated
$ in millions 	BB or lower 	Unrated 	Total
As of March 2020
Less than 1 year 	$ 8,790 $ 	428 $ 	9,218
1 - 5 years 	10,042 	163 	10,205
Greater than 5 years 	9,577 	142 	9,719
Total 	28,409 	733 	29,142
Netting 	(15,254) 	(109) 	(15,363)
Net credit exposure 	$ 13,155 $ 	624 $ 13,779
As of December 2019
Less than 1 year 	$ 3,964 $ 	283 $ 	4,247
1 - 5 years 	6,772 	107 	6,879
Greater than 5 years 	5,835 	61 	5,896
Total 	16,571 	451 	17,022
Netting 	(8,811) 	(167) 	(8,978)
Net credit exposure 	$ 7,760 $ 	284 $ 	8,044
Lending Activities. We manage our lending activities
using the credit risk process, measures, limits and risk
mitigants 	described 	above. 	Other 	lending 	positions,
including secondary trading positions, are risk-managed as
a component of market risk.
‰ Commercial 	Lending. 	Our 	commercial 	lending
activities 	include 	lending 	to 	investment-grade 	and
non-investment-grade corporate borrowers. Loans and
lending commitments associated with these activities are
principally used for operating and general corporate
purposes or in connection with contingent acquisitions.
Corporate loans may be secured or unsecured, depending
on the loan purpose, the risk profile of the borrower and
other factors. Our commercial lending activities also
include extending loans to borrowers that are secured by
commercial and other real estate.
The table below presents our credit exposure from
commercial loans and lending commitments, and the
concentration by industry, region and credit quality.
As of
$ in millions
March
2020
December
2019
Loans and Lending Commitments 	$221,203 	$222,745
Industry
Consumer, Retail & Healthcare 	18% 	19%
Diversified Industrials 	17% 	14%
Financial Institutions 	7% 	8%
Funds 	3% 	3%
Natural Resources & Utilities 	14% 	17%
Real Estate 	10% 	10%
Technology, Media & Telecommunications 	17% 	16%
Other (including Special Purpose Vehicles) 	14% 	13%
Total 	100% 	100%
Region
Americas 	73% 	73%
EMEA 	23% 	22%
Asia 	4% 	5%
Total 	100% 	100%
Credit Quality (Credit Rating Equivalent)
AAA 	1% 	1%
AA 	4% 	5%
A 	14% 	13%
BBB 	28% 	27%
BB or lower 	53% 	54%
Total 	100% 	100%
‰ Wealth Management, Residential Real Estate and
Other Lending. We extend wealth management loans
and 	lending 	commitments 	to 	private 	bank 	clients,
substantially all of which are secured by commercial and
residential real estate, securities or other assets. The fair
value of the collateral received against such loans and
lending commitments generally exceeds their carrying
value.
145 Goldman Sachs March 2020 Form 10-Q

-- 147 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We also have residential real estate and other lending
exposures, which include purchased residential real estate
and installment loans and commitments to purchase such
loans (including distressed loans) and securities.
The table below presents our credit exposure from
Wealth management, residential real estate and other
lending, and the concentration by region.
$ in millions
Wealth
Management
Residential Real
Estate and Other
As of March 2020
Credit Exposure 	$32,902 	$10,582
Americas 	89% 	75%
EMEA 	9% 	25%
Asia 	2% 	–
Total 	100% 	100%
As of December 2019
Credit Exposure 	$30,668 	$10,885
Americas 	89% 	74%
EMEA 	9% 	26%
Asia 	2% 	–
Total 	100% 	100%
‰ Installment and Credit Card Lending. We originate
installment and credit card loans. Our credit exposure to
installment loans was $4.83 billion as of March 2020 and
$4.75 billion as of December 2019 and our credit
exposure to credit card loans was $2.08 billion as of
March 2020 and $1.86 billion as of December 2019.
See Note 9 to the consolidated financial statements for
further information about U.S. state concentrations and
the credit quality indicators of installment and credit card
loans.
Securities 	Financing 	Transactions. 	We 	enter 	into
securities financing transactions in order to, among other
things, facilitate client activities, invest excess cash, acquire
securities to cover short positions and finance certain
activities. We bear credit risk related to resale agreements
and securities borrowed only to the extent that cash
advanced or the value of securities pledged or delivered to
the counterparty exceeds the value of the collateral
received. We also have credit exposure on repurchase
agreements and securities loaned to the extent that the
value of securities pledged or delivered to the counterparty
for these transactions exceeds the amount of cash or
collateral 	received. 	Securities 	collateral 	obtained 	for
securities financing transactions primarily includes U.S. and
non-U.S. government and agency obligations.
The table below presents our credit exposure from
securities financing transactions and the concentration by
industry, region and credit quality.
As of
$ in millions
March
2020
December
2019
Securities Financing Transactions 	$30,344 	$26,958
Industry
Financial Institutions 	32% 	37%
Funds 	28% 	27%
Municipalities & Nonprofit 	4% 	5%
Sovereign 	34% 	28%
Other (including Special Purpose Vehicles) 	2% 	3%
Total 	100% 	100%
Region
Americas 	22% 	38%
EMEA 	52% 	39%
Asia 	26% 	23%
Total 	100% 	100%
Credit Quality (Credit Rating Equivalent)
AAA 	11% 	15%
AA 	28% 	27%
A 	43% 	39%
BBB 	11% 	9%
BB or lower 	5% 	6%
Unrated 	2% 	4%
Total 	100% 	100%
The table above reflects both netting agreements and
collateral that we consider when determining credit risk.
Other Credit Exposures. We are exposed to credit risk
from our receivables from brokers, dealers and clearing
organizations 	and 	customers 	and 	counterparties.
Receivables 	from 	brokers, 	dealers 	and 	clearing
organizations primarily consist of initial margin placed
with clearing organizations and receivables related to sales
of securities which have traded, but not yet settled. These
receivables generally have minimal credit risk due to the
low probability of clearing organization default and the
short-term nature of receivables related to securities
settlements. Receivables from customers and counterparties
generally consist of collateralized receivables related to
customer 	securities 	transactions 	and 	generally 	have
minimal credit risk due to both the value of the collateral
received and the short-term nature of these receivables.
Goldman Sachs March 2020 Form 10-Q 146

-- 148 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
The table below presents our other credit exposures and the
concentration by industry, region and credit quality.
As of
$ in millions
March
2020
December
2019
Other Credit Exposures 	$61,139 	$44,931
Industry
Financial Institutions 	80% 	86%
Funds 	11% 	8%
Natural Resources & Utilities 	1% 	1%
Other (including Special Purpose Vehicles) 	8% 	5%
Total 	100% 	100%
Region
Americas 	48% 	49%
EMEA 	40% 	41%
Asia 	12% 	10%
Total 	100% 	100%
Credit Quality (Credit Rating Equivalent)
AAA 	3% 	2%
AA 	52% 	56%
A 	24% 	23%
BBB 	9% 	7%
BB or lower 	11% 	11%
Unrated 	1% 	1%
Total 	100% 	100%
The table above reflects collateral that we consider when
determining credit risk.
Selected Exposures
We have credit and market exposures, as described below,
that have had heightened focus due to recent events and
broad market concerns. Credit exposure represents the
potential for loss due to the default or deterioration in
credit quality of a counterparty or borrower. Market
exposure represents the potential for loss in value of our
long and short positions due to changes in market prices.
Country Exposures. High inflation in Turkey combined
with current account deficits and significant depreciation of
the Turkish Lira has led to concerns about its economic
stability. As of March 2020, our total credit exposure to
Turkey was $1.52 billion, which was with non-sovereign
counterparties or borrowers. Such exposure consisted of
$1.10 billion related to OTC derivatives, $411 million
related to loans and lending commitments and $12 million
related 	to 	secured 	receivables. 	After 	taking 	into
consideration 	the 	benefit 	of 	Turkish 	corporate 	and
sovereign collateral and other risk mitigants provided by
Turkish counterparties, our net credit exposure was
$524 million. Our total market exposure to Turkey as of
March 2020 was not material.
Liquidity pressures prompted the Argentine government to
delay payment on certain debt obligations, and announce
its intention to restructure most of its bonds, worsening the
country’s economic distress. As of March 2020, our total
credit exposure to Argentina was $182 million, which was
with non-sovereign counterparties or borrowers, and was
primarily related to loans and lending commitments. Our
total market exposure to Argentina as of March 2020 was
not material.
The restructuring of Lebanon’s sovereign debt has led to
concerns about its financial stability. As of March 2020,
our total credit exposure to Lebanon was $210 million,
substantially all of which related to loans and lending
commitments with non-sovereign borrowers. Our total
market exposure to Lebanon as of March 2020 was not
material.
Economic, social and political factors have led to concerns
that Ecuador may default on its sovereign debt. As of
March 2020, our total credit exposure to Ecuador was
$792 million, which was with sovereign counterparties or
borrowers. Such exposure consisted of $367 million related
to loans and lending commitments and $425 million related
to OTC derivatives. After taking into consideration the
benefit of highly liquid collateral, our net credit exposure
was $307 million. Our total market exposure to Ecuador as
of March 2020 was not material.
The potential restructuring of Zambia’s sovereign debt and
significant depreciation of the Zambian kwacha has led to
concerns 	about 	Zambia’s 	financial 	stability. 	As 	of
March 2020, our total credit exposure to Zambia was
$115 million and was related to loans and lending
commitments with non-sovereign borrowers. Our total
market exposure to Zambia as of March 2020 was not
material.
Venezuela has delayed payments on its sovereign debt and
its political situation remains unclear. As of March 2020,
our total credit and market exposure for Venezuela was not
material.
147 Goldman Sachs March 2020 Form 10-Q

-- 149 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
We have a comprehensive framework to monitor, measure
and assess our country exposures and to determine our risk
appetite. We determine the country of risk by the location
of the counterparty, issuer or underlier’s assets, where they
generate 	revenue, 	the 	country 	in 	which 	they 	are
headquartered, the jurisdiction where a claim against them
could be enforced, and/or the government whose policies
affect their ability to repay their obligations. We monitor
our credit exposure to a specific country both at the
individual counterparty level, as well as at the aggregate
country level. See “Stress Tests” for information about
stress tests that are designed to estimate the direct and
indirect impact of events involving the above countries.
Industry Exposures. The recent decline in oil prices has led
to market concerns regarding the creditworthiness of certain
companies in the oil and gas industry. As of March 2020, our
credit exposure to oil and gas companies related to loans and
lending commitments was $12.44 billion ($3.96 billion of
loans and $8.48 billion of lending commitments). Such
exposure 	included 	$6.81 	billion 	of 	exposure 	to
non-investment-grade counterparties ($3.07 billion related
to loans and $3.74 billion related to lending commitments),
of which 71% was secured. In addition, we have exposure to
our clients in the oil and gas industry arising from derivatives.
As of March 2020, our credit exposure related to derivatives
and receivables with oil and gas companies was $2.14 billion
($978 million with investment-grade counterparties and
$1.16 billion with non-investment-grade counterparties).
After taking into consideration the benefit of $624 million of
hedges, our net credit exposure was $13.96 billion. As of
March 2020, our market exposure related to oil and gas
companies was $(1.92) billion, which was primarily to
investment-grade issuers or underliers.
The sharp decline in economic activity as a result of the
COVID-19 pandemic has resulted in a significant impact to
the gaming and lodging industry. As of March 2020, our
credit 	exposure 	to 	gaming 	and 	lodging 	companies
(including hotel owners and operators) related to loans and
lending commitments was $3.44 billion ($1.27 billion of
loans and $2.17 billion of lending commitments). Such
exposure 	included 	$2.14 	billion 	of 	exposure 	to
non-investment-grade counterparties ($996 million related
to loans and $1.15 billion related to lending commitments),
of which 84% was secured. In addition, we extend loans
that are secured by hotel properties. As of March 2020, our
exposure related to such loans and lending commitments
was 	$1.31 	billion 	and 	was 	to 	non-investment-grade
counterparties. In addition, we have exposure to our clients
in the gaming and lodging industry arising from derivatives.
As of March 2020, our credit exposure related to
derivatives and receivables with gaming and lodging
companies 	was 	$228 	million, 	primarily 	with
non-investment-grade counterparties. As of March 2020,
our market exposure related to gaming and lodging
companies was not material.
Concerns surrounding the COVID-19 pandemic have
resulted in a sharp decline in travel which has significantly
impacted the airline industry. As of March 2020, our credit
exposure to airline companies related to loans and lending
commitments was $2.81 billion ($1.88 billion of loans and
$932 million of lending commitments). Such exposure
included $2.37 billion of exposure to non-investment-grade
counterparties 	($1.75 	billion 	related 	to 	loans 	and
$615 million related to lending commitments), of which
82% was secured. In addition, we have exposure to our
clients in the airline industry arising from derivatives. As of
March 2020, our credit exposure related to derivatives and
receivables with airline companies was $1.76 billion
($885 million with investment-grade counterparties and
$870 million with non-investment-grade counterparties).
After taking into consideration the benefit of $407 million
of hedges, our net credit exposure was $4.16 billion. As of
March 2020, our market exposure related to airline
companies was $(186) million, which was primarily to
non-investment-grade issuers or underliers.
Goldman Sachs March 2020 Form 10-Q 148

-- 150 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Operational Risk Management
Overview
Operational risk is the risk of an adverse outcome resulting
from inadequate or failed internal processes, people,
systems 	or 	from 	external 	events. 	Our 	exposure 	to
operational risk arises from routine processing errors, as
well as extraordinary incidents, such as major systems
failures or legal and regulatory matters.
Potential types of loss events related to internal and external
operational risk include:
‰ Clients, products and business practices;
‰ Execution, delivery and process management;
‰ Business disruption and system failures;
‰ Employment practices and workplace safety;
‰ Damage to physical assets;
‰ Internal fraud; and
‰ External fraud.
Operational Risk, which is independent of our revenue-
producing units and reports to our chief risk officer, has
primary responsibility for developing and implementing a
formalized 	framework 	for 	assessing, 	monitoring 	and
managing operational risk with the goal of maintaining our
exposure to operational risk at levels that are within our
risk appetite.
Operational Risk Management Process
Our process for managing operational risk includes the
critical components of our risk management framework
described 	in 	the 	“Overview 	and 	Structure 	of 	Risk
Management,” including a comprehensive data collection
process, as well as firmwide policies and procedures, for
operational risk events.
We combine top-down and bottom-up approaches to
manage and measure operational risk. From a top-down
perspective, our senior management assesses firmwide and
business-level operational risk profiles. From a bottom-up
perspective, our first and second lines of defense are
responsible for risk identification and risk management on
a day-to-day basis, including escalating operational risks to
senior management.
We maintain a comprehensive control framework designed
to provide a well-controlled environment to minimize
operational risks. The Firmwide Operational Risk and
Resilience 	Committee 	is 	responsible 	for 	overseeing
operational risk, and for ensuring our business and
operational resilience.
Our operational risk management framework is in part
designed to comply with the operational risk measurement
rules under the Capital Framework and has evolved based
on the changing needs of our businesses and regulatory
guidance.
We have established policies that require all employees to
report 	and 	escalate 	operational 	risk 	events. 	When
operational risk events are identified, our policies require
that the events be documented and analyzed to determine
whether changes are required in our systems and/or
processes to further mitigate the risk of future events.
We use operational risk management applications to
capture and organize operational risk event data and key
metrics. One of our key risk identification and assessment
tools is an operational risk and control self-assessment
process, which is performed by our managers. This process
consists of the identification and rating of operational risks,
on a forward-looking basis, and the related controls. The
results 	from 	this 	process 	are 	analyzed 	to 	evaluate
operational 	risk 	exposures 	and 	identify 	businesses,
activities or products with heightened levels of operational
risk.
Risk Measurement
We measure our operational risk exposure using both
statistical modeling and scenario analyses, which involve
qualitative and quantitative assessments of internal and
external operational risk event data and internal control
factors for each of our businesses. Operational risk
measurement also incorporates an assessment of business
environment factors, including:
‰ Evaluations of the complexity of our business activities;
‰ The degree of automation in our processes;
‰ New activity information;
‰ The legal and regulatory environment; and
‰ Changes in the markets for our products and services,
including 	the 	diversity 	and 	sophistication 	of 	our
customers and counterparties.
The results from these scenario analyses are used to
monitor changes in operational risk and to determine
business lines that may have heightened exposure to
operational 	risk. 	These 	analyses 	are 	used 	in 	the
determination of the appropriate level of operational risk
capital to hold. We also perform firmwide stress tests. See
“Overview and Structure of Risk Management” for
information about firmwide stress tests.
149 Goldman Sachs March 2020 Form 10-Q

-- 151 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Types of Operational Risks
Increased 	reliance 	on 	technology 	and 	third-party
relationships has resulted in increased operational risks,
such as information and cyber security risk, third-party risk
and business resilience risk. We manage those risks as
follows:
Information and Cyber Security Risk. Information and
cyber security risk is the risk of compromising the
confidentiality, integrity or availability of our data and
systems, leading to an adverse impact to us, our reputation,
our clients and/or the broader financial system. We seek to
minimize the occurrence and impact of unauthorized
access, disruption or use of information and/or information
systems. We deploy and operate preventive and detective
controls and processes to mitigate emerging and evolving
information security and cyber security threats, including
monitoring our network for known vulnerabilities and
signs of unauthorized attempts to access our data and
systems. There is increased information risk through
diversification of our data across external service providers,
including use of a variety of cloud-provided or -hosted
services and applications. See “Risk Factors” in Part I,
Item 1A of the 2019 Form 10-K for further information
about information and cyber security risk.
Third-Party Risk. Third-party risk, including vendor risk,
is the risk of an adverse impact due to reliance on third
parties performing services or activities on our behalf.
These risks may include legal, regulatory, information
security, reputational, operational or any other risks
inherent in engaging a third party. We identify, manage and
report key third-party risks and conduct due diligence
across 	multiple 	risk 	domains, 	including 	information
security and cyber security, resilience and additional third-
party 	dependencies. 	The 	Third-Party 	Risk 	Program
monitors, reviews and reassesses third-party risks on an
ongoing basis. See “Risk Factors” in Part II, Item 1A of this
Form 10-Q and Part I, Item 1A of the 2019 Form 10-K for
further information about third-party risk.
Business Resilience Risk. Business resilience risk is the
risk of disruption to our critical processes. We monitor
threats and assess risks and seek to ensure our state of
readiness in the event of a significant operational disruption
to the normal operations of our critical functions or their
dependencies, such as, critical facilities, systems, third
parties, data and/or personnel. We approach BCP through
the lens of business and operational resilience. The
resilience framework defines the fundamental principles for
BCP and crisis management to ensure that critical functions
can continue to operate in the event of a disruption. The
business continuity program is comprehensive, consistent
firmwide and up-to-date, incorporating new information,
techniques and technologies as and when they become
available, and our resilience recovery plans incorporate and
test specific and measurable recovery time objectives in
accordance with local market best practices and regulatory
requirements, and under specific scenarios. See “Regulatory
and Other Matters — Other Matters” for information
about 	the 	impact 	of 	the 	COVID-19 	pandemic. 	See
“Business 	— 	Business 	Continuity 	and 	Information
Security” in Part I, Item 1 of the 2019 Form 10-K for
further information about business continuity.
Model Risk Management
Overview
Model risk is the potential for adverse consequences from
decisions made based on model outputs that may be
incorrect or used inappropriately. We rely on quantitative
models across our business activities primarily to value
certain financial assets and liabilities, to monitor and
manage our risk, and to measure and monitor our
regulatory capital.
Model 	Risk, 	which 	is 	independent 	of 	our 	revenue-
producing units, model developers, model owners and
model users, and reports to our chief risk officer, has
primary 	responsibility 	for 	assessing, 	monitoring 	and
managing our model risk through firmwide oversight
across our global businesses, and provides periodic updates
to senior management, risk committees and the Risk
Committee of the Board.
Our model risk management framework is managed
through a governance structure and risk management
controls, which encompass standards designed to ensure we
maintain a comprehensive model inventory, including risk
assessment and classification, sound model development
practices, independent review and model-specific usage
controls. The Firmwide Model Risk Control Committee
oversees our model risk management framework.
Goldman Sachs March 2020 Form 10-Q 150

-- 152 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Model Review and Validation Process
Model Risk consists of quantitative professionals who
perform an independent review, validation and approval of
our models. This review includes an analysis of the model
documentation, independent testing, an assessment of the
appropriateness of the methodology used, and verification
of 	compliance 	with 	model 	development 	and
implementation standards.
We regularly refine and enhance our models to reflect
changes in market or economic conditions and our business
mix. All models are reviewed on an annual basis, and new
models or significant changes to existing models and their
assumptions are approved prior to implementation.
The model validation process incorporates a review of
models and trade and risk parameters across a broad range
of scenarios (including extreme conditions) in order to
critically evaluate and verify:
‰ The 	model’s 	conceptual 	soundness, 	including 	the
reasonableness of model assumptions, and suitability for
intended use;
‰ The testing strategy utilized by the model developers to
ensure that the models function as intended;
‰ The suitability of the calculation techniques incorporated
in the model;
‰ The model’s accuracy in reflecting the characteristics of
the related product and its significant risks;
‰ The 	model’s 	consistency 	with 	models 	for 	similar
products; and
‰ The 	model’s 	sensitivity 	to 	input 	parameters 	and
assumptions.
See “Critical Accounting Policies — Fair Value — Review
of Valuation Models,” “Liquidity Risk Management,”
“Market Risk Management,” “Credit Risk Management”
and 	“Operational 	Risk 	Management” 	for 	further
information about our use of models within these areas.
Available Information
Our internet address is www.goldmansachs.com and the
investor relations section of our website is located at
www.goldmansachs.com/investor-relations, 	where 	we
make available, free of charge, our annual reports on
Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K and amendments to those reports filed
or furnished pursuant to Section 13(a) or 15(d) of the
Exchange Act, as well as proxy statements, as soon as
reasonably practicable after we electronically file such
material with, or furnish it to, the SEC. Also posted on our
website, and available in print upon request of any
shareholder to our Investor Relations Department (Investor
Relations), are our certificate of incorporation and by-laws,
charters for our Audit, Risk, Compensation, Corporate
Governance and Nominating, and Public Responsibilities
Committees, our Policy Regarding Director Independence
Determinations, our Policy on Reporting of Concerns
Regarding Accounting and Other Matters, our Corporate
Governance Guidelines and our Code of Business Conduct
and Ethics governing our directors, officers and employees.
Within the time period required by the SEC, we will post on
our website any amendment to the Code of Business
Conduct and Ethics and any waiver applicable to any
executive officer, director or senior financial officer.
Our website also includes information about (i) purchases
and sales of our equity securities by our executive officers
and directors; (ii) disclosure relating to certain non-GAAP
financial measures (as defined in the SEC’s Regulation G)
that we may make public orally, telephonically, by webcast,
by broadcast or by other means; (iii) DFAST results; (iv) the
public portion of our resolution plan submission; (v) our
Pillar 3 disclosure; and (vi) our average daily LCR.
Investor Relations can be contacted at The Goldman Sachs
Group, Inc., 200 West Street, 29th Floor, New York, New
York 	10282, 	Attn: 	Investor 	Relations, 	telephone:
212-902-0300, e-mail: gs-investor-relations@gs.com. We
use 	our 	website, 	our 	Twitter 	account
(twitter.com/GoldmanSachs), 	our 	Instagram 	account
(instagram.com/GoldmanSachs) and other social media
channels 	as 	additional 	means 	of 	disclosing 	public
information to investors, the media and others. Our officers
may use similar social media channels to disclose public
information. It is possible that certain information we or
our officers post on our website and on social media could
be deemed material, and we encourage investors, the media
and others interested in Goldman Sachs to review the
business and financial information we or our officers post
on our website and on the social media channels identified
above. The information on our website and those social
media channels is not incorporated by reference into this
Form 10-Q.
151 Goldman Sachs March 2020 Form 10-Q

-- 153 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Cautionary Statement Pursuant to the
U.S. 	Private 	Securities 	Litigation
Reform Act of 1995
We have included in this Form 10-Q, and our management
may make, statements that may constitute “forward-looking
statements” within the meaning of the safe harbor provisions
of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements are not historical facts or
statements of current conditions, but instead represent only
our beliefs regarding future events, many of which, by their
nature, are inherently uncertain and outside our control.
These statements may relate to, among other things, (i) our
future plans and results, including our target ROE, ROTE,
efficiency ratio and CET1 capital ratio, and how they can be
achieved, 	(ii) 	various 	legal 	proceedings, 	governmental
investigations or other contingencies as set forth in Notes 27
and 18 to the consolidated financial statements in Part I,
Item 1 of this Form 10-Q, (iii) the results of stress tests,
(iv) the objectives and effectiveness of our business continuity
plan, information security program, risk management and
liquidity policies, (v) our resolution plan and resolution
strategy and their implications for stakeholders, (vi) the
design and effectiveness of our resolution capital and
liquidity 	models 	and 	triggers 	and 	alerts 	framework,
(vii) trends in or growth opportunities for our businesses,
including the timing and benefits of business and strategic
initiatives and changes in and the importance of the efficiency
ratio, (viii) the effect of changes to regulations, as well as our
future status, activities or reporting under banking and
financial regulation, (ix) our NSFR, (x) our level of future
compensation expense as a percentage of operating expenses,
(xi) our investment banking transaction backlog, (xii) our
expected tax rate, (xiii) the future state of our liquidity and
regulatory 	capital 	ratios, 	and 	our 	prospective 	capital
distributions, (xiv) our expected interest income, (xv) our
credit exposures, (xvi) our expected provisions for credit
losses, 	(xvii) 	our 	preparations 	for 	Brexit, 	(xviii) 	the
replacement of LIBOR and other IBORs and our program
for the transition to alternative risk-free reference rates,
(xix) the adequacy of our allowance for credit losses, (xx) the
projected growth of our deposits and associated interest
expense 	savings, 	(xxi) 	the 	projected 	growth 	of 	our
installment loan and credit card businesses, (xxii) our
business initiatives, including those related to transaction
banking and new consumer financial products, (xxiii) our
expense savings initiatives and increasing use of strategic
locations, (xxiv) our planned 2020 parent vanilla debt
issuances, (xxv) the amount of GCLA we expect to hold,
(xxvi) our expected SCB and G-SIB surcharge, (xxvii) the
impact of the COVID-19 pandemic on our business, results,
financial position and liquidity and (xxviii) expenses we may
incur, 	including 	future 	litigation 	expense 	and 	those
associated with investing in our installment lending, credit
card and transaction banking activities.
By identifying these statements for you in this manner, we
are alerting you to the possibility that our actual results,
financial condition and liquidity may differ, possibly
materially, from the anticipated results, financial condition
and 	liquidity 	in 	these 	forward-looking 	statements.
Important factors that could cause our results, financial
condition and capital actions to differ from those in these
statements include, among others, those described below
and in “Risk Factors” in Part II, Item 1A of this Form 10-Q
and in Part I, Item 1A of the 2019 Form 10-K.
Statements about our investment banking transaction
backlog are subject to the risk that such transactions may be
modified or may not be completed at all and related net
revenues may not be realized or may be materially less than
expected. Important factors that could have such a result
include, 	for 	underwriting 	transactions, 	a 	decline 	or
weakness in general economic conditions, outbreak of
hostilities, volatility in the securities markets or an adverse
development with respect to the issuer of the securities and,
for financial advisory transactions, a decline in the
securities 	markets, 	an 	inability 	to 	obtain 	adequate
financing, an adverse development with respect to a party
to the transaction or a failure to obtain a required
regulatory 	approval. 	For 	information 	about 	other
important 	factors 	that 	could 	adversely 	affect 	our
investment banking transactions, see “Risk Factors” in
Part II, Item 1A of this Form 10-Q and in Part I, Item 1A of
the 2019 Form 10-K.
Statements about our future effective income tax rate are
subject to the risk that it may differ from the anticipated
rate indicated in such statements, possibly materially, due
to, among other things, changes in our earnings mix, our
profitability and entities in which we generate profits, the
assumptions we have made in forecasting our expected tax
rate, as well as guidance that may be issued by the U.S.
Internal Revenue Service.
Statements about our NSFR and SCB are based on our
current interpretation and expectations of the relevant
proposal and final rule, and reflect significant assumptions
about how our NSFR and SCB are calculated. Our actual
NSFR will depend on the final rule and, for the SCB, the
results of the applicable supervisory stress tests, and the
methods used to calculate our NSFR and SCB may differ,
possibly materially, from those used to calculate our NSFR
and SCB for future disclosures.
Goldman Sachs March 2020 Form 10-Q 152

-- 154 of 356 --

T H E G O L D M A N S A C H S G R O U P , IN C . A N D S U B S I D I A R I E S
Management’s Discussion and Analysis
Statements about the level of compensation expense,
including as a percentage of operating expenses, and our
efficiency ratio as our platform business initiatives reach
scale are subject to the risks that the compensation and
other costs to operate our businesses, including platform
initiatives, may be greater than currently expected.
Statements about our expected provisions for credit losses
are subject to the risk that actual credit losses may differ
and our expectations may change, possibly materially, from
that currently anticipated due to, among other things,
changes to the composition of our loan portfolio and
changes in the economic environment in future periods and
our forecasts of future economic conditions, as well as
changes in our models, policies and other management
judgments.
Statements about the projected growth of our deposits and
associated interest expense savings, and our installment
loan and credit card businesses, are subject to the risk that
actual growth may differ, possibly materially, from that
currently anticipated due to, among other things, changes
in interest rates and competition from other similar
products.
Statements about our target ROE, ROTE, efficiency ratio,
and expense savings, and how they can be achieved, are
based on our current expectations regarding our business
prospects and are subject to the risk that we may be unable
to achieve our targets due to, among other things, changes
in our business mix, lower profitability of new business
initiatives, increases in technology and other costs to launch
and bring new business initiatives to scale, and increases in
liquidity requirements.
Statements about our target ROE, ROTE and CET1 capital
ratio, and how they can be achieved, are based on our
current expectations regarding the capital requirements
applicable to us and are subject to the risk that our actual
capital 	requirements 	may 	be 	higher 	than 	currently
anticipated because of, among other factors, changes in the
regulatory capital requirements applicable to us resulting
from changes in regulations or the interpretation or
application of existing regulations or changes in the nature
and composition of our activities.
Statements about the timing, costs and benefits of business
and expense savings initiatives, the level and composition of
more durable revenues and increases in market share are
based on our current expectations regarding our ability to
implement these initiatives and actual results may differ,
possibly materially, from current expectations due to,
among other things, a delay in the timing of these
initiatives, increased competition and an inability to reduce
expenses and grow businesses with durable revenues.
Statements 	about 	planned 	2020 	parent 	vanilla 	debt
issuances and the amount of GCLA we expect to hold are
subject to the risk that actual issuances and GCLA levels
may 	differ, 	possibly 	materially, 	from 	that 	currently
expected due to changes in market conditions, business
opportunities or our funding and projected liquidity needs.
Statements about the future state of our liquidity and
regulatory capital ratios, as well as our prospective capital
distributions, are subject to the risk that our actual
liquidity, regulatory capital ratios and capital distributions
may differ, possibly materially, from what is currently
expected due to, among other things, the need to use capital
to support clients, increased regulatory requirements and
changes to the composition of our balance sheet.
153 Goldman Sachs March 2020 Form 10-Q

-- 155 of 356 --

Item 3. 	Quantitative and Qualitative
Disclosures About Market Risk
Quantitative and qualitative disclosures about market risk
are set forth in “Management’s Discussion and Analysis of
Financial Condition and Results of Operations — Risk
Management” in Part I, Item 2 of this Form 10-Q.
Item 4. 	Controls and Procedures
As of the end of the period covered by this report, an
evaluation was carried out by our management, with the
participation of our Chief Executive Officer and Chief
Financial Officer, of the effectiveness of our disclosure
controls and procedures (as defined in Rule 13a-15(e)
under the Exchange Act). Based on that evaluation, our
Chief 	Executive 	Officer 	and 	Chief 	Financial 	Officer
concluded that these disclosure controls and procedures
were effective as of the end of the period covered by this
report. In addition, no change in our internal control over
financial reporting (as defined in Rule 13a-15(f) under the
Exchange 	Act) 	occurred 	during 	the 	quarter 	ended
March 2020 that has materially affected, or is reasonably
likely to materially affect, our internal control over
financial reporting.
PART II. OTHER INFORMATION
Item 1. 	Legal Proceedings
We are involved in a number of judicial, regulatory and
arbitration proceedings concerning matters arising in
connection with the conduct of our businesses. Many of
these proceedings are in early stages, and many of these
cases seek an indeterminate amount of damages. We have
estimated the upper end of the range of reasonably possible
aggregate loss for matters where we have been able to
estimate a range and we believe, based on currently
available information, that the results of matters where we
have not been able to estimate a range of reasonably
possible loss, in the aggregate, will not have a material
adverse effect on our financial condition, but may be
material to our operating results in a given period. Given
the range of litigation and investigations presently under
way, our litigation expenses can be expected to remain
high. See “Management’s Discussion and Analysis of
Financial Condition and Results of Operations — Use of
Estimates” in Part I, Item 2 of this Form 10-Q. See Notes 18
and 27 to the consolidated financial statements in Part I,
Item 1 of this Form 10-Q for information about our
reasonably possible aggregate loss estimate and judicial,
regulatory and legal proceedings.
Item 1A. 	Risk Factors
Our businesses, financial condition, liquidity and
results of operations have been, and will likely
continue to be, adversely affected by the emergence
of the COVID-19 pandemic.
The emergence of the global outbreak of the coronavirus
(COVID-19) pandemic has created economic and financial
disruptions that during the quarter adversely affected, and are
likely to continue to adversely affect, our business, financial
condition, liquidity and results of operations. The extent to
which the COVID-19 pandemic will continue to negatively
affect our businesses, financial condition, liquidity and results
of operations will depend on future developments, which are
highly uncertain and cannot be predicted.
The COVID-19 pandemic has contributed to (i) the sudden
and significant reduction in the valuation of the equity, fixed-
income and commodity markets and the significant increase in
the volatility of those markets; (ii) a decrease in the rates and
yields on U.S. Treasury securities, in some cases declining
below zero; (iii) a major reduction in merger and acquisition
activity and significant uncertainty about whether previously
announced deals will be completed or restructured; (iv) a
major reduction in equity new issue activity; (v) significantly
more challenging conditions in the new issue debt market;
(vi) significant draws in credit lines, including syndicated credit
lines, as clients seek to increase liquidity; (vii) the risk that
hedges become less effective, including, for example, due to the
movement of short and long positions in U.S. Treasuries and
the assets they hedge; (viii) significant increases in collateral
calls and disputes as the valuation of derivative positions and,
in some cases, collateral has become more challenging;
(ix) ratings downgrades, credit deterioration and defaults in
many industries, including oil and gas, gaming and lodging,
and airlines; (x) a reduction in assets under supervision as the
values 	of 	assets 	have 	declined; 	and 	(xi) 	heightened
cybersecurity, information security and operational risks as a
result of work-from-home arrangements.
The effects of the COVID-19 pandemic on economic and
market conditions have also increased demands on our
liquidity as we meet client needs. Likewise, these adverse
developments have affected our capital and leverage ratios.
We have ceased purchases of our common stock in order to
deploy more capital and liquidity to meet the needs of our
clients. The effects of the COVID-19 pandemic may cause
us to continue to limit future capital distributions.
Governmental authorities worldwide have taken increased
measures to stabilize the markets and support economic
growth. The success of these measures is unknown and they
may not be sufficient to address the market dislocations or
avert severe and prolonged reductions in economic activity.
We also face an increased risk of client disputes, litigation
and governmental and regulatory scrutiny as a result of the
effects of COVID-19 on economic and market conditions.
Goldman Sachs March 2020 Form 10-Q 154

-- 156 of 356 --

The length of the pandemic and the efficacy of the
extraordinary measures being put in place to address it are
unknown. 	Until 	the 	pandemic 	subsides, 	we 	expect
continued draws on lines of credit, reduced activity levels in
investment 	banking, 	reduced 	revenues 	in 	our 	asset
management and wealth management businesses and
increased client defaults, including defaults in unsecured
loans. Even after the pandemic subsides, the U.S. economy,
as well as most other major economies, may continue to
experience a recession, and we anticipate our businesses
would be materially and adversely affected by a prolonged
recession in the U.S. and other major markets.
Item 2. 	Unregistered Sales of Equity
Securities and Use of Proceeds
The table below presents purchases made by or on behalf of
Group Inc. or any “affiliated purchaser” (as defined in
Rule 10b-18(a)(3) under the Exchange Act) of our common
stock during the three months ended March 2020.
Total
Shares
Purchased
Average
Price Paid
Per Share
Total Shares
Purchased as
Part of a Publicly
Announced Program
Maximum Shares
That May Yet Be
Purchased Under
the Program
January 	4,985,018 	$241.74 	4,981,542 	52,869,372
February 3,175,610 	$227.90 	3,175,610 	49,693,762
March 	– 	– 	– 	49,693,762
Total 	8,160,628 	8,157,152
In 	the 	table 	above, 	total 	shares 	purchased 	during
January 2020 included 3,476 shares remitted to satisfy
statutory withholding taxes on the delivery of equity-based
awards.
Since March 2000, our Board has approved a repurchase
program authorizing repurchases of up to 605 million
shares of our common stock. The repurchase program is
effected primarily through regular open-market purchases
(which may include repurchase plans designed to comply
with Rule 10b5-1 and accelerated share repurchases), the
amounts and timing of which are determined primarily by
our current and projected capital position, but which may
also be influenced by general market conditions and the
prevailing price and trading volumes of our common stock.
The 	repurchase 	program 	has 	no 	set 	expiration 	or
termination date. Prior to repurchasing common stock, we
must receive confirmation that the FRB does not object to
such capital action.
Item 6. 	Exhibits
Exhibits
3.1 	Restated Certificate of Incorporation of The
Goldman Sachs Group, Inc., amended as of
March 12, 2020.
15.1 	Letter 	re: 	Unaudited 	Interim 	Financial
Information.
31.1 	Rule 13a-14(a) Certifications.
32.1 	Section 1350 Certifications (This information
is furnished and not filed for purposes of
Sections 11 and 12 of the Securities Act of
1933 	and 	Section 	18 	of 	the 	Securities
Exchange Act of 1934).
101 	Pursuant to Rules 405 and 406 of Regulation
S-T, the following information is formatted in
iXBRL (Inline eXtensible Business Reporting
Language): (i) the Consolidated Statements of
Earnings 	for 	the 	three 	months 	ended
March 31, 2020 and March 31, 2019, (ii) the
Consolidated 	Statements 	of 	Comprehensive
Income 	for 	the 	three 	months 	ended
March 31, 2020 and March 31, 2019, (iii) the
Consolidated 	Balance 	Sheets 	as 	of
March 31, 2020 and December 31, 2019, (iv)
the Consolidated Statements of Changes in
Shareholders’ 	Equity 	for 	the 	three 	months
ended March 31, 2020 and March 31, 2019,
(v) the Consolidated Statements of Cash Flows
for the three months ended March 31, 2020
and March 31, 2019, (vi) the notes to the
Consolidated Financial Statements and (vii) the
cover page.
104 	Cover Page Interactive Data File (formatted in
iXBRL in Exhibit 101).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
THE G OLDMAN SACHS G ROUP, INC .
By: 	/s/ 	Stephen M. Scherr
Name: 	Stephen M. Scherr
Title: 	Chief Financial Officer
(Principal Financial Officer)
Date: 	April 30, 2020
By: 	/s/ 	Sheara Fredman
Name: 	Sheara Fredman
Title: 	Chief Accounting Officer
(Principal Accounting Officer)
Date: 	April 30, 2020
155 Goldman Sachs March 2020 Form 10-Q

-- 157 of 356 --

EXHIBIT 3.1
RESTATED
CERTIFICATE OF INCORPORATION
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the Delaware
General Corporation Law (the “Corporation”), DOES HEREBY CERTIFY:
1. The name of the Corporation is The Goldman Sachs Group, Inc. The date of filing of its original certificate of incorporation
with the Secretary of State of the State of Delaware was July 21, 1998.
2. This Restated Certificate of Incorporation restates and integrates and does not further amend the provisions of the certificate
of incorporation of the Corporation as heretofore amended or supplemented. There is no discrepancy between the provisions of
this Restated Certificate of Incorporation and the provisions of the certificate of incorporation of the Corporation as heretofore
amended or supplemented. This Restated Certificate of Incorporation has been duly adopted in accordance with the provisions
of Section 245 of the General Corporation Law of the State of Delaware. The text of the certificate of incorporation is hereby
restated to read herein as set forth in full:
FIRST. The name of the Corporation is The Goldman Sachs Group, Inc.
SECOND. The address of the Corporation’s registered office in the State of Delaware is Corporation Trust Center, 1209
Orange Street in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address
is The Corporation Trust Company.
THIRD. The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be
organized under the Delaware General Corporation Law. Without limiting the generality of the foregoing, the Corporation
shall have all of the powers conferred on corporations by the Delaware General Corporation Law and other law, including
the power and authority to make an initial charitable contribution (as defined in Section 170(c) of the Internal Revenue
Code of 1986, as currently in effect or as the same may hereafter be amended) of up to an aggregate of $200,000,000 to
one or more entities (the “Contribution”), and to make other charitable contributions from time to time thereafter, in such
amounts, on such terms and conditions and for such purposes as may be lawful.
FOURTH. The total number of shares of all classes of stock which the Corporation shall have authority to issue is
4,350,000,000, of which 4,000,000,000 shares of the par value of $0.01 per share shall be a separate class designated as
Common Stock, 200,000,000 shares of the par value of $0.01 per share shall be a separate class designated as Nonvoting
Common Stock and 150,000,000 shares of the par value of $0.01 per share shall be a separate class designated as
Preferred Stock.

-- 158 of 356 --

COMMON STOCK AND NONVOTING COMMON STOCK
Except as set forth in this Article FOURTH, the Common Stock and the Nonvoting Common Stock (together, the
“Common Shares”) shall have the same rights and privileges and shall rank equally, share ratably and be identical in all
respects as to all matters.
(i) Voting. Except as may be provided in this Restated Certificate of Incorporation or required by law, the Common
Stock shall have voting rights in the election of directors and on all other matters presented to stockholders, with
each holder of Common Stock being entitled to one vote for each share of Common Stock held of record by such
holder on such matters. The Nonvoting Common Stock shall have no voting rights other than such rights as may be
required by the first sentence of Section 242(b)(2) of the Delaware General Corporation Law or any similar
provision hereafter enacted; provided that an amendment of this Restated Certificate of Incorporation to increase or
decrease the number of authorized shares of Nonvoting Common Stock (but not below the number of shares thereof
then outstanding) may be adopted by resolution adopted by the board of directors of the Corporation and approved
by the affirmative vote of the holders of a majority of the voting power of all outstanding shares of Common Stock
of the Corporation and all other outstanding shares of stock of the Corporation entitled to vote thereon irrespective of
the provisions of Section 242(b)(2) of the Delaware General Corporation Law or any similar provision hereafter
enacted, with such outstanding shares of Common Stock and other stock considered for this purpose as a single
class, and no vote of the holders of any shares of Nonvoting Common Stock, voting separately as a class, shall be
required therefor.
(ii) Dividends. Subject to the rights of the holders of any series of Preferred Stock, holders of Common Stock and
holders of Nonvoting Common Stock shall be entitled to receive such dividends and distributions (whether payable
in cash or otherwise) as may be declared on the Common Shares by the board of directors of the Corporation from
time to time out of assets or funds of the Corporation legally available therefor; provided that the board of directors
of the Corporation shall declare no dividend, and no dividend shall be paid, with respect to any outstanding share of
Common Stock or Nonvoting Common Stock, whether in cash or otherwise (including any dividend in shares of
Common Stock on or with respect to shares of Common Stock or any dividend in shares of Nonvoting Common
Stock on or with respect to shares of Nonvoting Common Stock (collectively, “Stock Dividends”)), unless,
simultaneously, the same dividend is declared or paid with respect to each share of Common Stock and Nonvoting
Common Stock. If a Stock Dividend is declared or paid with respect to one class, then a Stock Dividend shall
likewise be declared or paid with respect to the other class and shall consist of shares of such other class in a number
that bears the same relationship to the total number of shares of such other class, issued and outstanding immediately
prior to the payment of such dividend, as the number of shares comprising the Stock Dividend with respect to the
first referenced class bears to the total number of
-2-

-- 159 of 356 --

shares of such first referenced class, issued and outstanding immediately prior to the payment of such dividend.
Stock Dividends with respect to Common Stock may be paid only with shares of Common Stock. Stock Dividends
with respect to Nonvoting Common Stock may be paid only with shares of Nonvoting Common Stock.
Notwithstanding the foregoing, in the case of any dividend in the form of capital stock of a subsidiary of the
Corporation, the capital stock of the subsidiary distributed to holders of Common Stock shall be identical to the
capital stock of the subsidiary distributed to holders of Nonvoting Common Stock, except that the capital stock
distributed to holders of Common Stock may have full or any other voting rights and the capital stock distributed to
holders of Nonvoting Common Stock shall be non-voting to the same extent as the Nonvoting Common Stock is
non-voting.
(iii) Subdivisions, Combinations and Mergers. If the Corporation shall in any manner split, subdivide or combine the
outstanding shares of Common Stock or the outstanding shares of Nonvoting Common Stock, the outstanding shares
of the other such class of the Common Shares shall likewise be split, subdivided or combined in the same manner
proportionately and on the same basis per share. In the event of any merger, statutory share exchange, consolidation
or similar form of corporate transaction involving the Corporation (whether or not the Corporation is the surviving
entity), the holders of Common Stock and the holders of Nonvoting Common Stock shall be entitled to receive the
same per share consideration, if any, except that any securities received by holders of Common Stock in
consideration of such stock may have full or any other voting rights and any securities received by holders of
Nonvoting Common Stock in consideration of such stock shall be non-voting to the same extent as the Nonvoting
Common Stock is non-voting.
(iv) Rights on Liquidation. Subject to the rights of the holders of any series of Preferred Stock, in the event of any
liquidation, dissolution or winding-up of the Corporation (whether voluntary or involuntary), the assets of the
Corporation available for distribution to stockholders shall be distributed in equal amounts per share to the holders of
Common Stock and the holders of Nonvoting Common Stock, as if such classes constituted a single class. For
purposes of this paragraph, a merger, statutory share exchange, consolidation or similar corporate transaction
involving the Corporation (whether or not the Corporation is the surviving entity), or the sale, transfer or lease by the
Corporation of all or substantially all its assets, shall not constitute or be deemed a liquidation, dissolution or
winding-up of the Corporation.
-3-

-- 160 of 356 --

PREFERRED STOCK
Shares of Preferred Stock may be issued in one or more series from time to time as determined by the board of directors
of the Corporation, and the board of directors of the Corporation is authorized to fix by resolution or resolutions the
designations and the powers, preferences and rights, and the qualifications, limitations and restrictions thereof, of the
shares of each series of Preferred Stock, including the following:
(i) the distinctive serial designation of such series which shall distinguish it from other series;
(ii) the number of shares included in such series;
(iii) whether dividends shall be payable to the holders of the shares of such series and, if so, the basis on which such
holders shall be entitled to receive dividends (which may include, without limitation, a right to receive such
dividends or distributions as may be declared on the shares of such series by the board of directors of the
Corporation, a right to receive such dividends or distributions, or any portion or multiple thereof, as may be declared
on the Common Stock or any other class of stock or, in addition to or in lieu of any other right to receive dividends,
a right to receive dividends at a particular rate or at a rate determined by a particular method, in which case such rate
or method of determining such rate may be set forth), the form of such dividend, any conditions on which such
dividends shall be payable and the date or dates, if any, on which such dividends shall be payable;
(iv) whether dividends on the shares of such series shall be cumulative and, if so, the date or dates or method of
determining the date or dates from which dividends on the shares of such series shall be cumulative;
(v) the amount or amounts, if any, which shall be payable out of the assets of the Corporation to the holders of the
shares of such series upon the voluntary or involuntary liquidation, dissolution or winding-up of the Corporation,
and the relative rights of priority, if any, of payment of the shares of such series;
(vi) the price or prices (in cash, securities or other property or a combination thereof) at which, the period or periods
within which and the terms and conditions upon which the shares of such series may be redeemed, in whole or in
part, at the option of the Corporation or at the option of the holder or holders thereof or upon the happening of a
specified event or events;
(vii) the obligation, if any, of the Corporation to purchase or redeem shares of such series pursuant to a sinking fund
or otherwise and the price or prices (in cash, securities or other property or a combination thereof) at which, the
period or periods within which and the terms and conditions upon which the shares of such series shall be redeemed
or purchased, in whole or in part, pursuant to such obligation;
-4-

-- 161 of 356 --

(viii) whether or not the shares of such series shall be convertible or exchangeable, at any time or times at the option
of the holder or holders thereof or at the option of the Corporation or upon the happening of a specified event or
events, into shares of any other class or classes or any other series of the same or any other class or classes of stock
of the Corporation or any other securities or property of the Corporation or any other entity, and the price or prices
(in cash, securities or other property or a combination thereof) or rate or rates of conversion or exchange and any
adjustments applicable thereto; and
(ix) whether or not the holders of the shares of such series shall have voting rights, in addition to the voting rights
provided by law, and if so the terms of such voting rights, which may provide, among other things and subject to the
other provisions of this Restated Certificate of Incorporation, that each share of such series shall carry one vote or
more or less than one vote per share, that the holders of such series shall be entitled to vote on certain matters as a
separate class (which for such purpose may be comprised solely of such series or of such series and one or more
other series or classes of stock of the Corporation) and that all the shares of such series entitled to vote on a
particular matter shall be deemed to be voted on such matter in the manner that a specified portion of the voting
power of the shares of such series or separate class are voted on such matter.
For all purposes, this Restated Certificate of Incorporation shall include each certificate of designations (if any) setting
forth the terms of a series of Preferred Stock.
Subject to the rights, if any, of the holders of any series of Preferred Stock set forth in a certificate of designations, an
amendment of this Restated Certificate of Incorporation to increase or decrease the number of authorized shares of any
class of Preferred Stock (but not below the number of shares thereof then outstanding) may be adopted by resolution
adopted by the board of directors of the Corporation and approved by the affirmative vote of the holders of a majority of
the voting power of all outstanding shares of Common Stock of the Corporation and all other outstanding shares of stock
of the Corporation entitled to vote thereon irrespective of the provisions of Section 242(b)(2) of the Delaware General
Corporation Law or any similar provision hereafter enacted, with such outstanding shares of Common Stock and other
stock considered for this purpose as a single class, and no vote of the holders of Preferred Stock, voting as a separate
class, shall be required therefor.
Except as otherwise required by law or provided in the certificate of designations for the relevant series, holders of
Common Shares, as such, shall not be entitled to vote on any amendment of this Restated Certificate of Incorporation that
alters or changes the powers, preferences, rights or other terms of one or more outstanding series of Preferred Stock if the
holders of such affected series are entitled, either separately or together with the holders of one or more other series of
Preferred Stock, to vote thereon as a separate class pursuant to this Restated Certificate of Incorporation or pursuant to the
Delaware General Corporation Law as then in effect.
-5-

-- 162 of 356 --

Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee of the board of directors of the Corporation (the
“Securities Issuance Committee”), the Securities Issuance Committee created a series of shares of Preferred Stock
designated as Floating Rate Non-Cumulative Preferred Stock, Series A, by filing a certificate of designations of the
Corporation with the Secretary of State of the State of Delaware on April 22, 2005, and the voting powers, designations,
preferences and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions
thereof, of the Corporation’s Floating Rate Non-Cumulative Preferred Stock, Series A, are set forth in Appendix A hereto
and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as Floating Rate Non-Cumulative Preferred Stock, Series C, by filing a
certificate of designations of the Corporation with the Secretary of State of the State of Delaware on October 28, 2005,
and the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s Floating Rate Non-Cumulative Preferred Stock,
Series C, are set forth in Appendix B hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as Floating Rate Non-Cumulative Preferred Stock, Series D, by filing a
certificate of designations of the Corporation with the Secretary of State of the State of Delaware on May 23, 2006, and
the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s Floating Rate Non-Cumulative Preferred Stock,
Series D, are set forth in Appendix C hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as Perpetual Non-Cumulative Preferred Stock, Series E, by filing a
certificate of designations of the Corporation with the Secretary of State of the State of Delaware on May 14, 2007, and
the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s Perpetual Non-Cumulative Preferred Stock, Series
E, are set forth in Appendix D hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the
-6-

-- 163 of 356 --

Securities Issuance Committee, the Securities Issuance Committee created a series of shares of Preferred Stock designated
as Perpetual Non-Cumulative Preferred Stock, Series F, by filing a certificate of designations of the Corporation with the
Secretary of State of the State of Delaware on May 14, 2007, and the voting powers, designations, preferences and
relative, participating, optional or other special rights, and the qualifications, limitations or restrictions thereof, of the
Corporation’s Perpetual Non-Cumulative Preferred Stock, Series F, are set forth in Appendix E hereto and are
incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 5.50% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J,
by filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on April 23,
2013, and the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s 5.50% Fixed-to-Floating Rate Non-Cumulative
Preferred Stock, Series J, are set forth in Appendix F hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 6.375% Fixed-to-Floating Rate Non-Cumulative Preferred Stock,
Series K, by filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on
April 24, 2014, and the voting powers, designations, preferences and relative, participating, optional or other special
rights, and the qualifications, limitations or restrictions thereof, of the Corporation’s 6.375% Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series K, are set forth in Appendix G hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 5.375% Fixed-to-Floating Rate Non-Cumulative Preferred Stock,
Series M, by filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on
April 20, 2015, and the voting powers, designations, preferences and relative, participating, optional or other special
rights, and the qualifications, limitations or restrictions thereof, of the Corporation’s 5.375% Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series M, are set forth in Appendix H hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 6.30% Non-Cumulative Preferred Stock, Series N, by filing a certificate
of designations of the Corporation with the Secretary of
-7-

-- 164 of 356 --

State of the State of Delaware on February 19, 2016, and the voting powers, designations, preferences and relative,
participating, optional or other special rights, and the qualifications, limitations or restrictions thereof, of the
Corporation’s 6.30% Non-Cumulative Preferred Stock, Series N, are set forth in Appendix I hereto and are incorporated
herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 5.30% Fixed-to-Floating Rate Non-Cumulative Preferred Stock,
Series O, by filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on
July 26, 2016, and the voting powers, designations, preferences and relative, participating, optional or other special rights,
and 	the 	qualifications, 	limitations 	or 	restrictions 	thereof, 	of 	the 	Corporation’s 	5.30% 	Fixed-to-Floating 	Rate
Non-Cumulative Preferred Stock, Series O, are set forth in Appendix J hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 5.00% Fixed-to-Floating Rate Non-Cumulative Preferred Stock,
Series P, by filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on
October 27, 2017, and the voting powers, designations, preferences and relative, participating, optional or other special
rights, and the qualifications, limitations or restrictions thereof, of the Corporation’s 5.00% Fixed-to-Floating Rate
Non-Cumulative Preferred Stock, Series P, are set forth in Appendix K hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 5.50% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series Q, by
filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on June 14,
2019, and the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s 5.50% Fixed-Rate Reset Non-Cumulative Preferred
Stock, Series Q, are set forth in Appendix L hereto and are incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 4.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series R, by
filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on
November 14, 2019, and the voting powers, designations, preferences and relative, participating, optional or other special
rights, and the qualifications, limitations or restrictions thereof, of the Corporation’s
-8-

-- 165 of 356 --

4.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series R, are set forth in Appendix M hereto and are
incorporated herein by reference.
Pursuant to the authority conferred by this Article FOURTH upon the board of directors of the Corporation and authority
delegated by the board of directors to the Securities Issuance Committee, the Securities Issuance Committee created a
series of shares of Preferred Stock designated as 4.40% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series S, by
filing a certificate of designations of the Corporation with the Secretary of State of the State of Delaware on January 27,
2020, and the voting powers, designations, preferences and relative, participating, optional or other special rights, and the
qualifications, limitations or restrictions thereof, of the Corporation’s 4.40% Fixed-Rate Reset Non-Cumulative Preferred
Stock, Series S, are set forth in Appendix N hereto and are incorporated herein by reference.
-9-

-- 166 of 356 --

OPTIONS, WARRANTS AND OTHER RIGHTS
The board of directors of the Corporation is authorized to create and issue options, warrants and other rights from time to
time entitling the holders thereof to purchase securities or other property of the Corporation or any other entity, including
any class or series of stock of the Corporation or any other entity and whether or not in connection with the issuance or
sale of any securities or other property of the Corporation, for such consideration (if any), at such times and upon such
other terms and conditions as may be determined or authorized by the board of directors of the Corporation and set forth
in one or more agreements or instruments. Among other things and without limitation, such terms and conditions may
provide for the following:
(i) adjusting the number or exercise price of such options, warrants or other rights or the amount or nature of the
securities or other property receivable upon exercise thereof in the event of a subdivision or combination of any
securities, or a recapitalization, of the Corporation, the acquisition by any person of beneficial ownership of
securities representing more than a designated percentage of the voting power of any outstanding series, class or
classes of securities, a change in ownership of the Corporation’s securities or a merger, statutory share exchange,
consolidation, reorganization, sale of assets or other occurrence relating to the Corporation or any of its securities,
and restricting the ability of the Corporation to enter into an agreement with respect to any such transaction absent an
assumption by another party or parties thereto of the obligations of the Corporation under such options, warrants or
other rights;
(ii) restricting, precluding or limiting the exercise, transfer or receipt of such options, warrants or other rights by any
person that becomes the beneficial owner of a designated percentage of the voting power of any outstanding series,
class or classes of securities of the Corporation or any direct or indirect transferee of such a person, or invalidating or
voiding such options, warrants or other rights held by any such person or transferee; and
(iii) permitting the board of directors (or certain directors specified or qualified by the terms of the governing
instruments of such options, warrants or other rights) to redeem, terminate or exchange such options, warrants or
other rights.
This paragraph shall not be construed in any way to limit the power of the board of directors of the Corporation to create
and issue options, warrants or other rights.
FIFTH. [Reserved]
SIXTH. All corporate powers shall be exercised by the board of directors of the Corporation, except as otherwise
specifically required by law or as otherwise provided in this Restated Certificate of Incorporation. Any meeting of
stockholders may be postponed by action of the board of directors at any time in advance of such meeting. The board of
directors of the Corporation shall have the power to adopt such rules and regulations for the conduct of the meetings and
management of the affairs of the
-10-

-- 167 of 356 --

Corporation as they may deem proper and the power to adjourn any meeting of stockholders without a vote of the
stockholders, which powers may be delegated by the board of directors to the chairman of such meeting either in such
rules and regulations or pursuant to the by-laws of the Corporation.
Special meetings of stockholders of the Corporation may be called at any time by, but only by, the board of directors of
the Corporation or, as and to the extent required by the by-laws of the Corporation, by the Secretary of the Corporation
upon the written request of the holders of record of not less than 25% of the voting power of all outstanding shares of
Common Stock of the Corporation, such voting power to be calculated and determined in the manner specified, and with
any limitations as may be set forth, in the Corporation’s by-laws (the “Requisite Percent”). Each special meeting shall be
held at such date, time and place either within or without the State of Delaware as may be stated in the notice of the
meeting.
The board of directors of the Corporation is authorized to adopt, amend or repeal by-laws of the Corporation. No
adoption, amendment or repeal of a by-law by action of stockholders shall be effective unless approved by the affirmative
vote of not less than a majority of shares present in person or represented by proxy at the meeting and entitled to vote on
such matter, with all shares of Common Stock of the Corporation and other stock of the Corporation entitled to vote on
such matter considered for this purpose as a single class; for purposes of this sentence votes cast “for” or “against” and
“abstentions” with respect to such matter shall be counted as shares of stock of the Corporation entitled to vote on such
matter, while “broker nonvotes” (or other shares of stock of the Corporation similarly not entitled to vote) shall not be
counted as shares entitled to vote on such matter. Any vote of stockholders required by this Article SIXTH shall be in
addition to any other vote of stockholders that may be required by law, this Restated Certificate of Incorporation, the
by-laws of the Corporation, any agreement with a national securities exchange or otherwise.
SEVENTH. Elections of directors need not be by written ballot except and to the extent provided in the by-laws of the
Corporation.
EIGHTH. The number of directors of the Corporation shall be fixed only by resolution of the board of directors of the
Corporation from time to time. Each director who is serving as a director on the date of this Restated Certificate of
Incorporation shall hold office until the next annual meeting of stockholders after such date and until his or her successor
has been duly elected and qualified, notwithstanding that such director may have been elected for a term that extended
beyond the date of such next annual meeting of stockholders. At each annual meeting of stockholders after the date of this
Restated Certificate of Incorporation, directors elected at such annual meeting shall hold office until the next annual
meeting of stockholders and until their successors have been duly elected and qualified.
Vacancies and newly created directorships resulting from any increase in the authorized number of directors or from any
other cause (other than vacancies and newly created directorships which the holders of any class or classes of stock or
series
-11-

-- 168 of 356 --

thereof are expressly entitled by this Restated Certificate of Incorporation to fill) shall be filled by, and only by, a
majority of the directors then in office, although less than a quorum, or by the sole remaining director. Any director
appointed to fill a vacancy or a newly created directorship shall hold office until the next annual meeting of stockholders,
and until his or her successor is elected and qualified or until his or her earlier resignation or removal.
Notwithstanding the foregoing, in the event that the holders of any class or series of Preferred Stock of the Corporation
shall be entitled, voting separately as a class, to elect any directors of the Corporation, then the number of directors that
may be elected by such holders voting separately as a class shall be in addition to the number fixed pursuant to a
resolution of the board of directors of the Corporation. Except as otherwise provided in the terms of such class or series,
(i) the terms of the directors elected by such holders voting separately as a class shall expire at the annual meeting of
stockholders next succeeding their election and (ii) any director or directors elected by such holders voting separately as a
class may be removed, with or without cause, by the holders of a majority of the voting power of all outstanding shares of
stock of the Corporation entitled to vote separately as a class in an election of such directors.
NINTH. In taking any action, including action that may involve or relate to a change or potential change in the control of
the Corporation, a director of the Corporation may consider, among other things, both the long-term and short-term
interests of the Corporation and its stockholders and the effects that the Corporation’s actions may have in the short term
or long term upon any one or more of the following matters:
(i) the prospects for potential growth, development, productivity and profitability of the Corporation;
(ii) the Corporation’s current employees;
(iii) the retired former partners of The Goldman Sachs Group, L.P. (“GS Group”) and the Corporation’s employees
and other beneficiaries receiving or entitled to receive retirement, welfare or similar benefits from or pursuant to any
plan sponsored, or agreement entered into, by the Corporation;
(iv) the Corporation’s customers and creditors;
(v) the ability of the Corporation to provide, as a going concern, goods, services, employment opportunities and
employment benefits and otherwise to contribute to the communities in which it does business; and
(vi) such other additional factors as a director may consider appropriate in such circumstances.
Nothing in this Article NINTH shall create any duty owed by any director of the Corporation to any person or entity to
consider, or afford any particular weight to, any of the foregoing matters or to limit his or her consideration to the
foregoing matters. No such employee, retired former partner of GS Group, former employee, beneficiary,
-12-

-- 169 of 356 --

customer, creditor or community or member thereof shall have any rights against any director of the Corporation or the
Corporation under this Article NINTH.
TENTH. From and after the consummation of the initial public offering of the shares of Common Stock of the
Corporation, no action of stockholders of the Corporation required or permitted to be taken at any annual or special
meeting of stockholders of the Corporation may be taken without a meeting of stockholders, without prior notice and
without a vote, and the power of stockholders of the Corporation to consent in writing to the taking of any action without
a meeting is specifically denied. Notwithstanding this Article TENTH, the holders of any series of Preferred Stock of the
Corporation shall be entitled to take action by written consent to such extent, if any, as may be provided in the terms of
such series.
ELEVENTH. [Reserved]
TWELFTH. A director of the Corporation shall not be liable to the Corporation or its stockholders for monetary damages
for breach of fiduciary duty as a director of the Corporation, except to the extent that such exemption from liability or
limitation thereof is not permitted under the Delaware General Corporation Law as currently in effect or as the same may
hereafter be amended.
Pursuant to the Plan of Incorporation of GS Group, dated as of March 8, 1999, as currently in effect or as the same may
hereafter be amended (the “Plan”), the Corporation has the right, but not the obligation, to make special arrangements
with any person who was a partner of GS Group participating in the Plan to ameliorate, in whole or in part, certain
significantly disproportionate tax or other burdens. The board of directors of the Corporation is authorized to cause the
Corporation to make such arrangements (which may include special payments) as the board of directors of the
Corporation may, in its sole discretion, deem appropriate to effectuate the intent of the relevant provision of the Plan and
the Corporation and each stockholder of the Corporation shall, to the fullest extent permitted by law, be deemed to have
approved and ratified any such determination and to have waived any claim or objection on behalf of the Corporation or
any such stockholder arising out of the making of such arrangements.
Pursuant to the Plan, the Corporation has the right, but not the obligation, to register with the Securities and Exchange
Commission the resale of certain securities of the Corporation by directors, employees and former directors and
employees of the Corporation and its subsidiaries and affiliates and former partners and employees of GS Group and its
subsidiaries and affiliates and to undertake various actions and to enter into agreements and arrangements in connection
therewith (collectively, the “Registration Arrangements”). The board of directors of the Corporation is authorized to cause
the Corporation to undertake such Registration Arrangements as the board of directors of the Corporation may, in its sole
discretion, deem appropriate and the Corporation and each stockholder of the Corporation shall, to the fullest extent
permitted by law, be deemed to have approved and ratified any such determination and
-13-

-- 170 of 356 --

to have waived any claim or objection on behalf of the Corporation or any such stockholder arising out of the undertaking
of such Registration Arrangements.
The Corporation and each stockholder of the Corporation shall, to the fullest extent permitted by law, be deemed to have
approved and ratified any decision by the board of directors of the Corporation to make the Contribution referred to in
Article THIRD, including the amount thereof (up to the limit specified in Article THIRD) and to have waived any claim
or objection on behalf of the Corporation or any such stockholder arising out of any such decision to make, or the making
of, the Contribution.
The authorizations, approvals and ratifications contained in the second, third and fourth paragraphs of this Article
TWELFTH shall not be construed to indicate that any other arrangements or contributions not specifically referred to in
such paragraphs are, by reason of such omission, not within the power and authority of the board of directors of the
Corporation or that the determination of the board of directors of the Corporation with respect thereto should be judged by
any legal standard other than that which would have applied but for the inclusion of the second, third and fourth
paragraphs of this Article TWELFTH.
No amendment, modification or repeal of this Article TWELFTH shall adversely affect any right or protection of a
director of the Corporation that exists at the time of such amendment, modification or repeal.
-14-

-- 171 of 356 --

IN WITNESS WHEREOF, the Corporation has caused this Restated Certificate of Incorporation to be signed and attested by
its duly authorized officer on this 12th day of March, 2020.
By: 	/s/ Karen P. Seymour
Name: Karen P. Seymour
Title: 	Executive Vice President and
General Counsel
-15-

-- 172 of 356 --

Appendix A
CERTIFICATE OF DESIGNATIONS
OF
FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES A
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY:
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated April 6, 2005, the provisions of the
amended and restated certificate of incorporation and bylaws of the Corporation and applicable law, by unanimous written
consent dated April 18, 2005, adopted the following resolution creating a series of 50,000 shares of Preferred Stock of the
Corporation designated as “Floating Rate Non-Cumulative Preferred Stock, Series A”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated April 6, 2005, the provisions of the amended and restated certificate of
incorporation and bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of the
Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “Floating
Rate Non-Cumulative Preferred Stock, Series A” (“Series A”). Each share of Series A shall be identical in all respects to every
other share of Series A, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates
may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series A shall be 50,000. Shares of
Series A that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred
Stock, shall be cancelled and shall revert to authorized but unissued shares of Series A.
Section 3. 	Definitions. As used herein with respect to Series A:
(a) 	“Board of Directors” means the board of directors of the Corporation.

-- 173 of 356 --

(b) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(c) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(d) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series A is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series A, as it
may be amended from time to time.
(f) 	“Certification of Incorporation” shall mean the amended and restated certificate of incorporation of
the Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series A) that ranks junior to Series A either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(j) 	“Moneyline Telerate Page” means the display on Moneyline Telerate, Inc., or any successor service,
on the page or pages specified in Section 4 below or any replacement page or pages on that service.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series A) that ranks
equally with Series A both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series A.
A-2

-- 174 of 356 --

(m) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(n) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 8(b) below) or any other matter as to which the holders of Series A are entitled to vote as
specified in Section 8 of this Certificate of Designations, any and all series of Preferred Stock (other than Series A)
that rank equally with Series A either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series A shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $25,000 per share of Series A. Such dividends shall be payable
quarterly in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors), on February 10, May 10, August 10 and
November 10 (“Dividend Payment Dates”), commencing on August 10, 2005; provided that if any such Dividend Payment
Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any
dividend payable on Series A on such Dividend Payment Date shall instead be payable on) the immediately succeeding
Business Day, unless such immediately succeeding Business Day falls in the next calendar month, in which case such
Dividend Payment Date shall instead be (and any such dividend shall instead be payable on) the immediately preceding
Business Day. Dividends on Series A shall not be cumulative; holders of Series A shall not be entitled to receive any dividends
not declared by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) and
no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends that are payable on Series A on any Dividend Payment Date will be payable to holders of
record of Series A as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence
A-3

-- 175 of 356 --

on and include the date of original issue of the Series A, provided that, for any share of Series A issued after such original issue
date, the initial Dividend Period for such shares may commence on and include such other date as the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors) shall determine and publicly disclose) and shall
end on and include the calendar day next preceding the next Dividend Payment Date. Dividends payable on the Series A in
respect of any Dividend Period shall be computed by the Calculation Agent on the basis of a 360-day year and the actual
number of days elapsed in such Dividend Period. Dividends payable in respect of a Dividend Period shall be payable in arrears
– i.e., on the first Dividend Payment Date after such Dividend Period.
The dividend rate on the Series A, for each Dividend Period, shall be a rate per annum equal to the greater
of (1) 0.75% above LIBOR (as defined below) for such Dividend Period and (2) 3.75%. LIBOR, with respect to any Dividend
Period, means the offered rate expressed as a percentage per annum for three-month deposits in U.S. dollars on the first day of
such Dividend Period, as that rate appears on Moneyline Telerate Page 3750 as of 11:00 A.M., London time, on the second
London Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on Moneyline Telerate Page 3750, LIBOR
shall be determined on the basis of the rates, at approximately 11:00 A.M., London time, on the second London Business Day
immediately preceding the first day of such Dividend Period, at which deposits of the following kind are offered to prime
banks in the London interbank market by four major banks in that market selected by the Calculation Agent: three-month
deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a Representative Amount. The Calculation
Agent shall request the principal London office of each of these banks to provide a quotation of its rate at approximately
11:00 A.M., London time. If at least two quotations are provided, LIBOR for such Dividend Period shall be the arithmetic
mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M. New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If fewer than three banks selected by the Calculation Agent are quoting as described in the preceding
paragraph, LIBOR for such Dividend Period shall be LIBOR in effect for the prior Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices and will be available to any
stockholder upon request and will be final and binding in the absence of manifest error.
A-4

-- 176 of 356 --

Holders of Series A shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series A as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series A remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series A have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series A and any shares of Parity Stock,
all dividends declared on the Series A and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series A and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series A shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series A shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to
A-5

-- 177 of 356 --

stockholders of the Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before
any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the
Corporation ranking junior to the Series A as to such distribution, in full an amount equal to $25,000 per share (the “Series A
Liquidation Amount”), together with an amount equal to all dividends (if any) that have been declared but not paid prior to the
date of payment of such distribution (but without any amount in respect of dividends that have not been declared prior to such
payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series A
and all holders of any stock of the Corporation ranking equally with the Series A as to such distribution, the amounts paid to
the holders of Series A and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series A and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series A and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series A,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series A receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series A may not be redeemed by the Corporation prior to April 25,
2010. On or after April 25, 2010, the Corporation, at its option, may redeem, in whole at any time or in part from time to time,
the shares of Series A at the time outstanding, upon notice given as provided in Section 6(c) below, at a redemption price equal
to $25,000 per share, together (except as otherwise provided herein below) with an amount equal to any dividends that have
been declared but not paid prior to the redemption date (but with no amount in respect of any dividends that have not been
declared prior to such date). The redemption price for any shares of Series A shall be payable on the redemption date to the
holder of such shares against surrender of the
A-6

-- 178 of 356 --

certificate(s) evidencing such shares to the Corporation or its agent. Any declared but unpaid dividends payable on a
redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder
entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed
shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 4 above.
(b) 	No Sinking Fund. The Series A will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series A will have no right to require redemption of any shares of Series A.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series A shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series A designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series A. Notwithstanding the foregoing, if the Series A or any
depositary shares representing interests in the Series A are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series A at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series A to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be
surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series A at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series A shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed
A-7

-- 179 of 356 --

outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only
the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the
end of three years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which
time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price
of such shares.
Section 7. 	Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:
(i) 	after the date of the issuance of the Series A, the Corporation (by election or otherwise) becomes
subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which
Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities
and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time), (y)
provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any
governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its
subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on
Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve
System or any other United States national governmental agency, authority or other body, or any other applicable
regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or
(z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal
counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either
(y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and
(ii) 	the Corporation affirmatively elects to qualify the Series A for treatment as Allowable Capital or Tier
1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series A in
Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any
limitation requiring that common equity or a specified form of common equity constitute the dominant form of
Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,
then, upon such affirmative election, the Series A shall be convertible at the Corporation’s option into a new series of Preferred
Stock having terms and provisions substantially identical to those of the Series A, except that such new series may have such
additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions thereof, as are
necessary in the judgment of the Board of Directors or the Committee (or another duly authorized committee of the Board of
Directors) (after consultation with legal counsel of recognized standing) to comply with the Required Unrestricted Capital
Provisions (as defined below), provided that the Corporation will not cause any such conversion unless the Board of Directors
or the Committee (or another duly authorized committee of the Board of Directors) determines that the rights, preferences,
privileges and
A-8

-- 180 of 356 --

voting powers, and the qualifications, limitations and restrictions thereof, of such new series of Preferred Stock, taken as a
whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
the qualifications, limitations and restrictions thereof, of the Series A, taken as a whole.
As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as
are, in the judgment of the Corporation (after consultation with counsel of recognized standing), required for preferred stock to
be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative
restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than
any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common
equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.
The Corporation shall provide notice to the holders of Series A of any election to qualify the Series A for
Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series A into a new series of
Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination.
A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation
and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series A pursuant to
this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.
Except as specified in this Section 7, holders of Series A shares shall have no right to exchange or convert
such shares into any other securities.
Section 8. 	Voting Rights.
(a) 	General. The holders of Series A shall not have any voting rights except as set forth below or as
otherwise from to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series A shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series A, together with the holders of any outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that it shall be
a qualification for election for any such Preferred Stock Director that the election of such director shall not cause the
Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other securities
exchange or other trading facility on which securities of the Corporation may then be listed or traded) that listed or traded
companies must have a majority of independent directors.
In the event that the holders of the Series A, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock
A-9

-- 181 of 356 --

Directors following a Nonpayment Event, such directors shall be initially elected following such Nonpayment Event only at a
special meeting called at the request of the holders of record of at least 20% of the Series A or of any other series of Voting
Preferred Stock then outstanding (unless such request for a special meeting is received less than 90 days before the date fixed
for the next annual or special meeting of the stockholders of the Corporation, in which event such election shall be held only at
such next annual or special meeting of stockholders), and at each subsequent annual meeting of stockholders of the
Corporation. Such request to call a special meeting for the initial election of the Preferred Stock Directors after a Nonpayment
Event shall be made by written notice, signed by the requisite holders of Series A or Voting Preferred Stock, and delivered to
the Secretary of the Corporation in such manner as provided for in Section 10 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series A for at least four Dividend Periods (whether or not consecutive) after a Nonpayment Event, then the right of the
holders of Series A to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in
the case of any future Nonpayment Event), and, if and when any rights of holders of Series A and Voting Preferred Stock to
elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith
terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of the outstanding shares of the Series A and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of the outstanding shares of the Series A and all Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided
above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90
days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held
at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per
director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any
special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until the next
annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series A are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the
A-10

-- 182 of 356 --

shares of Series A and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting together as a
single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose,
shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series A with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series A. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series A, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series A, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series A remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series A immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series A or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series A with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the special rights, preferences, privileges or voting powers of the Series A.
In addition, any conversion of the Series A pursuant to Section 7 above shall not be deemed to adversely affect the rights,
preferences, privileges and voting powers of the Series A.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 8(c) would adversely affect the Series A and one or more but not all other series of Preferred Stock, then only the
Series A and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
A-11

-- 183 of 356 --

(d) 	Changes for Clarification. Without the consent of the holders of the Series A, so long as such
action does not adversely affect the special rights, preferences, privileges and voting powers, and limitations and restrictions
thereof, of the Series A, the Corporation may amend, alter, supplement or repeal any terms of the Series A:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series A that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series A shall be
required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series A shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series A (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series A is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series A and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series A are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
A-12

-- 184 of 356 --

Section 9. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series A may deem and treat the record holder of any share of Series A as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 10. 	Notices. All notices or communications in respect of Series A shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 11. 	No Preemptive Rights. No share of Series A shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 12. 	Other Rights. The shares of Series A shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
A-13

-- 185 of 356 --

Appendix B
CERTIFICATE OF DESIGNATIONS
OF
FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES C
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY:
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated September 16, 2005, the provisions
of the amended and restated certificate of incorporation and bylaws of the Corporation and applicable law, by unanimous
written consent dated October 25, 2005, adopted the following resolution creating a series of 25,000 shares of Preferred Stock
of the Corporation designated as “Floating Rate Non-Cumulative Preferred Stock, Series C”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated September 16, 2005, the provisions of the amended and restated certificate of
incorporation and bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of the
Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “Floating
Rate Non-Cumulative Preferred Stock, Series C” (“Series C”). Each share of Series C shall be identical in all respects to every
other share of Series C, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates
may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series C shall be 25,000. Shares of
Series C that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred
Stock, shall be cancelled and shall revert to authorized but unissued shares of Series C.
Section 3. 	Definitions. As used herein with respect to Series C:
(a) 	“Board of Directors” means the board of directors of the Corporation.

-- 186 of 356 --

(b) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(c) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(d) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series C is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series C, as it may
be amended from time to time.
(f) 	“Certification of Incorporation” shall mean the amended and restated certificate of incorporation of
the Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series C) that ranks junior to Series C either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(j) 	“Moneyline Telerate Page” means the display on Moneyline Telerate, Inc., or any successor service,
on the page or pages specified in Section 4 below or any replacement page or pages on that service.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series C) that ranks
equally with Series C both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series C.
B-2

-- 187 of 356 --

(m) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(n) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 8(b) below) or any other matter as to which the holders of Series C are entitled to vote as
specified in Section 8 of this Certificate of Designations, any and all series of Preferred Stock (other than Series C)
that rank equally with Series C either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series C shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $25,000 per share of Series C. Such dividends shall be payable
quarterly in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors), on February 10, May 10, August 10 and
November 10 (“Dividend Payment Dates”), commencing on February 10, 2006; provided that if any such Dividend Payment
Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any
dividend payable on Series C on such Dividend Payment Date shall instead be payable on) the immediately succeeding
Business Day, unless such immediately succeeding Business Day falls in the next calendar month, in which case such
Dividend Payment Date shall instead be (and any such dividend shall instead be payable on) the immediately preceding
Business Day. Dividends on Series C shall not be cumulative; holders of Series C shall not be entitled to receive any dividends
not declared by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) and
no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends that are payable on Series C on any Dividend Payment Date will be payable to holders of record
of Series C as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence
B-3

-- 188 of 356 --

on and include the date of original issue of the Series C, provided that, for any share of Series C issued after such original issue
date, the initial Dividend Period for such shares may commence on and include such other date as the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors) shall determine and publicly disclose) and shall
end on and include the calendar day next preceding the next Dividend Payment Date. Dividends payable on the Series C in
respect of any Dividend Period shall be computed by the Calculation Agent on the basis of a 360-day year and the actual
number of days elapsed in such Dividend Period. Dividends payable in respect of a Dividend Period shall be payable in arrears
– i.e., on the first Dividend Payment Date after such Dividend Period.
The dividend rate on the Series C, for each Dividend Period, shall be a rate per annum equal to the greater
of (1) 0.75% above LIBOR (as defined below) for such Dividend Period and (2) 4.00%. LIBOR, with respect to any Dividend
Period, means the offered rate expressed as a percentage per annum for three-month deposits in U.S. dollars on the first day of
such Dividend Period, as that rate appears on Moneyline Telerate Page 3750 as of 11:00 A.M., London time, on the second
London Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on Moneyline Telerate Page 3750, LIBOR
shall be determined on the basis of the rates, at approximately 11:00 A.M., London time, on the second London Business Day
immediately preceding the first day of such Dividend Period, at which deposits of the following kind are offered to prime
banks in the London interbank market by four major banks in that market selected by the Calculation Agent: three-month
deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a Representative Amount. The Calculation
Agent shall request the principal London office of each of these banks to provide a quotation of its rate at approximately
11:00 A.M., London time. If at least two quotations are provided, LIBOR for such Dividend Period shall be the arithmetic
mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M. New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If fewer than three banks selected by the Calculation Agent are quoting as described in the preceding
paragraph, LIBOR for such Dividend Period shall be LIBOR in effect for the prior Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices and will be available to any
stockholder upon request and will be final and binding in the absence of manifest error.
B-4

-- 189 of 356 --

Holders of Series C shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series C as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series C remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series C have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series C and any shares of Parity Stock,
all dividends declared on the Series C and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series C and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series C shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series C shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to
B-5

-- 190 of 356 --

stockholders of the Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before
any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the
Corporation ranking junior to the Series C as to such distribution, in full an amount equal to $25,000 per share (the “Series C
Liquidation Amount”), together with an amount equal to all dividends (if any) that have been declared but not paid prior to the
date of payment of such distribution (but without any amount in respect of dividends that have not been declared prior to such
payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series C and
all holders of any stock of the Corporation ranking equally with the Series C as to such distribution, the amounts paid to the
holders of Series C and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series C and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series C and on which dividends
accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as
applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series C,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series C receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series C may not be redeemed by the Corporation prior to October 31,
2010. On or after October 31, 2010, the Corporation, at its option, may redeem, in whole at any time or in part from time to
time, the shares of Series C at the time outstanding, upon notice given as provided in Section 6(c) below, at a redemption price
equal to $25,000 per share, together (except as otherwise provided herein below) with an amount equal to any dividends that
have been declared but not paid prior to the redemption date (but with no amount in respect of any dividends that have not
been declared prior to such date). The redemption price for any shares of Series C shall be payable on the redemption date to
the holder of such shares against surrender of the
B-6

-- 191 of 356 --

certificate(s) evidencing such shares to the Corporation or its agent. Any declared but unpaid dividends payable on a
redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder
entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed
shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 4 above.
(b) 	No Sinking Fund. The Series C will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series C will have no right to require redemption of any shares of Series C.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series C shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series C designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series C. Notwithstanding the foregoing, if the Series C or any
depositary shares representing interests in the Series C are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series C at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series C to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be
surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series C at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series C shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed
B-7

-- 192 of 356 --

outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only
the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the
end of three years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which
time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price
of such shares.
Section 7. 	Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:
(i) 	after the date of the issuance of the Series C, the Corporation (by election or otherwise) becomes
subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which
Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities
and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time), (y)
provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any
governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its
subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on
Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve
System or any other United States national governmental agency, authority or other body, or any other applicable
regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or
(z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal
counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either
(y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and
(ii) 	the Corporation affirmatively elects to qualify the Series C for treatment as Allowable Capital or Tier
1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series C in
Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any
limitation requiring that common equity or a specified form of common equity constitute the dominant form of
Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,
then, upon such affirmative election, the Series C shall be convertible at the Corporation’s option into a new series of Preferred
Stock having terms and provisions substantially identical to those of the Series C, except that such new series may have such
additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions thereof, as are
necessary in the judgment of the Board of Directors or the Committee (or another duly authorized committee of the Board of
Directors) (after consultation with legal counsel of recognized standing) to comply with the Required Unrestricted Capital
Provisions (as defined below), provided that the Corporation will not cause any such conversion unless the Board of Directors
or the Committee (or another duly authorized committee of the Board of Directors) determines that the rights, preferences,
privileges and
B-8

-- 193 of 356 --

voting powers, and the qualifications, limitations and restrictions thereof, of such new series of Preferred Stock, taken as a
whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
the qualifications, limitations and restrictions thereof, of the Series C, taken as a whole.
As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as
are, in the judgment of the Corporation (after consultation with counsel of recognized standing), required for preferred stock to
be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative
restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than
any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common
equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.
The Corporation shall provide notice to the holders of Series C of any election to qualify the Series C for
Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series C into a new series of
Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination.
A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation
and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series C pursuant to
this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.
Except as specified in this Section 7, holders of Series C shares shall have no right to exchange or convert
such shares into any other securities.
Section 8. 	Voting Rights.
(a) 	General. The holders of Series C shall not have any voting rights except as set forth below or as
otherwise from to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series C shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series C, together with the holders of any outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that it shall be
a qualification for election for any such Preferred Stock Director that the election of such director shall not cause the
Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other securities
exchange or other trading facility on which securities of the Corporation may then be listed or traded) that listed or traded
companies must have a majority of independent directors and provided further that the Board of Directors shall at no time
include more than two Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of any
series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
B-9

-- 194 of 356 --

In the event that the holders of the Series C, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series C or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series C or Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for
in Section 10 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series C for at least four Dividend Periods (whether or not consecutive) after a Nonpayment Event, then the right of the
holders of Series C to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in
the case of any future Nonpayment Event), and, if and when any rights of holders of Series C and Voting Preferred Stock to
elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith
terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of the outstanding shares of the Series C and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of the outstanding shares of the Series C and all Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided
above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90
days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held
at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per
director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any
special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until the next
annual meeting of the stockholders if such office shall not have previously terminated as above provided.
B-10

-- 195 of 356 --

(c) 	Other Voting Rights. So long as any shares of Series C are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
662⁄3% of the shares of Series C and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series C with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series C. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series C, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series C, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series C remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series C immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series C or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series C with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series C. In
addition, any conversion of the Series C pursuant to Section 7 above shall not be deemed to adversely affect the rights,
preferences, privileges and voting powers of the Series C.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 8(c) would adversely affect the Series C and one or more but not all other series of Preferred Stock, then only the
Series C and such
B-11

-- 196 of 356 --

series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the matter together as a
single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series C, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series C, the Corporation may amend, alter, supplement or repeal any terms of the Series C:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series C that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series C shall be
required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series C shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series C (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series C is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series C and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series C are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 9. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series C may deem and treat the record holder of any share of Series C as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 10. 	Notices. All notices or communications in respect of Series C shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this
B-12

-- 197 of 356 --

Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 11. 	No Preemptive Rights. No share of Series C shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 12. 	Other Rights. The shares of Series C shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
B-13

-- 198 of 356 --

Appendix C
CERTIFICATE OF DESIGNATIONS
OF
FLOATING RATE NON-CUMULATIVE PREFERRED STOCK, SERIES D
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY:
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated September 16, 2005, the provisions
of the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, by
unanimous written consent dated May 16, 2005, adopted the following resolution creating a series of 60,000 shares of
Preferred Stock of the Corporation designated as “Floating Rate Non-Cumulative Preferred Stock, Series D”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated September 16, 2005, the provisions of the restated certificate of incorporation and
the amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share,
of the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and
other powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “Floating
Rate Non-Cumulative Preferred Stock, Series D” (“Series D”). Each share of Series D shall be identical in all respects to every
other share of Series D, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates
may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series D shall be 60,000. Shares of
Series D that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred
Stock, shall be cancelled and shall revert to authorized but unissued shares of Series D.
Section 3. 	Definitions. As used herein with respect to Series D:
(a) 	“Board of Directors” means the board of directors of the Corporation.

-- 199 of 356 --

(b) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(c) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(d) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series D is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series D, as it
may be amended from time to time.
(f) 	“Certification 	of 	Incorporation” 	shall 	mean 	the 	restated 	certificate 	of 	incorporation 	of 	the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series D) that ranks junior to Series D either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(j) 	“Moneyline Telerate Page” means the display on Moneyline Telerate, Inc., or any successor service,
on the page or pages specified in Section 4 below or any replacement page or pages on that service.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series D) that ranks
equally with Series D both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series D.
C-2

-- 200 of 356 --

(m) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(n) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 8(b) below) or any other matter as to which the holders of Series D are entitled to vote as
specified in Section 8 of this Certificate of Designations, any and all series of Preferred Stock (other than Series D)
that rank equally with Series D either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series D shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $25,000 per share of Series D. Such dividends shall be payable
quarterly in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors), on February 10, May 10, August 10 and
November 10 (“Dividend Payment Dates”), commencing on August 10, 2006; provided that if any such Dividend Payment
Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any
dividend payable on Series D on such Dividend Payment Date shall instead be payable on) the immediately succeeding
Business Day, unless such immediately succeeding Business Day falls in the next calendar month, in which case such
Dividend Payment Date shall instead be (and any such dividend shall instead be payable on) the immediately preceding
Business Day. Dividends on Series D shall not be cumulative; holders of Series D shall not be entitled to receive any dividends
not declared by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) and
no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends that are payable on Series D on any Dividend Payment Date will be payable to holders of
record of Series D as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence
C-3

-- 201 of 356 --

on and include the date of original issue of the Series D, provided that, for any share of Series D issued after such original issue
date, the initial Dividend Period for such shares may commence on and include such other date as the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors) shall determine and publicly disclose) and shall
end on and include the calendar day next preceding the next Dividend Payment Date. Dividends payable on the Series D in
respect of any Dividend Period shall be computed by the Calculation Agent on the basis of a 360-day year and the actual
number of days elapsed in such Dividend Period. Dividends payable in respect of a Dividend Period shall be payable in arrears
– i.e., on the first Dividend Payment Date after such Dividend Period.
The dividend rate on the Series D, for each Dividend Period, shall be a rate per annum equal to the greater
of (1) 0.67% above LIBOR (as defined below) for such Dividend Period and (2) 4.00%. LIBOR, with respect to any Dividend
Period, means the offered rate expressed as a percentage per annum for three-month deposits in U.S. dollars on the first day of
such Dividend Period, as that rate appears on Moneyline Telerate Page 3750 (or any successor or replacement page) as of
11:00 A.M., London time, on the second London Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on Moneyline Telerate Page 3750 (or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M. New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If fewer than three banks selected by the Calculation Agent are quoting as described in the preceding
paragraph, LIBOR for such Dividend Period shall be LIBOR in effect for the prior Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices and will be available to any
stockholder upon request and will be final and binding in the absence of manifest error.
C-4

-- 202 of 356 --

Holders of Series D shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series D as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series D remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series D have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series D and any shares of Parity Stock,
all dividends declared on the Series D and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series D and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series D shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series D shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to
C-5

-- 203 of 356 --

stockholders of the Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before
any distribution of such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the
Corporation ranking junior to the Series D as to such distribution, in full an amount equal to $25,000 per share (the “Series D
Liquidation Amount”), together with an amount equal to all dividends (if any) that have been declared but not paid prior to the
date of payment of such distribution (but without any amount in respect of dividends that have not been declared prior to such
payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series D
and all holders of any stock of the Corporation ranking equally with the Series D as to such distribution, the amounts paid to
the holders of Series D and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series D and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series D and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series D,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series D receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series D may not be redeemed by the Corporation prior to May 24,
2011. On or after May 24, 2011, the Corporation, at its option, may redeem, in whole at any time or in part from time to time,
the shares of Series D at the time outstanding, upon notice given as provided in Section 6(c) below, at a redemption price equal
to $25,000 per share, together (except as otherwise provided hereinbelow) with an amount equal to any dividends that have
been declared but not paid prior to the redemption date (but with no amount in respect of any dividends that have not been
declared prior to such date). The redemption price for any shares of Series D shall be payable on the redemption date to the
holder of such shares against surrender of the
C-6

-- 204 of 356 --

certificate(s) evidencing such shares to the Corporation or its agent. Any declared but unpaid dividends payable on a
redemption date that occurs subsequent to the Dividend Record Date for a Dividend Period shall not be paid to the holder
entitled to receive the redemption price on the redemption date, but rather shall be paid to the holder of record of the redeemed
shares on such Dividend Record Date relating to the Dividend Payment Date as provided in Section 4 above.
(b) 	No Sinking Fund. The Series D will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series D will have no right to require redemption of any shares of Series D.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series D shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series D designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series D. Notwithstanding the foregoing, if the Series D or any
depositary shares representing interests in the Series D are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series D at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series D to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be
surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series D at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series D shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed
C-7

-- 205 of 356 --

outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only
the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the
end of three years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which
time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price
of such shares.
Section 7. 	Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:
(i) 	after the date of the issuance of the Series D, the Corporation (by election or otherwise) becomes
subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which
Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities
and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time), (y)
provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any
governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its
subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on
Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve
System or any other United States national governmental agency, authority or other body, or any other applicable
regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or
(z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal
counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either
(y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and
(ii) 	the Corporation affirmatively elects to qualify the Series D for treatment as Allowable Capital or Tier
1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series D in
Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any
limitation requiring that common equity or a specified form of common equity constitute the dominant form of
Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,
then, upon such affirmative election, the Series D shall be convertible at the Corporation’s option into a new series of Preferred
Stock having terms and provisions substantially identical to those of the Series D, except that such new series may have such
additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions thereof, as are
necessary in the judgment of the Board of Directors or the Committee (or another duly authorized committee of the Board of
Directors) (after consultation with legal counsel of recognized standing) to comply with the Required Unrestricted Capital
Provisions (as defined below), provided that the Corporation will not cause any such conversion unless the Board of Directors
or the Committee (or another duly authorized committee of the Board of Directors) determines that the rights, preferences,
privileges and
C-8

-- 206 of 356 --

voting powers, and the qualifications, limitations and restrictions thereof, of such new series of Preferred Stock, taken as a
whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
the qualifications, limitations and restrictions thereof, of the Series D, taken as a whole.
As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as
are, in the judgment of the Corporation (after consultation with counsel of recognized standing), required for preferred stock to
be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative
restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than
any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common
equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.
The Corporation shall provide notice to the holders of Series D of any election to qualify the Series D for
Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series D into a new series of
Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination.
A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation
and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series D pursuant to
this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.
Except as specified in this Section 7, holders of Series D shares shall have no right to exchange or convert
such shares into any other securities.
Section 8. 	Voting Rights.
(a) 	General. The holders of Series D shall not have any voting rights except as set forth below or as
otherwise from to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series D shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series D, together with the holders of any outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that it shall be
a qualification for election for any such Preferred Stock Director that the election of such director shall not cause the
Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other securities
exchange or other trading facility on which securities of the Corporation may then be listed or traded) that listed or traded
companies must have a majority of independent directors and provided further that the Board of Directors shall at no time
include more than two Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of any
series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
C-9

-- 207 of 356 --

In the event that the holders of the Series D, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series D or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series D or Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided
for in Section 10 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on the Series
D for at least four Dividend Periods (whether or not consecutive) after a Nonpayment Event, then the right of the holders of
Series D to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in the case of
any future Nonpayment Event), and, if and when any rights of holders of Series D and Voting Preferred Stock to elect the
Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith terminate
and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a majority of
the outstanding shares of the Series D and Voting Preferred Stock, when they have the voting rights described above (voting
together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a Preferred Stock
Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be filled by the
written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of
record of a majority of the outstanding shares of the Series D and all Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy in the office
of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided above for an
initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90 days before
the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next
annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any
matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any special meeting of
stockholders or by written consent of the other Preferred Stock Director shall hold office until the next annual meeting of the
stockholders if such office shall not have previously terminated as above provided.
C-10

-- 208 of 356 --

(c) 	Other Voting Rights. So long as any shares of Series D are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series D and any Voting Preferred Stock at the time outstanding and entitled to vote thereon,
voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting
called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series D with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series D. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series D, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series D, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series D remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series D immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series D or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series D with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series D. In
addition, any conversion of the Series D pursuant to Section 7 above shall not be deemed to adversely affect the rights,
preferences, privileges and voting powers of the Series D.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 8(c) would adversely affect the Series D and one or more but not all other series of Preferred Stock, then only the
Series D and such
C-11

-- 209 of 356 --

series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the matter together as a
single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series D, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series D, the Corporation may amend, alter, supplement or repeal any terms of the Series D:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series D that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series D shall be
required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series D shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series D (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series D is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series D and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series D are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 9. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series D may deem and treat the record holder of any share of Series D as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 10. 	Notices. All notices or communications in respect of Series D shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this
C-12

-- 210 of 356 --

Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 11. 	No Preemptive Rights. No share of Series D shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 12. 	Other Rights. The shares of Series D shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
C-13

-- 211 of 356 --

Appendix D
CERTIFICATE OF DESIGNATIONS
OF
PERPETUAL NON-CUMULATIVE PREFERRED STOCK, SERIES E
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY:
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated September 16, 2005 and
September 29, 2006, the provisions of the restated certificate of incorporation and the amended and restated bylaws of the
Corporation and applicable law, by unanimous written consent dated May 14, 2007, adopted the following resolution creating
a series of 17,500.1 shares of Preferred Stock of the Corporation designated as “Perpetual Non-Cumulative Preferred Stock,
Series E”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated September 16, 2005 and September 29, 2006, the provisions of the restated
certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, a series of Preferred
Stock, par value $.01 per share, of the Corporation be and hereby is created, and that the designation and number of shares of
such series, and the voting and other powers, preferences and relative, participating, optional or other rights, and the
qualifications, limitations and restrictions thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “Perpetual
Non-Cumulative Preferred Stock, Series E” (“Series E”). Each share of Series E shall be identical in all respects to every other
share of Series E.
Section 2. 	Number of Shares. The authorized number of shares of Series E shall be 17,500.1. Shares of
Series E that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred
Stock, shall be cancelled and shall revert to authorized but unissued shares of Series E.
Section 3. 	Definitions. As used herein with respect to Series E:
(a) 	“Board of Directors” means the board of directors of the Corporation.

-- 212 of 356 --

(b) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(c) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(d) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series E is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series E, as it may
be amended from time to time.
(f) 	“Certification 	of 	Incorporation” 	shall 	mean 	the 	restated 	certificate 	of 	incorporation 	of 	the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series E) that ranks junior to Series E either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(j) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series E) that ranks
equally with Series E both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(k) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series E.
(l) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment, is
representative of a single transaction in the relevant market at the relevant time.
D-2

-- 213 of 356 --

(m) 	“Reuters Screen LIBOR01” means the display designated on the Reuters 3000 Xtra (or such other
page as may replace that page on that service or such other service as may be nominated by the British Bankers’
Association for the purpose of displaying London interbank offered rates for U.S. Dollar deposits).
(n) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 8(b) below) or any other matter as to which the holders of Series E are entitled to vote as
specified in Section 8 of this Certificate of Designations, any and all series of Preferred Stock (other than Series E)
that rank equally with Series E either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series E shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $100,000 per share of Series E. Such dividends shall be payable in
arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors), (a) if the shares of Series E are issued prior to June 1, 2012
(or if such date is not a Business Day, the next Business Day), on June 1 and December 1 of each year until June 1, 2012, and
(b) thereafter, on March 1, June 1, September 1 and December 1 of each year (each a “Dividend Payment Date”); provided that
if any such Dividend Payment Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date
shall instead be (and any dividend payable on Series E on such Dividend Payment Date shall instead be payable on) the
immediately succeeding Business Day. If a Dividend Payment Date prior to June 1, 2012 is not a Business Day, the applicable
dividend shall be paid on the first Business Day following that day without adjustment. Dividends on Series E shall not be
cumulative; holders of Series E shall not be entitled to receive any dividends not declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors) and no interest, or sum of money in lieu of
interest, shall be payable in respect of any dividend not so declared.
Dividends that are payable on Series E on any Dividend Payment Date will be payable to holders of record
of Series E as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
D-3

-- 214 of 356 --

Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series E) and
shall end on and include the calendar day next preceding the next Dividend Payment Date. Dividends payable on the Series E
in respect of a Dividend Period shall be computed by the Calculation Agent (i) if shares of Series E are issued prior to June 1,
2012, on the basis of a 360-day year consisting of twelve-30 day months until the Dividend Payment Date in June 2012 and
(ii) thereafter, on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends
payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such
Dividend Period.
The dividend rate on the Series E, for each Dividend Period, shall be (a) if the shares of Series E are issued
prior to June 1, 2012, a rate per annum equal to 5.793% until the Dividend Payment date in June 2012, and (b) thereafter, a rate
per annum that will reset quarterly and shall be equal to the greater of (i) three-month LIBOR for such Dividend Period plus
0.7675% and (ii) 4.000%. Three-month LIBOR, with respect to any Dividend Period, means the offered rate expressed as a
percentage per annum for three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on
Reuters Screen LIBOR01 (or any successor or replacement page) as of 11:00 A.M., London time, on the second London
Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on Reuters Screen LIBOR01(or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M. New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If fewer than three banks selected by the Calculation Agent are quoting as described in the preceding
paragraph, LIBOR for such Dividend Period shall be LIBOR in effect for the prior Dividend Period.
D-4

-- 215 of 356 --

The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices and will be available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series E shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series E as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series E remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series E have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series E and any shares of Parity Stock,
all dividends declared on the Series E and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series E and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series E shall not be entitled to participate in any such dividends.
D-5

-- 216 of 356 --

Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series E shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series E as to such distribution, in full an amount equal to $100,000 per share (the “Series E Liquidation
Amount”), together with an amount equal to all dividends (if any) that have been declared but not paid prior to the date of
payment of such distribution (but without any amount in respect of dividends that have not been declared prior to such
payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series E and
all holders of any stock of the Corporation ranking equally with the Series E as to such distribution, the amounts paid to the
holders of Series E and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series E and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series E and on which dividends
accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as
applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series E,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series E receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series E may not be redeemed by the Corporation prior to the later of
June 1, 2012 and the date of original issue of Series E. On or after that date, the Corporation, at its option, may redeem, in
whole at any time or in part
D-6

-- 217 of 356 --

from time to time, the shares of Series E at the time outstanding, upon notice given as provided in Section 6(c) below, at a
redemption price equal to $100,000 per share, together (except as otherwise provided herein) with an amount equal to any
dividends that have been declared but not paid prior to the redemption date (but with no amount in respect of any dividends
that have not been declared prior to such date). The redemption price for any shares of Series E shall be payable on the
redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the Corporation or
its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the Dividend Record Date
for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption date, but rather
shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the Dividend Payment
Date as provided in Section 4 above.
(b) 	No Sinking Fund. The Series E will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series E will have no right to require redemption of any shares of Series E.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series E shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series E designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series E. Notwithstanding the foregoing, if the Series E or any
depositary shares representing interests in the Series E are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series E at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series E to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be
surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series E at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series E shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds
D-7

-- 218 of 356 --

necessary for the redemption have been set aside by the Corporation, separate and apart from its other funds, in trust for the pro
rata benefit of the holders of the shares called for redemption, so as to be and continue to be available therefor, then,
notwithstanding that any certificate for any share so called for redemption has not been surrendered for cancellation, on and
after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares so called for
redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption
date cease and terminate, except only the right of the holders thereof to receive the amount payable on such redemption,
without interest. Any funds unclaimed at the end of three years from the redemption date shall, to the extent permitted by law,
be released to the Corporation, after which time the holders of the shares so called for redemption shall look only to the
Corporation for payment of the redemption price of such shares.
Section 7. 	Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:
(i) 	after the date of the issuance of the Series E, the Corporation (by election or otherwise) becomes
subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which
Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities
and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time),
(y) provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any
governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its
subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on
Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve
System or any other United States national governmental agency, authority or other body, or any other applicable
regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or
(z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal
counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either
(y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and
(ii) 	the Corporation affirmatively elects to qualify the Series E for treatment as Allowable Capital or
Tier 1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series E in
Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any
limitation requiring that common equity or a specified form of common equity constitute the dominant form of
Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,
then, upon such affirmative election, the Series E shall be convertible at the Corporation’s option into a new series of Preferred
Stock having terms and provisions substantially identical to those of the Series E, except that such new series may have such
additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions
D-8

-- 219 of 356 --

thereof, as are necessary in the judgment of the Board of Directors or the Committee (or another duly authorized committee of
the Board of Directors) (after consultation with legal counsel of recognized standing) to comply with the Required Unrestricted
Capital Provisions (as defined below), provided that the Corporation will not cause any such conversion unless the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) determines that the rights,
preferences, privileges and voting powers, and the qualifications, limitations and restrictions thereof, of such new series of
Preferred Stock, taken as a whole, are not materially less favorable to the holders thereof than the rights, preferences, privileges
and voting powers, and the qualifications, limitations and restrictions thereof, of the Series E, taken as a whole.
As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as
are, in the judgment of the Corporation (after consultation with counsel of recognized standing), required for preferred stock to
be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative
restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than
any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common
equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.
The Corporation shall provide notice to the holders of Series E of any election to qualify the Series E for
Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series E into a new series of
Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination.
A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation
and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series E pursuant to
this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.
Except as specified in this Section 7, holders of Series E shares shall have no right to exchange or convert
such shares into any other securities.
Section 8. 	Voting Rights.
(a) 	General. The holders of Series E shall not have any voting rights except as set forth below or as
otherwise from to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series E shall not have been declared and paid for Dividend Periods, whether or not consecutive, equivalent to at
least eighteen months (a “Nonpayment Event”), the number of directors then constituting the Board of Directors shall
automatically be increased by two and the holders of Series E, together with the holders of any outstanding shares of Voting
Preferred Stock, voting together as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock
Directors”), provided that it shall be a qualification for election for any such Preferred Stock Director that the election of such
director shall not cause the Corporation to violate
D-9

-- 220 of 356 --

the corporate governance requirement of the New York Stock Exchange (or any other securities exchange or other trading
facility on which securities of the Corporation may then be listed or traded) that listed or traded companies must have a
majority of independent directors and provided further that the Board of Directors shall at no time include more than two
Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of any series of Voting
Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series E, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series E or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series E or Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for
in Section 10 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series E for Dividend Periods, whether or not consecutive, equivalent to at least one year after a Nonpayment Event, then
the right of the holders of Series E to elect the Preferred Stock Directors shall cease (but subject always to revesting of such
voting rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series E and Voting
Preferred Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors
shall forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced
accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of the outstanding shares of the Series E and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of the outstanding shares of the Series E and all Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided
above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90
days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held
at
D-10

-- 221 of 356 --

such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per
director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any
special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until the next
annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series E are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
662⁄3% of the shares of Series E and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series E with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series E. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series E, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series E, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series E remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series E immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series E or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series E with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will
D-11

-- 222 of 356 --

not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series E. In addition, any
conversion of the Series E pursuant to Section 7 above shall not be deemed to adversely affect the rights, preferences,
privileges and voting powers of the Series E.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 8(c) would adversely affect the Series E and one or more but not all other series of Preferred Stock, then only the
Series E and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series E, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series E, the Corporation may amend, alter, supplement or repeal any terms of the Series E:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series E that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series E shall be
required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series E shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series E (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series E is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series E and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series E are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 9. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series E may deem and treat
D-12

-- 223 of 356 --

the record holder of any share of Series E as the true and lawful owner thereof for all purposes, and neither the Corporation nor
such transfer agent shall be affected by any notice to the contrary.
Section 10. 	Notices. All notices or communications in respect of Series E shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 11. 	No Preemptive Rights. No share of Series E shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 12. 	Other Rights. The shares of Series E shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
D-13

-- 224 of 356 --

Appendix E
CERTIFICATE OF DESIGNATIONS
OF
PERPETUAL NON-CUMULATIVE PREFERRED STOCK, SERIES F
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY:
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated September 16, 2005 and
September 29, 2006, the provisions of the restated certificate of incorporation and the amended and restated bylaws of the
Corporation and applicable law, by unanimous written consent dated May 14, 2007, adopted the following resolution creating
a series of 5,000.1 shares of Preferred Stock of the Corporation designated as “Perpetual Non-Cumulative Preferred Stock,
Series F”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated September 16, 2005 and September 29, 2006, the provisions of the restated
certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, a series of Preferred
Stock, par value $.01 per share, of the Corporation be and hereby is created, and that the designation and number of shares of
such series, and the voting and other powers, preferences and relative, participating, optional or other rights, and the
qualifications, limitations and restrictions thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “Perpetual
Non-Cumulative Preferred Stock, Series F” (“Series F”). Each share of Series F shall be identical in all respects to every other
share of Series F.
Section 2. 	Number of Shares. The authorized number of shares of Series F shall be 5,000.1. Shares of
Series F that are redeemed, purchased or otherwise acquired by the Corporation, or converted into another series of Preferred
Stock, shall be cancelled and shall revert to authorized but unissued shares of Series F.
Section 3. 	Definitions. As used herein with respect to Series F:
(a) 	“Board of Directors” means the board of directors of the Corporation.

-- 225 of 356 --

(b) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(c) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(d) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series F is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series F, as it may
be amended from time to time.
(f) 	“Certification 	of 	Incorporation” 	shall 	mean 	the 	restated 	certificate 	of 	incorporation 	of 	the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series F) that ranks junior to Series F either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(j) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series F) that ranks
equally with Series F both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(k) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series F.
(l) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment, is
representative of a single transaction in the relevant market at the relevant time.
E-2

-- 226 of 356 --

(m) 	“Reuters Screen LIBOR01” means the display designated on the Reuters 3000 Xtra (or such other
page as may replace that page on that service or such other service as may be nominated by the British Bankers’
Association for the purpose of displaying London interbank offered rates for U.S. Dollar deposits).
(n) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 8(b) below) or any other matter as to which the holders of Series F are entitled to vote as
specified in Section 8 of this Certificate of Designations, any and all series of Preferred Stock (other than Series F)
that rank equally with Series F either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series F shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $100,000 per share of Series F. Such dividends shall be payable
quarterly in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors), on March 1, June 1, September 1 and
December 1 of each year (each a “Dividend Payment Date”); provided that if any such Dividend Payment Date would
otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any dividend payable
on Series F on such Dividend Payment Date shall instead be payable on) the immediately succeeding Business Day. If a
Dividend Payment Date is not a Business Day, the applicable dividend shall be paid on the first Business Day following that
day. Dividends on Series F shall not be cumulative; holders of Series F shall not be entitled to receive any dividends not
declared by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) and no
interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends that are payable on Series F on any Dividend Payment Date will be payable to holders of record
of Series F as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence
E-3

-- 227 of 356 --

on and include the date of original issue of the Series F) and shall end on and include the calendar day next preceding the next
Dividend Payment Date. Dividends payable on the Series F in respect of any Dividend Period shall be computed by the
Calculation Agent on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends
payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such
Dividend Period.
The dividend rate on the Series F, for each Dividend Period, shall be (a) if the shares of Series F are issued
prior to September 1, 2012, a rate per annum equal to three-month LIBOR plus 0.77% until the Dividend Payment date in
September 2012, and (b) thereafter, a rate per annum that will reset quarterly and shall be equal to the greater of (i) three-
month LIBOR for such Dividend Period plus 0.77 % and (ii) 	4.000%. Three-month LIBOR, with respect to any Dividend
Period, means the offered rate expressed as a percentage per annum for three-month deposits in U.S. dollars on the first day of
such Dividend Period, as that rate appears on Reuters Screen LIBOR01 (or any successor or replacement page) as of 11:00
A.M., London time, on the second London Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on Reuters Screen LIBOR01(or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M. New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If fewer than three banks selected by the Calculation Agent are quoting as described in the preceding
paragraph, LIBOR for such Dividend Period shall be LIBOR in effect for the prior Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices and will be available to any
stockholder upon request and will be final and binding in the absence of manifest error.
E-4

-- 228 of 356 --

Holders of Series F shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series F as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series F remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series F have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series F and any shares of Parity Stock,
all dividends declared on the Series F and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series F and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series F shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series F shall be entitled to receive, out of the
assets of the
E-5

-- 229 of 356 --

Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation, and
after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of such assets or
proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation ranking junior to the
Series F as to such distribution, in full an amount equal to $100,000 per share (the “Series F Liquidation Amount”), together
with an amount equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such
distribution (but without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series F and
all holders of any stock of the Corporation ranking equally with the Series F as to such distribution, the amounts paid to the
holders of Series F and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series F and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series F and on which dividends
accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as
applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series F,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series F receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series F may not be redeemed by the Corporation prior to the later of
September 1, 2012 and the date of original issue of Series F. On or after that date, the Corporation, at its option, may redeem,
in whole at any time or in part from time to time, the shares of Series F at the time outstanding, upon notice given as provided
in Section 6(c) below, at a redemption price equal to $100,000 per share, together (except as otherwise provided herein) with
an amount equal to any dividends that have been declared but not paid prior to the redemption date (but with no amount in
respect
E-6

-- 230 of 356 --

of any dividends that have not been declared prior to such date). The redemption price for any shares of Series F shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above.
(b) 	No Sinking Fund. The Series F will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series F will have no right to require redemption of any shares of Series F.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series F shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series F designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series F. Notwithstanding the foregoing, if the Series F or any depositary
shares representing interests in the Series F are issued in book-entry form through The Depository Trust Company or any other
similar facility, notice of redemption may be given to the holders of Series F at such time and in any manner permitted by such
facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series F to be
redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed
from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be surrendered
for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series F at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series F shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that
E-7

-- 231 of 356 --

any certificate for any share so called for redemption has not been surrendered for cancellation, on and after the redemption
date dividends shall cease to accrue on all shares so called for redemption, all shares so called for redemption shall no longer
be deemed outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate,
except only the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds
unclaimed at the end of three years from the redemption date shall, to the extent permitted by law, be released to the
Corporation, after which time the holders of the shares so called for redemption shall look only to the Corporation for payment
of the redemption price of such shares.
Section 7. 	Conversion Upon Regulatory Changes. If both (i) and (ii) below occur:
(i) 	after the date of the issuance of the Series F, the Corporation (by election or otherwise) becomes
subject to any law, rule, regulation or guidance (together, “Regulations”) relating to its capital adequacy, which
Regulation (x) modifies the existing requirements for treatment as Allowable Capital (as defined under the Securities
and Exchange Commission rules relating to consolidated supervised entities as in effect from time to time), (y)
provides for a type or level of capital characterized as “Tier 1” or its equivalent pursuant to Regulations of any
governmental agency, authority or other body having regulatory jurisdiction over the Corporation (or any of its
subsidiaries or consolidated affiliates) and implementing the capital standards published by the Basel Committee on
Banking Supervision, the Securities and Exchange Commission, the Board of Governors of the Federal Reserve
System or any other United States national governmental agency, authority or other body, or any other applicable
regime based on capital standards published by the Basel Committee on Banking Supervision or its successor, or
(z) provides for a type or level of capital that in the judgment of the Corporation (after consultation with legal
counsel of recognized standing) is substantially equivalent to such “Tier 1” capital (such capital described in either
(y) or (z) above is referred to below as “Tier 1 Capital Equivalent”), and
(ii) 	the Corporation affirmatively elects to qualify the Series F for treatment as Allowable Capital or Tier
1 Capital Equivalent without any sublimit or other quantitative restriction on the inclusion of the Series F in
Allowable Capital or Tier 1 Capital Equivalent (other than any limitation the Corporation elects to accept and any
limitation requiring that common equity or a specified form of common equity constitute the dominant form of
Allowable Capital or Tier 1 Capital Equivalent) under such Regulations,
then, upon such affirmative election, the Series F shall be convertible at the Corporation’s option into a new series of Preferred
Stock having terms and provisions substantially identical to those of the Series F, except that such new series may have such
additional or modified rights, preferences, privileges and voting powers, and limitations and restrictions thereof, as are
necessary in the judgment of the Board of Directors or the Committee (or another duly authorized committee of the Board of
Directors) (after consultation with legal
E-8

-- 232 of 356 --

counsel of recognized standing) to comply with the Required Unrestricted Capital Provisions (as defined below), provided that
the Corporation will not cause any such conversion unless the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors) determines that the rights, preferences, privileges and voting powers, and the
qualifications, limitations and restrictions thereof, of such new series of Preferred Stock, taken as a whole, are not materially
less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and the qualifications,
limitations and restrictions thereof, of the Series F, taken as a whole.
As used above, the term “Required Unrestricted Capital Provisions” means such terms and provisions as
are, in the judgment of the Corporation (after consultation with counsel of recognized standing), required for preferred stock to
be treated as Allowable Capital or Tier 1 Capital Equivalent, as applicable, without any sublimit or other quantitative
restriction on the inclusion of such preferred stock in Allowable Capital or Tier 1 Capital Equivalent, as applicable (other than
any limitation the Corporation elects to accept and any limitation requiring that common equity or a specified form of common
equity constitute the dominant form of Allowable Capital or Tier 1 Capital Equivalent) pursuant to the applicable Regulations.
The Corporation shall provide notice to the holders of Series F of any election to qualify the Series F for
Allowable Capital or Tier 1 Capital Equivalent treatment and of any determination to convert the Series F into a new series of
Preferred Stock pursuant to the terms of this Section 7, promptly upon the effectiveness of any such election or determination.
A copy of such notice and of the relevant Regulations shall be maintained on file at the principal offices of the Corporation
and, upon request, will be made available to any stockholder of the Corporation. Any conversion of the Series F pursuant to
this Section 7 shall be effected pursuant to such procedures as the Corporation may determine and publicly disclose.
Except as specified in this Section 7, holders of Series F shares shall have no right to exchange or convert
such shares into any other securities.
Section 8. 	Voting Rights.
(a) 	General. The holders of Series F shall not have any voting rights except as set forth below or as
otherwise from to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series F shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series F, together with the holders of any outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that it shall be
a qualification for election for any such Preferred Stock Director that the election of such director shall not cause the
Corporation to violate the corporate governance requirement of the New York Stock Exchange (or any other securities
exchange or other trading facility on
E-9

-- 233 of 356 --

which securities of the Corporation may then be listed or traded) that listed or traded companies must have a majority of
independent directors and provided further that the Board of Directors shall at no time include more than two Preferred Stock
Directors (including, for purposes of this limitation, all directors that the holders of any series of Voting Preferred Stock are
entitled to elect pursuant to like voting rights).
In the event that the holders of the Series F, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series F or of any other series of Voting Preferred Stock then outstanding (unless such request for a special meeting
is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the Corporation,
in which event such election shall be held only at such next annual or special meeting of stockholders), and at each subsequent
annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial election of the
Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite holders of Series
F or Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 10
below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on the Series
F for at least four Dividend Periods (whether or not consecutive) after a Nonpayment Event, then the right of the holders of
Series F to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in the case of
any future Nonpayment Event), and, if and when any rights of holders of Series F and Voting Preferred Stock to elect the
Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith terminate
and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a majority of
the outstanding shares of the Series F and Voting Preferred Stock, when they have the voting rights described above (voting
together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a Preferred Stock
Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be filled by the
written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the holders of
record of a majority of the outstanding shares of the Series F and all Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy in the office
of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided above for an
initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90 days before
the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held at such next
annual or special meeting of stockholders). The Preferred Stock Directors shall
E-10

-- 234 of 356 --

each be entitled to one vote per director on any matter that shall come before the Board of Directors for a vote. Each Preferred
Stock Director elected at any special meeting of stockholders or by written consent of the other Preferred Stock Director shall
hold office until the next annual meeting of the stockholders if such office shall not have previously terminated as above
provided.
(c) 	Other Voting Rights. So long as any shares of Series F are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
66 2⁄3% of the shares of Series F and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series F with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series F. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series F, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series F, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series F remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series F immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 8(c), any increase in the amount of the authorized or issued Series F or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series F with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will
E-11

-- 235 of 356 --

not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series F. In addition, any
conversion of the Series F pursuant to Section 7 above shall not be deemed to adversely affect the rights, preferences,
privileges and voting powers of the Series F.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 8(c) would adversely affect the Series F and one or more but not all other series of Preferred Stock, then only the
Series F and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series F, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series F, the Corporation may amend, alter, supplement or repeal any terms of the Series F:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series F that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series F shall be
required pursuant to Section 8(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series F shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series F (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series F is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series F and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series F are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
E-12

-- 236 of 356 --

Section 9. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series F may deem and treat the record holder of any share of Series F as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 10. 	Notices. All notices or communications in respect of Series F shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 11. 	No Preemptive Rights. No share of Series F shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 12. 	Other Rights. The shares of Series F shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
E-13

-- 237 of 356 --

Appendix F
CERTIFICATE OF DESIGNATIONS
OF
5.50% FIXED-TO-FLOATING RATE NON-CUMULATIVE
PREFERRED STOCK, SERIES J
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, at a
meeting duly called and held on April 22, 2013, adopted the following resolution creating a series of 46,000 shares of
Preferred Stock of the Corporation designated as “5.50% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “5.50%
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J” (“Series J”). Each share of Series J shall be identical in all
respects to every other share of Series J, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series J shall be 46,000. Shares of
Series J that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to authorized
but unissued shares of Series J.

-- 238 of 356 --

Section 3. 	Definitions. As used herein with respect to Series J:
(a) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(b) 	“Board of Directors” means the board of directors of the Corporation.
(c) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(d) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(e) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series J is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(f) 	“Certificate of Designations” means this Certificate of Designations relating to the Series J, as it may
be amended from time to time.
(g) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(h) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(i) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series J) that ranks junior to Series J either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(j) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and
is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series J) that ranks
equally with Series J both in the payment of
F-2

-- 239 of 356 --

dividends and in the distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series J.
(m) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of the
Series J (ii) any proposed change in those laws or regulations that is announced or becomes effective after the initial
issuance of any share of Series J, or (iii) any official administrative decision or judicial decision or administrative
action or other official pronouncement interpreting or applying those laws or regulations that is announced after the
initial issuance of any share of Series J, there is more than an insubstantial risk that the Corporation will not be
entitled to treat the full liquidation preference amount of $25,000 per share of Series J then outstanding as “tier 1
capital” (or its equivalent) for purposes of the capital adequacy guidelines of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate
Federal Banking Agency) as then in effect and applicable, for so long as any share of Series J is outstanding.
(n) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(o) 	“Reuters screen” means the display on the Reuters 3000 Xtra service, or any successor or
replacement service.
(p) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series J are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series J)
that rank equally with Series J either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series J shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate determined as set forth below in this
Section (4) applied to the liquidation preference amount of $25,000 per share of Series J. Such dividends shall be payable
quarterly in arrears (as provided below in
F-3

-- 240 of 356 --

this Section 4(a)), but only when, as and if declared by the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors), on February 10, May 10, August 10 and November 10 (“Dividend Payment Dates”),
commencing on August 10, 2013; provided that if any such Dividend Payment Date would otherwise occur on a day that is not
a Business Day, such Dividend Payment Date shall instead be (and any dividend payable on Series J on such Dividend
Payment Date shall instead be payable on) the immediately succeeding Business Day unless, after May 10, 2023, such
immediately succeeding Business Day falls in the next calendar month, in which case such Dividend Payment Date shall
instead be (and any such Dividend shall instead be payable on) the immediately preceding Business Day. Dividends on Series J
shall not be cumulative; holders of Series J shall not be entitled to receive any dividends not declared by the Board of Directors
or the Committee (or another duly authorized committee of the Board of Directors) and no interest, or sum of money in lieu of
interest, shall be payable in respect of any dividend not so declared.
Dividends on the Series J shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy guidelines of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series J on any Dividend Payment Date will be payable to holders of record
of Series J as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series J,
provided that, for any share of Series J issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series J in respect of any Dividend Period beginning prior to
May 10, 2023 shall be calculated on the basis of a 360-day year consisting of twelve 30-day months, and dividends payable on
the Series J in respect of any Dividend Period beginning on or after May 10, 2023 shall be calculated by the Calculation Agent
on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends payable in respect of
a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such Dividend Period.
F-4

-- 241 of 356 --

The dividend rate on the Series J, for each Dividend Period beginning prior to May 10, 2023, shall be a
rate per annum equal to 5.50%, and the dividend rate on the Series J, for each Dividend Period beginning on or after May 10,
2023, shall be a rate per annum equal to LIBOR (as defined below) for such Dividend Period plus 3.64%. LIBOR, with respect
to any Dividend Period beginning on or after May 10, 2023, means the offered rate expressed as a percentage per annum for
three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on Reuters screen LIBOR01
(or any successor or replacement page) as of approximately 11:00 A.M., London time, on the second London Business Day
immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on the Reuters screen LIBOR01 (or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M., New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If no quotation is provided as described in the preceding paragraph, then the Calculation Agent, after
consulting such sources as it deems comparable to any of the foregoing quotations or display page, or any such source as it
deems reasonable from which to estimate LIBOR or any of the foregoing lending rates, shall determine LIBOR for such
Dividend Period in its sole discretion.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series J shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series J as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
F-5

-- 242 of 356 --

(b) 	Priority of Dividends. So long as any share of Series J remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series J have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series J and any shares of Parity Stock, all
dividends declared on the Series J and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts of
such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series J and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series J shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series J shall be entitled to receive, out of the assets
of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the Corporation,
and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of such assets or
proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation ranking junior to the
Series J as to such distribution, in full an amount equal to $25,000 per
F-6

-- 243 of 356 --

share (the “Series J Liquidation Amount”), together with an amount equal to all dividends (if any) that have been declared but
not paid prior to the date of payment of such distribution (but without any amount in respect of dividends that have not been
declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series J and
all holders of any stock of the Corporation ranking equally with the Series J as to such distribution, the amounts paid to the
holders of Series J and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series J and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series J and on which dividends
accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as
applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series J,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series J receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series J is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series J at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after May 10, 2023, or (ii) in whole but not in part at any time within 90
days following a Regulatory Capital Treatment Event, in each case, at a redemption price equal to $25,000 per share, together
(except as otherwise provided hereinbelow) with an amount equal to any dividends that have accrued but not been paid for the
then-current Dividend Period to but excluding the redemption date, whether or not such dividends have been declared. The
redemption price for any shares of Series J shall be payable on the redemption date to the holder of such shares against
surrender of the certificate(s) evidencing such shares to the Corporation or its agent. Any declared but unpaid dividends
payable on a redemption date that occurs subsequent to the Dividend
F-7

-- 244 of 356 --

Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption
date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the
Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series J without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital guidelines applicable to the Corporation.
(b) 	No Sinking Fund. The Series J will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series J will have no right to require redemption of any shares of Series J.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series J shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series J designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series J. Notwithstanding the foregoing, if the Series J or any depositary
shares representing interests in the Series J are issued in book-entry form through The Depository Trust Company or any other
similar facility, notice of redemption may be given to the holders of Series J at such time and in any manner permitted by such
facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series J to be
redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed
from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be surrendered
for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series J at the time
outstanding, the shares to be redeemed shall be selected either pro rata or in such other manner as the Corporation may
determine to be fair and equitable. Subject to the provisions hereof, the Corporation shall have full power and authority to
prescribe the terms and conditions upon which shares of Series J shall be redeemed from time to time. If fewer than all the
shares represented by any certificate are redeemed, a new certificate shall be issued representing the unredeemed shares
without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for
F-8

-- 245 of 356 --

cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for redemption, all shares
so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares shall forthwith on
such redemption date cease and terminate, except only the right of the holders thereof to receive the amount payable on such
redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to the extent
permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption shall look
only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series J shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series J shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series J, together with the holders of any outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that the
Board of Directors shall at no time include more than two Preferred Stock Directors (including, for purposes of this limitation,
all directors that the holders of any series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series J, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series J or of any other series of Voting Preferred Stock then outstanding (unless such request for a special meeting
is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the Corporation,
in which event such election shall be held only at such next annual or special meeting of stockholders), and at each subsequent
annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial election of the
Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite holders of Series J
or Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in Section 9
below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series J for four consecutive Dividend Periods after a Nonpayment Event, then the right of the holders of Series J to elect
the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in the case of any future
Nonpayment Event), and, if and when any rights of holders of Series J and Voting Preferred Stock to elect the Preferred Stock
Directors shall have ceased, the terms
F-9

-- 246 of 356 --

of office of all the Preferred Stock Directors shall forthwith terminate and the number of directors constituting the Board of
Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of the outstanding shares of the Series J and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of the outstanding shares of the Series J and all Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided
above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90
days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held
at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per
director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any
special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until the next
annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series J are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
662⁄3% of the shares of Series J and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series J with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series J. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series J, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or
F-10

-- 247 of 356 --

reclassification involving the Series J, or of a merger or consolidation of the Corporation with another corporation or
other entity, unless in each case (x) the shares of Series J remain outstanding or, in the case of any such merger or
consolidation with respect to which the Corporation is not the surviving or resulting entity, are converted into or
exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares
remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and
voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the
holders thereof than the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of
the Series J immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series J or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series J with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series J.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series J and one or more but not all other series of Preferred Stock, then only the
Series J and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series J, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series J, the Corporation may amend, alter, supplement or repeal any terms of the Series J:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series J that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series J shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series J shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
F-11

-- 248 of 356 --

(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series J (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the Bylaws, applicable law and any national securities
exchange or other trading facility on which the Series J is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series J and any Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series J are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series J may deem and treat the record holder of any share of Series J as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series J shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or Bylaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series J shall have any rights of preemption whatsoever
as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of
how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series J shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
F-12

-- 249 of 356 --

Appendix G
CERTIFICATE OF DESIGNATIONS
OF
6.375% FIXED-TO-FLOATING RATE NON-CUMULATIVE
PREFERRED STOCK, SERIES K
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, at a
meeting duly called and held on April 24, 2014, adopted the following resolution creating a series of 32,200 shares of
Preferred Stock of the Corporation designated as “6.375% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “6.375%
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K” (“Series K”). Each share of Series K shall be identical in
all respects to every other share of Series K, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series K shall be 32,200. Shares of
Series K that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series K.

-- 250 of 356 --

Section 3. 	Definitions. As used herein with respect to Series K:
(a) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with
respect to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any
successor provision.
(b) 	“Board of Directors” means the board of directors of the Corporation.
(c) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended
from time to time.
(d) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not
a day on which banking institutions in New York City generally are authorized or obligated by law, regulation or
executive order to close.
(e) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series K is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(f) 	“Certificate of Designations” means this Certificate of Designations relating to the Series K, as it
may be amended from time to time.
(g) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(h) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(i) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series K) that ranks junior to Series K either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(j) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday
and is a day on which dealings in U.S. dollars are transacted in the London interbank market.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series K) that ranks
equally with Series K both in the payment of
G-2

-- 251 of 356 --

dividends and in the distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series K.
(m) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series K, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series K, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series K, there is more than
an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of
$25,000 per share of Series K then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital
adequacy guidelines of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital
adequacy guidelines or regulations of any successor Appropriate Federal Banking Agency) as then in effect and
applicable, for so long as any share of Series K is outstanding.
(n) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(o) 	“Reuters screen” means the display on the Reuters 3000 Xtra service, or any successor or
replacement service.
(p) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock
Director (as defined in Section 7(b) below) or any other matter as to which the holders of Series K are entitled to
vote as specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than
Series K) that rank equally with Series K either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series K shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series K at the rate
determined as set forth below in this Section (4) applied to the liquidation
G-3

-- 252 of 356 --

preference amount of $25,000 per share of Series K. Such dividends shall be payable quarterly in arrears (as provided below in
this Section 4(a)), but only when, as and if declared by the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors), on February 10, May 10, August 10 and November 10 (“Dividend Payment Dates”),
commencing on August 10, 2014; provided that if any such Dividend Payment Date would otherwise occur on a day that is not
a Business Day, such Dividend Payment Date shall instead be (and any dividend payable on Series K on such Dividend
Payment Date shall instead be payable on) the immediately succeeding Business Day unless, after May 10, 2024, such
immediately succeeding Business Day falls in the next calendar month, in which case such Dividend Payment Date shall
instead be (and any such Dividend shall instead be payable on) the immediately preceding Business Day. Dividends on
Series K shall not be cumulative; holders of Series K shall not be entitled to receive any dividends not declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) and no interest, or sum of money
in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends on the Series K shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy guidelines of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series K on any Dividend Payment Date will be payable to holders of
record of Series K as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series K,
provided that, for any share of Series K issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series K in respect of any Dividend Period beginning prior to
May 10, 2024 shall be calculated on the basis of a 360-day year consisting of twelve 30-day months, and dividends payable on
the Series K in respect of any Dividend Period beginning on or after May 10, 2024 shall be calculated by the Calculation
Agent on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends payable in
respect of a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such Dividend Period.
G-4

-- 253 of 356 --

The dividend rate on the Series K, for each Dividend Period beginning prior to May 10, 2024, shall be a
rate per annum equal to 6.375%, and the dividend rate on the Series K, for each Dividend Period beginning on or after May 10,
2024, shall be a rate per annum equal to LIBOR (as defined below) for such Dividend Period plus 3.55%. LIBOR, with respect
to any Dividend Period beginning on or after May 10, 2024, means the offered rate expressed as a percentage per annum for
three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on Reuters screen LIBOR01
(or any successor or replacement page) as of approximately 11:00 A.M., London time, on the second London Business Day
immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on the Reuters screen LIBOR01 (or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M., New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by three major banks in New York City selected by the Calculation Agent: three-month loans of U.S.
dollars, beginning on the first day of such Dividend Period, and in a Representative Amount.
If no quotation is provided as described in the preceding paragraph, then the Calculation Agent, after
consulting such sources as it deems comparable to any of the foregoing quotations or display page, or any such source as it
deems reasonable from which to estimate LIBOR or any of the foregoing lending rates, shall determine LIBOR for such
Dividend Period in its sole discretion.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series K shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series K as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
G-5

-- 254 of 356 --

(b) 	Priority of Dividends. So long as any share of Series K remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series K have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series K and any shares of Parity Stock,
all dividends declared on the Series K and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series K and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series K shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series K shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series K as to such distribution, in full an amount equal to $25,000 per
G-6

-- 255 of 356 --

share, together with an amount equal to all dividends (if any) that have been declared but not paid prior to the date of payment
of such distribution (but without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series K
and all holders of any stock of the Corporation ranking equally with the Series K as to such distribution, the amounts paid to
the holders of Series K and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series K and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series K and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series K,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series K receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series K is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series K at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after May 10, 2024 (or, if not a Business Day, the next succeeding
Business Day), or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event, in
each case, at a redemption price per share equal to $25,000, plus (except as otherwise provided hereinbelow) an amount equal
to any dividends per share that have accrued but not been paid for the then-current Dividend Period to but excluding the
redemption date, whether or not such dividends have been declared. The redemption price for any shares of Series K shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a
G-7

-- 256 of 356 --

Dividend Period shall not be paid to the holder entitled to receive the redemption price on the redemption date, but rather shall
be paid to the holder of record of the redeemed shares on such Dividend Record Date relating to the Dividend Payment Date as
provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem shares of Series K without
having received the prior approval of the Appropriate Federal Banking Agency if then required under capital guidelines
applicable to the Corporation.
(b) 	No Sinking Fund. The Series K will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series K will have no right to require redemption of any shares of Series K.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series K shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series K designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series K. Notwithstanding the foregoing, if the Series K or any
depositary shares representing interests in the Series K are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series K at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series K to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where certificates for such shares are to be
surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series K at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series K shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed
G-8

-- 257 of 356 --

outstanding and all rights with respect to such shares shall forthwith on such redemption date cease and terminate, except only
the right of the holders thereof to receive the amount payable on such redemption, without interest. Any funds unclaimed at the
end of three years from the redemption date shall, to the extent permitted by law, be released to the Corporation, after which
time the holders of the shares so called for redemption shall look only to the Corporation for payment of the redemption price
of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series K shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series K shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series K, together with the holders of all outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that the
Board of Directors shall at no time include more than two Preferred Stock Directors (including, for purposes of this limitation,
all directors that the holders of any series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series K, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series K or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series K or any series of Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner
as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series K for four consecutive Dividend Periods after a Nonpayment Event, then the right of the holders of Series K to elect
the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in the case of any future
Nonpayment Event), and, if and when any rights of holders of Series K and Voting Preferred Stock to elect the Preferred Stock
Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith terminate and the number of
directors constituting the Board of Directors shall automatically be reduced accordingly.
G-9

-- 258 of 356 --

Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series K and Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of
a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may
be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of
the holders of record of a majority of all of the outstanding shares of the Series K and Voting Preferred Stock, when they have
the voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a
vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as
provided above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received
less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election
shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to
one vote per director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director
elected at any special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until
the next annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series K are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series K and any Voting Preferred Stock at the time outstanding and entitled to vote thereon,
voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting
called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series K with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series K. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series K, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series K, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series K remain outstanding or, in the
case of any such merger or
G-10

-- 259 of 356 --

consolidation with respect to which the Corporation is not the surviving or resulting entity, are converted into or
exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares
remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and
voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the
holders thereof than the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of
the Series K immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series K or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series K with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series K.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series K and one or more but not all other series of Preferred Stock, then only the
Series K and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series K, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series K, the Corporation may amend, alter, supplement or repeal any terms of the Series K:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series K that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series K shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series K shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series K (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of
G-11

-- 260 of 356 --

proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or
such consents shall be governed by any rules the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures shall conform to the
requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities exchange or other
trading facility on which the Series K is listed or traded at the time. Whether the vote or consent of the holders of a plurality,
majority or other portion of the shares of Series K and all Voting Preferred Stock has been cast or given on any matter on
which the holders of shares of Series K are entitled to vote shall be determined by the Corporation by reference to the specified
liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series K may deem and treat the record holder of any share of Series K as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series K shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series K shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series K shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
G-12

-- 261 of 356 --

Appendix H
CERTIFICATE OF DESIGNATIONS
OF
5.375% FIXED-TO-FLOATING RATE NON-CUMULATIVE
PREFERRED STOCK, SERIES M
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, at a
meeting duly called and held on April 17, 2015, adopted the following resolution creating a series of 80,000 shares of
Preferred Stock of the Corporation designated as “5.375% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “5.375%
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series M” (“Series M”). Each share of Series M shall be identical in
all respects to every other share of Series M, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series M shall be 80,000. Shares of
Series M that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series M.

-- 262 of 356 --

Section 3. 	Definitions. As used herein with respect to Series M:
(a) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(b) 	“Board of Directors” means the board of directors of the Corporation.
(c) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(d) 	“Business Day” means (i) from the original issue date to and including May 10, 2020 (or, if such day
is not a Monday, Tuesday, Wednesday, Thursday or Friday or is a day on which banking institutions in New York
City are generally authorized or obligated by law or executive order to close, the next day that is a Monday,
Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City are
generally authorized or obligated by law or executive order to close), a day that is a Monday, Tuesday, Wednesday,
Thursday or Friday and is not a day on which banking institutions in New York City are generally authorized or
obligated by law or executive order to close, and (ii) thereafter, a day that is a Monday, Tuesday, Wednesday,
Thursday or Friday and is not a day on which banking institutions in New York City are generally authorized or
obligated by law or executive order to close and is a London Business Day.
(e) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series M is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(f) 	“Certificate of Designations” means this Certificate of Designations relating to the Series M, as it
may be amended from time to time.
(g) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(h) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(i) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series M) that ranks junior to Series
H-2

-- 263 of 356 --

M either or both as to the payment of dividends and/or as to the distribution of assets on any liquidation, dissolution
or winding up of the Corporation.
(j) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday that
is not a day on which banking institutions in London generally are authorized or obligated by law, regulation or
executive order to close and is a day on which dealings in U.S. dollars are transacted in the London interbank
market.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series M) that ranks
equally with Series M both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series M.
(m) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series M, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after
the initial issuance of any share of Series M, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series M, there is more than
an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of
$25,000 per share of Series M then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital
adequacy guidelines of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital
adequacy guidelines or regulations of any successor Appropriate Federal Banking Agency) as then in effect and
applicable, for so long as any share of Series M is outstanding.
(n) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(o) 	“Reuters screen” means the display on the Reuters 3000 Xtra service, or any successor or
replacement service.
(p) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series M are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series M)
that rank equally with Series M either as to the payment of
H-3

-- 264 of 356 --

dividends or as to the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon
which like voting rights have been conferred and are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series M shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series M at the rate
determined as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series M.
Such dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the
Board of Directors or the Committee (or another duly authorized committee of the Board of Directors), on the 10th day of May
and November of each year, commencing on November 10, 2015 and ending on May 10, 2020, and on the 10th day of
February, May, August and November of each year following May 10, 2020 (“Dividend Payment Dates”); provided that if any
such Dividend Payment Date that occurs on or before May 10, 2020 is a day that is not a Business Day, such dividend shall
instead be payable on the immediately succeeding Business Day without interest or other payment in respect of such delayed
payment, and provided further, if any such Dividend Payment Date that would otherwise occur for any Dividend Period after
the Dividend Period ending on but excluding May 10, 2020 is a day that is not a Business Day, such Dividend Payment Date
shall instead be (and any such dividend shall accrue to and instead be payable on) the immediately succeeding Business Day
unless such immediately succeeding Business Day falls in the next calendar month, in which case such Dividend Payment
Date shall instead be (and any such dividend shall accrue to and instead be payable on) the immediately preceding Business
Day. Dividends on Series M shall not be cumulative; holders of Series M shall not be entitled to receive any dividends not
declared by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) and no
interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so declared.
Dividends on the Series M shall not be declared or set aside for payment if and to the extent such
dividends would cause the Corporation to fail to comply with the capital adequacy guidelines of the Board of Governors of the
Federal Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate
Federal Banking Agency) applicable to the Corporation.
Dividends that are payable on Series M on any Dividend Payment Date will be payable to holders of
record of Series M as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
H-4

-- 265 of 356 --

Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series M,
provided that, for any share of Series M issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series M in respect of any Dividend Period beginning prior to
May 10, 2020 shall be calculated on the basis of a 360-day year consisting of twelve 30-day months, and dividends payable on
the Series M in respect of any Dividend Period beginning on or after May 10, 2020 shall be calculated by the Calculation
Agent on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends payable in
respect of a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such Dividend Period.
The dividend rate on the Series M, for each Dividend Period beginning prior to May 10, 2020, shall be a
rate per annum equal to 5.375%, and the dividend rate on the Series M, for each Dividend Period beginning on or after
May 10, 2020, shall be a rate per annum equal to LIBOR (as defined below) for such Dividend Period plus 3.922%. LIBOR,
with respect to any Dividend Period beginning on or after May 10, 2020, means the offered rate expressed as a percentage per
annum for three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on Reuters screen
LIBOR01 (or any successor or replacement page) as of approximately 11:00 A.M., London time, on the second London
Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on the Reuters screen LIBOR01 (or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M., New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by major banks in New York City selected by the Calculation Agent: three-month loans of U.S. dollars,
beginning on the first day of such Dividend Period, and in a Representative Amount.
H-5

-- 266 of 356 --

If no quotation is provided as described in the preceding paragraph, then the Calculation Agent, after
consulting such sources as it deems comparable to any of the foregoing quotations or display page, or any such source as it
deems reasonable from which to estimate LIBOR or any of the foregoing lending rates, shall determine LIBOR for such
Dividend Period in its sole discretion.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series M shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series M as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series M remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series M have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series M and any shares of Parity Stock,
all dividends declared on the Series M and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
parity stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series M and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
H-6

-- 267 of 356 --

Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series M shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series M shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series M as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series M
and all holders of any stock of the Corporation ranking equally with the Series M as to such distribution, the amounts paid to
the holders of Series M and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series M and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series M and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series M,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series M receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of
H-7

-- 268 of 356 --

the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series M is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series M at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after May 10, 2020 (or, if not a Business Day, the next succeeding
Business Day), or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event, in
each case, at a redemption price per share equal to $25,000, plus (except as otherwise provided hereinbelow) an amount equal
to any dividends per share that have accrued but not been paid for the then-current Dividend Period to but excluding the
redemption date, whether or not such dividends have been declared. The redemption price for any shares of Series M shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series M without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital guidelines applicable to the Corporation.
(b) 	No Sinking Fund. The Series M will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series M will have no right to require redemption of any shares of Series M.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series M shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series M designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series M. Notwithstanding the foregoing, if the Series M or any
depositary shares representing interests in the Series M are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series M at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series M to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to
be redeemed from such holder; (3) the redemption price; and (4)
H-8

-- 269 of 356 --

the place or places where certificates for such shares are to be surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series M at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series M shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series M shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series M shall not have been declared and paid for any Dividend Periods that, in aggregate, equal at least 18 months,
whether or not consecutive (a “Nonpayment Event”), the number of directors then constituting the Board of Directors shall
automatically be increased by two and the holders of Series M, together with the holders of all outstanding shares of Voting
Preferred Stock, voting together as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock
Directors”), provided that the Board of Directors shall at no time include more than two Preferred Stock Directors (including,
for purposes of this limitation, all directors that the holders of any series of Voting Preferred Stock are entitled to elect
pursuant to like voting rights).
In the event that the holders of the Series M, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the
H-9

-- 270 of 356 --

holders of record of at least 20% of the Series M or of any other series of Voting Preferred Stock then outstanding (unless such
request for a special meeting is received less than 90 days before the date fixed for the next annual or special meeting of the
stockholders of the Corporation, in which event such election shall be held only at such next annual or special meeting of
stockholders), and at each subsequent annual meeting of stockholders of the Corporation. Such request to call a special
meeting for the initial election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice,
signed by the requisite holders of Series M or any series of Voting Preferred Stock, and delivered to the Secretary of the
Corporation in such manner as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series M for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series M to elect the Preferred Stock Directors shall cease (but subject always to revesting of such
voting rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series M and Voting
Preferred Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors
shall forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced
accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series M and Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of
a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may
be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of
the holders of record of a majority of all of the outstanding shares of the Series M and Voting Preferred Stock, when they have
the voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a
vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as
provided above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received
less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election
shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to
one vote per director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director
elected at any special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until
the next annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series M are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series M and any Voting Preferred Stock at the time outstanding and entitled to
H-10

-- 271 of 356 --

vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at
any meeting called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series M with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series M. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series M, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series M, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series M remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series M immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series M or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series M with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series M.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series M and one or more but not all other series of Preferred Stock, then only the
Series M and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
H-11

-- 272 of 356 --

(d) 	Changes for Clarification. Without the consent of the holders of the Series M, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series M, the Corporation may amend, alter, supplement or repeal any terms of the Series M:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series M that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series M shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series M shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series M (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series M is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series M and all Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series M are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series M may deem and treat the record holder of any share of Series M as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series M shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
H-12

-- 273 of 356 --

Section 10. 	No Preemptive Rights. No share of Series M shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series M shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
H-13

-- 274 of 356 --

Appendix I
CERTIFICATE OF DESIGNATIONS
OF
6.30% NON-CUMULATIVE PREFERRED STOCK, SERIES N
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, at a
meeting duly called and held on February 18, 2016, adopted the following resolution creating a series of 31,050 shares of
Preferred Stock of the Corporation designated as “6.30% Non-Cumulative Preferred Stock, Series N”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “6.30%
Non-Cumulative Preferred Stock, Series N” (“Series N”). Each share of Series N shall be identical in all respects to every other
share of Series N, except as to the respective dates from which dividends thereon shall accrue, to the extent such dates may
differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series N shall be 31,050. Shares of
Series N that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series N.

-- 275 of 356 --

Section 3. 	Definitions. As used herein with respect to Series N:
(a) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(b) 	“Board of Directors” means the board of directors of the Corporation.
(c) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(d) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City are generally authorized or obligated by law, regulation or
executive order to close.
(e) 	“Certificate of Designations” means this Certificate of Designations relating to the Series N, as it
may be amended from time to time.
(f) 	“Certification 	of 	Incorporation” 	shall 	mean 	the 	restated 	certificate 	of 	incorporation 	of 	the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(g) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(h) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series N) that ranks junior to Series N either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(i) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series N) that ranks
equally with Series N both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(j) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series N.
(k) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series N, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series N, or (iii) any official administrative decision or judicial
I-2

-- 276 of 356 --

decision or administrative action or other official pronouncement interpreting or applying those laws, rules or
regulations or policies with respect thereto that is announced after the initial issuance of any share of Series N, there
is more than an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference
amount of $25,000 per share of Series N then outstanding as “tier 1 capital” (or its equivalent) for purposes of the
capital adequacy guidelines of the Board of Governors of the Federal Reserve System (or, as and if applicable, the
capital adequacy guidelines or regulations of any successor Appropriate Federal Banking Agency) as then in effect
and applicable, for so long as any share of Series N is outstanding.
(l) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series N are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series N)
that rank equally with Series N either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series N shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends at the rate per annum equal to 6.30% applied to
the liquidation preference amount of $25,000 per share of Series N. Such dividends shall be payable quarterly in arrears (as
provided below in this Section 4(a)), but only when, as and if declared by the Board of Directors or the Committee (or another
duly authorized committee of the Board of Directors), on February 10, May 10, August 10 and November 10 (“Dividend
Payment Dates”), commencing on May 10, 2016; provided that if any such Dividend Payment Date would otherwise occur on
a day that is not a Business Day, such dividend shall instead be payable on the immediately succeeding Business Day, without
interest or other payment in respect of such delayed payment. Dividends on Series N shall not be cumulative; holders of Series
N shall not be entitled to receive any dividends not declared by the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors) and no interest, or sum of money in lieu of interest, shall be payable in respect
of any dividend not so declared.
Dividends on the Series N shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy guidelines of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
I-3

-- 277 of 356 --

Dividends that are payable on Series N on any Dividend Payment Date will be payable to holders of
record of Series N as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series N,
provided that, for any share of Series N issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series N in respect of any Dividend Period shall be calculated on
the basis of a 360-day year consisting of twelve 30-day months. Dividends payable in respect of a Dividend Period shall be
payable in arrears – i.e., on the first Dividend Payment Date after such Dividend Period.
Holders of Series N shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series N as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series N remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series N have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series N and any shares of Parity Stock,
all dividends declared on the Series N and all such Parity Stock and payable
I-4

-- 278 of 356 --

on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend
Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend Payment Date) shall
be declared pro rata so that the respective amounts of such dividends shall bear the same ratio to each other as all accrued but
unpaid dividends per share on the Series N and all Parity Stock payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series N shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series N shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series N as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series N
and all holders of any stock of the Corporation ranking equally with the Series N as to such distribution, the amounts paid to
the holders of Series N and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series N and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series N and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series N,
the holders of other stock of the Corporation shall be
I-5

-- 279 of 356 --

entitled to receive all remaining assets of the Corporation (or proceeds thereof) according to their respective rights and
preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series N receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series N is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series N at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after May 10, 2021 (or, if not a Business Day, the next succeeding
Business Day), or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event, in
each case, at a redemption price per share equal to $25,000, plus (except as otherwise provided herein below) an amount equal
to any dividends per share that have accrued but not been paid for the then-current Dividend Period to but excluding the
redemption date, whether or not such dividends have been declared. The redemption price for any shares of Series N shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series N without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital guidelines applicable to the Corporation.
(b) 	No Sinking Fund. The Series N will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series N will have no right to require redemption of any shares of Series N.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series N shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series N designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series N.
I-6

-- 280 of 356 --

Notwithstanding the foregoing, if the Series N or any depositary shares representing interests in the Series N are issued in
book-entry form through The Depository Trust Company or any other similar facility, notice of redemption may be given to
the holders of Series N at such time and in any manner permitted by such facility. Each such notice given to a holder shall
state: (1) the redemption date; (2) the number of shares of Series N to be redeemed and, if less than all the shares held by such
holder are to be redeemed, the number of such shares to be redeemed from such holder; (3) the redemption price; and (4) the
place or places where certificates for such shares are to be surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series N at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series N shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series N shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series N shall not have been declared and paid for at least six Dividend Periods, whether or not consecutive (a
“Nonpayment Event”), the number of directors then constituting the Board of Directors shall automatically be increased by
two and the holders of Series N, together with the holders of all outstanding shares of Voting Preferred Stock, voting together
as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that the
Board of Directors shall at no time include more than two Preferred Stock Directors (including, for
I-7

-- 281 of 356 --

purposes of this limitation, all directors that the holders of any series of Voting Preferred Stock are entitled to elect pursuant to
like voting rights).
In the event that the holders of the Series N, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series N or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series N or any series of Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner
as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series N for four consecutive Dividend Periods after a Nonpayment Event, then the right of the holders of Series N to elect
the Preferred Stock Directors shall cease (but subject always to revesting of such voting rights in the case of any future
Nonpayment Event), and, if and when any rights of holders of Series N and Voting Preferred Stock to elect the Preferred Stock
Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall forthwith terminate and the number of
directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series N and Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of
a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may
be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of
the holders of record of a majority of all of the outstanding shares of the Series N and Voting Preferred Stock, when they have
the voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a
vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as
provided above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received
less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election
shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to
one vote per director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director
elected at any special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office
I-8

-- 282 of 356 --

until the next annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series N are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series N and any Voting Preferred Stock at the time outstanding and entitled to vote thereon,
voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting
called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series N with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series N. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series N, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series N, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series N remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series N immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series N or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series N with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series N.
I-9

-- 283 of 356 --

If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series N and one or more but not all other series of Preferred Stock, then only the
Series N and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series N, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series N, the Corporation may amend, alter, supplement or repeal any terms of the Series N:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series N that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series N shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series N shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series N (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series N is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series N and all Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series N are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series N may deem and treat the record holder of any share of Series N as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
I-10

-- 284 of 356 --

Section 9. 	Notices. All notices or communications in respect of Series N shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series N shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series N shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
I-11

-- 285 of 356 --

Appendix J
CERTIFICATE OF DESIGNATIONS
OF
5.30% FIXED-TO-FLOATING RATE NON-CUMULATIVE
PREFERRED STOCK, SERIES O
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, at a
meeting duly called and held on July 25, 2016, adopted the following resolution creating a series of 26,000 shares of Preferred
Stock of the Corporation designated as “5.30% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series O”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “5.30%
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series O” (“Series O”). Each share of Series O shall be identical in
all respects to every other share of Series O, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series O shall be 26,000. Shares of
Series O that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series O.

-- 286 of 356 --

Section 3. 	Definitions. As used herein with respect to Series O:
(a) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(b) 	“Board of Directors” means the board of directors of the Corporation.
(c) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(d) 	“Business Day” means (i) from the original issue date to and including November 10, 2026 (or, if
such day is not a Monday, Tuesday, Wednesday, Thursday or Friday or is a day on which banking institutions in
New York City are generally authorized or obligated by law or executive order to close, the next day that is a
Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City
are generally authorized or obligated by law or executive order to close), a day that is a Monday, Tuesday,
Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City are generally
authorized or obligated by law or executive order to close, and (ii) thereafter, a day that is a Monday, Tuesday,
Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City are generally
authorized or obligated by law or executive order to close and is a London Business Day.
(e) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series O is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(f) 	“Certificate of Designations” means this Certificate of Designations relating to the Series O, as it may
be amended from time to time.
(g) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(h) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(i) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series O) that ranks junior to Series O
J-2

-- 287 of 356 --

either or both as to the payment of dividends and/or as to the distribution of assets on any liquidation, dissolution or
winding up of the Corporation.
(j) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday that
is not a day on which banking institutions in London generally are authorized or obligated by law, regulation or
executive order to close and is a day on which dealings in U.S. dollars are transacted in the London interbank
market.
(k) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series O) that ranks
equally with Series O both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(l) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series O.
(m) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series O, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series O, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series O, there is more than
an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of
$25,000 per share of Series O then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital
adequacy guidelines of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital
adequacy guidelines or regulations of any successor Appropriate Federal Banking Agency) as then in effect and
applicable, for so long as any share of Series O is outstanding.
(n) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(o) 	“Reuters screen” means the display on the Reuters 3000 Xtra service, or any successor or
replacement service.
(p) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series O are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series O)
that rank equally with Series O either as to the payment of
J-3

-- 288 of 356 --

dividends or as to the distribution of assets upon liquidation, dissolution or winding up of the Corporation and upon
which like voting rights have been conferred and are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series O shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series O at the rate
determined as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series O.
Such dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the
Board of Directors or the Committee (or another duly authorized committee of the Board of Directors), on the 10th day of May
and November of each year, commencing on November 10, 2016 and ending on November 10, 2026, and on the 10th day of
February, May, August and November of each year following November 10, 2026 (“Dividend Payment Dates”); provided that
if any such Dividend Payment Date that occurs on or before November 10, 2026 is a day that is not a Business Day, such
dividend shall instead be payable on the immediately succeeding Business Day without interest or other payment in respect of
such delayed payment, and provided further, if any such Dividend Payment Date that would otherwise occur for any Dividend
Period after the Dividend Period ending on but excluding November 10, 2026 is a day that is not a Business Day, such
Dividend Payment Date shall instead be (and any such dividend shall accrue to and instead be payable on) the immediately
succeeding Business Day unless such immediately succeeding Business Day falls in the next calendar month, in which case
such Dividend Payment Date shall instead be (and any such dividend shall accrue to and instead be payable on) the
immediately preceding Business Day. Dividends on Series O shall not be cumulative; holders of Series O shall not be entitled
to receive any dividends not declared by the Board of Directors or the Committee (or another duly authorized committee of the
Board of Directors) and no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so
declared.
Dividends on the Series O shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy guidelines of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy guidelines or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series O on any Dividend Payment Date will be payable to holders of
record of Series O as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a
J-4

-- 289 of 356 --

“Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or not such
day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series O,
provided that, for any share of Series O issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series O in respect of any Dividend Period beginning prior to
November 10, 2026 shall be calculated on the basis of a 360-day year consisting of twelve 30-day months, and dividends
payable on the Series O in respect of any Dividend Period beginning on or after November 10, 2026 shall be calculated by the
Calculation Agent on the basis of a 360-day year and the actual number of days elapsed in such Dividend Period. Dividends
payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first Dividend Payment Date after such
Dividend Period.
The dividend rate on the Series O, for each Dividend Period beginning prior to November 10, 2026, shall
be a rate per annum equal to 5.30%, and the dividend rate on the Series O, for each Dividend Period beginning on or after
November 10, 2026, shall be a rate per annum equal to LIBOR (as defined below) for such Dividend Period plus 3.834%.
LIBOR, with respect to any Dividend Period beginning on or after November 10, 2026, means the offered rate expressed as a
percentage per annum for three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on
Reuters screen LIBOR01 (or any successor or replacement page) as of approximately 11:00 A.M., London time, on the second
London Business Day immediately preceding the first day of such Dividend Period.
If the rate described in the preceding paragraph does not appear on the Reuters screen LIBOR01 (or any
successor or replacement page), LIBOR shall be determined on the basis of the rates, at approximately 11:00 A.M., London
time, on the second London Business Day immediately preceding the first day of such Dividend Period, at which deposits of
the following kind are offered to prime banks in the London interbank market by four major banks in that market selected by
the Calculation Agent: three-month deposits in U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount. The Calculation Agent shall request the principal London office of each of these banks to provide a
quotation of its rate at approximately 11:00 A.M., London time. If at least two quotations are provided, LIBOR for such
Dividend Period shall be the arithmetic mean of such quotations.
If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks quoted, at
approximately 11:00 A.M., New York City time, on the second London Business Day immediately preceding the first day of
such Dividend Period, by major banks in New York City selected by the
J-5

-- 290 of 356 --

Calculation Agent: three-month loans of U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount.
If no quotation is provided as described in the preceding paragraph, then the Calculation Agent, after
consulting such sources as it deems comparable to any of the foregoing quotations or display page, or any such source as it
deems reasonable from which to estimate LIBOR or any of the foregoing lending rates, shall determine LIBOR for such
Dividend Period in its sole discretion.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series O shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series O as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series O remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series O have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman, Sachs & Co., or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series O and any shares of Parity Stock,
all dividends declared on the Series O and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series O and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment
J-6

-- 291 of 356 --

dates different from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to
such Dividend Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series O shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series O shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series O as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series O
and all holders of any stock of the Corporation ranking equally with the Series O as to such distribution, the amounts paid to
the holders of Series O and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series O and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series O and on which
dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not
declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series O,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series O receive cash, securities or other property for their shares, or the sale, lease or
J-7

-- 292 of 356 --

exchange (for cash, securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a
liquidation, dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series O is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series O at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after November 10, 2026 (or, if not a Business Day, the next succeeding
Business Day), or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event, in
each case, at a redemption price per share equal to $25,000, plus (except as otherwise provided herein below) an amount equal
to any dividends per share that have accrued but not been paid for the then-current Dividend Period to but excluding the
redemption date, whether or not such dividends have been declared. The redemption price for any shares of Series O shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series O without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital guidelines applicable to the Corporation.
(b) 	No Sinking Fund. The Series O will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series O will have no right to require redemption of any shares of Series O.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series O shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series O designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series O. Notwithstanding the foregoing, if the Series O or any
depositary shares representing interests in the Series O are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series O at such time and in any manner
permitted by such facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of
Series O to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4)
J-8

-- 293 of 356 --

the place or places where certificates for such shares are to be surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series O at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series O shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series O shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series O shall not have been declared and paid for any Dividend Periods that, in aggregate, equal at least 18 months,
whether or not consecutive (a “Nonpayment Event”), the number of directors then constituting the Board of Directors shall
automatically be increased by two and the holders of Series O, together with the holders of all outstanding shares of Voting
Preferred Stock, voting together as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock
Directors”), provided that the Board of Directors shall at no time include more than two Preferred Stock Directors (including,
for purposes of this limitation, all directors that the holders of any series of Voting Preferred Stock are entitled to elect
pursuant to like voting rights).
In the event that the holders of the Series O, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the
J-9

-- 294 of 356 --

holders of record of at least 20% of the Series O or of any other series of Voting Preferred Stock then outstanding (unless such
request for a special meeting is received less than 90 days before the date fixed for the next annual or special meeting of the
stockholders of the Corporation, in which event such election shall be held only at such next annual or special meeting of
stockholders), and at each subsequent annual meeting of stockholders of the Corporation. Such request to call a special
meeting for the initial election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice,
signed by the requisite holders of Series O or any series of Voting Preferred Stock, and delivered to the Secretary of the
Corporation in such manner as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series O for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series O to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting
rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series O and Voting Preferred
Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall
forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series O and Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of
a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may
be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of
the holders of record of a majority of all of the outstanding shares of the Series O and Voting Preferred Stock, when they have
the voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a
vacancy in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as
provided above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received
less than 90 days before the date fixed for the next annual or special meeting of the stockholders, in which event such election
shall be held at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to
one vote per director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director
elected at any special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until
the next annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series O are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series O and any Voting Preferred Stock at the time outstanding and entitled to
J-10

-- 295 of 356 --

vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at
any meeting called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series O with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series O. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series O, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series O, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series O remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series O immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series O or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series O with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series O.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series O and one or more but not all other series of Preferred Stock, then only the
Series O and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
J-11

-- 296 of 356 --

(d) 	Changes for Clarification. Without the consent of the holders of the Series O, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series O, the Corporation may amend, alter, supplement or repeal any terms of the Series O:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series O that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series O shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series O shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series O (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series O is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series O and all Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series O are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series O may deem and treat the record holder of any share of Series O as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series O shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
J-12

-- 297 of 356 --

Section 10. 	No Preemptive Rights. No share of Series O shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series O shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
J-13

-- 298 of 356 --

Appendix K
CERTIFICATE OF DESIGNATIONS
OF
5.00% FIXED-TO-FLOATING RATE NON-CUMULATIVE
PREFERRED STOCK, SERIES P
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, by
unanimous written consent dated October 26, 2017, adopted the following resolution creating a series of 66,000 shares of
Preferred Stock of the Corporation designated as “5.00% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series P”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “5.00%
Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series P” (“Series P”). Each share of Series P shall be identical in all
respects to every other share of Series P, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series P shall be 66,000. Shares of
Series P that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series P.

-- 299 of 356 --

Section 3. 	Definitions. As used herein with respect to Series P:
(a) 	“30/360 (ISDA) Day Count Convention” means the number of days in the Dividend Period in respect
of which payment is being made divided by 360, calculated on a formula basis as follows:
[360×(Y2–Y1)]+[30×(M2–M1)]+(D2–D1)
360
where:
“Y1” is the year, expressed as a number, in which the first day of the Dividend Period falls;
“Y2” is the year, expressed as a number, in which the day immediately following the last day included in
the Dividend Period falls;
“M1” is the calendar month, expressed as a number, in which the first day of the Dividend Period falls;
“M2” is the calendar month, expressed as a number, in which the day immediately following the last day
included in the Dividend Period falls;
“D1” is the first calendar day, expressed as a number, of the Dividend Period, unless such number would
be 31, in which case D1 will be 30; and
“D2” is the calendar day, expressed as a number, immediately following the last day included in the
Dividend Period, unless such number would be 31 and D1 is greater than 29, in which case D2 will be 30.
(b) 	“Actual/360 (ISDA) Day Count Convention” means the actual number of days in the Interest Period
divided by 360.
(c) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(d) 	“Board of Directors” means the board of directors of the Corporation.
(e) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(f) 	“Business Day” means (i) from the original issue date to and including November 10, 2022 (or, if
such day is not a Monday, Tuesday, Wednesday, Thursday or Friday or is a day on which banking institutions in
New York City are generally authorized or obligated by law or executive order to close, the next day that is a
Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York City
are generally authorized or obligated by law or executive order to close), a day that is a Monday, Tuesday,
Wednesday, Thursday or Friday and is not a day on which banking institutions in
K-2

-- 300 of 356 --

New York City are generally authorized or obligated by law or executive order to close, and (ii) thereafter, a day that
is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a day on which banking institutions in New York
City are generally authorized or obligated by law or executive order to close and is a London Business Day.
(g) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its best efforts to ensure
that there is, at all relevant times when the Series P is outstanding, a person or entity appointed and serving as such
agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(h) 	“Certificate of Designations” means this Certificate of Designations relating to the Series P, as it may
be amended from time to time.
(i) 	“Certification 	of 	Incorporation” 	shall 	mean 	the 	restated 	certificate 	of 	incorporation 	of 	the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(j) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(k) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series P) that ranks junior to Series P either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(l) 	“London Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday that
is not a day on which banking institutions in London generally are authorized or obligated by law, regulation or
executive order to close and is a day on which dealings in U.S. dollars are transacted in the London interbank
market.
(m) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series P) that ranks
equally with Series P both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(n) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series P.
(o) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the
K-3

-- 301 of 356 --

initial issuance of any share of Series P, (ii) any proposed change in those laws, rules or regulations that is
announced or becomes effective after the initial issuance of any share of Series P, or (iii) any official administrative
decision or judicial decision or administrative action or other official pronouncement interpreting or applying those
laws, rules or regulations or policies with respect thereto that is announced after the initial issuance of any share of
Series P, there is more than an insubstantial risk that the Corporation will not be entitled to treat the full liquidation
preference amount of $25,000 per share of Series P then outstanding as “tier 1 capital” (or its equivalent) for
purposes of the capital adequacy rules of the Board of Governors of the Federal Reserve System (or, as and if
applicable, the capital adequacy rules or regulations of any successor Appropriate Federal Banking Agency) as then
in effect and applicable, for so long as any share of Series P is outstanding.
(p) 	“Representative Amount” means, at any time, an amount that, in the Calculation Agent’s judgment,
is representative of a single transaction in the relevant market at the relevant time.
(q) 	“Reuters screen” means the display on the Thomson Reuters Eikon service, or any successor or
replacement service.
(r) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series P are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series P)
that rank equally with Series P either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series P shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series P at the rate determined
as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series P. Such
dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors), on the 10th day of May and
November of each year, commencing on May 10, 2018 and ending on November 10, 2022, and on the 10th day of February,
May, August and November of each year following November 10, 2022 (“Dividend Payment Dates”); provided that if any
such Dividend Payment Date that occurs on or before November 10, 2022 is a day that is not a Business Day, such dividend
shall instead be payable on the immediately succeeding Business Day without interest or other payment in respect of such
K-4

-- 302 of 356 --

delayed payment, and provided further, if any such Dividend Payment Date that would otherwise occur for any Dividend
Period after the Dividend Period ending on but excluding November 10, 2022 is a day that is not a Business Day, such
Dividend Payment Date shall instead be (and any such dividend shall accrue to and instead be payable on) the immediately
succeeding Business Day unless such immediately succeeding Business Day falls in the next calendar month, in which case
such Dividend Payment Date shall instead be (and any such dividend shall accrue to and instead be payable on) the
immediately preceding Business Day. Dividends on Series P shall not be cumulative; holders of Series P shall not be entitled
to receive any dividends not declared by the Board of Directors or the Committee (or another duly authorized committee of the
Board of Directors) and no interest, or sum of money in lieu of interest, shall be payable in respect of any dividend not so
declared.
Dividends on the Series P shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy rules of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy rules or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series P on any Dividend Payment Date will be payable to holders of record
of Series P as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee
(or another duly authorized committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such
Dividend Payment Date (each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend
Record Date whether or not such day is a Business Day.
Each dividend period (a “Dividend Period”) shall commence on and include a Dividend Payment Date
(other than the initial Dividend Period, which shall commence on and include the date of original issue of the Series P,
provided that, for any share of Series P issued after such original issue date, the initial Dividend Period for such shares may
commence on and include such other date as the Board of Directors or the Committee (or another duly authorized committee
of the Board of Directors) shall determine and publicly disclose) and shall end on and include the calendar day next preceding
the next Dividend Payment Date. Dividends payable on the Series P in respect of any Dividend Period beginning prior to
November 10, 2022 shall be calculated on the basis of the 30/360 (ISDA) Day Count Convention, and dividends payable on
the Series P in respect of any Dividend Period beginning on or after November 10, 2022 shall be calculated by the Calculation
Agent on the basis of the Actual/360 (ISDA) Day Count Convention. Dividends payable in respect of a Dividend Period shall
be payable in arrears – i.e., on the first Dividend Payment Date after such Dividend Period.
The dividend rate on the Series P, for each Dividend Period beginning prior to November 10, 2022, shall
be a rate per annum equal to 5.00%, and the dividend rate on the Series P, for each Dividend Period beginning on or after
November 10, 2022, shall be a
K-5

-- 303 of 356 --

rate per annum equal to LIBOR (as defined below) for such Dividend Period plus 2.874%. LIBOR, with respect to any
Dividend Period beginning on or after November 10, 2022, means the offered rate expressed as a percentage per annum for
three-month deposits in U.S. dollars on the first day of such Dividend Period, as that rate appears on Reuters screen LIBOR01
(or any successor or replacement page) as of approximately 11:00 A.M., London time, on the second London Business Day
immediately preceding the first day of such Dividend Period.
If the Calculation Agent determines on the relevant dividend determination date that the LIBOR base rate
described in the preceding paragraph has been discontinued, then the Calculation Agent will use a substitute or successor base
rate that it has determined in its sole discretion is most comparable to the LIBOR base rate, provided that if the Calculation
Agent determines there is an industry-accepted successor base rate, then the Calculation Agent shall use such successor base
rate. If the Calculation Agent has determined a substitute or successor base rate in accordance with the foregoing, the
Calculation Agent in its sole discretion may determine the business day convention, the definition of business day and the
dividend determination date to be used and any other relevant methodology for calculating such substitute or successor base
rate, including any adjustment factor needed to make such substitute or successor base rate comparable to the LIBOR base rate,
in a manner that is consistent with industry-accepted practices for such substitute or successor base rate. Unless the Calculation
Agent uses a substitute or successor base rate as so provided, the following will apply.
(i) 	If the LIBOR base rate described in the second preceding paragraph does not appear on the Reuters
screen LIBOR01 (or any successor or replacement page), LIBOR shall be determined on the basis of the rates, at
approximately 11:00 A.M., London time, on the second London Business Day immediately preceding the first day
of such Dividend Period, at which deposits of the following kind are offered to prime banks in the London interbank
market by four major banks in that market selected by the Calculation Agent: three-month deposits in U.S. dollars,
beginning on the first day of such Dividend Period, and in a Representative Amount. The Calculation Agent shall
request the principal London office of each of these banks to provide a quotation of its rate at approximately 11:00
A.M., London time. If at least two quotations are provided, LIBOR for such Dividend Period shall be the arithmetic
mean of such quotations.
(ii) 	If fewer than two quotations are provided as described in the preceding paragraph, LIBOR for such
Dividend Period shall be the arithmetic mean of the rates for loans of the following kind to leading European banks
quoted, at approximately 11:00 A.M., New York City time, on the second London Business Day immediately
preceding the first day of such Dividend Period, by major banks in New York City selected by the Calculation
Agent: three-month loans of U.S. dollars, beginning on the first day of such Dividend Period, and in a
Representative Amount.
K-6

-- 304 of 356 --

(iii) 	If no quotation is provided as described in the preceding paragraph, then the Calculation Agent, after
consulting such sources as it deems comparable to any of the foregoing quotations or display page, or any such
source as it deems reasonable from which to estimate LIBOR or any of the foregoing lending rates, shall determine
LIBOR for such Dividend Period in its sole discretion.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, will be maintained on file at the Corporation’s principal offices, will be made available to any
stockholder upon request and will be final and binding in the absence of manifest error.
Holders of Series P shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series P as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series P remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series P have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman Sachs & Co. LLC, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series P and any shares of Parity Stock,
all dividends declared on the Series P and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series P and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
K-7

-- 305 of 356 --

Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series P shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series P shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series P as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series P and
all holders of any stock of the Corporation ranking equally with the Series P as to such distribution, the amounts paid to the
holders of Series P and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series P and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any declared but unpaid dividends (and, in the case of any holder of stock other than Series P and on which dividends
accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as
applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series P,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series P receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of
K-8

-- 306 of 356 --

the Corporation, shall not constitute a liquidation, dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series P is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series P at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, from time to time, on any date on or after November 10, 2022 (or, if not a Business Day, the next succeeding
Business Day), or (ii) in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event, in
each case, at a redemption price per share equal to $25,000, plus (except as otherwise provided herein below) an amount equal
to any dividends per share that have accrued but not been paid for the then-current Dividend Period to but excluding the
redemption date, whether or not such dividends have been declared. The redemption price for any shares of Series P shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series P without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital rules applicable to the Corporation.
(b) 	No Sinking Fund. The Series P will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series P will have no right to require redemption of any shares of Series P.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series P shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 30 days and not more than 60 days before the date
fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have been duly
given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice
or in the mailing thereof, to any holder of shares of Series P designated for redemption shall not affect the validity of the
proceedings for the redemption of any other shares of Series P. Notwithstanding the foregoing, if the Series P or any depositary
shares representing interests in the Series P are issued in book-entry form through The Depository Trust Company or any other
similar facility, notice of redemption may be given to the holders of Series P at such time and in any manner permitted by such
facility. Each such notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series P to be
redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be redeemed
from such holder; (3) the redemption price; and (4)
K-9

-- 307 of 356 --

the place or places where certificates for such shares are to be surrendered for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series P at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series P shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series P shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series P shall not have been declared and paid for any Dividend Periods that, in aggregate, equal at least 18 months,
whether or not consecutive (a “Nonpayment Event”), the number of directors then constituting the Board of Directors shall
automatically be increased by two and the holders of Series P, together with the holders of all outstanding shares of Voting
Preferred Stock, voting together as a single class, shall be entitled to elect the two additional directors (the “Preferred Stock
Directors”), provided that the Board of Directors shall at no time include more than two Preferred Stock Directors (including,
for purposes of this limitation, all directors that the holders of any series of Voting Preferred Stock are entitled to elect
pursuant to like voting rights).
In the event that the holders of the Series P, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the
K-10

-- 308 of 356 --

holders of record of at least 20% of the Series P or of any other series of Voting Preferred Stock then outstanding (unless such
request for a special meeting is received less than 90 days before the date fixed for the next annual or special meeting of the
stockholders of the Corporation, in which event such election shall be held only at such next annual or special meeting of
stockholders), and at each subsequent annual meeting of stockholders of the Corporation. Such request to call a special
meeting for the initial election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice,
signed by the requisite holders of Series P or any series of Voting Preferred Stock, and delivered to the Secretary of the
Corporation in such manner as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series P for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series P to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting
rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series P and Voting Preferred
Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall
forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series P and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of all of the outstanding shares of the Series P and Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred Stock Director may be taken only at a special meeting of such stockholders, called as provided
above for an initial election of Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90
days before the date fixed for the next annual or special meeting of the stockholders, in which event such election shall be held
at such next annual or special meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per
director on any matter that shall come before the Board of Directors for a vote. Each Preferred Stock Director elected at any
special meeting of stockholders or by written consent of the other Preferred Stock Director shall hold office until the next
annual meeting of the stockholders if such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series P are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
66 2⁄3% of the shares of Series P and any Voting Preferred Stock at the time outstanding and entitled to
K-11

-- 309 of 356 --

vote thereon, voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at
any meeting called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series P with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series P. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series P, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series P, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series P remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series P immediately prior to such consummation, taken as a whole;
provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series P or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series P with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series P.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series P and one or more but not all other series of Preferred Stock, then only the
Series P and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
K-12

-- 310 of 356 --

(d) 	Changes for Clarification. Without the consent of the holders of the Series P, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series P, the Corporation may amend, alter, supplement or repeal any terms of the Series P:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series P that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series P shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series P shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series P (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series P is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series P and all Voting Preferred Stock has been cast or given
on any matter on which the holders of shares of Series P are entitled to vote shall be determined by the Corporation by
reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series P may deem and treat the record holder of any share of Series P as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series P shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
K-13

-- 311 of 356 --

Section 10. 	No Preemptive Rights. No share of Series P shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series P shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
K-14

-- 312 of 356 --

Appendix L
CERTIFICATE OF DESIGNATIONS
OF
5.50% FIXED-RATE RESET NON-CUMULATIVE PREFERRED
STOCK, SERIES Q
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, by
unanimous written consent dated June 13th , 2019, adopted the following resolution creating a series of 20,000 shares of
Preferred Stock of the Corporation designated as “5.50% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series Q”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “5.50%
Fixed-Rate Reset Non-Cumulative Preferred Stock, Series Q” (“Series Q”). Each share of Series Q shall be identical in all
respects to every other share of Series Q, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series Q shall be 20,000. Shares of
Series Q that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series Q.

-- 313 of 356 --

Section 3. 	Definitions. As used herein with respect to Series Q:
(a) 	“30/360 (ISDA) Day Count Convention” means the number of days in the Dividend Period in respect
of which payment is being made divided by 360, calculated on a formula basis as follows:
[360×(Y2–Y1)]+[30×(M2–M1)]+(D2–D1)
360
where:
“Y1” is the year, expressed as a number, in which the first day of the Dividend Period falls;
“Y2” is the year, expressed as a number, in which the day immediately following the last day included in
the Dividend Period falls;
“M1” is the calendar month, expressed as a number, in which the first day of the Dividend Period falls;
“M2” is the calendar month, expressed as a number, in which the day immediately following the last day
included in the Dividend Period falls;
“D1” is the first calendar day, expressed as a number, of the Dividend Period, unless such number would
be 31, in which case D1 will be 30; and
“D2” is the calendar day, expressed as a number, immediately following the last day included in the
Dividend Period, unless such number would be 31 and D1 is greater than 29, in which case D2 will be 30.
(b) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(c) 	“Board of Directors” means the board of directors of the Corporation.
(d) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended from
time to time.
(e) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City are generally authorized or obligated by law or executive order
to close, subject to any adjustments made by the Calculation Agent as provided for herein.
(f) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its
L-2

-- 314 of 356 --

best efforts to ensure that there is, at all relevant times when the Series Q is outstanding, a person or entity appointed
and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(g) 	“Certificate of Designations” means this Certificate of Designations relating to the Series Q, as it
may be amended from time to time.
(h) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(i) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(j) 	“Dividend Payment Date” means the 10th day of February and August of each year, commencing on
February 10, 2020.
(k) 	“Dividend Period” is the period from and including a Dividend Payment Date to but excluding the
next Dividend Payment Date, except that the initial dividend period will commence on and include the original issue
date of the Series Q and will end on and exclude the February 10, 2020 Dividend Payment Date.
(l) 	“Five-Year Treasury Rate” means:
● 	The average of the yields on actively traded U.S. treasury securities adjusted to constant maturity, for
five-year maturities, for the five Business Days appearing under the caption “Treasury Constant
Maturities” in the most recently published statistical release designated H.15 Daily Update or any
successor publication which is published by the Board of Governors of the Federal Reserve System,
as determined by the Calculation Agent in its sole discretion.
● 	If no calculation is provided as described above, then the Calculation Agent, after consulting such
sources as it deems comparable to any of the foregoing calculations, or any such source as it deems
reasonable from which to estimate the five-year treasury rate, shall determine the five-year treasury
rate in its sole discretion, provided that if the Calculation Agent determines there is an industry-
accepted successor five-year treasury rate, then the Calculation Agent shall use such successor rate. If
the Calculation Agent has determined a substitute or successor base rate in accordance with the
foregoing, the Calculation Agent in its sole discretion may determine the Business Day convention,
the definition of Business Day and the Reset Dividend Determination Dates to be used and any other
relevant methodology for calculating such substitute or successor base rate, including any adjustment
factor
L-3

-- 315 of 356 --

needed to make such substitute or successor base rate comparable to the Five-Year Treasury Rate, in
a manner that is consistent with industry-accepted practices for such substitute or successor base rate.
The Five-Year Treasury Rate will be determined by the Calculation Agent on the Reset Dividend
Determination Date.
(m) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series Q) that ranks junior to Series Q either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(n) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series Q) that ranks
equally with Series Q both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(o) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series Q.
(p) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series Q, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series Q, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series Q, there is more than
an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of
$25,000 per share of Series Q then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital
adequacy rules of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital
adequacy rules or regulations of any successor Appropriate Federal Banking Agency) as then in effect and
applicable, for so long as any share of Series Q is outstanding.
(q) 	“Reset Date” means August 10, 2024 and each date falling on the fifth anniversary of the preceding
Reset Date, in each case, regardless of whether such day is a Business Day.
(r) 	“Reset Dividend Determination Date” means, in respect of any Reset Period, the day falling three
Business Days prior to the beginning of such Reset Period, subject to any adjustments made by the Calculation
Agent as provided for herein.
L-4

-- 316 of 356 --

(s) 	“Reset Period” means the period from and including August 10, 2024 to, but excluding, the next
following Reset Date and thereafter each period from and including each Reset Date to, but excluding, the next
following Reset Date.
(t) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series Q are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series Q)
that rank equally with Series Q either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series Q shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series Q at the rate
determined as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series Q.
Such dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the
Board of Directors or the Committee (or another duly authorized committee of the Board of Directors), on each Dividend
Payment Date. Dividends will accrue (i) from the date of original issue to, but excluding, August 10, 2024 at a fixed rate per
annum of 5.50%, and (ii) from, and including August 10, 2024, during each Reset Period, at a rate per annum equal to the
Five-Year Treasury Rate as of the most recent Reset Dividend Determination Date plus 3.623%; provided that if any such
Dividend Payment Date is a day that is not a Business Day, such dividend shall instead be payable on the next succeeding
Business Day without interest or other payment in respect of such delayed payment. Dividends on Series Q shall not be
cumulative; holders of Series Q shall not be entitled to receive any dividends not declared by the Board of Directors or the
Committee (or another duly authorized committee of the Board of Directors) and no interest, or sum of money in lieu of
interest, shall be payable in respect of any dividend not so declared.
Dividends on the Series Q shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy rules of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy rules or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series Q on any Dividend Payment Date will be payable to holders of
record of Series Q as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such
L-5

-- 317 of 356 --

Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such Dividend Payment Date
(each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or
not such day is a Business Day.
Each Dividend Period shall commence on and include a Dividend Payment Date (other than the initial
Dividend Period, which shall commence on and include the date of original issue of the Series Q, provided that, for any share
of Series Q issued after such original issue date, the initial Dividend Period for such shares may commence on and include
such other date as the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors)
shall determine and publicly disclose) and shall end on and include the calendar day next preceding the next Dividend Payment
Date. Dividends payable on the Series Q in respect of any Dividend Period shall be calculated on the basis of the 30/360
(ISDA) Day Count Convention. Dividends payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first
Dividend Payment Date after such Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, and any other adjustments made by the Calculation Agent pursuant to the terms hereof will be
maintained on file at the Corporation’s offices, will be made available to any stockholder upon request and will be final and
binding in the absence of manifest error.
Holders of Series Q shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series Q as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series Q remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series Q have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman Sachs & Co. LLC, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
L-6

-- 318 of 356 --

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series Q and any shares of Parity Stock,
all dividends declared on the Series Q and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series Q and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series Q shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series Q shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series Q as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series Q
and all holders of any stock of the Corporation ranking equally with the Series Q as to such distribution, the amounts paid to
the holders of Series Q and to the holders of all such other stock shall be paid pro rata in accordance with the respective
aggregate Liquidation Preferences of the holders of Series Q and the holders of all such other stock. In any such distribution,
the “Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder
in such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an
amount equal to any
L-7

-- 319 of 356 --

declared but unpaid dividends (and, in the case of any holder of stock other than Series Q and on which dividends accrue on a
cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series Q,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series Q receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series Q is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series Q at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, on any Dividend Payment Date on or after August 10, 2024, or (ii) in whole but not in part at any time within
90 days following a Regulatory Capital Treatment Event, in each case, at a redemption price per share equal to $25,000, plus
(except as otherwise provided herein below) an amount equal to any declared and unpaid dividends per share to but excluding
the redemption date, without accumulation of undeclared dividends. The redemption price for any shares of Series Q shall be
payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such shares to the
Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent to the
Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on the
redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date relating
to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may not redeem
shares of Series Q without having received the prior approval of the Appropriate Federal Banking Agency if then required
under capital rules applicable to the Corporation.
(b) 	No Sinking Fund. The Series Q will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series Q will have no right to require redemption of any shares of Series Q.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series Q shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 15 days and not more than 60 days
L-8

-- 320 of 356 --

before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have
been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in
such notice or in the mailing thereof, to any holder of shares of Series Q designated for redemption shall not affect the validity
of the proceedings for the redemption of any other shares of Series Q. Notwithstanding the foregoing, if the Series Q or any
depositary shares representing interests in the Series Q are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series Q at such time and in any manner
permitted by such facility. Each notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series
Q to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where holders may surrender certificates
evidencing shares of Series Q Preferred Stock for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series Q at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series Q shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series Q shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series Q shall not have been declared and paid for
L-9

-- 321 of 356 --

any Dividend Periods that, in aggregate, equal at least 18 months, whether or not consecutive (a “Nonpayment Event”), the
number of directors then constituting the Board of Directors shall automatically be increased by two and the holders of Series
Q, together with the holders of all outstanding shares of Voting Preferred Stock, voting together as a single class, shall be
entitled to elect the two additional directors (the “Preferred Stock Directors”), provided that the Board of Directors shall at no
time include more than two Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of
any series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series Q, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series Q or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series Q or any series of Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner
as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series Q for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series Q to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting
rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series Q and Voting Preferred
Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall
forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series Q and Voting Preferred Stock, when they have the voting rights
described above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of
a Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may
be filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of
the holders of record of a majority of all of the outstanding shares of the Series Q and Voting Preferred Stock, when they have
the voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a
vacancy in the office of, a Preferred
L-10

-- 322 of 356 --

Stock Director may be taken only at a special meeting of such stockholders, called as provided above for an initial election of
Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90 days before the date fixed for
the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special
meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter that shall
come before the Board of Directors for a vote. Each Preferred Stock Director elected at any special meeting of stockholders or
by written consent of the other Preferred Stock Director shall hold office until the next annual meeting of the stockholders if
such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series Q are outstanding, in addition to any other
vote or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at
least 662⁄3 % of the shares of Series Q and any Voting Preferred Stock at the time outstanding and entitled to vote thereon,
voting together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting
called for the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series Q with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series Q. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series Q, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series Q, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series Q remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series Q immediately prior to such consummation, taken as a whole;
L-11

-- 323 of 356 --

provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series Q or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series Q with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series Q.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series Q and one or more but not all other series of Preferred Stock, then only the
Series Q and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series Q, so long as such
action does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof,
of the Series Q, the Corporation may amend, alter, supplement or repeal any terms of the Series Q:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series Q that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series Q shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series Q shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series Q (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series Q is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series Q and all Voting Preferred Stock has been
L-12

-- 324 of 356 --

cast or given on any matter on which the holders of shares of Series Q are entitled to vote shall be determined by the
Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series Q may deem and treat the record holder of any share of Series Q as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series Q shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series Q shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series Q shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
L-13

-- 325 of 356 --

Appendix M
CERTIFICATE OF DESIGNATIONS
OF
4.95% FIXED-RATE RESET NON-CUMULATIVE PREFERRED
STOCK, SERIES R
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, by
unanimous written consent dated November 14, 2019, adopted the following resolution creating a series of 24,000 shares of
Preferred Stock of the Corporation designated as “4.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series R”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “4.95%
Fixed-Rate Reset Non-Cumulative Preferred Stock, Series R” (“Series R”). Each share of Series R shall be identical in all
respects to every other share of Series R, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series R shall be 24,000. Shares of
Series R that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series R.

-- 326 of 356 --

Section 3. 	Definitions. As used herein with respect to Series R:
(a) 	“30/360 (ISDA) Day Count Convention” means the number of days in the Dividend Period in respect
of which payment is being made divided by 360, calculated on a formula basis as follows:
[360×(Y2–Y1)]+[30×(M2–M1)]+(D2–D1)
360
where:
“Y1” is the year, expressed as a number, in which the first day of the Dividend Period falls;
“Y2” is the year, expressed as a number, in which the day immediately following the last day included in
the Dividend Period falls;
“M1” is the calendar month, expressed as a number, in which the first day of the Dividend Period falls;
“M2” is the calendar month, expressed as a number, in which the day immediately following the last day
included in the Dividend Period falls;
“D1” is the first calendar day, expressed as a number, of the Dividend Period, unless such number would
be 31, in which case D1 will be 30; and
“D2” is the calendar day, expressed as a number, immediately following the last day included in the
Dividend Period, unless such number would be 31 and D1 is greater than 29, in which case D2 will be 30.
(b) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(c) 	“Board of Directors” means the board of directors of the Corporation.
(d) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City are generally authorized or obligated by law or executive order
to close, subject to any adjustments made by the Calculation Agent as provided for herein.
(e) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended
from time to time.
(f) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its
M-2

-- 327 of 356 --

best efforts to ensure that there is, at all relevant times when the Series R is outstanding, a person or entity appointed
and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(g) 	“Certificate of Designations” means this Certificate of Designations relating to the Series R, as it
may be amended from time to time.
(h) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(i) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(j) 	“Dividend Payment Date” means the 10th day of February and August of each year, commencing on
August 10, 2020.
(k) 	“Dividend Period” is the period from and including a Dividend Payment Date to but excluding the
next Dividend Payment Date, except that the initial dividend period will commence on and include the original issue
date of the Series R and will end on and exclude the August 10, 2020 Dividend Payment Date.
(l) 	“Five-Year Treasury Rate” means:
● 	The average of the yields on actively traded U.S. treasury securities adjusted to constant maturity, for
five-year maturities, for the five Business Days appearing under the caption “Treasury Constant
Maturities” in the most recently published statistical release designated H.15 Daily Update or any
successor publication which is published by the Board of Governors of the Federal Reserve System,
as determined by the Calculation Agent in its sole discretion.
● 	If no calculation is provided as described above, then the Calculation Agent, after consulting such
sources as it deems comparable to any of the foregoing calculations, or any such source as it deems
reasonable from which to estimate the five-year treasury rate, shall determine the five-year treasury
rate in its sole discretion, provided that if the Calculation Agent determines there is an industry-
accepted successor five-year treasury rate, then the Calculation Agent shall use such successor rate. If
the Calculation Agent has determined a substitute or successor base rate in accordance with the
foregoing, the Calculation Agent in its sole discretion may determine the Business Day convention,
the definition of Business Day and the Reset Dividend Determination Dates to be used and any other
relevant methodology for calculating such substitute or successor base rate, including any adjustment
factor needed to make such substitute or successor base rate comparable to the
M-3

-- 328 of 356 --

Five-Year Treasury Rate, in a manner that is consistent with industry-accepted practices for such
substitute or successor base rate.
The Five-Year Treasury Rate will be determined by the Calculation Agent on the Reset Dividend
Determination Date.
(m) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series R) that ranks junior to Series R either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(n) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series R) that ranks
equally with Series R both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(o) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series R.
(p) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series R, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series R, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series R, there is more than
an insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of
$25,000 per share of Series R then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital
adequacy rules of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital
adequacy rules or regulations of any successor Appropriate Federal Banking Agency) as then in effect and
applicable, for so long as any share of Series R is outstanding.
(q) 	“Reset Date” means February 10, 2025 and each date falling on the fifth anniversary of the preceding
Reset Date, in each case, regardless of whether such day is a Business Day.
(r) 	“Reset Dividend Determination Date” means, in respect of any Reset Period, the day falling three
Business Days prior to the beginning of such Reset Period, subject to any adjustments made by the Calculation
Agent as provided for herein.
M-4

-- 329 of 356 --

(s) 	“Reset Period” means the period from and including February 10, 2025 to, but excluding, the next
following Reset Date and thereafter each period from and including each Reset Date to, but excluding, the next
following Reset Date.
(t) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series R are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series R)
that rank equally with Series R either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series R shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series R at the rate determined
as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series R. Such
dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors), on each Dividend Payment Date.
Dividends will accrue (i) from the date of original issue to, but excluding, February 10, 2025 at a fixed rate per annum of
4.95%, and (ii) from, and including February 10, 2025, during each Reset Period, at a rate per annum equal to the Five-Year
Treasury Rate as of the most recent Reset Dividend Determination Date plus 3.224%; provided that if any such Dividend
Payment Date is a day that is not a Business Day, such dividend shall instead be payable on the next succeeding Business Day
without interest or other payment in respect of such delayed payment. Dividends on Series R shall not be cumulative; holders
of Series R shall not be entitled to receive any dividends not declared by the Board of Directors or the Committee (or another
duly authorized committee of the Board of Directors) and no interest, or sum of money in lieu of interest, shall be payable in
respect of any dividend not so declared.
Dividends on the Series R shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy rules of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy rules or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series R on any Dividend Payment Date will be payable to holders of record
of Series R as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such
M-5

-- 330 of 356 --

Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such Dividend Payment Date
(each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or
not such day is a Business Day.
Each Dividend Period shall commence on and include a Dividend Payment Date (other than the initial
Dividend Period, which shall commence on and include the date of original issue of the Series R, provided that, for any share
of Series R issued after such original issue date, the initial Dividend Period for such shares may commence on and include
such other date as the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors)
shall determine and publicly disclose) and shall end on and include the calendar day next preceding the next Dividend Payment
Date. Dividends payable on the Series R in respect of any Dividend Period shall be calculated on the basis of the 30/360
(ISDA) Day Count Convention. Dividends payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first
Dividend Payment Date after such Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, and any other adjustments made by the Calculation Agent pursuant to the terms hereof will be
maintained on file at the Corporation’s offices, will be made available to any stockholder upon request and will be final and
binding in the absence of manifest error.
Holders of Series R shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series R as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series R remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series R have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman Sachs & Co. LLC, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
M-6

-- 331 of 356 --

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series R and any shares of Parity Stock,
all dividends declared on the Series R and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series R and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series R shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series R shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series R as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series R and
all holders of any stock of the Corporation ranking equally with the Series R as to such distribution, the amounts paid to the
holders of Series R and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series R and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any
M-7

-- 332 of 356 --

declared but unpaid dividends (and, in the case of any holder of stock other than Series R and on which dividends accrue on a
cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series R,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series R receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series R is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series R at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, on any Dividend Payment Date on or after February 10, 2025, or (ii) in whole but not in part at any time
within 90 days following a Regulatory Capital Treatment Event, in each case, at a redemption price per share equal to $25,000,
plus (except as otherwise provided herein below) an amount equal to any declared and unpaid dividends per share to but
excluding the redemption date, without accumulation of undeclared dividends. The redemption price for any shares of Series R
shall be payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such
shares to the Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent
to the Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on
the redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date
relating to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may
not redeem shares of Series R without having received the prior approval of the Appropriate Federal Banking Agency if then
required under capital rules applicable to the Corporation.
(b) 	No Sinking Fund. The Series R will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series R will have no right to require redemption of any shares of Series R.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series R shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 15 days and not more than 60 days
M-8

-- 333 of 356 --

before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have
been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in
such notice or in the mailing thereof, to any holder of shares of Series R designated for redemption shall not affect the validity
of the proceedings for the redemption of any other shares of Series R. Notwithstanding the foregoing, if the Series R or any
depositary shares representing interests in the Series R are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series R at such time and in any manner
permitted by such facility. Each notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series
R to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where holders may surrender certificates
evidencing shares of Series R Preferred Stock for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series R at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series R shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series R shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series R shall not have been declared and paid for any
M-9

-- 334 of 356 --

Dividend Periods that, in aggregate, equal at least 18 months, whether or not consecutive (a “Nonpayment Event”), the number
of directors then constituting the Board of Directors shall automatically be increased by two and the holders of Series R,
together with the holders of all outstanding shares of Voting Preferred Stock, voting together as a single class, shall be entitled
to elect the two additional directors (the “Preferred Stock Directors”), provided that the Board of Directors shall at no time
include more than two Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of any
series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series R, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series R or of any other series of Voting Preferred Stock then outstanding (unless such request for a special
meeting is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the
Corporation, in which event such election shall be held only at such next annual or special meeting of stockholders), and at
each subsequent annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial
election of the Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite
holders of Series R or any series of Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner
as provided for in Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series R for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series R to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting
rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series R and Voting Preferred
Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall
forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series R and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of all of the outstanding shares of the Series R and Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred
M-10

-- 335 of 356 --

Stock Director may be taken only at a special meeting of such stockholders, called as provided above for an initial election of
Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90 days before the date fixed for
the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special
meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter that shall
come before the Board of Directors for a vote. Each Preferred Stock Director elected at any special meeting of stockholders or
by written consent of the other Preferred Stock Director shall hold office until the next annual meeting of the stockholders if
such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series R are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
662⁄3% of the shares of Series R and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series R with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series R. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series R, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series R, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series R remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series R immediately prior to such consummation, taken as a whole;
M-11

-- 336 of 356 --

provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series R or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series R with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series R.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series R and one or more but not all other series of Preferred Stock, then only the
Series R and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series R, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series R, the Corporation may amend, alter, supplement or repeal any terms of the Series R:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series R that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series R shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series R shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series R (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series R is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series R and all Voting Preferred Stock has been
M-12

-- 337 of 356 --

cast or given on any matter on which the holders of shares of Series R are entitled to vote shall be determined by the
Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series R may deem and treat the record holder of any share of Series R as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series R shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series R shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series R shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
M-13

-- 338 of 356 --

Appendix N
CERTIFICATE OF DESIGNATIONS
OF
4.40% FIXED-RATE RESET NON-CUMULATIVE PREFERRED
STOCK, SERIES S
OF
THE GOLDMAN SACHS GROUP, INC.
THE GOLDMAN SACHS GROUP, INC., a corporation organized and existing under the General
Corporation Law of the State of Delaware (the “Corporation”), in accordance with the provisions of Sections 103 and 151
thereof, DOES HEREBY CERTIFY :
The Securities Issuance Committee (the “Committee”) of the board of directors of the Corporation (the
“Board of Directors”), in accordance with the resolutions of the Board of Directors dated October 28, 2011, the provisions of
the restated certificate of incorporation and the amended and restated bylaws of the Corporation and applicable law, by
unanimous written consent dated January 27, 2020, adopted the following resolution creating a series of 14,000 shares of
Preferred Stock of the Corporation designated as “4.40% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series S”.
RESOLVED, that pursuant to the authority vested in the Committee and in accordance with the
resolutions of the Board of Directors dated October 28, 2011, the provisions of the restated certificate of incorporation and the
amended and restated bylaws of the Corporation and applicable law, a series of Preferred Stock, par value $.01 per share, of
the Corporation be and hereby is created, and that the designation and number of shares of such series, and the voting and other
powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions
thereof, of the shares of such series, are as follows:
Section 1. 	Designation. The distinctive serial designation of such series of Preferred Stock is “4.40%
Fixed-Rate Reset Non-Cumulative Preferred Stock, Series S” (“Series S”). Each share of Series S shall be identical in all
respects to every other share of Series S, except as to the respective dates from which dividends thereon shall accrue, to the
extent such dates may differ as permitted pursuant to Section 4(a) below.
Section 2. 	Number of Shares. The authorized number of shares of Series S shall be 14,000. Shares of
Series S that are redeemed, purchased or otherwise acquired by the Corporation shall be cancelled and shall revert to
authorized but unissued shares of Series S.

-- 339 of 356 --

Section 3. 	Definitions. As used herein with respect to Series S:
(a) 	“30/360 (ISDA) Day Count Convention” means the number of days in the Dividend Period in respect
of which payment is being made divided by 360, calculated on a formula basis as follows:
[360×(Y2–Y1)]+[30×(M2–M1)]+(D2–D1)
360
where:
“Y1” is the year, expressed as a number, in which the first day of the Dividend Period falls;
“Y2” is the year, expressed as a number, in which the day immediately following the last day included in
the Dividend Period falls;
“M1” is the calendar month, expressed as a number, in which the first day of the Dividend Period falls;
“M2” is the calendar month, expressed as a number, in which the day immediately following the last day
included in the Dividend Period falls;
“D1” is the first calendar day, expressed as a number, of the Dividend Period, unless such number would
be 31, in which case D1 will be 30; and
“D2” is the calendar day, expressed as a number, immediately following the last day included in the
Dividend Period, unless such number would be 31 and D1 is greater than 29, in which case D2 will be 30.
(b) 	“Appropriate Federal Banking Agency” means the “appropriate federal banking agency” with respect
to the Corporation as that term is defined in Section 3(q) of the Federal Deposit Insurance Act or any successor
provision.
(c) 	“Board of Directors” means the board of directors of the Corporation.
(d) 	“Business Day” means a day that is a Monday, Tuesday, Wednesday, Thursday or Friday and is not a
day on which banking institutions in New York City are generally authorized or obligated by law or executive order
to close, subject to any adjustments made by the Calculation Agent as provided for herein.
(e) 	“ByLaws” means the amended and restated bylaws of the Corporation, as they may be amended
from time to time.
(f) 	“Calculation Agent” means, at any time, the person or entity appointed by the Corporation and
serving as such agent at such time. The Corporation may terminate any such appointment and may appoint a
successor agent at any time and from time to time, provided that the Corporation shall use its
N-2

-- 340 of 356 --

best efforts to ensure that there is, at all relevant times when the Series S is outstanding, a person or entity appointed
and serving as such agent. The Calculation Agent may be a person or entity affiliated with the Corporation.
(g) 	“Certificate of Designations” means this Certificate of Designations relating to the Series S, as it may
be amended from time to time.
(h) 	“Certification of Incorporation” shall mean the restated certificate of incorporation of the
Corporation, as it may be amended from time to time, and shall include this Certificate of Designations.
(i) 	“Common Stock” means the common stock, par value $0.01 per share, of the Corporation.
(j) 	“Dividend Payment Date” means the 10th day of February and August of each year, commencing on
August 10, 2020.
(k) 	“Dividend Period” is the period from and including a Dividend Payment Date to but excluding the
next Dividend Payment Date, except that the initial dividend period will commence on and include the original issue
date of the Series S and will end on and exclude the August 10, 2020 Dividend Payment Date.
(l) 	“Five-Year Treasury Rate” means:
● 	The average of the yields on actively traded U.S. treasury securities adjusted to constant maturity, for
five-year maturities, for the five Business Days appearing under the caption “Treasury Constant
Maturities” in the most recently published statistical release designated H.15 Daily Update or any
successor publication which is published by the Board of Governors of the Federal Reserve System,
as determined by the Calculation Agent in its sole discretion.
● 	If no calculation is provided as described above, then the Calculation Agent, after consulting such
sources as it deems comparable to any of the foregoing calculations, or any such source as it deems
reasonable from which to estimate the five-year treasury rate, shall determine the five-year treasury
rate in its sole discretion, provided that if the Calculation Agent determines there is an industry-
accepted successor five-year treasury rate, then the Calculation Agent shall use such successor rate. If
the Calculation Agent has determined a substitute or successor base rate in accordance with the
foregoing, the Calculation Agent in its sole discretion may determine the Business Day convention,
the definition of Business Day and the Reset Dividend Determination Dates to be used and any other
relevant methodology for calculating such substitute or successor base rate, including any adjustment
factor needed to make such substitute or successor base rate comparable to the
N-3

-- 341 of 356 --

Five-Year Treasury Rate, in a manner that is consistent with industry-accepted practices for such
substitute or successor base rate.
The Five-Year Treasury Rate will be determined by the Calculation Agent on the Reset Dividend
Determination Date.
(m) 	“Junior Stock” means the Common Stock and any other class or series of stock of the Corporation
(other than Series S) that ranks junior to Series S either or both as to the payment of dividends and/or as to the
distribution of assets on any liquidation, dissolution or winding up of the Corporation.
(n) 	“Parity Stock” means any class or series of stock of the Corporation (other than Series S) that ranks
equally with Series S both in the payment of dividends and in the distribution of assets on any liquidation,
dissolution or winding up of the Corporation.
(o) 	“Preferred Stock” means any and all series of Preferred Stock, having a par value of $0.01 per share,
of the Corporation, including the Series S.
(p) 	“Regulatory Capital Treatment Event” means the good faith determination by the Corporation that,
as a result of (i) any amendment to, or change in, the laws, rules or regulations of the United States or any political
subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of
Series S, (ii) any proposed change in those laws, rules or regulations that is announced or becomes effective after the
initial issuance of any share of Series S, or (iii) any official administrative decision or judicial decision or
administrative action or other official pronouncement interpreting or applying those laws, rules or regulations or
policies with respect thereto that is announced after the initial issuance of any share of Series S, there is more than an
insubstantial risk that the Corporation will not be entitled to treat the full liquidation preference amount of $25,000
per share of Series S then outstanding as “tier 1 capital” (or its equivalent) for purposes of the capital adequacy rules
of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital adequacy rules or
regulations of any successor Appropriate Federal Banking Agency) as then in effect and applicable, for so long as
any share of Series S is outstanding.
(q) 	“Reset Date” means February 10, 2025 and each date falling on the fifth anniversary of the preceding
Reset Date, in each case, regardless of whether such day is a Business Day.
(r) 	“Reset Dividend Determination Date” means, in respect of any Reset Period, the day falling three
Business Days prior to the beginning of such Reset Period, subject to any adjustments made by the Calculation
Agent as provided for herein.
N-4

-- 342 of 356 --

(s) 	“Reset Period” means the period from and including February 10, 2025 to, but excluding, the next
following Reset Date and thereafter each period from and including each Reset Date to, but excluding, the next
following Reset Date.
(t) 	“Voting Preferred Stock” means, with regard to any election or removal of a Preferred Stock Director
(as defined in Section 7(b) below) or any other matter as to which the holders of Series S are entitled to vote as
specified in Section 7 of this Certificate of Designations, any and all series of Preferred Stock (other than Series S)
that rank equally with Series S either as to the payment of dividends or as to the distribution of assets upon
liquidation, dissolution or winding up of the Corporation and upon which like voting rights have been conferred and
are exercisable with respect to such matter.
Section 4. 	Dividends.
(a) 	Rate. Holders of Series S shall be entitled to receive, when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors) out of funds legally available for
the payment of dividends under Delaware law, non-cumulative cash dividends per each share of Series S at the rate determined
as set forth below in this Section (4) applied to the liquidation preference amount of $25,000 per share of Series S. Such
dividends shall be payable in arrears (as provided below in this Section 4(a)), but only when, as and if declared by the Board of
Directors or the Committee (or another duly authorized committee of the Board of Directors), on each Dividend Payment Date.
Dividends will accrue (i) from the date of original issue to, but excluding, February 10, 2025 at a fixed rate per annum of
4.40%, and (ii) from, and including February 10, 2025, during each Reset Period, at a rate per annum equal to the Five-Year
Treasury Rate as of the most recent Reset Dividend Determination Date plus 2.85%; provided that if any such Dividend
Payment Date is a day that is not a Business Day, such dividend shall instead be payable on the next succeeding Business Day
without interest or other payment in respect of such delayed payment. Dividends on Series S shall not be cumulative; holders
of Series S shall not be entitled to receive any dividends not declared by the Board of Directors or the Committee (or another
duly authorized committee of the Board of Directors) and no interest, or sum of money in lieu of interest, shall be payable in
respect of any dividend not so declared.
Dividends on the Series S shall not be declared or set aside for payment if and to the extent such dividends
would cause the Corporation to fail to comply with the capital adequacy rules of the Board of Governors of the Federal
Reserve System (or, as and if applicable, the capital adequacy rules or regulations of any successor Appropriate Federal
Banking Agency) applicable to the Corporation.
Dividends that are payable on Series S on any Dividend Payment Date will be payable to holders of record
of Series S as they appear on the stock register of the Corporation on the applicable record date, which shall be the 15th
calendar day before such
N-5

-- 343 of 356 --

Dividend Payment Date or such other record date fixed by the Board of Directors or the Committee (or another duly authorized
committee of the Board of Directors) that is not more than 60 nor less than 10 days prior to such Dividend Payment Date
(each, a “Dividend Record Date”). Any such day that is a Dividend Record Date shall be a Dividend Record Date whether or
not such day is a Business Day.
Each Dividend Period shall commence on and include a Dividend Payment Date (other than the initial
Dividend Period, which shall commence on and include the date of original issue of the Series S, provided that, for any share
of Series S issued after such original issue date, the initial Dividend Period for such shares may commence on and include such
other date as the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) shall
determine and publicly disclose) and shall end on and include the calendar day next preceding the next Dividend Payment
Date. Dividends payable on the Series S in respect of any Dividend Period shall be calculated on the basis of the 30/360
(ISDA) Day Count Convention. Dividends payable in respect of a Dividend Period shall be payable in arrears – i.e., on the first
Dividend Payment Date after such Dividend Period.
The Calculation Agent’s determination of any dividend rate, and its calculation of the amount of dividends
for any Dividend Period, and any other adjustments made by the Calculation Agent pursuant to the terms hereof will be
maintained on file at the Corporation’s offices, will be made available to any stockholder upon request and will be final and
binding in the absence of manifest error.
Holders of Series S shall not be entitled to any dividends, whether payable in cash, securities or other
property, other than dividends (if any) declared and payable on the Series S as specified in this Section 4 (subject to the other
provisions of this Certificate of Designations).
(b) 	Priority of Dividends. So long as any share of Series S remains outstanding, no dividend shall be
declared or paid on the Common Stock or any other shares of Junior Stock (other than a dividend payable solely in Junior
Stock), and no Common Stock or other Junior Stock shall be purchased, redeemed or otherwise acquired for consideration by
the Corporation, directly or indirectly (other than as a result of a reclassification of Junior Stock for or into other Junior Stock,
or the exchange or conversion of one share of Junior Stock for or into another share of Junior Stock and other than through the
use of the proceeds of a substantially contemporaneous sale of Junior Stock) during a Dividend Period, unless the full
dividends for the latest completed Dividend Period on all outstanding shares of Series S have been declared and paid (or
declared and a sum sufficient for the payment thereof has been set aside). The foregoing provision shall not restrict the ability
of Goldman Sachs & Co. LLC, or any other affiliate of the Corporation, to engage in any market-making transactions in Junior
Stock in the ordinary course of business.
N-6

-- 344 of 356 --

When dividends are not paid (or declared and a sum sufficient for payment thereof set aside) on any
Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different from the Dividend Payment
Dates, on a dividend payment date falling within a Dividend Period) in full upon the Series S and any shares of Parity Stock,
all dividends declared on the Series S and all such Parity Stock and payable on such Dividend Payment Date (or, in the case of
Parity Stock having dividend payment dates different from the Dividend Payment Dates, on a dividend payment date falling
within the Dividend Period related to such Dividend Payment Date) shall be declared pro rata so that the respective amounts
of such dividends shall bear the same ratio to each other as all accrued but unpaid dividends per share on the Series S and all
Parity Stock payable on such Dividend Payment Date (or, in the case of Parity Stock having dividend payment dates different
from the Dividend Payment Dates, on a dividend payment date falling within the Dividend Period related to such Dividend
Payment Date) bear to each other.
Subject to the foregoing, such dividends (payable in cash, securities or other property) as may be
determined by the Board of Directors or the Committee (or another duly authorized committee of the Board of Directors) may
be declared and paid on any securities, including Common Stock and other Junior Stock, from time to time out of any funds
legally available for such payment, and the Series S shall not be entitled to participate in any such dividends.
Section 5. 	Liquidation Rights.
(a) 	Voluntary or Involuntary Liquidation. In the event of any liquidation, dissolution or winding up of
the affairs of the Corporation, whether voluntary or involuntary, holders of Series S shall be entitled to receive, out of the
assets of the Corporation or proceeds thereof (whether capital or surplus) available for distribution to stockholders of the
Corporation, and after satisfaction of all liabilities and obligations to creditors of the Corporation, before any distribution of
such assets or proceeds is made to or set aside for the holders of Common Stock and any other stock of the Corporation
ranking junior to the Series S as to such distribution, in full an amount equal to $25,000 per share, together with an amount
equal to all dividends (if any) that have been declared but not paid prior to the date of payment of such distribution (but
without any amount in respect of dividends that have not been declared prior to such payment date).
(b) 	Partial Payment. If in any distribution described in Section 5(a) above the assets of the Corporation
or proceeds thereof are not sufficient to pay the Liquidation Preferences (as defined below) in full to all holders of Series S and
all holders of any stock of the Corporation ranking equally with the Series S as to such distribution, the amounts paid to the
holders of Series S and to the holders of all such other stock shall be paid pro rata in accordance with the respective aggregate
Liquidation Preferences of the holders of Series S and the holders of all such other stock. In any such distribution, the
“Liquidation Preference” of any holder of stock of the Corporation shall mean the amount otherwise payable to such holder in
such distribution (assuming no limitation on the assets of the Corporation available for such distribution), including an amount
equal to any
N-7

-- 345 of 356 --

declared but unpaid dividends (and, in the case of any holder of stock other than Series S and on which dividends accrue on a
cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not declared, as applicable).
(c) 	Residual Distributions. If the Liquidation Preference has been paid in full to all holders of Series S,
the holders of other stock of the Corporation shall be entitled to receive all remaining assets of the Corporation (or proceeds
thereof) according to their respective rights and preferences.
(d) 	Merger, Consolidation and Sale of Assets Not Liquidation. For purposes of this Section 5, the
merger or consolidation of the Corporation with any other corporation or other entity, including a merger or consolidation in
which the holders of Series S receive cash, securities or other property for their shares, or the sale, lease or exchange (for cash,
securities or other property) of all or substantially all of the assets of the Corporation, shall not constitute a liquidation,
dissolution or winding up of the Corporation.
Section 6. 	Redemption.
(a) 	Optional Redemption. The Series S is perpetual and has no maturity date. The Corporation may, at
its option, redeem the shares of Series S at the time outstanding, upon notice given as provided in Section 6(c) below, (i) in
whole or in part, on any Dividend Payment Date on or after February 10, 2025, or (ii) in whole but not in part at any time
within 90 days following a Regulatory Capital Treatment Event, in each case, at a redemption price per share equal to $25,000,
plus (except as otherwise provided herein below) an amount equal to any declared and unpaid dividends per share to but
excluding the redemption date, without accumulation of undeclared dividends. The redemption price for any shares of Series S
shall be payable on the redemption date to the holder of such shares against surrender of the certificate(s) evidencing such
shares to the Corporation or its agent. Any declared but unpaid dividends payable on a redemption date that occurs subsequent
to the Dividend Record Date for a Dividend Period shall not be paid to the holder entitled to receive the redemption price on
the redemption date, but rather shall be paid to the holder of record of the redeemed shares on such Dividend Record Date
relating to the Dividend Payment Date as provided in Section 4 above. Notwithstanding the foregoing, the Corporation may
not redeem shares of Series S without having received the prior approval of the Appropriate Federal Banking Agency if then
required under capital rules applicable to the Corporation.
(b) 	No Sinking Fund. The Series S will not be subject to any mandatory redemption, sinking fund or
other similar provisions. Holders of Series S will have no right to require redemption of any shares of Series S.
(c) 	Notice of Redemption. Notice of every redemption of shares of Series S shall be given by first class
mail, postage prepaid, addressed to the holders of record of the shares to be redeemed at their respective last addresses
appearing on the books of the Corporation. Such mailing shall be at least 15 days and not more than 60 days
N-8

-- 346 of 356 --

before the date fixed for redemption. Any notice mailed as provided in this Subsection shall be conclusively presumed to have
been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in
such notice or in the mailing thereof, to any holder of shares of Series S designated for redemption shall not affect the validity
of the proceedings for the redemption of any other shares of Series S. Notwithstanding the foregoing, if the Series S or any
depositary shares representing interests in the Series S are issued in book-entry form through The Depository Trust Company
or any other similar facility, notice of redemption may be given to the holders of Series S at such time and in any manner
permitted by such facility. Each notice given to a holder shall state: (1) the redemption date; (2) the number of shares of Series
S to be redeemed and, if less than all the shares held by such holder are to be redeemed, the number of such shares to be
redeemed from such holder; (3) the redemption price; and (4) the place or places where holders may surrender certificates
evidencing shares of Series S Preferred Stock for payment of the redemption price.
(d) 	Partial Redemption. In case of any redemption of only part of the shares of Series S at the time
outstanding, the shares to be redeemed shall be selected either pro rata or by lot. Subject to the provisions hereof, the
Corporation shall have full power and authority to prescribe the terms and conditions upon which shares of Series S shall be
redeemed from time to time. If fewer than all the shares represented by any certificate are redeemed, a new certificate shall be
issued representing the unredeemed shares without charge to the holder thereof.
(e) 	Effectiveness of Redemption. If notice of redemption has been duly given and if on or before the
redemption date specified in the notice all funds necessary for the redemption have been set aside by the Corporation, separate
and apart from its other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and
continue to be available therefor, then, notwithstanding that any certificate for any share so called for redemption has not been
surrendered for cancellation, on and after the redemption date dividends shall cease to accrue on all shares so called for
redemption, all shares so called for redemption shall no longer be deemed outstanding and all rights with respect to such shares
shall forthwith on such redemption date cease and terminate, except only the right of the holders thereof to receive the amount
payable on such redemption, without interest. Any funds unclaimed at the end of three years from the redemption date shall, to
the extent permitted by law, be released to the Corporation, after which time the holders of the shares so called for redemption
shall look only to the Corporation for payment of the redemption price of such shares.
Section 7. 	Voting Rights.
(a) 	General. The holders of Series S shall not have any voting rights except as set forth below or as
otherwise from time to time required by law.
(b) 	Right To Elect Two Directors Upon Nonpayment Events. If and whenever dividends on any
shares of Series S shall not have been declared and paid for any
N-9

-- 347 of 356 --

Dividend Periods that, in aggregate, equal at least 18 months, whether or not consecutive (a “Nonpayment Event”), the number
of directors then constituting the Board of Directors shall automatically be increased by two and the holders of Series S,
together with the holders of all outstanding shares of Voting Preferred Stock, voting together as a single class, shall be entitled
to elect the two additional directors (the “Preferred Stock Directors”), provided that the Board of Directors shall at no time
include more than two Preferred Stock Directors (including, for purposes of this limitation, all directors that the holders of any
series of Voting Preferred Stock are entitled to elect pursuant to like voting rights).
In the event that the holders of the Series S, and such other holders of Voting Preferred Stock, shall be
entitled to vote for the election of the Preferred Stock Directors following a Nonpayment Event, such directors shall be initially
elected following such Nonpayment Event only at a special meeting called at the request of the holders of record of at least
20% of the Series S or of any other series of Voting Preferred Stock then outstanding (unless such request for a special meeting
is received less than 90 days before the date fixed for the next annual or special meeting of the stockholders of the Corporation,
in which event such election shall be held only at such next annual or special meeting of stockholders), and at each subsequent
annual meeting of stockholders of the Corporation. Such request to call a special meeting for the initial election of the
Preferred Stock Directors after a Nonpayment Event shall be made by written notice, signed by the requisite holders of Series
S or any series of Voting Preferred Stock, and delivered to the Secretary of the Corporation in such manner as provided for in
Section 9 below, or as may otherwise be required by law.
When dividends have been paid (or declared and a sum sufficient for payment thereof set aside) in full on
the Series S for consecutive Dividend Periods that, in aggregate, equal at least one year after a Nonpayment Event, then the
right of the holders of Series S to elect the Preferred Stock Directors shall cease (but subject always to revesting of such voting
rights in the case of any future Nonpayment Event), and, if and when any rights of holders of Series S and Voting Preferred
Stock to elect the Preferred Stock Directors shall have ceased, the terms of office of all the Preferred Stock Directors shall
forthwith terminate and the number of directors constituting the Board of Directors shall automatically be reduced accordingly.
Any Preferred Stock Director may be removed at any time without cause by the holders of record of a
majority of all of the outstanding shares of the Series S and Voting Preferred Stock, when they have the voting rights described
above (voting together as a single class). So long as a Nonpayment Event shall continue, any vacancy in the office of a
Preferred Stock Director (other than prior to the initial election of Preferred Stock Directors after a Nonpayment Event) may be
filled by the written consent of the Preferred Stock Director remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of all of the outstanding shares of the Series S and Voting Preferred Stock, when they have the
voting rights described above (voting together as a single class). Any such vote of stockholders to remove, or to fill a vacancy
in the office of, a Preferred
N-10

-- 348 of 356 --

Stock Director may be taken only at a special meeting of such stockholders, called as provided above for an initial election of
Preferred Stock Director after a Nonpayment Event (unless such request is received less than 90 days before the date fixed for
the next annual or special meeting of the stockholders, in which event such election shall be held at such next annual or special
meeting of stockholders). The Preferred Stock Directors shall each be entitled to one vote per director on any matter that shall
come before the Board of Directors for a vote. Each Preferred Stock Director elected at any special meeting of stockholders or
by written consent of the other Preferred Stock Director shall hold office until the next annual meeting of the stockholders if
such office shall not have previously terminated as above provided.
(c) 	Other Voting Rights. So long as any shares of Series S are outstanding, in addition to any other vote
or consent of stockholders required by law or by the Certificate of Incorporation, the vote or consent of the holders of at least
66 2⁄3% of the shares of Series S and any Voting Preferred Stock at the time outstanding and entitled to vote thereon, voting
together as a single class, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be necessary for effecting or validating:
(i) 	Authorization of Senior Stock. Any amendment or alteration of the Certificate of Incorporation to
authorize or create, or increase the authorized amount of, any shares of any class or series of capital stock of the
Corporation ranking senior to the Series S with respect to either or both the payment of dividends and/or the
distribution of assets on any liquidation, dissolution or winding up of the Corporation;
(ii) 	Amendment of Series S. Any amendment, alteration or repeal of any provision of the Certificate of
Incorporation so as to materially and adversely affect the special rights, preferences, privileges or voting powers of
the Series S, taken as a whole; or
(iii) 	Share Exchanges, Reclassifications, Mergers and Consolidations. Any consummation of a
binding share exchange or reclassification involving the Series S, or of a merger or consolidation of the Corporation
with another corporation or other entity, unless in each case (x) the shares of Series S remain outstanding or, in the
case of any such merger or consolidation with respect to which the Corporation is not the surviving or resulting
entity, are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate
parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights,
preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not
materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and
limitations and restrictions thereof, of the Series S immediately prior to such consummation, taken as a whole;
N-11

-- 349 of 356 --

provided, however, that for all purposes of this Section 7(c), any increase in the amount of the authorized or issued Series S or
authorized Preferred Stock, or the creation and issuance, or an increase in the authorized or issued amount, of any other series
of Preferred Stock ranking equally with and/or junior to the Series S with respect to the payment of dividends (whether such
dividends are cumulative or non-cumulative) and/or the distribution of assets upon liquidation, dissolution or winding up of the
Corporation will not be deemed to adversely affect the rights, preferences, privileges or voting powers of the Series S.
If any amendment, alteration, repeal, share exchange, reclassification, merger or consolidation specified in
this Section 7(c) would adversely affect the Series S and one or more but not all other series of Preferred Stock, then only the
Series S and such series of Preferred Stock as are adversely affected by and entitled to vote on the matter shall vote on the
matter together as a single class (in lieu of all other series of Preferred Stock).
(d) 	Changes for Clarification. Without the consent of the holders of the Series S, so long as such action
does not adversely affect the rights, preferences, privileges and voting powers, and limitations and restrictions thereof, of the
Series S, the Corporation may amend, alter, supplement or repeal any terms of the Series S:
(i) to cure any ambiguity, or to cure, correct or supplement any provision contained in this Certificate of
Designations that may be defective or inconsistent; or
(ii) to make any provision with respect to matters or questions arising with respect to the Series S that is
not inconsistent with the provisions of this Certificate of Designations.
(e) 	Changes after Provision for Redemption. No vote or consent of the holders of Series S shall be
required pursuant to Section 7(b), (c) or (d) above if, at or prior to the time when any such vote or consent would otherwise be
required pursuant to such Section, all outstanding shares of Series S shall have been redeemed, or shall have been called for
redemption upon proper notice and sufficient funds shall have been set aside for such redemption, in each case pursuant to
Section 6 above.
(f) 	Procedures for Voting and Consents. The rules and procedures for calling and conducting any
meeting of the holders of Series S (including, without limitation, the fixing of a record date in connection therewith), the
solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard
to such a meeting or such consents shall be governed by any rules the Board of Directors or the Committee (or another duly
authorized committee of the Board of Directors), in its discretion, may adopt from time to time, which rules and procedures
shall conform to the requirements of the Certificate of Incorporation, the ByLaws, applicable law and any national securities
exchange or other trading facility on which the Series S is listed or traded at the time. Whether the vote or consent of the
holders of a plurality, majority or other portion of the shares of Series S and all Voting Preferred Stock has been
N-12

-- 350 of 356 --

cast or given on any matter on which the holders of shares of Series S are entitled to vote shall be determined by the
Corporation by reference to the specified liquidation amounts of the shares voted or covered by the consent.
Section 8. 	Record Holders. To the fullest extent permitted by applicable law, the Corporation and the
transfer agent for the Series S may deem and treat the record holder of any share of Series S as the true and lawful owner
thereof for all purposes, and neither the Corporation nor such transfer agent shall be affected by any notice to the contrary.
Section 9. 	Notices. All notices or communications in respect of Series S shall be sufficiently given if
given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be
permitted in this Certificate of Designations, in the Certificate of Incorporation or ByLaws or by applicable law.
Section 10. 	No Preemptive Rights. No share of Series S shall have any rights of preemption
whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto,
regardless of how such securities, or such warrants, rights or options, may be designated, issued or granted.
Section 11. 	Other Rights. The shares of Series S shall not have any voting powers, preferences or
relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set
forth herein or in the Certificate of Incorporation or as provided by applicable law.
N-13

-- 351 of 356 --

EXHIBIT 15.1
April 30, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: 	The Goldman Sachs Group, Inc.
Registration Statements on Form S-8
(No. 333-80839)
(No. 333-42068)
(No. 333-106430)
(No. 333-120802)
(No. 333-235973)
Registration Statements on Form S-3
(No. 333-219206)
Commissioners:
We are aware that our report dated April 30, 2020 on our review of the consolidated balance sheet of The Goldman Sachs
Group, Inc. and its subsidiaries (the Company) as of March 31, 2020, and the related consolidated statements of earnings,
comprehensive income, changes in shareholders’ equity and cash flows for the three months ended March 31, 2020 and 2019
included in the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2020 is incorporated by reference
in the registration statements referred to above. Pursuant to Rule 436(c) under the Securities Act of 1933 (the Act), such
report should not be considered a part of such registration statements, and is not a report within the meaning of Sections 7
and 11 of the Act.
Very truly yours,
/s/ PricewaterhouseCoopers LLP

-- 352 of 356 --

EXHIBIT 31.1
CERTIFICATIONS
I, David M. Solomon, certify that:
1. 	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 of The Goldman Sachs
Group, Inc.;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant’s internal control over financial reporting.
Date: April 30, 2020 	/s/ 	David M. Solomon
Name: 	David M. Solomon
Title: 	Chief Executive Officer

-- 353 of 356 --

CERTIFICATIONS
I, Stephen M. Scherr, certify that:
1. 	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 of The Goldman Sachs
Group, Inc.;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;
c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and
d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant’s internal control over financial reporting.
Date: April 30, 2020
/s/ 	Stephen M. Scherr
Name: 	Stephen M. Scherr
Title: 	Chief Financial Officer

-- 354 of 356 --

EXHIBIT 32.1
Certification
Pursuant to 18 U.S.C. § 1350, the undersigned officer of The Goldman Sachs Group, Inc. (the “Company”) hereby certifies
that the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 (the “Report”) fully complies
with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.
Dated: April 30, 2020 	/s/ 	David M. Solomon
Name: 	David M. Solomon
Title: 	Chief Executive Officer
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report
or as a separate disclosure document.

-- 355 of 356 --

Certification
Pursuant to 18 U.S.C. § 1350, the undersigned officer of The Goldman Sachs Group, Inc. (the “Company”) hereby certifies
that the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 (the “Report”) fully complies
with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.
Dated: April 30, 2020
/s/ 	Stephen M. Scherr
Name: 	Stephen M. Scherr
Title: 	Chief Financial Officer
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report
or as a separate disclosure document.

-- 356 of 356 --